CHIMERIC GENES AND METHODS FOR INCREASING THE LYSINE CONTENT OF THE SEEDS OF PLANTS

Abstract: Chimeric genes are disclosed. One chimeric gene encodes a plant lysine ketoglutarate reductase and a second chimeric gene encodes lysine-insensitive dihydrodipicolinic acid synthase (DHDPS) which is operably linked to a plant chloroplast transit sequence, all operably linked to plant seed-specific regulatory sequences. Methods for their use to produce increased levels of lysine in the seeds of transformed plants are provided.

Description: TITLE CHIMERIC GENES AND METHODS FOR INCREASING THE LYSINE CONTENT OF THE SEEDS OF PLANTS CROSS-REFERENCE TO RELATED APPLICATIONS This is a continuation-in-part of Serial No.08/824,627, filed on March 27, 1997, pending, which is a continuation-in-part of Serial No. 08/474,633, filed on June 7, 1995, pending, which is a continuation-in-part of Serial No. 08/178,212, filed on January 6, 1994 which was the national filing of PCT/US93/02480, now abandoned, filed on March 18, 1993 and which is a continuation-in-part of Serial No. 07/855,414, filed on March 19, 1992, now abandoned. FIELD OF THE INVENTION This invention relates to chimeric genes and methods for increasing the lysine content of the seeds of plants and, in particular, to two chimeric genes, a first encoding plant lysine ketoglutarate reductase (LKR) and a second encoding lysine-insensitive dihydrodipicolinic acid synthase (DHDPS) which is operably linked to a plant chloroplast transit sequence, all operably linked to plant seed- specific regulatory sequences. BACKGROUND OF THE INVENTION Many vertebrates, including man, lack the ability to manufacture a number of amino acids and, therefore, require these amino acids preformed in the diet. These are called essential amino acids. Human food and animal feed derived from many grains are deficient in some of the ten essential amino acids. In corn (Zea mays L.), lysine is the most limiting amino acid for the dietary requirements of many animals. Soybean (Glycine max L.) meal is used as an additive to corn based animal feeds primarily as a lysine supplement. Thus, an increase in the lysine content of either corn or soybean would reduce or eliminate the need to supplement mixed grain feeds with lysine produced via fermentation of microbes. Plant breeders have long been interested in using naturally occurring variations to improve protein quality and quantity in crop plants. Maize lines containing higher than normal levels of lysine (70%) have been identified [Mertz et al. (1964) Science 145:219, Mertz et al. (1965) Science 750:1469-70]. However, these lines which incorporate a mutant gene, opaque-2, exhibit poor agronomic qualities (increased susceptibility to disease and pests, 8-14% reduction in yield, low kernel weight, slower drying, lower dry milling yield of flaking grits, and increased storage problems) and thus are not commercially useful [Deutscher (1978) Adv. Exp. Medicine and Biology 705:281-300]. Quality Protein Maize (QPM) bred at CIMMYT using the opaque-2 and sugary-2 genes and associated modifiers has a hard endosperm and enriched levels of lysine and tryptophan in the kernels [Vasal, S. K., et al. Proceedings of the 3rd seed protein symposium, Gatersleben, August 31 - September 2, 1983]. However, the gene pools represented in the QPM lines are tropical and subtropical. Quality Protein Maize is a genetically complex trait and the existing lines are not easily adapted to the dent germplasm in use in the United States, preventing the adoption of QPM by corn breeders. The amino acid content of seeds is determined primarily (90-99%) by the amino acid composition of the proteins in the seed and to a lesser extent (1-10%) by the free amino acid pools. The quantity of total protein in seeds varies from about 10% of the dry weight in cereals to 20-40% of the dry weight of legumes. Much of the protein-bound amino acids is contained in the seed storage proteins which are synthesized during seed development and which serve as a major nutrient reserve following germination. In many seeds the storage proteins account for 50% or more of the total protein. To improve the amino acid composition of seeds genetic engineering technology is being used to isolate, and express genes for storage proteins in transgenic plants. For example, a gene from Brazil nut for a seed 2S albumin composed of 26% sulfur-containing amino acids has been isolated [Altenbach et al. (1987) Plant Mol. Biol. 5:239-250] and expressed in the seeds of transformed tobacco under the control of the regulatory sequences from a bean phaseolin storage protein gene. The accumulation of the sulfur-rich protein in the tobacco seeds resulted in an up to 30% increase in the level of methionine in the seeds [Altenbach et al. (1989) Plant Mol. Biol. 75:513-522]. However, no plant seed storage proteins similarly enriched in lysine relative to average lysine content of plant proteins have been identified to date, preventing this approach from being used to increase lysine. An alternative approach is to increase the production and accumulation of specific free amino acids such as lysine via genetic engineering technology. However, little guidance is available on the control of the biosynthesis and metabolism of lysine in the seeds of plants. Lysine, along with threonine, methionine and isoleucine, are amino acids derived from aspartate, and regulation of the biosynthesis of each member of this family is interconnected. Regulation of the metabolic flow in the pathway appears to be primarily via end products. The first step in the pathway is the phosphorylation of aspartate by the enzyme aspartokinase (AK), and this enzyme has been found to be an important target for regulation in many organisms. However, detailed physiological studies on the flux of 4-carbon molecules through the aspartate pathway have been carried out in the model plant system Lemna paucicostata [Giovanelli et al. (1989) Plant Physiol. 90:1584-1599]. It was stated in this reference that "These data now provide definitive evidence that the step catalyzed by aspartokinase is not normally an important site for regulation of the entry of 4-carbon units into the aspartate family of amino acids [in plants]." The aspartate family pathway is also believed to be regulated at the branchpoint reactions. For lysine this is the condensation of aspartyl β-semialdehyde with pyruvate catalyzed by dihydrodipicolinic acid synthase (DHDPS), while for threonine and methionine the reduction of aspartyl β-semialdehyde by homoserine dehydrogenase (HDH) followed by the phosphorylation of homoserine by homoserine kinase (HK) are important points of control. The E. coli dapA gene encodes a DHDPS enzyme that is about 20-fold less sensitive to inhibition by lysine than a typical plant DHDPS enzyme, e.g., wheat germ DHDPS. The E. coli dapA gene has been linked to the 35S promoter of Cauliflower Mosaic Virus and a plant chloroplast transit sequence. The chimeric gene was introduced into tobacco cells via transformation and shown to cause a substantial increase in free lysine levels in leaves [Glassman et al. (1989) PCT Patent Appl. PCT/US89/01309, Shaul et al. (1992) Plant Jour. 2:203-209, Galili et al. (1992) ΕPO Patent Appl. 91119328.2]. However, the lysine content of the seeds was not increased in any of the transformed plants described in these studies. The same chimeric gene was also introduced into potato cells and lead to small increases in free lysine in leaves, roots and tubers of regenerated plants [Galili et al. (1992) ΕPO Patent Appl. 91119328.2, Perl et al. (1992) Plant Mol. Biol. 79:815-823]. These workers have also reported on the introduction of an E. coli lysC gene that encodes a lysine-insensitive AK enzyme into tobacco cells via transformation [Galili et al. (1992) Εur. Patent Appl. 91119328.2; Shaul et al. (1992) Plant Physiol. 100:1157-1163]. Expression of the E. coli enzyme results in increases in the levels of free threonine in the leaves and seeds of transformed plants. Crosses of plants expressing E. coli DHDPS and AK resulted in progeny that accumulated more free lysine in leaves than the parental DHDPS plant, but less free threonine in leaves than the parental AK plant. No evidence for increased levels of free lysine in seeds was presented. The limited understanding of the details of the regulation of the biosynthetic pathway in plants makes the application of genetic engineering technology, particularly to seeds, uncertain. There is little information available on the source of the aspartate-derived amino acids in seeds. It is not known, for example, whether they are synthesized in seeds, or transported to the seeds from leaves, or both, from most plants. In addition, free amino acids make up only a small fraction of the total amino acid content of seeds. Therefore, over-accumulation of free amino acids must be many-fold in order to significantly affect the total amino acid composition of the seeds. Furthermore, little is known about catabolism of free amino acids in seeds. Catabolism of free lysine has been observed in developing endosperm of corn and barley. The first step in the catabolism of lysine is believed to be catalyzed by lysine-ketoglutarate reductase (LKR) [Brochetto-Braga et al. (1992) Plant Physiol. 98ύ 139-1147]. This protein is actually a bifunctional enzyme that is also responsible for catalysis of the presumed second reaction in the catabolism of lysine, saccharopine dehydrogenase (SDH) [Goncalves-Butruille et al. (1996) Plant Physiol. 110:765- 771]. There are only a few reports of the isolation of genomic or cDNA clones encoding various portions of LKR/SDH proteins from plants. GenBank accession ATU9579 presents the sequence of a full-length cDNA clone for the bifunctional enzyme from Arabidopsis thaliana. The protein encoded by this clone is a homologue of both LKR and SDH proteins from fungal organisms. The DNA sequence for the genomic clone from Arabidopsis is also available as GenBank accession U95758 (Tang, et al. (1997) Plant Cell 9:1305-1316 and Epelbaum, et al. (1997) Plant Mol. Biol. 35: 735-748). GenBank accession AF003551 discloses a cDNA from corn which would direct the synthesis of a polypeptide from within the SDH domain of LKR/SDH proteins. GenBank accession AF042184 discloses the sequence of a cDNA from Brassica napus that is homologous to a relatively short portion of the full length clone from Arabidodpsis. However, whether such catabolic pathways are widespread in plants and whether they affect the level of accumulation of free amino acids is unknown. Finally, the effects of over- accumulation of a free amino acid such as lysine or threonine on seed development and viability is not known. Heretofore, no method to increase the level of lysine in seeds via genetic engineering was known. Thus, there is a need for genes, chimeric genes, and methods for expressing them in seeds so that an over-accumulation of lysine in seeds will result in an improvement in nutritional quality. SUMMARY OF THE INVENTION This invention concerns an isolated nucleic acid fragment comprising a nucleic acid sequence encoding all or part of lysine ketoglutarate reductase. In another embodiment this invention concerns a chimeric gene comprising the aforesaid nucleic acid fragment encoding all or part of lysine ketoglutarate reductase, or a subfragment thereof, operably linked to suitable seed-specific regulatory sequences wherein said chimeric gene reduces lysine ketoglutarate reductase activity in seeds of transformed plants, as well as a plant cell or plant seed transformed with the aforesaid chimeric gene.. In a third embodiment this invention concerns a plant cell wherein lysine ketoglutarate reductase activity is reduced due to a mutation in a gene encoding lysine ketoglutarate reductase. In a fourth embodiment this invention concerns a plant seed wherein lysine ketoglutarate reductase activity is reduced due to a mutation in a gene encoding lysine ketoglutarate reductase. In a fifth embodiment this invention concerns a method for reducing lysine ketoglutarate reductase activity in a plant seed which comprises: (a) transforming plant cells with the chimeric gene comprising the aforesaid nucleic acid fragment encoding all or part of lysine ketoglutarate reductase or a subfragment thereof, operably linked to suitable seed-specific regulatory sequences wherein said chimeric gene reduces lysine ketoglutarate reductase activity in seeds of transformed plants; (b) regenerating fertile mature plants from the transformed plant cells obtained from step (a) under conditions suitable to obtain seeds; (c) screening progeny seed of step (b) for reduced lysine ketoglutarate reductase activity; and (d) selecting those lines whose seeds contain for reduced lysine ketoglutarate reductase activity. In a sixth embodiment this invention concerns a nucleic acid fragment comprising (a) a first chimeric gene comprising the aforesaid nucleic acid fragment encoding all or part of lysine ketoglutarate or a subfragment thereof, operably linked to suitable seed-specific regulatory sequences wherein said chimeric gene reduces lysine ketoglutarate reductase activity in seeds of transformed plants and (b) a second chimeric gene wherein a nucleic acid fragment encoding dihydrodipicolinic acid synthase which is insensitive to inhibition by lysine is operably linked to a plant chloroplast transit sequence and to a plant seed-specific regulatory sequence. A seventh embodiment of this invention concerns a plant and a seed comprising in its genome the aforesaid nucleic acid fragments or the first and second aforesaid chimeric genes. BRIEF DESCRIPTION OF THE DRAWINGS AND SEQUENCE DESCRIPTIONS The invention can be more fully understood from the following detailed description and the accompanying drawings and the sequence descriptions which form a part of this application. Figure 1 shows an alpha helix from the side and top views. Figure 2 shows end (Figure 2a) and side (Figure 2b) views of an alpha helical coiled-coil structure. Figure 3 shows the chemical structure of leucine and methionine emphasizing their similar shapes. Figure 4a shows a schematic representation of a leaf gene expression cassette; Figure 4b shows a schematic representation of a seed-specific gene expression cassette. Figure 5 shows a map of the binary plasmid vector pZS97K. Figure 6 shows a map of the binary plasmid vector pZS97. Figure 7A shows a map of the binary plasmid vector pZS199; Figure 7B shows a map of the binary plasmid vector pFS926; Figure 7C shows a map of the binary plasmid vector pBT593; Figure 7D shows a map of the binary plasmid vector pBT597. Figure 8 A shows a map of the plasmid vector pBT603; Figure 8B shows a map of the plasmid vector pBT614. Figure 9 shows the amino acid sequence similarity between the polypeptides encoded by two plant cDNAs and fungal SDH (glutamate-forming). Figure 10 depicts the strategy for creating a vector (pSK5) for use in construction and expression of the SSP gene sequences. Figure 11 shows the strategy for inserting oligonucleotide sequences into the unique Ear I site of the base gene sequence. Figure 12 shows the insertion of the base gene oligonucleotides into the Nco I/EcoR I sites of pSK5 to create the plasmid pSK6. This base gene sequence was used as in Figure 8 to insert the various SSP coding regions at the unique Ear I site to create the cloned segments listed. Figure 13 shows the insertion of the 63 bp "segment" oligonucleotides used to create non-repetitive gene sequences for use in the duplication scheme in Figure 12. Figure 14 (A and B) shows the strategy for multiplying non-repetitive gene "segments" utilizing in-frame fusions. Figure 15 shows the vectors containing seed specific promoter and 3' sequence cassettes. SSP sequences were inserted into these vectors using the Nco I and Asp718 sites. Figure 16 shows a map of the plasmid vector pML63. Figure 17 shows a map of the plasmid vector pBT680. Figure 18 shows a map of the plasmid vector pBT681. Figure 19 shows a map of the plasmid vector pLH104. Figure 20 shows a map of the plasmid vector pLH105. Figure 21 shows a map of the plasmid vector pBT739. Figure 22 shows a map of the plasmid vector pBT756. SEQ ID NO:l shows the nucleotide and amino acid sequence of the coding region of the wild type E. coli lysC gene, which encodes AKIII, described in Example 1. SEQ ID NOS:2 and 3 were used in Example 2 to create an Nco I site at the translation start codon of the E. coli lysC gene. SEQ ID NOS:4 and 5 were used in Example 3 as PCR primers for the isolation of the Corynebacterium dapA gene. SEQ ID NO:6 shows the nucleotide and amino acid sequence of the coding region of the wild type Corynebacterium dapA gene, which encodes lysine- insensitive DHDPS, described in Example 3. SEQ ID NO: 7 was used in Example 4 to create an Nco I site at the translation start codon of the E. coli dapA gene. SEQ ID NOS: 8, 9, 10 and 11 were used in Example 6 to create a chloroplast transit sequence and link the sequence to the E. coli lysC, E. coli lysC-M4. E. coli dapA and Corynebacteria dapA genes. SEQ ID NOS: 12 and 13 were used in Example 6 to create a Kpn I site immediately following the translation stop codon of the E. coli dapA gene. SEQ ID NOS: 14 and 15 were used in Example 6 as PCR primers to create a chloroplast transit sequence and link the sequence to the Corynebacterium dapA gene. SEQ ID NOS: 16-92 represent nucleic acid fragments and the polypeptides they encode that are used to create chimeric genes for lysine-rich synthetic seed storage proteins suitable for expression in the seeds of plants. SEQ ID NO:93 was used in Example 6 as a constitutive expression cassette for corn. SEQ ID NOS:94-99 were used in Example 6 to create a corn chloroplast transit sequence and link the sequence to the E. coli lysC-M4 gene. SEQ ID NOS: 100 and 101 were used in Example 6 as PCR primers to create a corn chloroplast transit sequence and link the sequence to the E. coli dapA gene. SEQ ID NOS: 102 and 103 are cDNAs for plant lysine ketoglutarate reductase/saccharopine dehydrogenase from Arabidopsis thaliana. SEQ ID NOS:104 and 105 are polypeptides homologous to fungal saccharopine dehydrogenase (glutamate-forming) encoded by SEQ ID NOS: 102 and 103, respectively. SEQ ID NOS: 106 and 107 were used in Example 25 as PCR primers to add Nco I and Kpn I sites at the 5' and 3' ends of the corn DHDPS gene. SEQ ID NOS: 108 and 109 were used for PCR amplification of a 2.24 kb DNA fragment from genomic Arabidopsis DNA. SEQ ID NO:l 10 shows the sequence of the Arabidopsis LKR/SDH genomic DNA fragment. SEQ ID NO: 111 shows the sequence of the Arabidopsis LKR SDH cDNA. SEQ ID NO:l 12 shows the deduced amino acid sequence of Arabidopsis LKR/SDH protein. SEQ ID NOS: 113 and 114 were used for PCR amplification of soybean and corn LKR/SDH cDNA fragment. SEQ ID NO:l 15 shows the sequence of a soybean LKR/SDH cDNA fragment. SEQ ID NO: 116 shows the sequence of a corn LKR/SDH cDNA fragment. SEQ ID NO:l 17 shows the deduced partial amino acid sequence of soybean LKR/SDH protein. SEQ ID NO:l 18 shows the deduced partial amino acid sequence of corn LRK/SDH protein. SEQ ID NO:l 19 shows the sequence of a 2582 nucleotide cDNA from soybean. SEQ ID NO: 120 shows the sequence of a 3265 nucleotide cDNA from corn. SEQ ID NO: 121 shows the deduced partial amino acid sequence of soybean LKR/SDH protein encoded by nucleotides 3 through 2357 of SEQ ID NO:l 19. SEQ ID NO: 122 shows the deduced partial amino acid sequence of soybean LKR SDH protein encoded by nucleotides 3 through 3071 of SEQ ID NO: 120. SEQ ID NO: 123 is a nucleotide sequence corresponding to nucleotides 1 through 1908 of SED ID NO: 120. SEQ ID NO:124 is the deduced amino acid sequence from SEQ ID NO:123. SEQ ID NO: 125 shows the sequence of a 720 nucleotide LKR/SDH cDNA from rice. SEQ ID NO: 126 shows the deduced partial amino acid sequence of rice LKR/SDH protein encoded by nucleotides 2 through 720 of SEQ ID NO:125. SEQ ID NO:127 shows the sequence of a 308 nucleotide LKR/SDH cDNA from rice. SEQ ID NO: 128 shows the deduced partial amino acid sequence of rice LKR/SDH protein encoded by nucleotides 1 through 129 of SEQ ID NO: 127. SEQ ID NO: 129 shows the sequence of a 429 nucleotide cDNA from wheat. SEQ ID NO: 130 shows the deduced partial amino acid sequence of wheat LKR/SDH protein encoded by nucleotides 1 through 252 of SEQ ID NO: 129. SEQ ID NO: 131 shows the SDH coding region of the Arabidopsis cDNA clone. SEQ ID NO: 132 shows the amino acid sequence of the SDH domain of the Arabidopsis LKR/SDH protein. The Sequence Descriptions contain the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUB standards described in Nucleic Acids Research 13:3021-3030(1985) and in the Biochemical Journal 219 (No. 2):345-373(1984) which are incorporated by reference herein. DETAILED DESCRIPTION OF THE INVENTION Nucleic acid fragments and procedures are described which are useful for increasing the accumulation of lysine in the seeds of transformed plants, as compared to levels of lysine in untransformed plants. In order to increase the accumulation of free lysine in the seeds of plants via genetic engineering, a determination was made of which enzymes in this pathway controlled the pathway in the seeds of plants. In order to accomplish this, genes encoding enzymes in the pathway were isolated from bacteria. In some cases, mutations in the genes were obtained so that the enzyme encoded was made insensitive to end-product inhibition. Intracellular localization sequences and suitable regulatory sequences for expression in the seeds of plants were linked to create chimeric genes. The chimeric genes were then introduced into plants via transformation and assessed for their ability to elicit accumulation of the lysine in seeds. A unique first nucleic acid fragment is provided which comprises two nucleic acid subfragments (subsequences), one encoding LKR and the other encoding DHDPS which is substantially insensitive to feedback inhibition by lysine. For the purposes of the present application, the term substantially insensitive will mean at least 20-fold less sensitive to feedback inhibition by lysine than a typical plant enzyme catalyzing the same reaction. It has been found that a combination of subfragments successfully increases the lysine accumulated in seeds of transformed plants as compared to untransformed host plants. It also has been discovered that the full potential for accumulation of excess free lysine in seeds is reduced by lysine catabolism. Furthermore, it has been discovered that lysine catabolism results in the accumulation of lysine breakdown products such as saccharopine and α-amino adipic acid. Provided herein are two alternative routes to reduce the loss of excess lysine due to catabolism and to reduce the accumulation of lysine breakdown products. In the first approach, lysine catabolism is prevented through reduction in the activity of the enzyme lysine ketoglutarate reductase (LKR), which catalyzes the first step in lysine breakdown. This can be accomplished by introducing a mutation that reduces or eliminates enzyme function in the plant gene that encodes LKR. Such mutations can be identified in lysine over-producer lines by screening mutants for a failure to accumulate the lysine breakdown products, saccharopine and α-amino adipic acid. Alternatively, several procedures to isolate plant LKR genes are provided; nucleic acid fragments containing plant LKR cDNAs are also provided. Chimeric genes for expression of antisense LKR RNA or for cosuppression of LKR in the seeds of plants can then be created. The chimeric LKR gene is linked to the chimeric genes encoding lysine insensitive DHDPS and both are introduced into plants via transformation simultaneously, or the chimeric genes are brought together by crossing plants transformed independently with each of the chimeric genes. In the second approach, excess free lysine is incorporated into a form that is insensitive to breakdown, e.g., by incorporating it into a di-, tri- or oligopeptide, or preferably a lysine-rich storage protein. The lysine-rich storage protein chosen should contain higher levels of lysine than average proteins. Ideally, these storage proteins should contain at least 15% lysine by weight. The design of a preferred class of polypeptides which can be expressed in vivo to serve as lysine-rich seed storage proteins is provided. Genes encoding the lysine-rich synthetic storage proteins (SSP) are synthesized and chimeric genes wherein the SSP genes are linked to suitable regulatory sequences for expression in the seeds of plants are created. The SSP chimeric gene is then linked to the chimeric DHDPS gene and both are introduced into plants via transformation simultaneously, or the genes are brought together by crossing plants transformed independently with each of the chimeric genes. A method for transforming plants is taught herein wherein the resulting seeds of the plants have at least ten percent, preferably ten percent to four-fold greater, lysine than do the seeds of untransformed plants. Provided as examples herein are transformed rapeseed plants with seed lysine levels increased by 100% over untransformed plants and soybean plants with seed lysine levels increased by four-fold over lysine levels of untransformed plants, and corn plants with seed lysine levels increased by 130%. In the context of this disclosure, a number of terms shall be utilized. As used herein, the term "nucleic acid" refers to a large molecule which can be single-stranded or double-stranded, composed of monomers (nucleotides) containing a sugar, phosphate and either a purine or pyrimidine. A "nucleic acid fragment" is a fraction of a given nucleic acid molecule. In higher plants, deoxyribonucleic acid (DNA) is the genetic material while ribonucleic acid (RNA) is involved in the transfer of the information in DNA into proteins. A "genome" is the entire body of genetic material contained in each cell of an organism. The term "nucleotide sequence" refers to a polymer of DNA or RNA which can be single- or double-stranded, optionally containing synthetic, non- natural or altered nucleotide bases capable of incorporation into DNA or RNA polymers. As used herein, the term "homologous to" refers to the complementarity between the nucleotide sequence of two nucleic acid molecules or between the amino acid sequences of two protein molecules. Quantitative estimates of homology are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art [as described in Hames and Higgins (eds.) Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.]; or by the comparison of sequence similarity between two nucleic acids or proteins. As used herein, "essentially similar" refers to DNA sequences that may involve base changes that do not cause a change in the encoded amino acid, or which involve base changes which may alter one or more amino acids, but do not affect the functional properties of the protein encoded by the DNA sequence. It is therefore understood that the invention encompasses more than the specific exemplary sequences. Modifications to the sequence, such as deletions, insertions, or substitutions in the sequence which produce silent changes that do not substantially affect the functional properties of the resulting protein molecule are also contemplated. For example, alteration in the gene sequence which reflect the degeneracy of the genetic code, or which result in the production of a chemically equivalent amino acid at a given site, are contemplated; thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a biologically equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the protein molecule would also not be expected to alter the activity of the protein. In some cases, it may in fact be desirable to make mutants of the sequence in order to study the effect of alteration on the biological activity of the protein. Each of the proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity of the encoded products. Moreover, the skilled artisan recognizes that "essentially similar" sequences encompassed by this invention are also defined by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65°C), with the sequences exemplified herein. "Gene" refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding) and following (3' non- coding) the coding region. "Native" gene refers to the gene as found in nature with its own regulatory sequences. "Chimeric" gene refers to a gene comprising heterogeneous regulatory and coding sequences. "Endogenous" gene refers to the native gene normally found in its natural location in the genome. A "foreign" gene refers to a gene not normally found in the host organism but that is introduced by gene transfer. "Coding sequence" refers to a DNA sequence that codes for a specific protein and excludes the non-coding sequences. "Initiation codon" and "termination codon" refer to a unit of three adjacent nucleotides in a coding sequence that specifies initiation and chain termination, respectively, of protein synthesis (mRNA translation). "Open reading frame" refers to the amino acid sequence encoded between translation initiation and termination codons of a coding sequence. "RNA transcript" refers to the product resulting from RNA polymerase- catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript. "Messenger RNA (mRNA) refers to RNA that can be translated into protein by the cell. "cDNA" refers to a double-stranded DNA that is complementary to and derived from mRNA. "Sense" RNA refers to RNA transcript that includes the mRNA. "Antisense RNA" refers to a RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene by interfering with the processing, transport and or translation of its primary transcript or mRNA. The complementarity of an antisense RNA may be with any part of the specific gene transcript, i.e., at the 5' non-coding sequence, 3' non-coding sequence, introns, or the coding sequence. In addition, as used herein, antisense RNA may contain regions of ribozyme sequences that increase the efficacy of antisense RNA to block gene expression. "Ribozyme" refers to a catalytic RNA and includes sequence-specific endoribonucleases. As used herein, suitable "regulatory sequences" refer to nucleotide sequences located upstream (5 1 ), within, and/or downstream (3') to a coding sequence, which control the transcription and/or expression of the coding sequences, potentially in conjunction with the protein biosynthetic apparatus of the cell. These regulatory sequences include promoters, translation leader sequences, transcription termination sequences, and polyadenylation sequences. "Promoter" refers to a DNA sequence in a gene, usually upstream (5') to its coding sequence, which controls the expression of the coding sequence by providing the recognition for RNA polymerase and other factors required for proper transcription. A promoter may also contain DNA sequences that are involved in the binding of protein factors which control the effectiveness of transcription initiation in response to physiological or developmental conditions. It may also contain enhancer elements. An "enhancer" is a DNA sequence which can stimulate promoter activity. It may be an innate element of the promoter or a heterologous element inserted to enhance the level and/or tissue-specificity of a promoter. "Constitutive promoters" refers to those that direct gene expression in all tissues and at all times. "Organ-specific" or "development-specific" promoters as referred to herein are those that direct gene expression almost exclusively in specific organs, such as leaves or seeds, or at specific development stages in an organ, such as in early or late embryogenesis, respectively. The term "operably linked" refers to nucleic acid sequences on a single nucleic acid molecule which are associated so that the function of one is affected by the other. For example, a promoter is operably linked with a structure gene (i.e., a gene encoding aspartokinase that is lysine-insensitive as given herein) when it is capable of affecting the expression of that structural gene (i.e., that the structural gene is under the transcriptional control of the promoter). The term "expression", as used herein, is intended to mean the production of the protein product encoded by a gene. More particularly, "expression" refers to the transcription and stable accumulation of the sense (mRNA) or antisense RNA derived from the nucleic acid fragment(s) of the invention that, in conjunction with the protein apparatus of the cell, results in altered levels of protein product. "Antisense inhibition" refers to the production of antisense RNA transcripts capable of preventing the expression of the target protein. "Overexpression" refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms. "Cosuppression" refers to the expression of a foreign gene which has substantial homology to an endogenous gene resulting in the suppression of expression of both the foreign and the endogenous gene. "Altered levels" refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms. The "3' non-coding sequences" refers to the DNA sequence portion of a gene that contains a polyadenylation signal and any other regulatory signal capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3' end of the mRNA precursor. The "translation leader sequence" refers to that DNA sequence portion of a gene between the promoter and coding sequence that is transcribed into RNA and is present in the fully processed mRNA upstream (5') of the translation start codon. The translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. "Mature" protein refers to a post-translationally processed polypeptide without its targeting signal. "Precursor" protein refers to the primary product of translation of mRNA. A "chloroplast targeting signal" is an amino acid sequence which is translated in conjunction with a protein and directs it to the chloroplast. "Chloroplast transit sequence" refers to a nucleotide sequence that encodes a chloroplast targeting signal. "Transformation" herein refers to the transfer of a foreign gene into the genome of a host organism and its genetically stable inheritance. Examples of methods of plant transformation include Agrobacterium-mediated transformation and particle-accelerated or "gene gun" transformation technology. "Amino acids" herein refer to the naturally occurring L amino acids (Alanine, Arginine, Aspartic acid, Asparagine, Cystine, Glutamic acid, Glutamine, Glycine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Proline, Phenylalanine, Serine, Threonine, Tryptophan, Tyrosine, and Valine). "Essential amino acids" are those amino acids which cannot be synthesized by animals. A "polypeptide" or "protein" as used herein refers to a molecule composed of monomers (amino acids) linearly linked by amide bonds (also known as peptide bonds). "Synthetic protein" herein refers to a protein consisting of amino acid sequences that are not known to occur in nature. The amino acid sequence may be derived from a consensus of naturally occurring proteins or may be entirely novel. "Primary sequence" refers to the connectivity order of amino acids in a polypeptide chain without regard to the conformation of the molecule. Primary sequences are written from the amino terminus to the carboxy terminus of the polypeptide chain by convention. "Secondary structure" herein refers to physico-chemically favored regular backbone arrangements of a polypeptide chain without regard to variations in side chain identities or conformations. "Alpha helices" as used herein refer to right- handed helices with approximately 3.6 residues per turn of the helix. An "amphipathic helix" refers herein to a polypeptide in a helical conformation where one side of the helix is predominantly hydrophobic and the other side is predominantly hydrophilic. "Coiled-coil" herein refers to an aggregate of two parallel right-handed alpha helices which are wound around each other to form a left-handed superhelix. "Salt bridges" as discussed here refer to acid-base pairs of charged amino acid side chains so arranged in space that an attractive electrostatic interaction is maintained between two parts of a polypeptide chain or between one chain and another. "Host cell" means the cell that is transformed with the introduced genetic material. Isolation of AK Genes The E. coli lysC gene has been cloned, restriction endonuclease mapped and sequenced previously [Cassan et al. (1986) J. Biol. Chem. 251:1052-1057]. For the present invention the lysC gene was obtained on a bacteriophage lambda clone from an ordered library of 3400 overlapping segments of cloned E. coli DNA constructed by Kohara, Akiyama and Isono [Kohara et al. (1987) Cell 50:595-508]. The E. coli lysC gene encodes the enzyme AKIII, which is sensitive to lysine inhibition. Mutations were obtained in the lysC gene that cause the AKIII enzyme to be resistant to lysine. To determine the molecular basis for lysine-resistance, the sequence of the wild type lysC gene and three mutant genes were determined. The sequence of the cloned wild type lysC gene, indicated in SΕQ ID NO: 1 :, differed from the published lysC sequence in the coding region at 5 positions. The sequences of the three mutant IvsC genes that encoded lysine- insensitive aspartokinase each differed from the wild type sequence by a single nucleotide, resulting in a single amino acid substitution in the protein. One mutant (M2) had an A substituted for a G at nucleotide 954 of SΕQ ID NO:l : resulting in an isoleucine for methionine substitution in the amino acid sequence of AKIII and two mutants (M3 and M4) had identical T for C substitutions at nucleotide 1055 of SEQ ID NO:l resulting in an isoleucine for threonine substitution. Other mutations could be generated, either in vivo as described in Example 1 or in vitro by site-directed mutagenesis by methods known to those skilled in the art, that result in amino acid substitutions for the methionine or threonine residue present in the wild type AKIII at these positions. Such mutations would be expected to result in a lysine-insensitive enzyme. Furthermore, the method described in Example 1 could be used to easily isolate and characterize as many additional mutant lysC genes encoding lysine insensitive AKIII as desired. A number of other AK genes have been isolated and sequenced. These include the thrA gene of E. coli (Katinka et al. (1980) Proc. Natl. Acad. Sci. USA 77:5730-5733], the metL gene of E. coli (Zakin et al. (1983) J Biol. Chem. 255:3028-3031], the HOM3 gene of S. cerevisiae [Rafalski et al. (1988) J. Biol. Chem. 255:2146-2151]. The thrA gene of E. coli encodes a bifunctional protein, AKI-HDHI. The AK activity of this enzyme is insensitive to lysine, but sensitive to threonine. The metL gene of E. coli also encodes a bifunctional protein, AKII-HDHII, and the AK activity of this enzyme is also insensitive to lysine. The HOM3 gene of yeast encodes an AK which is insensitive to lysine, but sensitive to threonine. In addition to these genes, several plant genes encoding lysine-insensitive AK are known. In barley lysine plus threonine-resistant mutants bearing mutations in two unlinked genes that result in two different lysine-insensitive AK isoenzymes have been described [Bright et al. (1982) Nature 299:278-279, Rognes et al. (1983) Planta 757:32-38, Arruda et al. (1984) Plant Physiol 76:442-446]. In corn, a lysine plus threonine-resistant cell line had AK activity that was less sensitive to lysine inhibition than its parent line [Hibberd et al. (1980) Planta 745:183-187]. A subsequently isolated lysine plus threonine- resistant corn mutant is altered at a different genetic locus and also produces lysine-insensitive AK [Diedrick et al. (1990) Theor. Appl. Genet. 79:209-215, Dotson et al. (1990) Planta 752:546-552]. In tobacco there are two AK enzymes in leaves, one lysine-sensitive and one threonine-sensitive. A lysine plus threonine-resistant tobacco mutant that expressed completely lysine-insensitive AK has been described [Frankard et al. (1991) Theor. Appl. Genet. 52:273-282]. These plant mutants could serve as sources of genes encoding lysine-insensitive AK and used, based on the teachings herein, to increase the accumulation of lysine and threonine in the seeds of transformed plants. A partial amino acid sequence of AK from carrot has been reported [Wilson et al. (1991) Plant Physiol: 97:1323:1328]. Using this information a set of degenerate DNA oligonucleotides could be designed, synthesized and used as hybridization probes to permit the isolation of the carrot AK gene. Recently the carrot AK gene has been isolated and its nucleotide sequence has been determined [Matthews et al. (1991) U.S.S.N. 07/746,705]. This gene can be used as a heterologous hybridization probe to isolate the genes encoding lysine-insensitive AK described above. High level expression of wild type and mutant lysC genes in E. coli To achieve high level expression of the IvsC genes in E. coli, a bacterial expression vector which employs the bacteriophage T7 RNA polymerase/T7 promoter system [Rosenberg et al. (1987) Gene 56:125-135] was used. The expression vector and IvsC gene were modified as described in Example 2 to construct a IvsC expression vector. For expression of the mutant lysC genes (M2, M3 and M4), the wild type lysC gene was replaced with the mutant genes as described in Example 2. For high level expression, each of the expression vectors was transformed into E. coli strain B121(DE3) [Studier et al. (1986) J. Mol. Biol. 759:113-130]. Cultures were grown, expression was induced, cells were collected, and extracts were prepared as described in Example 2. Supernatant and pellet fractions of extracts from uninduced and induced cultures were analyzed by SDS polyacrylamide gel electrophoresis and by AK enzyme assays as described in Example 2. The major protein visible by Coomassie blue staining in the supernatant and pellet fractions of induced cultures was AKIII. About 80% of the AKIII protein was in the supernatant and AKIII represented 10-20% of the total E. coli protein in the extract. Approximately 80% of the AKIII enzyme activity was in the supernatant fraction. The specific activity of wild type and mutant crude extracts was 5-7 μmoles product per minute per milligram total protein. Wild type AKIII was sensitive to the presence of L-lysine in the assay. Fifty percent inhibition was found at a concentration of about 0.4 mM and 90 percent inhibition at about 0.1 mM. In contrast, mutants AKIII-M2, M3 and M4 were not inhibited at all by 15 mM L-lysine. Wild type AKIII protein was purified from the supernatant of an induced culture as described in Example 2. Rabbit antibodies were raised against the purified AKIII protein. Many other microbial expression vectors have been described in the literature. One skilled in the art could make use of any of these to construct lysC expression vectors. These lysC expression vectors could then be introduced into appropriate microorganisms via transformation to provide a system for high level expression of AKIII. Isolation of DHDPS genes The E. coli dapA gene (ecodapAI has been cloned, restriction endonuclease mapped and sequenced previously [Richaud et al. (1986) J. Bacteriol. 766:297-300]. For the present invention the dapA gene was obtained on a bacteriophage lambda clone from an ordered library of 3400 overlapping segments of cloned E. coli. DNA constructed by Kohara, Akiyama and Isono [Kohara et al. (1987) Cell 50:595-508]. The ecodapA gene encodes a DHDPS enzyme that is sensitive to lysine inhibition. However, it is about 20-fold less sensitive to inhibition by lysine than a typical plant DHDPS, e.g., wheat germ DHDPS. The Corynebacterium dapA gene (cordapA) was isolated from genomic DNA from ATCC strain 13032 using polymerase chain reaction (PCR). The nucleotide sequence of the Corynebacterium dapA gene has been published [Bonnassie et al. (1990) Nucleic Acids Res. 75:6421]. From the sequence it was possible to design oligonucleotide primers for polymerase chain reaction (PCR) that would allow amplification of a DNA fragment containing the gene, and at the same time add unique restriction endonuclease sites at the start codon and just past the stop codon of the gene to facilitate further constructions involving the gene. The details of the isolation of the cordapA gene are presented in Example 3. The cordapA gene encodes a DHDPS enzyme that is insensitive to lysine inhibition. In addition to introducing a restriction endonuclease site at the translation start codon, the PCR primers also changed the second codon of the cordapA gene from AGC coding for serine to GCT coding for alanine. Several cloned DNA fragments that expressed active, lysine-insensitive DHDPS were isolated, indicating that the second codon amino acid substitution did not affect enzyme activity. The PCR-generated Corynebacterium dapA gene was subcloned into the phagemid vector pGEM-9zf(-) from Promega, and single-stranded DNA was generated and sequenced (SEQ ID NO: 6). Aside from the differences in the second codon already mentioned, the sequence matched the published sequence except at two positions, nucleotides 798 and 799. In the published sequence these are TC, while in the gene shown in SEQ ID NO:6 they are CT. This change results in an amino acid substitution of leucine for serine. The reason for this difference is not known. The difference has no apparent effect on DHDPS enzyme activity. The isolation of other genes encoding DHDPS has been described in the literature. A cDNA encoding DHDPS from wheat [Kaneko et al. (1990) J. Biol. Chem. 265:17451-17455], and a cDNA encoding DHDPS from corn [Frisch et al. (1991) Mol. Gen. Genet. 225:287-293] are two examples. These genes encode wild type lysine-sensitive DHDPS enzymes. However, Negrutui et al. [(1984) Theor. Appl. Genet. 65:11-20], obtained two AEC-resistant tobacco mutants in which DHDPS activity was less sensitive to lysine inhibition than the wild type enzyme. These genes could be isolated using the methods already described for isolating the wheat or corn genes or, alternatively, by using the wheat or corn genes as heterologous hybridization probes. Still other genes encoding DHDPS could be isolated by one skilled in the art by using either the ecodapA gene, the cordapA gene, or either of the plant DHDPS genes as DNA hybridization probes. Alternatively, other genes encoding DHDPS could be isolated by functional complementation of an E. coli dapA mutant, as was done to isolate the cordapA gene [Yeh et al. (1988) Mol. Gen. Genet. 272:105-111] and the corn DHDPS gene. High level expression of ecodapA and cordapA genes in E. coli To achieve high level expression of the ecodapA and cordapA genes in E. coli, a bacterial expression vector which employs the bacteriophage T7 RNA polymerase/T7 promoter system [Rosenberg et al. (1987) Gene 56:127-135] was used. The vector and dapA genes were modified as described below to construct ecodapA and cordapA expression vectors. For high level expression each of the expression vectors was transformed into E. coli strain BL21(DE3) [Studier et al. (1986) J. Mol. Biol. 759:113-130]. Cultures were grown, expression was induced, cells were collected, and extracts were prepared as described in Example 4. Supernatant and pellet fractions of extracts from uninduced and induced cultures were analyzed by SDS polyacrylamide gel electrophoresis and by DHDPS enzyme assays as described in Example 4. The major protein visible by Coomassie blue staining in the supernatant and pellet fractions of both induced cultures had a molecular weight of 32-34 kd, the expected size for DHDPS. Even in the uninduced cultures this protein was the most prominent protein produced. In the induced culture with the ecodapA gene about 80% of the DHDPS protein was in the supernatant and DHDPS represented 10-20% of the total protein in the extract. In the induced culture with the cordapA gene more than 50% of the DHDPS protein was in the pellet fraction. The pellet fractions in both cases were 90-95% pure DHDPS, with no other single protein present in significant amounts. Thus, these fractions were pure enough for use in the generation of rabbit antibodies. The specific activity of E. coli DHDPS in the supernatant fraction of induced extracts was about 50 OD540 units per milligram protein. E. coli DHDPS was sensitive to the presence of L-lysine in the assay. Fifty percent inhibition was found at a concentration of about 0.5 mM. For Corynebacterium DHDPS, enzyme activity was measured in the supernatant fraction of uninduced extracts, rather than induced extracts. Enzyme activity was about 4 OD530 units per minute per milligram protein. In contrast to E. coli DHDPS, Corynebacterium DHDPS was not inhibited at all by L-lysine, even at a concentration of 70 mM. Many other microbial expression vectors have been described in the literature. One skilled in the art could make use of any of these to construct ecodapA or cordapA expression vectors. These expression vectors could then be introduced into appropriate microorganisms via transformation to provide a system for high level expression of DHDPS. Excretion of amino acids by E. coli expressing high levels of DHDPS and/or AKIII The E. coli expression cassettes were inserted into expression vectors and then transformed into E. coli strain BL21(DE3) [Studier et al. (1986) J. Mol. Biol. 759:113-130] to induce E. coli to produce and excrete amino acids. Details of the procedures used and results are presented in Example 5. Other microbial expression vectors known to those skilled in the art could be used to make and combine expression cassettes for the IvsC and dapA genes. These expression vectors could then be introduced into appropriate microorganisms via transformation to provide alternative systems for production and excretion of lysine, threonine and methionine. Construction of Chimeric Genes for Expression in Plants A preferred class of heterologous hosts for the expression of the chimeric genes of this invention are eukaryotic hosts, particularly the cells of higher plants. Preferred among the higher plants and the seeds derived from them are soybean, rapeseed (Brassica napus, B. campestris), sunflower (Helianthus annus), cotton (Gossypium hirsutum), corn, tobacco (Nicotiana tabacum), alfalfa (Medicago sativd), wheat (Triticum sp), barley (Hordeum vulgare), oats (Avena sativa, L), sorghum {Sorghum bicolor), rice (Oryza sativa), and forage grasses. Expression in plants will use regulatory sequences functional in such plants. The expression of foreign genes in plants is well-established [De Blaere et al. (1987) Meth. Enzymol. 143:277-291]. Proper level of expression of the different chimeric genes of this invention in plant cells may be achieved through the use of many different promoters. Such chimeric genes can be transferred into host plants either together in a single expression vector or sequentially using more than one vector. The origin of promoter chosen to drive the expression of the coding sequence is not critical as long as it has sufficient transcriptional activity to accomplish the invention by expressing translatable mRNA or antisense RNA in the desired host tissue. Preferred promoters for expression in all plant organs, and especially for expression in leaves include those directing the 19S and 35S transcripts in Cauliflower mosaic virus [Odell et al.(1985) Nature 575:810-812; Hull et al. (1987) Virology 56:482-493], small subunit of ribulose 1,5-bisphosphate carboxylase [Morelli et al.(1985) Nature 575:200; Broglie et al. (1984) Science 224:838; Hererra-Estrella et al.(1984) Nature 570:115; Coruzzi et al.(1984) EMBOJ. 5:1671; Faciotti et al.(1985) Bio/Technology 5:241], maize zein protein [Matzke et al.(1984) EMBOJ. 5:1525], and chlorophyll a/b binding protein [Lampa et al.(1986) Nature 576:750-752]. Depending upon the application, it may be desirable to select promoters that are specific for expression in one or more organs of the plant. Examples include the light-inducible promoters of the small subunit of ribulose 1,5-bisphosphate carboxylase, if the expression is desired in photosynthetic organs, or promoters active specifically in seeds. Preferred promoters are those that allow expression specifically in seeds. This may be especially useful, since seeds are the primary source of vegetable amino acids and also since seed-specific expression will avoid any potential deleterious effect in non-seed organs. Examples of seed-specific promoters include, but are not limited to, the promoters of seed storage proteins. The seed storage proteins are strictly regulated, being expressed almost exclusively in seeds in a highly organ-specific and stage-specific manner [Higgins et al.(1984) Ann. Rev. Plant Physiol. 55:191-221; Goldberg et al.(1989) Cell 56:149-160; Thompson et al. (1989) BioEssays 70:108-113]. Moreover, different seed storage proteins may be expressed at different stages of seed development. There are currently numerous examples for seed-specific expression of seed storage protein genes in transgenic dicotyledonous plants. These include genes from dicotyledonous plants for bean β-phaseolin [Sengupta-Goplalan et al. (1985) Proc. Natl. Acad. Sci. USA 52:3320-3324; Hoffman et al. (1988) Plant Mol. Biol. 77:717-729], bean lectin [Voelker et al. (1987) EMBOJ. 6: 3571-3577], soybean lectin [Okamuro et al. (1986) Proc. Natl. Acad. Sci. USA 55:8240-8244], soybean kunitz trypsin inhibitor [Perez-Grau et al. (1989) Plant Cell 7:095-1109], soybean β-conglycinin [Beachy et al. (1985) EMBO J. 4:3047-3053; Barker et al. (1988) Proc. Natl. Acad. Sci. USA 55:458-462; Chen et al. (1988) EMBOJ. 7:297-302; Chen et al. (1989) E>ev. Genet. 70:112-122; Naito et al. (1988) Plant Mol. Biol. 77:109-123], pea vicilin [Higgins et al. (1988) Plant Mol. Biol. 77:683-695], pea convicilin [Newbigin et al. (1990) Planta 750:461], pea legumin [Shirsat et al. (1989) Mol. Gen. Genetics 275:326]; rapeseed napin [Radke et al. (1988) Theor. Appl. Genet. 75:685-694] as well as genes from monocotyledonous plants such as for maize 15 kD zein [Hoffman et al. (1987) EMBO J. 6:3213-3221; Schemthaner et al. (1988) EMBO J. 7:1249-1253; Williamson et al. (1988) Plant Physiol. 55:1002-1007], barley β-hordein [Marris et al. (1988) Plant Mol. Biol. 70:359-366] and wheat glutenin [Colot et al. (1987) EMBOJ 6:3559-3564]. Moreover, promoters of seed-specific genes, operably linked to heterologous coding sequences in chimeric gene constructs, also maintain their temporal and spatial expression pattern in transgenic plants. Such examples include Arabidopsis thaliana 2S seed storage protein gene promoter to express enkephalin peptides in Arabidopsis and B. napus seeds [Vandekerckhove et al. (1989) Bio/Technology 7:929-932], bean lectin and bean β-phaseolin promoters to express luciferase [Riggs et al. (1989) Plant Sci. 65:47-57], and wheat glutenin promoters to express chloramphenicol acetyl transferase [Colot et al. (1987) EMBO J 6:3559-3564]. Of particular use in the expression of the nucleic acid fragment of the invention will be the heterologous promoters from several extensively- characterized soybean seed storage protein genes such as those for the Kunitz trypsin inhibitor [Jofuku et al. (1989) Plant Cell 7:1079-1093; Perez-Grau et al. (1989) Plant Cell 7:1095-1109], glycinin [Nielson et al. (1989) Plant Cell 7:313-328], β-conglycinin [Harada et al. (1989) Plant Cell 7:415-425]. Promoters of genes for α'- and β-subunits of soybean β-conglycinin storage protein will be particularly useful in expressing mRNAs or antisense RNAs in the cotyledons at mid- to late-stages of soybean seed development [Beachy et al. (1985) EMBOJ. 4:3047-3053; Barker et al. (1988) Proc. Natl. Acad. Sci. USA 55:458-462; Chen et al. (1988) EMBOJ. 7:297-302; Chen et al. (1989) Dev. Genet. 70:112-122; Naito et al. (1988) Plant Mol. Biol. 77:109-123] in transgenic plants, since: a) there is very little position effect on their expression in transgenic seeds, and b) the two promoters show different temporal regulation: the promoter for the α'-subunit gene is expressed a few days before that for the β-subunit gene. Also of particular use in the expression of the nucleic acid fragments of the invention will be the heterologous promoters from several extensively characterized com seed storage protein genes such as endosperm-specific promoters from the 10 kD zein [Kirihara et al. (1988) Gene 77:359-370], the 27 kD zein [Prat et al. (1987) Gene 52:51-49; Gallardo et al. (1988) Plant Sci. 54:211-281], and the 19 kD zein [Marks et al. (1985) J Biol. Chem. 260: 16451-16459] . The relative transcriptional activities of these promoters in com have been reported [Kodrzyck et al. (1989) Plant Cell 7:105-114] providing a basis for choosing a promoter for use in chimeric gene constructs for com. For expression in com embryos, the strong embryo-specific promoter from the GLB 1 gene [Kriz (1989) Biochemical Genetics 27:239-251, Wallace et al. (1991) Plant Physiol. 95:973-975] can be used. It is envisioned that the introduction of enhancers or enhancer-like elements into other promoter constructs will also provide increased levels of primary transcription to accomplish the invention. These would include viral enhancers such as that found in the 35S promoter [Odell et al. (1988) Plant Mol. Biol. 70:263-272], enhancers from the opine genes [Fromm et al. (1989) Plant Cell 7:977-984], or enhancers from any other source that result in increased transcription when placed into a promoter operably linked to the nucleic acid fragment of the invention. Of particular importance is the DNA sequence element isolated from the gene for the α'-subunit of β-conglycinin that can confer 40-fold seed-specific enhancement to a constitutive promoter [Chen et al. (1988) EMBOJ. 7:297-302; Chen et al. (1989) Dev. Genet. 70:112-122]. One skilled in the art can readily isolate this element and insert it within the promoter region of any gene in order to obtain seed-specific enhanced expression with the promoter in transgenic plants. Insertion of such an element in any seed-specific gene that is expressed at different times than the β-conglycinin gene will result in expression in transgenic plants for a longer period during seed development. Any 3' non-coding region capable of providing a polyadenylation signal and other regulatory sequences that may be required for the proper expression can be used to accomplish the invention. This would include the 3' end from any storage protein such as the 3' end of the bean phaseolin gene, the 3' end of the soybean β-conglycinin gene, the 3' end from viral genes such as the 3' end of the 35S or the 19S cauliflower mosaic vims transcripts, the 3' end from the opine synthesis genes, the 3' ends of ribulose 1,5-bisphosphate carboxylase or chlorophyll a/b binding protein, or 3' end sequences from any source such that the sequence employed provides the necessary regulatory information within its nucleic acid sequence to result in the proper expression of the promoter/coding region combination to which it is operably linked. There are numerous examples in the art that teach the usefulness of different 3' non-coding regions [for example, see Ingelbrecht et al. (1989) Plant Cell 7:671-680]. DNA sequences coding for intracellular localization sequences may be added to the lysC and dapA coding sequence if required for the proper expression of the proteins to accomplish the invention. Plant amino acid biosynthetic enzymes are known to be localized in the chloroplasts and therefore are synthesized with a chloroplast targeting signal. Bacterial proteins such as DHDPS and AKIII have no such signal. A chloroplast transit sequence could, therefore, be fused to the dapA and lysC coding sequences. Preferred chloroplast transit sequences are those of the small subunit of ribulose 1,5-bisphosphate carboxylase, e.g. from soybean [Berry-Lowe et al. (1982) J. Mol. Appl. Genet. 7:483-498] for use in dicotyledonous plants and from com [Lebrun et al. (1987) Nucleic Acids Res. 75:4360] for use in monocotyledonous plants. Introduction of Chimeric Genes into Plants Various methods of introducing a DNA sequence (i.e., of transforming) into eukaryotic cells of higher plants are available to those skilled in the art (see EPO publications 0 295 959 A2 and 0 138 341 Al). Such methods include those based on transformation vectors based on the Ti and Ri plasmids of Agrobacterium spp. It is particularly preferred to use the binary type of these vectors. Ti-derived vectors transform a wide variety of higher plants, including monocotyledonous and dicotyledonous plants, such as soybean, cotton and rape [Pacciotti et al. (1985) Bio/Technology 5:241; Byrne et al. (1987) Plant Cell, Tissue and Organ Culture 8:3; Sukhapinda et al. (1987) Plant Mol. Biol. 5:209-216; Lorz et al. (1985) Mol. Gen. Genet. 799:178; Potrykus (1985) Mol. Gen. Genet. 799:183]. For introduction into plants the chimeric genes of the invention can be inserted into binary vectors as described in Examples 7-12 and 14-16. The vectors are part of a binary Ti plasmid vector system [Bevan, (1984) Nucl. Acids. Res. 72:8711-8720] of Agrobacterium tumefaciens. Other transformation methods are available to those skilled in the art, such as direct uptake of foreign DNA constructs [see EPO publication 0 295 959 A2], techniques of electroporation [see Fromm et al. (1986) Nature (London) 579:791] or high- velocity ballistic bombardment with metal particles coated with the nucleic acid constructs [see Kline et al. (1987) Nature (London) 527:70, and see U.S. Pat. No. 4,945,050]. Once transformed, the cells can be regenerated by those skilled in the art. Of particular relevance are the recently described methods to transform foreign genes into commercially important crops, such as rapeseed [see De Block et al. (1989) Plant Physiol. 97:694-701], sunflower [Everett et al. (1987) Bio/Technology 5:1201], soybean [McCabe et al. (1988) Bio/Technology 6:923; Hinchee et al. (1988) Bio/Technology 6:915; Chee et al. (1989) Plant Physiol. 97:1212-1218; Christou et al. (1989) Proc. Natl. Acad. Sci USA 86:7500-7504; EPO Publication 0 301 749 A2], and com [Gordon-Kamm et al. (1990) Plant Cell 2:603-618; Fromm et al. (1990) Biotechnology 8:833-839]. For introduction into plants by high-velocity ballistic bombardment, the chimeric genes of the invention can be inserted into suitable vectors as described in Example 6. Transformed plants can be obtained as described in Examples 17-19. Expression of IvsC and dapA Chimeric Genes in Tobacco Plants To assay for expression of the chimeric genes in leaves or seeds of the transformed plants, the AKIII or DHDPS proteins can be detected and quantitated enzymatically and/or immunologically by methods known to those skilled in the art. In this way lines producing high levels of expressed protein can be easily identified. In order to measure the free amino acid composition of the leaves, free amino acids can be extracted by various methods including those as described in Example 7. To measure the free or total amino acid composition of seeds, extracts can be prepared by various methods including those as described in Example 8. There was no significant effect of expression of AKIII or AKIII-M4 (with a chloroplast targeting signal) on the free lysine or threonine (or any other amino acid) levels in the leaves (see Table 2 in Example 7). Since AKIII-M4 is insensitive to feedback inhibition by any of the end-products of the pathway, this indicates that control must be exerted at other steps in the biosynthetic pathway in leaves. In contrast, expression of the AKIII or AKIII-M4 (with a chloroplast targeting signal) in the seeds resulted in 2 to 4-fold or 4 to 23-fold increases, respectively, in the level of free threonine in the seeds compared to untransformed plants and 2 to 3 -fold increases in the level of free lysine in some cases (Table 3, Example 8). There was a good correlation between transformants expressing higher levels of AKIII or AKIII-M4 protein and those having higher levels of free threonine, but this was not the case for lysine. The relatively small increases of free threonine or lysine achieved with the AKIII protein were not sufficient to yield detectable increases compared to untransformed plants, in the levels of total threonine or lysine in the seeds. The larger increases of free threonine achieved via expression of the AKIII-M4 protein were sufficient to yield detectable increases, compared to seeds from untransformed plants, in the levels of total threonine in the seeds. Sixteen to twenty-five percent increases in total threonine content of the seeds were observed. The lines that showed increased total threonine were the same ones that showed the highest levels of increase in free threonine and high expression of the AKIII-M4 protein. The above teachings show that amino acid biosynthesis takes place in seeds and can be modulated by the expression of foreign genes encoding amino acid biosynthetic enzymes. Furthermore, they show that control of an amino acid biosynthetic pathway can differ markedly from one plant organ to another, e.g. seeds and leaves. The importance of this observation is emphasized upon considering the different effects of expressing a foreign DHDPS in leaves and seeds described below. It can be concluded that threonine biosynthesis in seeds is controlled primarily via end-product inhibition of AK. Therefore, threonine accumulation in the seeds of plants can be increased by expression of a gene, introduced via transformation, that encodes AK which is insensitive to lysine inhibition and which is localized in the chloroplast. The above teachings also demonstrate that transformed plants which express higher levels of the introduced enzyme in seeds accumulate higher levels of free threonine in seeds. Furthermore, the teachings demonstrate that transformed plants which express a lysine-insensitive AK in seeds accumulate higher levels of free threonine in seeds than do transformed plants which express similar levels of a lysine-sensitive AK. To achieve commercially valuable increases in free threonine, a lysine-insensitive AK is preferred. These teachings indicate that the level of free lysine in seeds controls the accumulation of another aspartate-derived amino acid, threonine, through end- product inhibition of AK. In order to accumulate high levels of free lysine itself, it will be necessary to bypass lysine inhibition of AK via expression of a lysine- insensitive AK. Expression of active E. coli DHDPS enzyme was achieved in both young and mature leaves of the transformed tobacco plants (Table 4, Example 9). High levels of free lysine, 50 to 100-fold higher than normal tobacco plants, accumulated in the young leaves of the plants expressing the enzyme with a chloroplast targeting signal, but not without such a targeting signal. However, a much smaller accumulation of free lysine (2 to 8-fold) was seen in the larger leaves. Experiments that measure lysine in the phloem suggest that lysine is exported from the large leaves. This exported lysine may contribute to the accumulation of lysine in the small growing leaves, which are known to take up, rather than export nutrients. No effect on the free lysine levels in the seeds of these plants was observed even though E. coli DHDPS enzyme was expressed in the seeds as well as the leaves. High level seed-specific expression of E. coli DHDPS enzyme, either with or without a chloroplast targeting signal, had no effect on the total, or free, lysine or threonine (or any other amino acid) composition of the seeds in any transformed line (Table 5, Example 10). These results demonstrate that expression in seeds of a DHDPS enzyme that is substantially insensitive to lysine inhibition is not sufficient to lead to increased production or accumulation of free lysine. These teachings from transformants expressing the E. coli DHDPS enzyme indicate that lysine biosynthesis in leaves is controlled primarily via end-product inhibition of DHDPS, while in seeds there must be at least one additional point of control in the pathway. The teachings from transformants expressing the E. coli AKIII and AKIII-M4 enzymes indicate that the level of free lysine in seeds controls the accumulation of all aspartate-derived amino acids through end- product inhibition of AK. AK is therefore an additional control point. To achieve simultaneous, high level expression of both E. coli DHDPS and AKIII-M4 in leaves and seeds, plants that express each of the genes could be crossed and hybrids that express both could be selected. Another method would be to construct vectors that contain both genes on the same DNA fragment and introduce the linked genes into plants via transformation. This is preferred because the genes would remain linked throughout subsequent plant breeding efforts. Representative vectors carrying both genes on the same DNA fragment are described in Examples 11, 12, 15, 16, 18, 19, and 25. Tobacco plants transformed with a vector carrying both E. coli DHDPS and AKIII-M4 genes linked to the 35S promoter are described in Example 11. In transformants that express little or no AKIII-M4, the level of expression of E. coli DHDPS determines the level of lysine accumulation in leaves (Example 11, Table 6). However, in transformants that express both AKIII-M4 and E. coli DHDPS, the level of expression of each protein plays a role in controlling the level of lysine accumulation. Transformed lines that express DHDPS at comparable levels accumulate more lysine when AKIII-M4 is also expressed (Table 6, compare lines 564-18A, 564-56A, 564-36E, 564-55B, and 564-47 A). Thus, expression of a lysine-insensitive AK increases lysine accumulation in leaves when expressed in concert with a DHDPS enzyme that is 20-fold less sensitive to lysine than the endogenous plant enzyme. These leaf results, taken together with the seed results derived from expressing E. coli AKIII-M4 and E. coli DHDPS separately in seeds, suggest that simultaneous expression of both E. coli AKIII-M4 and E. coli DHDPS in seeds would lead to increased accumulation of free lysine and would also lead to an increased accumulation of free threonine. Tobacco plants transformed with a vector carrying both E. coli DHDPS and AKIII-M4 genes linked to the phaseolin promoter are described in Example 12. There is an increased accumulation of free lysine and free threonine in these plants. The increased level of free threonine was 4-fold over normal seeds, rather than the 20-fold increase seen in seeds expressing AKIII-M4 alone. The reduction in accumulation of free threonine indicates that pathway intermediates are being diverted down the lysine branch of the biosynthetic pathway. The increased level of free lysine was 2-fold over normal seeds (or seeds expressing E. coli DHDPS alone). However, the lysine increase in seeds is not equivalent to the 100-fold increase seen in leaves. The E. coli DHDPS enzyme is less sensitive to lysine inhibition than plant DHDPS, but is still inhibited by lysine. The above teachings on the AK proteins indicate that expression of a completely lysine-insensitive enzyme can lead to a much greater accumulation of the aspartate pathway end-product threonine than expression of an enzyme which, while less sensitive than the plant enzyme, is still inhibited by lysine. Therefore vectors carrying both Corynebacterium DHDPS and AKIII-M4 genes linked to the seed-specific promoters were constructed as described in Examples 15 and 19. Tobacco plants transformed with vectors carrying both Corynebacterium DHDPS and AKIII-M4 genes linked to seed- specific promoters are described in Example 15. As shown in Table 9, these plants did not show a greater accumulation of free lysine in seeds than previously described plants expressing the E. coli DHDPS enzyme in concert with the lysine- insensitive AK. In hindsight this result can be explained by the fact that lysine accumulation in seeds never reached a level high enough to inhibit the E. coli DHDPS, so replacement of this enzyme with lysine-insensitive Corynebacterium DHDPS had no effect. In transformed lines expressing high levels of E. coli AKIII-M4 and E. coli DHDPS or Corynebacterium DHDPS, it was possible to detect substantial amounts of α-aminoadipic acid in seeds. This compound is thought to be an intermediate in the catabolism of lysine in cereal seeds, but is normally detected only via radioactive tracer experiments due to its low level of accumulation. The discovery of high levels of this intermediate, comparable to levels of free amino acids, indicates that a large amount of lysine is being produced in the seeds of these transformed lines and is entering the catabolic pathway. The build-up of α-aminoadipic acid was not observed in transformants expressing only E. coli DHDPS or only AKIII-M4 in seeds. These results show that it is necessary to express both enzymes simultaneously to produce high levels of free lysine in seeds. To accumulate high levels of free lysine it may also be necessary to prevent lysine catabolism. Alternatively, it may be desirable to convert the high levels of lysine produced into a form that is insensitive to breakdown, e.g. by incorporating it into a di-, tri- or oligopeptide, or a lysine-rich storage protein. Expression of IvsC and dapA Chimeric Genes in Rapeseed and Soybean Plants To analyze for expression of the chimeric lysC and dapA genes in seeds of transformed rapeseed and soybean and to determine the consequences of expression on the amino acid content in the seeds, a seed meal can be prepared as described in Examples 16 or 19 or by any other suitable method. The seed meal can be partially or completely defatted, via hexane extraction for example, if desired. Protein extracts can be prepared from the meal and analyzed for AK and/or DHDPS enzyme activity. Alternatively the presence of the AK and/or DHDPS protein can be tested for immunologically by methods well-known to those skilled in the art. To measure free amino acid composition of the seeds, free amino acids can be extracted from the meal and analyzed by methods known to those skilled in the art (see Examples 8, 16 and 19 for suitable procedures). All of the rapeseed transformants obtained from a vector carrying the cordapA gene expressed the Corynebacterium DHDPS protein, and six of eight transformants obtained from a vector carrying the lysC-M4 gene expressed the AKIII-M4 protein (Example 16, Table 12). Thus it is straightforward to express these proteins in oilseed rape seeds. Transformants expressing DHDPS protein showed a greater than 100-fold increase in free lysine level in their seeds. There was a good correlation between transformants expressing higher levels of DHDPS protein and those having higher levels of free lysine. One transformant that expressed AKIII-M4 in the absence of Corynebacteria DHDPS showed a 5-fold increase in the level of free threonine in the seeds. Concomitant expression of both enzymes resulted in accumulation of high levels of free lysine, but not threonine. A high level of α-aminoadipic acid, indicative of lysine catabolism, was observed in many of the transformed lines, especially lines expressing the highest levels of DHDPS and AKIII protein. Thus, prevention of lysine catabolism by inactivation of lysine ketoglutarate reductase should further increase the accumulation of free lysine in the seeds. Alternatively, incorporation of lysine into a peptide or lysine-rich protein would prevent catabolism and lead to an increase in the accumulation of lysine in the seeds. To measure the total amino acid composition of mature rapeseed seeds, defatted meal was analyzed as described in Example 16. Relative amino acid levels in the seeds were compared as percentages of lysine to total amino acids. Seeds with a 5-100% increase in the lysine level, compared to the untransformed control, were observed. The transformant with the highest lysine content expressed high levels of both E. coli AKIII-M4 and Corynebacterium DHDPS. In this transformant lysine makes up about 13% of the total seed amino acids, considerably higher than any previously known rapeseed seed. Six of seven soybean transformants expressed the DHDPS protein. In the six transformants that expressed DHDPS, there was excellent correlation between expression of GUS and DHDPS in individual seeds. Therefore, the GUS and DHDPS genes are integrated at the same site in the soybean genome. Four of seven transformants expressed the AKIII protein, and again there was excellent correlation between expression of AKIII, GUS and DHDPS in individual seeds. Thus, in these four transformants the GUS, AKIII and DHDPS genes are integrated at the same site in the soybean genome. Soybean transformants expressing Corynebacteria DHDPS alone and in concert with E. coli AKIII-M4 accumulated high levels of free lysine in their seeds. A high level of saccharopine, the first metabolic product of lysine catabolism, was also observed in seeds that contained high levels of lysine. Lesser amounts of α-amino adipic acid were also observed. Thus, prevention of lysine catabolism by inactivation of lysine ketoglutarate reductase should further increase the accumulation of free lysine in the soybean seeds. Alternatively, incorporation of lysine into a peptide or lysine-rich protein would prevent catabolism and lead to an increase in the accumulation of lysine in the soybean seeds. Analyses of free lysine levels in individual seeds from transformants in which the transgenes segregated as a single locus revealed that the increase in free lysine level was significantly higher in about one-fourth of the seeds. Since one- fourth of the seeds are expected to be homozygous for the transgene, it is likely that the higher lysine seeds are the homozygotes. Furthermore, this indicates that the level of increase in free lysine is dependent upon the transgene copy number. Therefore, lysine levels could be further increased by making hybrids of two different transformants, and obtaining progeny that are homozygous at both transgene loci. The soybean seeds expressing Corynebacteria DHDPS showed substantial increases in accumulation of total seed lysine. Seeds with a 5-35% increase in total lysine content, compared to the untransformed control, were observed. In these seeds lysine makes up 7.5-7.7% of the total seed amino acids. Soybean seeds expressing Corynebacteria DHDPS in concert with E. coli AKIII-M4 showed much greater accumulation of total seed lysine than those expressing Corynebacteria DHDPS alone. Seeds with a more than four-fold increase in total lysine content were observed. In these seeds lysine makes up 20-25% of the total seed amino acids, considerably higher than any previously known soybean seed. Expression of IvsC and dapA Chimeric Genes in Com Plants Com plants regenerated from transformed callus can be analyzed for the presence of the intact lysC and dapA transgenes via Southern blot or PCR. Plants carrying the genes are either selfed or outcrossed to an elite line to generate FI seeds. Six to eight seeds are pooled and assayed for expression of the Corynebacterium DHDPS protein and the E. coli AKIII-M4 protein by western blot analysis. The free amino acid composition and total amino acid composition of the seeds are determined as described above. Expression of the Corynebacterium DHDPS protein, and/or the E. coli AKIII-M4 protein can be obtained in the embryo of the seed using regulatory sequences active in the embryo, preferably derived from the globulin 1 gene, or in the endosperm using regulatory sequences active in the endosperm, preferably derived from the glutelin 2 gene or the 10 kD zein gene (see Example 26 for details). Free lysine levels in the seeds is increased from about 1.4% of free amino acids in control seeds to 15-27% in seeds of transformants expressing Corynebacterium DHDPS alone from the globulin 1 promoter. The increased free lysine was localized to the embryo in seeds expressing Corynebacterium DHDPS from the globulin 1 promoter. The large increases in free lysine result in significant increases in the total seed lysine content. Total lysine levels can be increased at least 130% in seeds expressing Corynebacterium DHDPS from the globulin 1 promoter. Greater increases in free lysine levels can be achieved by expressing E. coli AKIII-M4 protein from the globulin 1 promoter in concert with Corynebacterium DHDPS. Lysine catabolism is expected to be much greater in the com endosperm than the embryo. Thus, to achieve significant lysine increases in the endosperm it is preferable to express both Corynebacterium DHDPS and the E. coli AKIII-M4 in the endosperm and to reduce lysine catabolism by reducing the level of lysine ketoglutarate reductase as described below. Isolation of a Plant Lysine Ketoglutarate Reductase Gene It may be desirable to prevent lysine catabolism in order to accumulate higher levels of free lysine and to prevent accumulation of lysine breakdown products such as saccharopine and α-amino adipic acid. Evidence indicates that lysine is catabolized in plants via the saccharopine pathway. The first enzymatic evidence for the existence of this pathway was the detection of lysine ketoglutarate reductase (LKR) activity in immature endosperm of developing maize seeds [Arruda et al. (1982) Plant Physiol 69:988-989]. LKR catalyzes the first step in lysine catabolism, the condensation of L-lysine with α-ketoglutarate into saccharopine using NADPH as a cofactor. LKR activity increases sharply from the onset of endosperm development in com, reaches a peak level at about 20 days after pollination, and then declines [Arruda et al. (1983) Phytochemistry 22:2687-2689]. In order to prevent the catabolism of lysine it would be desirable to reduce or eliminate LKR expression or activity. This could be accomplished by cloning the LKR gene, preparing a chimeric gene for cosuppression of LKR or preparing a chimeric gene to express antisense RNA for LKR, and introducing the chimeric gene into plants via transformation. Alternatively, plant mutants could be obtained wherein LKR enzyme activity is absent. Several methods to clone a plant LKR gene are available to one skilled in the art. The protein can be purified from com endosperm, as described in Brochetto-Braga et al. [(1992) Plant Physiol 95:1139-1147] and used to raise antibodies. The antibodies can then be used to screen an cDNA expression library for LKR clones. Alternatively the purified protein can be used to determine amino acid sequence at the amino-terminal of the protein or from protease derived internal peptide fragments. Degenerate oligonucleotide probes can be prepared based upon the amino acid sequence and used to screen a plant cDNA or genomic DNA library via hybridization. Another method makes use of an E. coli strain that is unable to grow in a synthetic medium containing 20 μg/mL of L-lysine. Expression of LKR full- length cDNA in this strain will reverse the growth inhibition by reducing the lysine concentration. Construction of a suitable E. coli strain and its use to select clones from a plant cDNA library that lead to lysine-resistant growth is described in Example 20. Yet another method relies upon homology between plant LKR and saccharopine dehydrogenase. Fungal saccharopine dehydrogenase (glutamate- forming) and saccharopine dehydrogenase (lysine-forming) catalyze the final two steps in the fungal lysine biosynthetic pathway. Plant LKR and fungal saccharopine dehydrogenase (lysine-forming) catalyze both forward and reverse reactions, use identical substrates and use similar co-factors. Similarly, plant saccharopine dehydrogenase (glutamate-forming), which catalyzes the second step in the lysine catabolic pathway, works in both forward and reverse reactions, uses identical substrates and uses similar co-factors as fungal saccharopine dehydrogenase (glutamate-forming). Several genes for fungal saccharopine dehydrogenases have been isolated and sequenced and are readily available to those skilled in the art [Xuan et al. (1990) Mol. Cell. Biol. 70:4795-4806, Feller et al. (1994) Mol. Cell. Biol 74:6411-6418]. These genes could be used as heterologous hybridization probes to identify plant LKR and plant saccharopine dehydrogenase (glutamate-forming) nucleic acid fragments, or alternatively to identify homologous protein coding regions in plant cDNAs. Biochemical and genetic evidence derived from human and bovine studies has demonstrated that mammalian LKR and saccharopine dehydrogenase (glutamate-forming) enzyme activities are present on a single protein with a monomer molecular weight of about 117,000. This contrasts with the fungal enzymes which are carried on separate proteins, saccharopine dehydrogenase (lysine-forming) with a molecular weight of about 44,000, and saccharopine dehydrogenase (glutamate-forming) with a molecular weight of about 51,000. Plant LKR has been reported to have a molecular weight of about 140,000 indicating that it is like the animal catabolic protein wherein both LKR and saccharopine dehydrogenase (glutamate-forming) enzyme activities are present on a single protein. Two plant saccharopine dehydrogenase (glutamate-forming) nucleic acid fragments (SEQ ID NOS:102 and 103) containing cDNA derived from Arabidopsis thaliana are provided. These were identified as cDNAs that encode proteins homologous to fungal saccharopine dehydrogenase (glutamate-forming). These nucleic acid fragments were used to design and synthesize oligonucleotide primers (SEQ ID NO: 108 and SEQ ID NO: 109). The primers were synthesized and used for PCR amplification of a 2.24 kb DNA fragment from genomic Arabidopsis DNA. This DNA fragment was used to isolate a larger genomic DNA fragment, which included the entire coding region, as well as 5' and 3' flanking regions, via hybridization to a genomic DNA library. The sequence of this genomic DNA fragment is provided (SEQ ID NO:l 10); oligonucleotides were synthesized based on this sequence and used to isolate a full length cDNA via RT-PCR. The sequence of the full length cDNA (SEQ ID NO:l 11) is provided. These nucleic acid fragments can be used as hybridization probes to identify and isolate genomic DNA fragments or cDNA fragments encoding both LKR and saccharopine dehydrogenase (glutamate-forming) enzyme activities from any plant desired. The deduced amino acid sequence of Arabidopsis LKR/SDH protein is shown in SEQ ID NO: 112. The amino acid sequence shows that in plants LKR and SDH enzyme activities are carried on a single bi-functional protein, and that the protein lacks an N-terminal targeting sequence indicating that the lysine degradative pathway is located in the plant cell cytosol. The amino acid sequence of Arabidopsis LKR/SDH protein was compared to that of other LKR and SDH proteins thus revealing regions of conserved amino acid sequence. Degenerate oligonucleotides can be designed based upon this information and used to amplify genomic or cDNA fragments via PCR from other organisms, preferably plants. As an example of this, SEQ ID NO:l 13 and SEQ ID NO: 114 were designed and used to amplify soybean and com LKR/SDH cDNA fragments. The sequence of a partial soybean LKR/SDH cDNA is shown in SEQ ID NO:l 15, and the sequence of a partial com cDNA is shown in SEQ ID NO:l 16. These DNA fragments can be used to isolate larger genomic DNA fragments, which include the entire coding region, as well as 5' and 3' flanking regions, via hybridization to com or soybean genomic DNA or cDNA libraries, as was done for Arabidopsis. More complete sequence information from the coding regions for soybean and com LKR/SDH was obtained using the sequences in SEQ ID NOS: 115 and 116 as starting materials in protocols such as 5' RACE and hybridization to cDNA libraries. A near full-length cDNA for soybean LKR/SDH is shown in SEQ ID NO:l 19, and a near full-length cDNA for com LKR SDH is shown in SEQ ID NO: 120. A truncated version of the LKR/SDH cDNA from com is set forth in SEQ ID NO: 123. The deduced partial amino acid sequences of soybean LRK/SDH protein is shown in SEQ ID NOS: 117 and 121 and the deduced partial amino acid sequences of com LKR/SDH protein is shown in SEQ ID NO:l 18, 122 and 124. These amino acid sequences can be compared to other LKR/SDH protein sequences, e.g., the Arabidopsis LKR/SDH protein sequence, thus revealing regions of conserved amino acid sequence. With this information oligonucleotide primers can be designed and synthesized to permit isolation of LKR/SDH genomic or cDNA fragments from any plant source. The availibility of sequence information for plant LKR/SDH proteins from Arabidopsis, soybean, and com allowed comparisons of those sequences to EST sequences obtained from other plants, including ESTs from rice and wheat. SEQ ID NOS: 125 and 127 set forth sequences for partial cDNA clones encoding LKR/SDH from rice, and SEQ ID NO: 129 set forth the sequence of a partial cDNA encoding a ffragment of LKR/SDH from wheat. The prdicted protein fragments encoded by the sequences presented in SEQ ID NOS: 125, 127 and 129 are set forth in SEQ ID NOS: 126, 128 and 130, respectively, The availability of plant LKR/SDH genes makes it possible to block expression of the LKR/SDH gene in transformed plants. To accomplish this a chimeric gene designed for cosuppression of LKR can be constructed by linking the LKR gene or gene fragment to any of the plant promoter sequences described above. (See U.S. Patent No. 5,231,020 for methodology to block plant gene expression via cosuppression.) Altematively, a chimeric gene designed to express antisense RNA for all or part of the LKR gene can be constructed by linking the LKR gene or gene fragment in reverse orientation to any of the plant promoter sequences described above. (See U.S. Patent 5,107,065 for methodology to block plant gene expression via antisense RNA.) Either the cosuppression or antisense chimeric gene can be introduced into plants via transformation. Transformants wherein expression of the endogenous LKR gene is reduced or eliminated are then selected. Preferred promoters for the chimeric genes would be seed-specific promoters. For soybean, rapeseed and other dicotyledonous plants, strong seed- specific promoters from a bean phaseolin gene, a soybean β-conglycinin gene, glycinin gene, Kunitz trypsin inhibitor gene, or rapeseed napin gene would be preferred. For com and other monocotyledonous plants, a strong endosperm- specific promoter, e.g., the 10 kD or 27 kD zein promoter, or a strong embryo- specific promoter, e.g., the FLB1 promoter, would be preferred. Transformed plants containing any of the chimeric LKR genes can be obtained by the methods described above. In order to obtain transformed plants that express a chimeric gene for cosuppression of LKR or antisense LKR, as well as a chimeric gene encoding substantially lysine-insensitive DHDPS, the cosuppression or antisense LKR gene could be linked to the chimeric gene encoding substantially lysine-insensitve DHDPS and the two genes could be introduced into plants via transformation. Altematively, the chimeric gene for cosuppression of LKR or antisense LKR could be introduced into previously transformed plants that express substantially lysine-insensitive DHDPS, or the cosuppression or antisense LKR gene could be introduced into normal plants and the transformants obtained could be crossed with plants that express substantially lysine-insensitive DHDPS. The availability of plant LKR/SDH genes makes it possible to express the proteins in heterologous systems. To demonstrate this, a DNA fragment which includes the Arabidopsis SDH coding region (SEQ ID NO:l 19) was generated using PCR primers and ligated into a prokaryotic expression vector. High level expression of Arabidopsis SDH was achieved in E. coli and the SDH protein has been purified from the bacterial extracts, and used to raise rabbit antibodies to the protein. These antibodies can be used to screen for plant mutants in order to find variants which do not produce LKR/SDH protein, or produce reduced amounts of the protein compared to the parent plant. The plant mutants that express reduced LKR/SDH protein, or no protein at all, could be crossed with plants that express substantially lysine-insensitive DHDPS. Design of Lvsine-Rich Polypeptides It may be desirable to convert the high levels of lysine produced into a form that is insensitive to breakdown, e.g., by incorporating it into a di-, tri- or oligopeptide, or a lysine-rich storage protein. No natural lysine-rich proteins are known. One aspect of this invention is the design of polypeptides which can be expressed in vivo to serve as lysine-rich seed storage proteins. Polypeptides are linear polymers of amino acids where the α-carboxyl group of one amino acid is covalently bound to the α-amino group of the next amino acid in the chain. Non- covalent interactions among the residues in the chain and with the surrounding solvent determine the final conformation of the molecule. Those skilled in the art must consider electrostatic forces, hydrogen bonds, Van der Waals forces, hydrophobic interactions, and conformational preferences of individual amino acid residues in the design of a stable folded polypeptide chain [see for example: Creighton, (1984) Proteins, Structures and Molecular Properties, W. H. Freeman and Company, New York, pp 133-197, or Schulz et al., (1979) Principles of Protein Structure, Springer Verlag, New York, pp 27-45]. The number of interactions and their complexity suggest that the design process may be aided by the use of natural protein models where possible. The synthetic storage proteins (SSPs) embodied in this invention are chosen to be polypeptides with the potential to be enriched in lysine relative to average levels of proteins in plant seeds. Lysine is a charged amino acid at physiological pH and is therefore found most often on the surface of protein molecules [Chothia, (1976) Journal of Molecular Biology 705:1-14]. To maximize lysine content, Applicants chose a molecular shape with a high surface-to-volume ratio for the synthetic storage proteins embodied in this invention. The altematives were either to stretch the common globular shape of most proteins to form a rod-like extended structure or to flatten the globular shape to a disk-like structure. Applicants chose the former configuration as there are several natural models for long rod-like proteins in the class of fibrous proteins [Creighton, (1984) Proteins, Structures and Molecular Properties, W.H. Freeman and Company, New York, p 191]. Coiled-coils constitute a well-studied subset of the class of fibrous proteins [see Cohen et al., (1986) Trends Biochem. Sci. 77:245-248]. Natural examples are found in α-keratins, paramyosin, light meromyosin and tropomyosin. These protein molecules consist of two parallel alpha helices twisted about each other in a left-handed supercoil. The repeat distance of this supercoil is 140 A (compared to a repeat distance of 5.4 A for one turn of the individual helices). The supercoil causes a slight skew (10°) between the axes of the two individual alpha helices. In a coiled coil there are 3.5 residues per turn of the individual helices resulting in an exact 7 residue periodicity with respect to the superhelix axis (see Figure 1). Every seventh amino acid in the polypeptide chain therefore occupies an equivalent position with respect to the helix axis. Applicants refer to the seven positions in this heptad unit of the invention as (d e f g a b c) as shown in Figures 1 and 2a. This conforms to the conventions used in the coiled-coil literature. The a and d amino acids of the heptad follow a 4,3 repeat pattern in the primary sequence and fall on one side of an individual alpha helix (See Figure 1). If the amino acids on one side of an alpha helix are all non-polar, that face of the helix is hydrophobic and will associate with other hydrophobic surfaces as, for example, the non-polar face of another similar helix. A coiled-coil structure results when two helices dimerize such that their hydrophobic faces are aligned with each other (See Figure 2a). The amino acids on the external faces of the component alpha helices (b, c, e, f, g) are usually polar in natural coiled-coils in accordance with the expected pattern of exposed and buried residue types in globular proteins [Schulz, et al., (1979) Principles of Protein Structure. Springer Verlag, New York, p 12; Talbot, et al , (1982) Ace. Chem. Res. 75:224-230; Hodges et al., (1981) Journal of Biological Chemistry 256:1214-1224]. Charged amino acids are sometimes found forming salt bridges between positions e and g' or positions g and e' on the opposing chain (see Figure 2a). Thus, two amphipathic helices like the one shown in Figure 1 are held together by a combination of hydrophobic interactions between the a, a', d, and d' residues and by salt bridges between e and g' and/or g and e' residues. The packing of the hydrophobic residues in the supercoil maintains the chains "in register". For short polypeptides comprising only a few turns of the component alpha helical chains, the 10° skew between the helix axes can be ignored and the two chains treated as parallel (as shown in Figure 2a). A number of synthetic coiled-coils have been reported in the literature (Lau et al., (1984) Journal of Biological Chemistry 259:13253-13261; Hodges et al., (1988) Peptide Research 7:19-30; DeGrado et al., (1989) Science 245:622-628; O'Neil et al., (1990) Science 250:646-651]. Although these polypeptides vary in size, Lau et al. found that 29 amino acids were sufficient for dimerization to form the coiled-coil structure [Lau et al., (1984) Journal of Biological Chemistry 259:13253-13261]. Applicants constructed the polypeptides in this invention as 28-residue and larger chains for reasons of conformational stability. The polypeptides of this invention are designed to dimerize with a coiled- coil motif in aqueous environments. Applicants have used a combination of hydrophobic interactions and electrostatic interactions to stabilize the coiled-coil conformation. Most nonpolar residues are restricted to the a and d positions which creates a hydrophobic stripe parallel to the axis of the helix. This is the dimerization face. Applicants avoided large, bulky amino acids along this face to minimize steric interference with dimerization and to facilitate formation of the stable coiled-coil structure. Despite recent reports in the literature suggesting that methionine at positions a and d is destabilizing to coiled-coils in the leucine zipper subgroup [Landschulz et al., (1989) Science 245:1681-1688 and Hu et al., (1990) Science 250:1400-1403], Applicants chose to substitute methiomne residues for leucine on the hydrophobic face of the SSP polypeptides. Methionine and leucine are similar in molecular shape (Figure 3). Applicants demonstrated that any destabilization of the coiled-coil that may be caused by methionine in the hydrophobic core appears to be compensated in sequences where the formation of salt bridges (e-g' and g-e') occurs at all possible positions in the helix (i.e., twice per heptad). To the extent that it is compatible with the goal of creating a polypeptide enriched in lysine, Applicants minimized the unbalanced charges in the polypeptide. This may help to prevent undesirable interactions between the synthetic storage proteins and other plant proteins when the polypeptides are expressed in vivo. The polypeptides of this invention are designed to spontaneously fold into a defined, conformationally stable structure, the alpha helical coiled-coil, with minimal restrictions on the primary sequence. This allows synthetic storage proteins to be custom-tailored for specific end-user requirements. Any amino acid can be incorporated at a frequency of up to one in every seven residues using the b, c, and f positions in the heptad repeat unit. Applicants note that up to 43% of an essential amino acid from the group isoleucine, leucine, lysine, methionine, threonine, and valine can be incorporated and that up to 14% of the essential amino acids from the group phenylalanine, tryptophan, and tyrosine can be incorporated into the synthetic storage proteins of this invention. In the SSPs only Met, Leu, lie, Val or Thr are located in the hydrophobic core. Furthermore, the e, g, e', and g' positions in the SSPs are restricted such that an attractive electrostatic interaction always occurs at these positions between the two polypeptide chains in an SSP dimer. This makes the SSP polypeptides more stable as dimers. Thus, the novel synthetic storage proteins described in this invention represent a particular subset of possible coiled-coil polypeptides. Not all polypeptides which adopt an amphipathic alpha helical conformation in aqueous solution are suitable for the applications described here. The following rules derived from Applicants' work define the SSP polypeptides that Applicants use in their invention: The synthetic polypeptide comprises n heptad units (d e f g a b c), each heptad being either the same or different, wherein: n is at least 4; a and d are independently selected from the group consisting of Met, Leu, Val, He and Thr; e and g are independently selected from the group consisting of the acid/base pairs Glu Lys, Lys/Glu, Arg/Glu, Arg/Asp, Lys/Asp, Glu/Arg, Asp/Arg and Asp/Lys; and b, c and fare independently any amino acids except Gly or Pro and at least two amino acids of b, c and f in each heptad are selected from the group consisting of Glu, Lys, Asp, Arg, His, Thr, Ser, Asn, Gin, Cys and Ala. Chimeric Genes Encoding Lysine-Rich Polypeptides DNA sequences which encode the polypeptides described above can be designed based upon the genetic code. Where multiple codons exist for particular amino acids, codons should be chosen from those preferable for translation in plants. Oligonucleotides corresponding to these DNA sequences can be synthesized using an ABI DNA synthesizer, annealed with oligonucleotides corresponding to the complementary strand and inserted into a plasmid vector by methods known to those skilled in the art. The encoded polypeptide sequences can be lengthened by inserting additional annealed oligonucleotides at restriction endonuclease sites engineered into the synthetic gene. Some representative strategies for constructing genes encoding lysine-rich polypeptides of the invention, as well as DNA and amino acid sequences of preferred embodiments are provided in Example 21. A chimeric gene designed to express RNA for a synthetic storage protein gene encoding a lysine-rich polypeptide can be constructed by linking the gene to any of the plant promoter sequences described above. Preferred promoters would be seed-specific promoters. For soybean, rapeseed and other dicotyledonous plants strong seed-specific promoters from a bean phaseolin gene, a soybean β-conglycinin gene, glycinin gene, Kunitz trypsin inhibitor gene, or rapeseed napin gene would be preferred. For com or other monocotyledonous plants, a strong endosperm-specific promoter, e.g., the 10 kD or 27 kD zein promoter, or a strong embyro-specific promoter, e.g., the com globulin 1 promoter, would be preferred. In order to obtain plants that express a chimeric gene for a synthetic storage protein gene encoding a lysine-rich polypeptide, plants can be transformed by any of the methods described above. In order to obtain plants that express both a chimeric SSP gene and chimeric genes encoding substantially lysine-insensitive DHDPS and AK, the SSP gene could be linked to the chimeric genes encoding substantially lysine-insensitive DHDPS and AK and the three genes could be introduced into plants via transformation. Altematively, the chimeric SSP gene could be introduced into previously transformed plants that express substantially lysine-insensitive DHDPS and AK, or the SSP gene could be introduced into normal plants and the transformants obtained could be crossed with plants that express substantially lysine-insensitive DHDPS and AK. Results from genetic crosses of transformed plants containing lysine biosynthesis genes with transformed plants containing lysine-rich protein genes (see Example 23) demonstrate that the total lysine levels in seeds can be increased by the coordinate expression of these genes. This result was especially striking because the gene copy number of all of the transgenes was reduced in the hybrid. It is expected that the lysine level would be further increased if the biosynthesis genes and the lysine-rich protein genes were all homozygous. Use of the cts/lvsC-M4 Chimeric Gene as a Selectable Marker for Plant Transformation Growth of cell cultures and seedlings of many plants is inhibited by high concentrations of lysine plus threonine. Growth is restored by addition of methionine (or homoserine which is converted to methionine in vivo). Lysine plus threonine inhibition is thought to result from feedback inhibition of endogenous AK, which reduces flux through the pathway leading to starvation for methionine. In tobacco there are two AK enzymes in leaves, one lysine-sensitive and one threonine sensitive. [Negrutui et al. (1984) Theor. Appl. Genet. 65:11-20]. High concentrations of lysine plus threonine inhibit growth of shoots from tobacco leaf disks and inhibition is reversed by addition of low concentrations of methionine. Thus, growth inhibition is presumably due to inhibition of the two AK isozymes. Expression of active lysine and threonine insensitive AKIII-M4 also reverses lysine plus threonine growth inhibition (Table 2, Example 7). There is a good correlation between the level of AKIII-M4 protein expressed and the resistance to lysine plus threonine. Expression of lysine-sensitive wild type AKIII does not have a similar effect. Since expression of the AKIII-M4 protein permits growth under normally inhibitory conditions, a chimeric gene that causes expression of AKIII-M4 in plants can be used as a selectable genetic marker for transformation as illustrated in Examples 13 and 17. EXAMPLES The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions. EXAMPLE 1 Isolation of the E. coli IvsC Gene and mutations in lysC resulting in lysine-insensitive AKIII The E. coli lysC gene has been cloned, restriction endonuclease mapped and sequenced previously [Cassan et al. (1986) J Biol. Chem. 261:1052-1057]. For the present invention the lysC gene was obtained on a bacteriophage lambda clone from an ordered library of 3400 overlapping segments of cloned E. coli DNA constructed by Kohara, Akiyama and Isono [Kohara et al. (1987) Cell 50:595-508]. This library provides a physical map of the whole E. coli chromosome and ties the physical map to the genetic map. From the knowledge of the map position of IvsC at 90 min on the E. coli genetic map [Theze et al. (1974) J. Bacteriol 7 7:133-143], the restriction endonuclease map of the cloned gene [Cassan et al. (1986) J. Biol. Chem. 267:1052-1057], and the restriction endonuclease map of the cloned DNA fragments in the E. coli library [Kohara et al. (1987) Cell 50:595-508], it was possible to choose lambda phages 4E5 and 7A4 [Kohara et al. (1987) Cell 50:595-508] as likely candidates for carrying the lysC gene. The phages were grown in liquid culture from single plaques as described [see Current Protocols in Molecular Biology (1987) Ausubel et al. Eds. John Wiley & Sons New York] using LE392 as host [see Sambrook et al. (1989) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press]. Phage DNA was prepared by phenol extraction as described [see Current Protocols in Molecular Biology (1987) Ausubel et al. eds. John Wiley & Sons New York]. From the sequence of the gene several restriction endonuclease fragments diagnostic for the lysC gene were predicted, including an 1860 bp EcoR I-Nhe I fragment, a 2140 bp EcoR I-Xmn I fragment and a 1600 bp EcoR I-BamH I fragment. Each of these fragments was detected in both of the phage DNAs confirming that these carried the lysC gene. The EcoR I-Nhe I fragment was isolated and subcloned in plasmid pBR322 digested with the same enzymes, yielding an ampicillin-resistant, tetracycline-sensitive E. coli transformant. The plasmid was designated pBT436. To establish that the cloned IvsC gene was functional, pBT436 was transformed into E. coli strain GiflOόMl (E. coli Genetic Stock Center strain CGSC-5074) which has mutations in each of the three E. coli AK genes [Theze et al. (1974) J. Bacteriol 777:133-143]. This strain lacks all AK activity and therefore requires diaminopimelate (a precursor to lysine which is also essential for cell wall biosynthesis), threonine and methionine. In the transformed strain all these nutritional requirements were relieved demonstrating that the cloned lysC gene encoded functional AKIII. Addition of lysine (or diaminopimelate which is readily converted to lysine in vivo) at a concentration of approximately 0.2 mM to the growth medium inhibits the growth of GiflOόMl transformed with pBT436. M9 media [see Sambrook et al. (1989) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press] supplemented with the arginine and isoleucine, required for GiflOόMl growth, and ampicillin, to maintain selection for the pBT436 plasmid, was used. This inhibition is reversed by addition of threonine plus methionine to the growth media. These results indicated that AKIII could be inhibited by exogenously added lysine leading to starvation for the other amino acids derived from aspartate. This property of pBT436-transformed GiflOόMl was used to select for mutations in lysC that encoded lysine-insensitive AKIII. Single colonies of GiflOόMl transformed with pBT436 were picked and resuspended in 200 μL of a mixture of 100 μL 1% lysine plus 100 μL of M9 media. The entire cell suspension containing 10 7 -10 8 cells was spread on a petri dish containing M9 media supplemented with the arginine, isoleucine, and ampicillin. Sixteen petri dishes were thus prepared. From 1 to 20 colonies appeared on 11 of the 16 petri dishes. One or two (if available) colonies were picked and retested for lysine resistance and from this nine lysine-resistant clones were obtained. Plasmid DNA was prepared from eight of these and re- transformed into GiflOόMl to determine whether the lysine resistance determinant was plasmid-bome. Six of the eight plasmid DNAs yielded lysine- resistant colonies. Three of these six carried lysC genes encoding AKIII that was uninhibited by 15 mM lysine, whereas wild type AKIII is 50% inhibited by 0.3-0.4 mM lysine and >90% inhibited by 1 mM lysine (see Example 2 for details). To determine the molecular basis for lysine-resistance the sequences of the wild type lysC gene and three mutant genes were determined. A method for "Using mini-prep plasmid DNA for sequencing double stranded templates with Sequenase™" [Kraft et al. (1988) BioTechniques 6:544-545] was used. Oligonucleotide primers, based on the published lysC sequence and spaced approximately every 200 bp, were synthesized to facilitate the sequencing. The sequence of the wild type IvsC gene cloned in pBT436 (SEQ ID NO:l) differed from the published IvsC sequence in the coding region at 5 positions. Four of these nucleotide differences were at the third position in a codon and would not result in a change in the amino acid sequence of the AKIII protein. One of the differences would result in a cysteine to glycine substitution at amino acid 58 of AKIII. These differences are probably due to the different strains from which the lysC genes were cloned. The sequences of the three mutant lysC genes that encoded lysine- insensitive AK each differed from the wild type sequence by a single nucleotide, resulting in a single amino acid substitution in the protein. Mutant M2 had an A substituted for a G at nucleotide 954 of SEQ ID NO:l resulting in an isoleucine for methionine substitution at amino acid 318 and mutants M3 and M4 had identical T for C substitutions at nucleotide 1055 of SEQ ID NO:l resulting in an isoleucine for threonine substitution at amino acid 352. Thus, either of these single amino acid substitutions is sufficient to render the AKIII enzyme insensitive to lysine inhibition. EXAMPLE 2 High level expression of wild type and mutant IvsC genes in E. coli An Nco I (CCATGG) site was inserted at the translation initiation codon of the IvsC gene using the following oligonucleotides: SEQ ID NO:2: GATCCATGGC TGAAATTGTT GTCTCCAAAT TTGGCG SEQ ID NO:3: GTACCGCCAA ATTTGGAGAC AACAATTTCA GCCATG When annealed these oligonucleotides have BamH I and Asp718 "sticky" ends. The plasmid pBT436 was digested with BamH I, which cuts upstream of the lysC coding sequence and Asp718 which cuts 31 nucleotides downstream of the initiation codon. The annealled oligonucleotides were ligated to the plasmid vector and E. coli transformants were obtained. Plasmid DNA was prepared and screened for insertion of the oligonucleotides based on the presence of an Nco I site. A plasmid containing the site was sequenced to assure that the insertion was correct, and was designated pBT457. In addition to creating an Nco I site at the initiation codon of lysC. this oligonucleotide insertion changed the second codon from TCT, coding for serine, to GCT, coding for alanine. This amino acid substitution has no apparent effect on the AKIII enzyme activity. To achieve high level expression of the IvsC genes in E. coli, the bacterial expression vector pBT430 was used. This vector is a derivative of pΕT-3a [Rosenberg et al. (1987) Gene 56:125-135] which employs the bacteriophage T7 RNA polymerase/T7 promoter system. Plasmid pBT430 was constmcted by first destroying the EcoR I and Hind III sites in pET-3a at their original positions. An oligonucleotide adaptor containing EcoR I and Hind III sites was inserted at the BamH I site of pET-3a. This created pET-3aM with additional unique cloning sites for insertion of genes into the expression vector. Then, the Nde I site at the position of translation initiation was converted to an Nco I site using oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM in this region, 5'-CATATGG. was converted to 5'-CCCATGG in pBT430. The lysC gene was cut out of plasmid pBT457 as a 1560 bp Nco I-EcoR I fragment and inserted into the expression vector pBT430 digested with the same enzymes, yielding plasmid pBT461. For expression of the mutant lysC genes (M2, M3 and M4) pBT461 was digested with Kpn I-EcoR I, which removes the wild type lysC gene from about 30 nucleotides downstream from the translation start codon, and inserting the homologous Kpn I-EcoR I fragments from the mutant genes yielding plasmids pBT490, pBT491 and pBT492, respectively. For high level expression each of the plasmids was transformed into E. coli strain BL21(DE3) [Studier et al. (1986) J. Mol. Biol. 759:113-130]. Cultures were grown in LB medium containing ampicillin (100 mg/L) at 25°C. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio-β-galactoside, the inducer) was added to a final concentration of 0.4 mM and incubation was continued for 3 h at 25°. The cells were collected by centrifugation and resuspended in l/20th (or 1/lOOth) the original culture volume in 50 mM NaCl; 50 mM Tris-Cl, pH 7.5; 1 mM EDTA, and frozen at -20°. Frozen aliquots of 1 mL were thawed at 37° and sonicated, in an ice-water bath, to lyse the cells. The lysate was centrifuged at 4° for 5 min at 15,000 rpm. The supernatant was removed and the pellet was resuspended in 1 mL of the above buffer. The supernatant and pellet fractions of uninduced and IPTG-induced cultures of BL21(DE3)/pBT461 were analyzed by SDS polyacrylamide gel electrophoresis. The major protein visible by Coomassie blue staining in the supernatant of the induced culture had a molecular weight of about 48 kd, the expected size for AKIII. About 80% of the AKIII protein was in the supernatant and AKIII represented 10-20% of the total E. coli protein in the extract. AK activity was assayed as shown below: Assay mix (for 12 assay tubes): 4.5 mL H 2 0 1.0 mL 8M KOH 1.0 mL 8M NH 2 OH-HCl 0.5 mL 0.2M ATP (121 mg/mL in 0.2M NaOH) 50 μL 1M MgSO 4 Each 1.5 mL eppendorf assay tube contained: 0.64 mL assay mix 0.04 mL 0.2 M L-aspartic acid or 0.04 mL H O 0.0005-0.12 mL extract H 2 0 to total volume 0.8 mL Assay tubes were incubated at 30° for desired time (10-60 min). Then 0.4 mL FeCl 3 reagent (10% w/v FeCl 3 , 3.3% trichloroacetic acid, 0.7 M HCl) was added and the material centrifuged for 2 min in an eppendorf centrifuge. The supernatant was decanted. The OD was read at 540 nm and compared to the aspartyl-hydroxamate standard. Approximately 80% of the AKIII activity was in the supernatant fraction. The specific activity of wild type and mutant crude extracts was 5-7 μM product per min per milligram total protein. Wild type AKIII was sensitive to the presence of L-lysine in the assay. Fifty percent inhibition was found at a concentration of about 0.4 mM and 90% inhibition at about 1.0 mM. In contrast, mutants AKIII-M2, M3 and M4 (see Example 1) were not inhibited at all by 15 mM L-lysine. Wild type AKIII protein was purified from the supernatant of the IPTG- induced culture as follows. To 1 mL of extract, 0.25 mL of 10% streptomycin sulfate was added and kept at 4° overnight. The mixture was centrifuged at 4° for 15 min at 15,000 rpm. The supernatant was collected and desalted using a Sephadex G-25 M column (Column PD-10, Pharmacia). It was then run on a Mono-Q HPLC column and eluted with a 0-1M NaCl gradient. The two 1 mL fractions containing most of the AKIII activity were pooled, concentrated, desalted and run on an HPLC sizing column (TSK G3000SW). Fractions were eluted in 20 mM KPO 4 buffer, pH7.2, 2 mM MgSO 4 , 10 mM β-mercaptoethanol, 0.15 M KC1, 0.5 mM L-lysine and were found to be >95% pure by SDS polyacrylamide gel electrophoresis. Purified AKIII protein was sent to Hazelton Research Facility (310 Swampridge Road, Denver, PA 17517) to have rabbit antibodies raised against the protein. EXAMPLE 3 Isolation of the E. coli and Corynebacterium glutamicum dap A genes The E. coli dapA gene (ecodapA) has been cloned, restriction endonuclease mapped and sequenced previously [Richaud et al. (1986) J Bacteriol 766:297-300]. For the present invention the dapA gene was obtained on a bacteriophage lambda clone from an ordered library of 3400 overlapping segments of cloned E. coli DNA constmcted by Kohara, Akiyama and Isono [Kohara et al. (1987) Cell 50:595-508, see Example 1]. From the knowledge of the map position of dap A at 53 min on the E. coli genetic map [Bachman (1983) Microbiol Rev. 47:180-230], the restriction endonuclease map of the cloned gene [Richaud et al. (1986) J. Bacteriol. 766:297-300], and the restriction endonuclease map of the cloned DNA fragments in the E. coli library [Kohara et al. (1987) Cell 50:595-508], it was possible to choose lambda phages 4C11 and 5A8 [Kohara et al. (1987) Cell 50:595-508] as likely candidates for carrying the dapA gene. The phages were grown in liquid culture from single plaques as described [see Current Protocols in Molecular Biology (1987) Ausubel et al. eds., John Wiley & Sons New York] using LE392 as host [see Sambrook et al. (1989) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press]. Phage DNA was prepared by phenol extraction as described [see Current Protocols in Molecular Biology (1987) Ausubel et al. eds., John Wiley & Sons New York]. Both phages contained an approximately 2.8 kb Pst I DNA fragment expected for the dapA gene [Richaud et al. (1986) J. Bacteriol. 766:297-300]. The fragment was isolated from the digest of phage 5A8 and inserted into Pst I digested vector pBR322 yielding plasmid pBT427. The Corynebacterium dapA gene (cordapA) was isolated from genomic DNA from ATCC strain 13032 using polymerase chain reaction (PCR). The nucleotide sequence of the Corynebacterium dapA gene has been published [Bonnassie et al. (1990) Nucleic Acids Res. 75:6421]. From the sequence it was possible to design oligonucleotide primers for PCR that would allow amplification of a DNA fragment containing the gene, and at the same time add unique restriction endonuclease sites at the start codon (Nco I) and just past the stop codon (EcoR I) of the gene. The oligonucleotide primers used were: SEQ ID NO:4: CCCGGGCCAT GGCTACAGGT TTAACAGCTA AGACCGGAGT AGAGCACT SEQ ID NO:5: GATATCGAAT TCTCATTATA GAACTCCAGC TTTTTTC PCR was performed using a Perkin-Elmer Cetus kit according to the instructions of the vendor on a thermocycler manufactured by the same company. The reaction product, when run on an agarose gel and stained with ethidium bromide, showed a strong DNA band of the size expected for the Corynebacterium dapA gene, about 900 bp. The PCR-generated fragment was digested with restriction endonucleases Nco I and EcoR I and inserted into expression vector pBT430 (see Example 2) digested with the same enzymes. In addition to introducing an Nco I site at the translation start codon, the PCR primers also resulted in a change of the second codon from AGC coding for serine to GCT coding for alanine. Several clones that expressed active, lysine- insensitive DHDPS (see Example 4) were isolated, indicating that the second codon amino acid substitution did not affect activity; one clone was designated FS766. The Nco I to EcoR I fragment carrying the PCR-generated Corynebacterium dapA gene was subcloned into the phagemid vector pGEM-9Zf(-) from Promega, single-stranded DNA was prepared and sequenced. This sequence is shown in SEQ ID NO:6. Aside from the differences in the second codon already mentioned, the sequence matched the published sequence except at two positions, nucleotides 798 and 799. In the published sequence these are TC, while in the gene shown in SEQ ID NO: 6 they are CT. This change results in an amino acid substitution of leucine for serine. The reason for this difference is not known. It may be due to an error in the published sequence, the difference in strains used to isolate the gene, or a PCR-generated error. The latter seems unlikely since the same change was observed in at least 3 independently isolated PCR-generated dapA genes. The difference has no apparent effect on DHDPS enzyme activity (see Example 4). EXAMPLE 4 High level expression of the E. coli and Corynebacterium glutamicum dapA genes in E. coli An Nco I (CCATGG) site was inserted at the translation initiation codon of the E. coli dapA gene using oligonucleotide-directed mutagenesis. The 2.8 kb Pst I DNA fragment carrying the dapA gene in plasmid pBT427 (see Example 3) was inserted into the Pst I site of phagemid vector pTZ18R (Pharmacia) yielding pBT431. The orientation of the dapA gene was such that the coding strand would be present on the single-stranded phagemid DNA. Oligonucleotide-directed mutagenesis was carried out using a Muta-Gene kit from Bio-Rad according to the manufacturer's protocol with the mutagenic primer shown below: SEQ ID NO:7: CTTCCCGTGA CCATGGGCCATC Putative mutants were screened for the presence of an Nco I site and a plasmid, designated pBT437, was shown to have the proper sequence in the vicinity of the mutation by DNA sequencing. The addition of an Nco I site at the translation start codon also resulted in a change of the second codon from TTC coding for phenylalanine to GTC coding for valine. To achieve high level expression of the dapA genes in E. coli the bacterial expression vector pBT430 (see Example 2) was used. The E. coli dapA gene was cut out of plasmid pBT437 as an 1150 bp Nco I-Hind III fragment and inserted into the expression vector pBT430 digested with the same enzymes, yielding plasmid pBT442. For expression of the Corynebacterium dapA gene, the 910 bp Nco I to EcoR I fragment of SEQ ID NO:6 inserted in pBT430 (pFS766, see Example 3) was used. For high level expression each of the plasmids was transformed into E. coli strain BL21(DE3) [Studier et al. (1986) J. Mol. Biol. 759:113-130]. Cultures were grown in LB medium containing ampicillin (100 mg/L) at 25°. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio-β-galactoside, the inducer) was added to a final concentration of 0.4 mM and incubation was continued for 3 h at 25°. The cells were collected by centrifugation and resuspended in l/20th (or 1/100th) the original culture volume in 50 mM NaCl; 50 mM Tris-Cl, pH 7.5; 1 mM EDTA, and frozen at -20°. Frozen aliquots of 1 mL were thawed at 37° and sonicated, in an ice-water bath, to lyse the cells. The lysate was centrifuged at 4° for 5 min at 15,000 rpm. The supernatant was removed and the pellet was resuspended in 1 mL of the above buffer. The supernatant and pellet fractions of uninduced and IPTG-induced cultures of BL21(DE3)/pBT442 or BL21(DE3)/pFS766 were analyzed by SDS polyacrylamide gel electrophoresis. The major protein visible by Coomassie blue staining in the supernatant and pellet fractions of both induced cultures had a molecular weight of 32-34 kd, the expected size for DHDPS. Even in the uninduced cultures this protein was the most prominent protein produced. In the BL21(DE3)/pBT442 IPTG-induced culture about 80% of the DHDPS protein was in the supernatant and DHDPS represented 10-20% of the total protein in the extract. In the BL21(DE3)/pFS766 IPTG-induced culture more than 50% of the DHDPS protein was in the pellet fraction. The pellet fractions in both cases were 90-95% pure DHDPS, with no other single protein present in significant amounts. Thus, these fractions were pure enough for use in the generation of antibodies. The pellet fractions containing 2-4 mg of either E. coli DHDPS or Corynebacterium DHDPS were solubilized in 50 mM NaCl; 50 mM Tris-Cl, pH 7.5; 1 mM EDTA, 0.2 mM dithiothreitol, 0.2% SDS and sent to Hazelton Research Facility (310 Swampridge Road, Denver, PA 17517) to have rabbit antibodies raised against the proteins. DHDPS enzyme activity was assayed as follows: Assay mix (for 10 X 1.0 mL assay tubes or 40 X 0.25 mL for microtiter dish); made fresh, just before use: 2.5 mL H 2 0 0.5 mL 1.0 M Tris-HCl pH8.0 0.5 mL 0.1 M Na Pyruvate 0.5 mL o-Aminobenzaldehyde (lOmg/mL in ethanol) 25 μL 1.0M DL-Aspartic-β-semialdehyde (ASA) in 1.ON HCl Assay (1.0 mL): MicroAssay (0.25mL): DHDPS assay mix 0.40 mL 0.10 mL enzyme extract + H 2 0; 0.10 mL .025 mL 10 mM L-lysine 5 μL or 20 μL 1 μL or 5 μL Incubate at 30° for desired time. Stop by addition of: 1.0 N HCl 0.50 mL 0.125 mL Color allowed to develop for 30-60 min. Precipitate spun down in eppendorf centrifuge. OD540 vs 0 min read as blank. For MicroAssay, aliquot 0.2 mL into microtiter well and read at OD 5 30. The specific activity of E. coli DHDPS in the supernatant fraction of induced extracts was about 50 OD540 units per minute per milligram protein in a 1.0 mL assay. E. coli DHDPS was sensitive to the presence of L-lysine in the assay. Fifty percent inhibition was found at a concentration of about 0.5 mM. For Corynebacterium DHDPS, the activity was measured in the supernatant fraction of uninduced extracts, rather than induced extracts. Enzyme activity was about 4 OD530 units per min per milligram protein in a 0.25 mL assay. In contrast to E. coli DHDPS, Corynebacterium DHDPS was not inhibited at all by L-lysine, even at a concentration of 70 mM. EXAMPLE 5 Excretion of amino acids by E. coli expressing high levels of DHDPS and/or AKIII The E. coli expression cassette with the E. coli dapA gene linked to the T7 RNA polymerase promoter was isolated by digesting pBT442 (see Example 4) with Bgl II and BamH I separating the digestion products via agarose gel electrophoresis and eluting the approximately 1250 bp fragment from the gel. This fragment was inserted into the BamH I site of plasmids pBT461 (containing the T7 promoter/lvsC gene) and pBT492 (containing the T7 promoter/lysC-M4 gene). Inserts where transcription of both genes would be in the same direction were identified by restriction endonuclease analysis yielding plasmids pBT517 (T7/dapA + T7/lvsC-M4) and pBT519 (T7/daoA + T7/lvsC). In order to induce E. coli to produce and excrete amino acids, these plasmids, as well as plasmids pBT442, pBT461 and pBT492 (and pBR322 as a control) were transformed into E. coli strain BL21(DE3) [Studier et al. (1986) J Mol Biol. 759:113-130]. All of these plasmids, but especially pBT517 and pBT519, are somewhat unstable in this host strain, necessitating careful maintenance of selection for ampicillin resistance during growth. All strains were grown in minimal salts M9 media [see Sambrook et al. (1989) Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press] supplemented with ampicillin to maintain selection for the plasmids ovemight at 37°. Cultures were collected when they reached an ODβoo of 1. Cells were removed by centrifugation and the supernatants (3 mL) were passed through 0.2 micron filters to remove remaining cells and large molecules. Five microliter aliquots of the supernatant fractions were analyzed for amino acid composition with a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Results are shown in Table 1. TABLE 1 Amino Acid Concentration in Culture Supernatants [mM] Plasmid Lys Thr Met Ah Val Asp Glu pBR322 0 0 0 0.05 0.1 0 0 pBT442 0.48 0 0 0.04 0.06 0 0 pBT461 0.14 0.05 0 0.02 0.03 0 0 pBT492 0.16 0.07 0 0.02 0.03 0 0 pBT517 0.18 0 0.01 0 0 0.02 0.02 pBT519 0.14 0 0.01 0 0 0.01 0 All of the plasmids, except the pBR322 control, lead to the excretion of lysine into the culture medium. Expression of the lysC or the lvsC-M4 gene lead to both lysine and threonine excretion. Expression of lvsC-M4 + dapA lead to excretion of lysine, methionine, aspartic acid and glutamic acid, but not threonine. In addition, alanine and valine were not detected in the culture supernatant. Similar results were obtained with lysC + dapA. except that no glutamic acid was excreted. EXAMPLE 6 Construction of Chimeric dapA. IvsC and fysC-M4 Genes for Expression in Plants Several gene expression cassettes were used for construction of chimeric genes for expression of ecodapA. cordapA, IvsC and lvsC-M4 in plants. A leaf expression cassette (Figure 4a) is composed of the 35S promoter of cauliflower mosaic vims [Odell et al.(1985) Nature 575:810-812; Hull et al. (1987) Virology 56:482-493], the translation leader from the chlorophyll a/b binding protein (Cab) gene, [Dunsmuir (1985) Nucleic Acids Res. 75:2503-2518] and 3' transcription termination region from the nopaline synthase (Nos) gene [Depicker et al. (1982) J Mol. Appl. Genet. 7:561-570]. Between the 5' and 3' regions are the restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), EcoR I, Sma I and Kpn I. The entire cassette is flanked by Sal I sites; there is also a BamH I site upstream of the cassette. A seed-specific expression cassette (Figure 4b) is composed of the promoter and transcription terminator from the gene encoding the β subunit of the seed storage protein phaseolin from the bean Phaseolus vulgaris [Doyle et al. (1986) J. Biol. Chem. 267:9228-9238]. The phaseolin cassette includes about 500 nucleotides upstream (5') from the translation initiation codon and about 1650 nucleotides downstream (3') from the translation stop codon of phaseolin. Between the 5' and 3' regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Sma I, Kpn I and Xba I. The entire cassette is flanked by Hind III sites. A second seed expression cassette was used for the cordapA gene. This was composed of the promoter and transcription terminator from the soybean Kunitz tyrosine inhibitor 3 (KTI3) gene [Jofuku et al. (1989) Plant Cell 7:427-435]. The KTI3 cassette includes about 2000 nucleotides upstream (5') from the translation initiation codon and about 240 nucleotides downstream (3') from the translation stop codon of phaseolin. Between the 5' and 3' regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Xba I, Kpn I and Sma I. The entire cassette is flanked by BamH I sites. A constitutive expression cassette for com was used for expression of the lysC-M4 gene and the ecodapA gene. It was composed of a chimeric promoter derived from pieces of two com promoters and modified by in vitro site-specific mutagenesis to yield a high level constitutive promoter and a 3' region from a com gene of unknown function. Between the 5' and 3' regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Sma I and Bgl II. The nucleotide sequence of the constitutive com expression cassette is shown in SEQ ID NO:93. Plant amino acid biosynthetic enzymes are known to be localized in the chloroplasts and therefore are synthesized with a chloroplast targeting signal. Bacterial proteins such as DHDPS and AKIII have no such signal. A chloroplast transit sequence (cts) was therefore fused to the ecodapA. cordapA. lysC. and lysC-M4 coding sequence in some chimeric genes. The cts used was based on the cts of the small subunit of ribulose 1,5-bisphosphate carboxylase from soybean [Berry-Lowe et al. (1982) J. Mol. Appl. Genet. 7:483-498]. The oligonucleotides SEQ ID NOS: 8-11 were synthesized and used as described below. For com the cts used was based on the cts of the small subunit of ribulose 1,5-bisphosphate carboxylase from com [Lebrun et al. (1987) Nucleic Acids Res. 75:4360] and is designated mcts to distinguish it from the soybean cts. The oligonucleotides SEQ ID NOS: 17-22 were synthesized and used as described below. Fourteen chimeric genes were created: No. 1) 35S promoter/Cab leader/lvsC/Nos 3' No. 2) 35S promoter/Cab leader/cts/lvsC/Nos 3' No. 3) 35S promoter/Cab leader/cts/_χsC-M4/Nos 3' No. 4) phaseolin 5' region/cts/lvsC/phaseolin 3' region No. 5) phaseolin 5' region/cts/lvsC-M4/phaseolin 3' region No. 6) 35S promoter/Cab leader/ecodapA/Nos 3' No. 7) 35S promoter/Cab leader/cts/ecodapA/Nos 3 No. 8) phaseolin 5' region/ecodapA/phaseolin 3' region No. 9) phaseolin 5' region/cts/ecodapA/phaseolin 3' region No. 10) 35S promoter/Cab leader/cts/cordapA/Nos 3 No. 11) phaseolin 5' region/cts/cordapA/phaseolin 3' region No. 12) KTI3 5' region/cts/cordapA/KTD 3' region No. 13) HH534 5' region/mcts/lvsC-M4/HH2- 1 3' region No. 14) HH534 5* region/mcts/ecodaEA/HH2-l 3' region A 1440 bp Nco I-Hpa I fragment containing the entire lysC coding region plus about 90 bp of 3' non-coding sequence was isolated from an agarose gel following electrophoresis and inserted into the leaf expression cassette digested with Nco I and Sma I (chimeric gene No. 1), yielding plasmid pBT483. Oligonucleotides SEQ ID NO:8 and SEQ ID NO:9, which encode the carboxy terminal part of the chloroplast targeting signal, were annealed, resulting in Nco I compatible ends, purified via polyacrylamide gel electrophoresis, and inserted into Nco I digested pBT461. The insertion of the correct sequence in the correct orientation was verified by DNA sequencing yielding pBT496. Oligonucleotides SEQ ID NO: 10 and SEQ ID NO:l 1, which encode the amino terminal part of the chloroplast targeting signal, were annealed, resulting in Nco I compatible ends, purified via polyacrylamide gel electrophoresis, and inserted into Nco I digested pBT496. The insertion of the correct sequence in the correct orientation was verified by DNA sequencing yielding pBT521. Thus the cts was fused to the lysC gene. To fuse the cts to the lysC-M4 gene, pBT521 was digested with Sal I, and an approximately 900 bp DNA fragment that included the cts and the amino terminal coding region of IvsC was isolated. This fragment was inserted into Sal I digested pBT492, effectively replacing the amino terminal coding region of lysC-M4 with the fused cts and the amino terminal coding region oflysC. Since the mutation that resulted in lysine-insensitivity was not in the replaced fragment, the new plasmid, pBT523, carried the cts fused to lysC-M4. The 1600 bp Nco I-Hpa I fragment containing the cts fused to lysC plus about 90 bp of 3' non-coding sequence was isolated and inserted into the leaf expression cassette digested with Nco I and Sma I (chimeric gene No. 2), yielding plasmid pBT541 and the seed-specific expression cassette digested with Nco I and Sma I (chimeric gene No. 4), yielding plasmid pBT543. Similarly, the 1600 bp Nco I-Hpa I fragment containing the cts fused to lysC-M4 plus about 90 bp of 3' non-coding sequence was isolated and inserted into the leaf expression cassette digested with Nco I and Sma I (chimeric gene No. 3), yielding plasmid pBT540 and the seed-specific expression cassette digested with Nco I and Sma I (chimeric gene No. 5), yielding plasmid pBT544. Before insertion into the expression cassettes, the ecodapA gene was modified to insert a restriction endonuclease site, Kpn I, just after the translation stop codon. The oligonucleotides SEQ ID NOS: 12- 13 were synthesized for this purpose: SEQ ID NO: 12: CCGGTTTGCT GTAATAGGTA CCA SEQ ID NO:13: AGCTTGGTAC CTATTACAGC AAACCGGCAT G Oligonucleotides SEQ ID NO:12 and SEQ ID NO:13 were annealed, resulting in an Sph I compatible end on one end and a Hind III compatible end on the other and inserted into Sph I plus Hind III digested pBT437. The insertion of the correct sequence was verified by DNA sequencing yielding pBT443. An 880 bp Nco I-Kpn I fragment from pBT443 containing the entire ecodapA coding region was isolated from an agarose gel following electrophoresis and inserted into the leaf expression cassette digested with Nco I and Kpn I (chimeric gene No. 6), yielding plasmid pBT450 and into the seed-specific expression cassette digested with Nco I and Kpn I (chimeric gene No. 8), yielding plasmid pBT494. Oligonucleotides SEQ ID NO:8 and SEQ ID NO:9, which encode the carboxy terminal part of the chloroplast targeting signal, were annealed resulting in Nco I compatible ends, purified via polyacrylamide gel electrophoresis, and inserted into Nco I digested pBT450. The insertion of the correct sequence in the correct orientation was verified by DNA sequencing yielding pBT451. A 950 bp Nco I-Kpn I fragment from pBT451 encoding the carboxy terminal part of the chloroplast targeting signal fused to the entire ecodapA coding region was isolated from an agarose gel following electrophoresis and inserted into the seed-specific expression cassette digested with Nco I and Kpn I, yielding plasmid pBT495. Oligonucleotides SEQ ID NO: 10: and SEQ ID NO: 11 :, which encode the amino terminal part of the chloroplast targeting signal, were annealed resulting in Nco I compatible ends, purified via polyacrylamide gel electrophoresis, and inserted into Nco I digested pBT451 and pBT495. Insertion of the correct sequence in the correct orientation was verified by DNA sequencing yielding pBT455 and pBT520, respectively. Thus the cts was fused to the ecodapA gene in the leaf expression cassette (chimeric gene No. 7) and the seed-specific expression cassette (chimeric gene No. 9). An 870 bp Nco I-EcoR I fragment from pFS766 containing the entire cordapA coding region was isolated from an agarose gel following electrophoresis and inserted into the leaf expression cassette digested with Nco I and EcoR I, yielding plasmid pFS789. To attach the cts to the cordapA gene, a DNA fragment containing the entire cts was prepared using PCR. The template DNA was pBT540 and the oligonucleotide primers used were: SEQ ID NO: 14: GCTTCCTCAA TGATCTCCTC CCCAGCT SEQ ID NO: 15: CATTGTACTC TTCCACCGTT GCTAGCAA PCR was performed using a Perkin-Elmer Cetus kit according to the instructions of the vendor on a thermocycler manufactured by the same company. The PCR-generated 160 bp fragment was treated with T4 DNA polymerase in the presence of the 4 deoxyribonucleotide triphosphates to obtain a blunt-ended fragment. The cts fragment was inserted into pFS789 which had been digested with Nco I and treated with the Klenow fragment of DNA polymerase to fill in the 5' overhangs. The inserted fragment and the vector/insert junctions were determined to be correct by DNA sequencing, yielding pFS846 containing chimeric gene No. 10. A 1030 bp Nco I-Kpn I fragment from pFS846 containing the cts attached to the cordapA coding region was isolated from an agarose gel following electrophoresis and inserted into the phaseolin seed expression cassette digested with Nco I and Kpn I, yielding plasmid pFS889 containing chimeric gene No. 11. Similarly, the 1030 bp Nco I-Kpn I fragment from pFS846 was inserted into the KTI3 seed expression cassette digested with Nco I and Kpn I, yielding plasmid pFS862 containing chimeric gene No. 12. Oligonucleotides SEQ ID NO:94 and SEQ ID NO:95, which encode the carboxy terminal part of the com chloroplast targeting signal, were annealed, resulting in Xba I and Nco I compatible ends, purified via polyacrylamide gel electrophoresis, and inserted into Xba I plus Nco I digested pBT492 (see Example 2). The insertion of the correct sequence was verified by DNA sequencing yielding pBT556. Oligonucleotides SEQ ID Nθ:96 and SEQ ID NO:97, which encode the middle part of the chloroplast targeting signal, were annealed, resulting in Bgl II and Xba I compatible ends, purified via polyacrylamide gel electrophoresis, and inserted into Bgl II and Xba I digested pBT556. The insertion of the correct sequence was verified by DNA sequencing yielding pBT557. Oligonucleotides SEQ ID NO:98 and SEQ ID NO:99, which encode the amino terminal part of the chloroplast targeting signal, were annealed, resulting in Nco I and Afl II compatible ends, purified via polyacrylamide gel electrophoresis, and inserted into Nco I and Afl II digested pBT557. The insertion of the correct sequence was verified by DNA sequencing yielding pBT558. Thus the mcts was fused to the lysC-M4 gene. A 1.6 kb Nco I-Hpa I fragment from pBT558 containing the mcts attached to the lysC-M4 gene was isolated from an agarose gel following electrophoresis and inserted into the constitutive com expression cassette digested with Nco I and Sma I, yielding plasmid pBT573 containing chimeric gene No. 13. To attach the mcts to the ecodapA gene a DNA fragment containing the entire mcts was prepared using PCR as described above. The template DNA was pBT558 and the oligonucleotide primers used were: SEQ ID NO:100: GCGCCCACCG TGATGA SEQIDNO:101: CACCGGATTC TTCCGC The mcts fragment was inserted into pBT450 (above) which had been digested with Nco I and treated with the Klenow fragment of DNA polymerase to fill in the 5' overhangs. The inserted fragment and the vector/insert junctions were determined to be correct by DNA sequencing, yielding pBT576. Plasmid pBT576 was digested with Asp718, treated with the Klenow fragment of DNA polymerase to yield a blunt-ended fragment, and then digested with Nco I. The resulting 1030 bp Nco I-blunt-ended fragment containing the ecodapA gene attached to the mcts was isolated from an agarose gel following electrophoresis. This fragment was inserted into the constitutive com expression cassette digested with Bgl II, treated with the Klenow fragment of DNA polymerase to yield a blunt-ended fragment, and then digested with Nco I, yielding plasmid pBT583 containing chimeric gene No. 14. EXAMPLE 7 Transformation of Tobacco with the 35S Promoter/lvsC Chimeric Genes Transformation of tobacco with the 35S promoter/lvsC chimeric genes was effected according to the following: The 35S promoter/Cab leader/lvsC/Nos 3', 35S promoter/Cab leader/cts/lvsC/Nos 3', and 35S promoter/Cab leader/cts/lvsC-M4/Nos 3' chimeric genes were isolated as 3.5-3.6 kb BamH I-EcoR I fragments and inserted into BamH I-EcoR I digested vector pZS97K (Figure 5), yielding plasmids ρBT497, pBT545 and pBT542, respectively. The vector is part of a binary Ti plasmid vector system [Bevan, (1984) Nucl. Acids. Res. 72:8711-8720] of Agrobacterium tumefaciens. The vector contains: (1) the chimeric gene nopaline synthase promoter/neomycin phosphotransferase coding region (nos:NPT II) as a selectable marker for transformed plant cells [Bevan et al. (1983) Nature 504:184-186]; (2) the left and right borders of the T-DNA of the Ti plasmid [Bevan (1984) Nucl Acids. Res. 72:8711-8720]; (3) the E. coli lacZ α-complementing segment [Viera and Messing (1982) Gene 79:259-267] with unique restriction endonuclease sites for EcoR I, Kpn I, BamH I and Sal I; (4) the bacterial replication origin from the Pseudomonas plasmid pVSl [Itoh et al. (1984) Plasmid 77:206-220]; and (5) the bacterial neomycin phosphotransferase gene from Tn5 [Berg et al. (1975) Proc. Natl. Acad Sci. U.S.A. 72:3628-3632] as a selectable marker for transformed _4. tumefaciens. The 35S promoter/Cab leader/cts/lvsC/Nos 3', and 35S promoter/Cab leader/cts/lysC-M4/Nos 3' chimeric genes were also inserted into the binary vector pBT456, yielding pBT547 and pBT546, respectively. This vector is pZS97K, into which the chimeric gene 35S promoter/Cab leader/cts/dapA/Nos 3' had previously been inserted as a BamH I-Sal I fragment (see Example 9). In the cloning process large deletions of the dapA chimeric gene occurred. As a consequence these plasmids are equivalent to pBT545 and pBT542, in that the only transgene expressed in plants (other than the selectable marker gene, NPT II) was 35 S promoter/Cab leader/cts/lvsC/Nos 3' or 35S promoter/Cab leader/cts/lysC-M4/Nos 3'. The binary vectors containing the chimeric IvsC genes were transferred by tri-parental matings [Ruvkin et al. (1981) Nature 289:85-88] to Agrobacterium strain LBA4404/pAL4404 [Hockema et al (1983), Nature 505:179-180]. The Agrobacterium transformants were used to inoculate tobacco leaf disks [Horsch et al. (1985) Science 227:1229-1231]. Transgenic plants were regenerated in selective medium containing kanamycin. To assay for expression of the chimeric genes in leaves of the transformed plants, protein was extracted as follows. Approximately 2.5 g of young plant leaves, with the midrib removed, were placed in a dounce homogenizer with 0.2 g of polyvinyl polypyrrolidone and 11 mL of 50mM Tris-HCl pH8.0, 50mM NaCl, ImM EDTA (TNE) and ground thoroughly. The suspension was further homogenized by a 20 sec treatment with a Brinkman Polytron Homogenizer operated at setting 7. The resultant suspensions were centrifuged at 16,000 rpm for 20 min at 4° in a Dupont-Sorvall superspeed centrifuge using an SS34 rotor to remove particulates. The supernatant was decanted, the volume was adjusted to be 10 mL by addition of TNE if necessary, and 8 mL of cold, saturated ammonium sulfate was added. The mixture was set on ice for 30 min and centrifuged as described above. The supernatant was decanted and the pellet, which contained the AKIII protein, was resuspended in 1 mL of TNE and desalted by passage over a Sephadex G-25 M column (Column PD-10, Pharmacia). For immunological characterization, three volumes of extract were mixed with 1 volume of 4 X SDS-gel sample buffer (0.17M Tris-HCl pH6.8, 6.7% SDS, 16.7% (v/v) β-mercaptoethanol, 33% (v/v) glycerol) and 3 μL from each extract were run per lane on an SDS polyacrylamide gel, with bacterially produced AKIII serving as a size standard and protein extracted from untransformed tobacco leaves serving as a negative control. The proteins were then electrophoretically blotted onto a nitrocellulose membrane (Western Blot). The membranes were exposed to the AKIII antibodies prepared as described in Example 2 at a 1 :5000 dilution of the rabbit serum using standard protocol provided by BioRad with their Immun-Blot Kit. Following rinsing to remove unbound primary antibody, the membranes were exposed to the secondary antibody, donkey anti-rabbit Ig conjugated to horseradish peroxidase (Amersham) at a 1:3000 dilution. Following rinsing to remove unbound secondary antibody, the membranes were exposed to Amersham chemiluminescence reagent and X-ray film. Seven of thirteen transformants containing the chimeric gene, 35S promoter/Cab leader/cts/lvsC-M4/Nos 3', and thirteen of seventeen transformants containing the chimeric gene, 35S promoter/Cab leader/cts/lvsC/Nos 3', produced AKIII protein (Table 2). In all cases protein which reacted with the AKIII antibody was of several sizes. Approximately equal quantities of proteins equal in size to AKIII produced in E. coli, and a protein about 6 kd larger were evident in all samples, suggesting that the chloroplast targeting signal had been removed from about half of the protein synthesized. This further suggests that about half of the protein entered the chloroplast. In addition, a considerable amount of protein of higher molecular weight was observed. The origin of this protein is unclear; the total amount present was equal or slightly greater than the amounts of the mature and putative AKIII precursor proteins combined. The leaf extracts were assayed for AK activity as described in Example 2. AKIII could be distinguished from endogenous AK activity, if it were present, by its increased resistance to lysine plus threonine. Unfortunately, however, this assay was not sensitive enough to reliably detect AKIII activity in these extracts. Zero of four transformants containing the chimeric gene, 35S promoter/Cab leader/lvsC/Nos 3', showed AKIII activity. Only one extract, from a transformant containing the 35S promoter/Cab leader/cts/lysC-M4/Nos 3' gene, produced a convincing level of enzyme activity. This came from transformant 546-49 A, and was also the extract that showed the highest level of AKIII-M4 protein via Western blot. An alternative method to detect the expression of active AKIII enzyme was to evaluate the sensitivity or resistance of leaf tissue to high concentrations of lysine plus threonine. Growth of cell cultures and seedlings of many plants is inhibited by high concentrations of lysine plus threonine; this is reversed by addition of methionine (or homoserine which is converted to methionine in vivo). Lysine plus threonine inhibition is thought to result from feedback inhibition of endogenous AK, which reduces flux through the pathway leading to starvation for methionine. In tobacco there are two AK enzymes in leaves, one lysine-sensitive and one threonine sensitive [Negrutui et al. (1984) Theor. Appl. Genet. 68:11-20]. High concentrations of lysine plus threonine inhibit growth of shoots from tobacco leaf disks and inhibition is reversed by addition of low concentrations of methionine. Thus, growth inhibition is presumably due to inhibition of the two AK isozymes. Expression of active lysine and threonine insensitive AKIII-M4 would be predicted to reverse the growth inhibition. As can be seen in Table 2, this was observed. There is, in fact, a good correlation between the level of AKIII-M4 protein expressed and the resistance to lysine plus threonine inhibition. Expression of lysine-sensitive wild type AKIII does not have a similar effect. Only the highest expressing transformant showed any resistance to lysine plus threonine inhibition, and this was much less dramatic than that observed with AKIII-M4. To measure free amino acid composition of the leaves, free amino acids were extracted as follows. Approximately 30-40 mg of young leaf tissue was chopped with a razor and dropped into 0.6 mL of methanol/ chloroform/water mixed in ratio of 12v/5v/3v (MCW) on dry ice. After 10-30 min the suspensions were brought to room temperature and homogenized with an Omni 1000 Handheld Rechargeable Homogenizer and then centrifuged in an eppendorf microcentrifuge for 3 min. Approximately 0.6 mL of supernatant was decanted and an additional 0.2 mL of MCW was added to the pellet which was then vortexed and centrifuged as above. The second supernatant, about 0.2 mL, was added to the first. To this, 0.2mL of chloroform was added followed by 0.3 mL of water. The mixture was vortexed and the centrifuged in an eppendorf microcentrifuge for about 3 min, the upper aqueous phase, approximately 1.0 mL, was removed, and was dried down in a Savant Speed Vac Concentrator. One-tenth of the sample was run on a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Relative free amino acid levels in the leaves were compared as ratios of lysine or threonine to leucine, thus using leucine as an internal standard. There was no consistent effect of expression of AKIII or AKIII-M4 on the lysine or threonine (or any other amino acid) levels in the leaves (Table 2). TABLE 2 BT542 transformants: 35S promoter/Cab leader/cts/lvsC-M4/Nos 3' BT545 transformants: 35S promoter/Cab leader/cts/lvsC/Nos 3' BT546 transformants: 35S promoter/Cab leader/cts/lysC-M4/Nos 3' BT547 transformants: 35S promoter/Cab leader/cts/lvsC/Nos 3' FREE AMINO AKIII RESISTANCE ACIDS/LEAF ACTIVITY WESTERN TO Lys 3mM LINE K/L T/L U/MG/HR BLOT + Thr 3mM 542-5B 0.5 3.5 0 - - 542-26A 0.5 3.3 0 - - 542-27B 0.5 3.4 0 ++ +++ 542-35A 0.5 4.3 0.01 - - 542-54A 0.5 2.8 0 - - 542-57B 0.5 3.4 0 - + 545-5A n.d. n.d. 0.02 ++ 545-7B 0.5 3.4 0 + 545- 17B 0.6 2.5 0.01 + 545-27A 0.6 3.5 0 ++ 545-50E 0.6 3.6 0.03 ++ 545-52A 0.5 3.6 0.02 - 546-4A 0.4 4.5 0 + + 546-24B 0.6 4.9 0.04 ++ -H- 546-44A 0.5 6.0 0.03 + ++ 546-49A 0.7 7.0 0.10 +++ +-H- 546-54A 0.5 6.4 0 + + 546-56B 0.5 4.4 0.01 - - 546-58B 0.6 8.0 0 + ++ 547-3D 0.4 5.4 0 ++ - 547-8B 0.6 5.0 0.02 - 547-9A 0.5 4.3 0.03 547- 12A 0.7 3.9 547- 15B 0.6 4.5 547- 16A 0.5 3.6 547- 18A 0.5 4.0 547-22A 0.8 4.4 547-25C 0.5 4.3 547-28C 0.6 5.6 547-29C 0.5 3.8 EXAMPLE 8 Transformation of Tobacco with the Phaseolin Promoter/lvsC Chimeric Genes The phaseolin promoter/lvsC chimeric gene cassettes, phaseolin 5' region/cts/lvsC/phaseolin 3' region, and phaseolin 5' region/cts/lysC-M4/phaseolin 3' region (Example 6) were isolated as approximately 3.3 kb Hind III fragments. These fragments were inserted into the unique Hind III site of the binary vector pZS97 (Figure 6) yielding pBT548 and pBT549, respectively. This vector is similar to pZS97K described in Example 7 except for the presence of two additional unique cloning sites, Sma I and Hind III, and the bacterial β-lactamase gene (causing ampicillin resistance) as a selectable marker for transformed A. tumefaciens instead of the bacterial neomycin phosphotransferase gene. The binary vectors containing the chimeric lysC genes were transferred by tri-parental matings to Agrobacterium strain LBA4404/pAL4404, the Agrobacterium transformants were used to inoculate tobacco leaf disks and transgenic plants regenerated by the methods set out in Example 7. To assay for expression of the chimeric genes in the seeds of the transformed plants, the plants were allowed to flower, self-pollinate and go to seed. Total proteins were extracted from mature seeds as follows. Approximately 30-40 mg of seeds were put into a 1.5mL disposable plastic microfuge tube and ground in 0.25 mL of 50 mM Tris-HCl pH6.8, 2 mM EDTA, 1% SDS, 1% (v/v) β-mercaptoethanol. The grinding was done using a motorized grinder with disposable plastic shafts designed to fit into the microfuge tube. The resultant suspensions were centrifuged for 5 min at room temperature in a microfuge to remove particulates. Three volumes of extract was mixed with 1 volume of 4 X SDS-gel sample buffer (0.17 M Tris-HCl pH 6.8, 6.7% SDS, 16.7% (v/v) β-mercaptoethanol, 33% (v/v) glycerol) and 5 μL from each extract were run per lane on an SDS polyacrylamide gel, with bacterially produced AKIII serving as a size standard and protein extracted from untransformed tobacco seeds serving as a negative control. The proteins were then electrophoretically blotted onto a nitrocellulose membrane. The membranes were exposed to the AKIII antibodies (prepared as described in Example 2) at a 1 :5000 dilution of the rabbit serum using standard protocol provided by BioRad with their Immun-Blot Kit. Following rinsing to remove unbound primary antibody the membranes were exposed to the secondary antibody, donkey anti-rabbit Ig conjugated to horseradish peroxidase (Amersham) at a 1 :3000 dilution. Following rinsing to remove unbound secondary antibody, the membranes were exposed to Amersham chemiluminescence reagent and X-ray film. Ten of eleven transformants containing the chimeric gene, phaseolin 5' region/cts/lvsC/phaseolin 3' region, and ten of eleven transformants containing the chimeric gene, phaseolin 5' region/cts/lysC-M4/phaseolin 3' region, produced AKIII protein (Table 3). In all cases protein which reacted with the AKIII antibody was of several sizes. Approximately equal quantities of proteins equal in size to AKIII produced in E. coli, and about 6 kd larger were evident in all samples, suggesting that the chloroplast targeting signal had been removed from about half of the protein synthesized. This further suggests that about half of the protein entered the chloroplast. In addition, some proteins of lower molecular weight were observed, probably representing breakdown products of the AKIII polypeptide. To measure free amino acid composition of the seeds, free amino acids were extracted from mature seeds as follows. Approximately 30-40 mg of seeds and an approximately equal amount of sterilized sand were put into a 1.5 mL disposable plastic microfuge tube along with 0.2 mL of methanol/chloroform/water mixed in ratio of 12v/5v/3v (MCW) at room temperature. The seeds were ground using a motorized grinder with disposable plastic shafts designed to fit into the microfuge tube. After grinding an additional 0.5 mL of MCW was added, the mixture was vortexed and then centrifuged in an eppendorf microcentrifuge for about 3 min. Approximately 0.6 mL of supernatant was decanted and an additional 0.2 mL of MCW was added to the pellet which was then vortexed and centrifuged as above. The second supernatant, about 0.2 mL, was added to the first. To this, 0.2 mL of chloroform was added followed by 0.3 mL of water. The mixture was vortexed and then centrifuged in an eppendorf microcentrifuge for about 3 min, the upper aqueous phase, approximately 1.0 mL, was removed, and was dried down in a Savant Speed Vac Concentrator. The samples were hydrolyzed in 6N hydrochloric acid, 0.4% (v/v) β-mercaptoethanol under nitrogen for 24 h at 110-120°; 1/4 of the sample was run on a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Relative free amino acid levels in the seeds were compared as ratios of lysine, methionine, threonine or isoleucine to leucine, thus using leucine as an internal standard. To measure the total amino acid composition of the seeds, 6 seeds were hydrolyzed in 6 N hydrochloric acid, 0.4% (v/v) β-mercaptoethanol under nitrogen for 24 h at 110-120°; 1/10 of the sample was run on a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Relative amino acid levels in the seeds were compared as ratios of lysine, methionine, threonine or isoleucine to leucine, thus using leucine as an internal standard. Because the transgene was segregating in these self-pollinated progeny of the primary transformant and only six seeds were analyzed, there was expected to be some sampling error. Therefore, the measurement was repeated multiple times for some of the lines (Table 3). Expression of the cts/lvsC gene in the seeds resulted in a 2 to 4-fold increase in the level of free threonine in the seeds and a 2 to 3-fold increase in the level of free lysine in some cases. There was a good correlation between transformants expressing higher levels of AKIII protein and those having higher levels of free threonine, but this was not the case for lysine. These relatively small increases of free threonine or lysine were not sufficient to yield detectable increases in the levels of total threonine or lysine in the seeds. Expression of the cts/lysC-M4 gene in the seeds resulted in a 4 to 23-fold increase in the level of free threonine in the seeds and a 2 to 3-fold increase in the level of free lysine in some cases. There was a good correlation between transformants expressing higher levels of AKIII protein and those having higher levels of free threonine, but this was again not the case for lysine. The larger increases of free threonine were sufficient to yield detectable increases in the levels of total threonine in the seeds. Sixteen to twenty-five percent increases in total threonine content of the seeds were observed in three lines which were sampled multiple times. (Isoleucine to leucine ratios are shown for comparison.) The lines that showed increased total threonine were the same ones the showed the highest levels of increase in free threonine and high expression of the AKIII-M4 protein. From these results it can be estimated that free threonine represents about 1% of the total threonine present in a normal tobacco seed, but about 18% of the total threonine present in seeds expressing high levels of AKIII-M4. TABLE 3 BT548 Transformants: phaseolin 5' region/cts/lvsC/phaseolin 3' BT549 Transformants: phaseolin 5' region/cts/lγsC-M4/phaseolin 3' SEED SEED FREE AMINO ACID TOTAL AMINO ACID LINE K/L T/L I/L K L T/L I/L WESTERN NORMAL 0.49 1.34 0.68 0.35 0.68 0.63 - 548-2A 1.15 2.3 0.78 0.43 0.71 0.67 + 548-4D 0.69 5.3 0.80 0.35 0.69 0.65 +-H- 548-6A 0.39 3.5 0.85 0.35 0.69 0.64 + 548-7A 0.82 4.2 0.83 0.36 0.68 0.65 ++ 548-14A 0.41 3.1 0.82 0.32 0.67 0.65 + 548- 18A 0.51 1.5 0.69 0.37 0.67 0.63 - 548-22A 1.41 2.9 0.75 0.47 0.74 0.65 -H-l- 548-24A 0.73 3.7 0.81 0.38 0.68 0.65 ++ 548-41 A 0.40 2.8 0.77 0.37 0.68 0.65 + 548-50A 0.46 4.0 0.81 0.33 0.68 0.65 + 548-57A 0.50 3.8 0.80 0.33 0.67 0.65 ++ 549-5A 0.63 5.9 0.69 0.32 0.65 0.65 + 549-7A 0.51 8.3 0.78 0.33 0.67 0.63 ++ 549-20A 0.67 30 0.88 0.38* 0.82* 0.65* 1 1 1 1 549-34A 0.43 1.3 0.69 0.32 0.64 0.63 549-39D 0.83 16 0.83 0.35 0.71 0.63 +++ 549-40A 0.80 4.9 0.74 0.33 0.63 0.64 + 549-41C 0.99 13 0.80 0.38* 0.79* 0.65* -H- 549-46A 0.48 7.7 0.84 0.34 0.70 0.64 + 549-52A 0.81 9.2 0.80 0.39 0.70 0.65 ++ 549-57A 0.60 15 0.77 0.35* 0.85* 0.64* +++ 549-60D 0.85 11 0.79 0.37 0.73 0.65 ++ Normal was calculated as the average of 6 samples for free amino acid and 23 samples for total amino acids. * Indicates average of at least 5 samples Seeds derived from self-pollination of two plants transformed with the phaseolin 5' region/cts/lvsC-M4/phaseolin 3' region, plants 549-5 A and 549-40 A, showed 3 kanamycin resistant to 1 kanamycin sensitive seedlings, indicative of a single site of insertion of the transgene. Progeny plants were grown, self- pollinated and seed was analyzed for segregation of the kanamycin marker gene. Progeny plants that were homozygous for the transgene insert, thus containing two copies of the gene cassette, accumulated approximately 2 times as much threonine in their seed as their sibling heterozygous progeny with one copy of the gene cassette and about 8 times as much as seed without the gene. This demonstrates that the level of expression of the E. coli enzyme controls the accumulation of free threonine. EXAMPLE 9 Transformation of Tobacco with the 35S Promoter/ecodapA Chimeric Genes The 35S promoter/Cab leader/ecodapA/Nos 3' and 35S promoter/Cab leader/cts/ecodapA/Nos 3', chimeric genes were isolated as 3.1, and 3.3 kb BamH I-Sal I fragments, respectively and inserted into BamH I-Sal I digested binary vector pZS97K (Figure 5), yielding plasmids pBT462 and pBT463, respectively. The binary vector is described in Example 7. The binary vectors containing the chimeric ecodapA genes were transferred by tri-parental matings to Agrobacterium strain LBA4404/pAL4404, the Agrobacterium transformants used to inoculate tobacco leaf disks and the resulting transgenic plants regenerated by the methods set out in Example 7. To assay for expression of the chimeric genes in leaves of the transformed plants, protein was extracted as described in Example 7, with the following modifications. The supernatant from the first ammonium sulfate precipitation, approximately 18 mL, was mixed with an additional 12 mL of cold, saturated ammonium sulfate. The mixture was set on ice for 30 min and centrifuged as described in Example 7. The supernatant was decanted and the pellet, which contained the DHDPS protein, was resuspended in 1 mL of TNE and desalted by passage over a Sephadex G-25 M column (Column PD-10, Pharmacia). The leaf extracts were assayed for DHDPS activity as described in Example 4. E. coli DHDPS could be distinguished from tobacco DHDPS activity by its increased resistance to lysine; E. coli DHDPS retained 80-90% of its activity at O.lmM lysine, while tobacco DHDPS was completely inhibited at that concentration of lysine. One often transformants containing the chimeric gene, 35S promoter/Cab leader/ecodapA/Nos 3', showed E. coli DHDPS expression, while five often transformants containing the chimeric gene, 35S promoter/Cab leader/cts/ecodapA/Nos 3' showed E. coli DHDPS expression. Free amino acids were extracted from leaves as described in Example 7. Expression of the chimeric gene, 35S promoter/Cab leader/cts/ecodapA/Nos 3', but not 35S promoter/Cab leader/ecodapA/Nos 3' resulted in substantial increases in the level of free lysine in the leaves. Free lysine levels from two to 90-fold higher than untransformed tobacco were observed. The transformed plants were allowed to flower, self-pollinate and go to seed. Seeds from several lines transformed with the 35S promoter/Cab leader/ cts/ecodapA/Nos 3' gene were surface sterilized and germinated on agar plates in the presence of kanamycin. Lines that showed 3 kanamycin resistant to 1 kanamycin sensitive seedlings, indicative of a single site of insertion of the transgenes, were identified. Progeny that were homozygous for the transgene insert were obtained from these lines using standard genetic analysis. The homozygous progeny were then characterized for expression of E. coli DHDPS in young and mature leaves and for the levels of free amino acids accumulated in young and mature leaves and in mature seeds. Expression of active E. coli DHDPS enzyme was clearly evident in both young and mature leaves of the homozygous progeny of the transformants (Table 4). High levels of free lysine, 50 to 100-fold higher than normal tobacco plants, accumulated in the young leaves of the plants, but a much smaller accumulation of free lysine (2 to 8-fold) was seen in the larger leaves. Experiments that measure lysine in the phloem suggest that lysine is exported from the large leaves. This exported lysine may contribute to the accumulation of lysine in the small growing leaves, which are known to take up, rather than export nutrients. Since the larger leaves make up the major portion of the biomass of the plant, the total increased accumulation of lysine in the plant is more influenced by the level of lysine in the larger leaves. No effect on the free lysine levels in the seeds of these plants was observed (Table 4). TABLE 4 Progeny of BT463 transformants homozygous for 35S promoter/Cab leader/cts/ecodapA/Nos 3' LEAF E. COLI SEED FREE LEAF FREE AMINO ACID DHDPS AMINO ACID LINE SIZE K/L K/TOT OD/60'/mg K L NORMAL 3 in. 0.5 0.006 0 0.5 463-18C-2 3 in. 47 0.41 7.6 0.4 463-18C-2 12 in. 1 0.02 5.5 — 463-25A-4 3 in. 58 0.42 6.6 0.4 463-25A-4 12 in. 4 0.02 12.2 — 463-38C-3 3 in. 28 0.28 6.1 0.5 463-38C-3 12 in. 2 0.04 8.3 EXAMPLE 10 Transformation of Tobacco with the Phaseolin Promoter/ecodapA Chimeric Genes The chimeric gene cassettes, phaseolin 5' region/ecodapA/phaseolin 3' region, and phaseolin 5' region/cts/ecodapA/phaseolin 3' region (Example 6) were isolated as approximately 2.6 and 2.8 kb Hind III fragments, respectively. These fragments were inserted into the unique Hind III site of the binary vector pZS97 (Figure 6), yielding pBT506 and pBT534, respectively. This vector is described in Example 8. The binary vectors containing the chimeric ecodapA genes were transferred by tri-parental matings to Agrobacterium strain LBA4404/pAL4404, the Agrobacterium transformants used to inoculate tobacco leaf disks and the resulting transgenic plants were regenerated by the methods set out in Example 7. To assay for expression of the chimeric genes, the transformed plants were allowed to flower, self-pollinate and go to seed. Total seed proteins were extracted as described in Example 8 and immunologically analyzed as described in Example 7, with the following modification. The Western blot membranes were exposed to the DHDPS antibodies prepared in Example 4 at a 1 :5000 dilution of the rabbit serum using standard protocol provided by BioRad with their Immun-Blot Kit. Thirteen of fourteen transformants containing the chimeric gene, phaseolin 5' region/ecodapA/phaseolin 3' region and nine of thirteen transformants containing the chimeric gene, phaseolin 5' region/cts/ecodapA/phaseolin 3' region, produced DHDPS protein detectable via Western blotting (Table 3). Protein which reacted with the DHDPS antibody was of several sizes. Most of the protein was equal in size to DHDPS produced in E. coli, whether or not the chimeric gene included the chloroplast transit sequence. This indicated that the chloroplast targeting signal had been efficiently removed from the precursor protein synthesized. This further suggests the majority of the protein entered the chloroplast. In addition, some proteins of lower molecular weight were observed, probably representing breakdown products of the DHDPS polypeptide. To measure free amino acid composition and total amino acid composition of the seeds, free amino acids and total amino acids were extracted from mature seeds and analyzed as described in Example 8. Expression of either the ecodapA gene or cts/ecodapA had no effect on the total lysine or threonine composition of the seeds in any of the transformed lines (Table 5). Several of the lines that were transformed with the phaseolin 5' region/cts/ecodapA/phaseolin 3' chimeric gene were also tested for any effect on the free amino acid composition. Again, not even a modest effect on the lysine or threonine composition of the seeds was observed in lines expressing high levels of E. coli DHDPS protein (Table 5). This was a surprising result, given the dramatic effect (described in Example 9) that expression of this protein has on the free lysine levels in leaves. One possible explanation for this was that the DHDPS protein observed via Western blot was not functional. To test this hypothesis, total protein extracts were prepared from mature seeds and assayed for DHDPS activity. Approximately 30-40 mg of seeds were put into a 1.5 mL disposable plastic microfuge tube and ground in 0.25 mL of 50 mM Tris-HCl, 50 mM NaCl, 1 mM EDTA (TNE). The grinding was done using a motorized grinder with disposable plastic shafts designed to fit into the microfuge tube. The resultant suspensions were centrifuged for 5 min at room temperature in a microfuge to remove particulates. Approximately 0.1 mL of aqueous supernatant was removed between the pelleted material and the upper oil phase. The seed extracts were assayed for DHDPS activity as described in Example 4. E. coli DHDPS could be distinguished from tobacco DHDPS activity by its increased resistance to lysine; E. coli DHDPS retained about 50% of its activity at 0.4 mM lysine, while tobacco DHDPS was completely inhibited at that concentration of lysine. High levels of E. coli DHDPS activity were seen in all four seed extracts tested eliminating this explanation. The presence of the cts sequence in the chimeric ecodapA gene was essential for eliciting accumulation of high levels of lysine in leaves. Thus another possible explanation was that the cts sequence had somehow been lost during the insertion of the chimeric phaseolin 5' region/cts/ecodapA/phaseolin 3' gene into the binary vector. PCR analysis of several of the transformed lines demonstrated the presence of the cts sequence, however, ruling out this possibility. A third explanation was that amino acids are not normally synthesized in seeds, and therefore the other enzymes in the pathway were not present in the seeds. The results of experiments presented in Example 8, wherein expression of phaseolin 5' region/cts/lysC-M4/phaseolin 3' gene resulted in accumulation of high levels of free threonine in seeds, indicate that this is not the case. Taken together these results and the results presented in Example 9, demonstrate that expression of a lysine-insensitive DHDPS in either seeds or leaves is not sufficient to achieve accumulation of increased free lysine in seeds. TABLE 5 BT506 Transformants: phaseolin 5' region/ecodapA/phaseolin 3' BT534 Transformants: phaseolin 5' region/cts/ecodapA/phaseolin 3' SEED: FREE SEED: TOTAL E. COLI AMINO ACIDS AMINO ACIDS DHDPS LINE K L T/L K/L T/L 0D/60'/MG WESTERN NORMAL 0.49 1.34 0.35 0.68 506-2B 0.34 0.66 + 506-4B 0.33 0.67 + 506- 16A 0.34 0.67 + 506- 17A 0.36 0.55 7.7 506- 19A 0.37 0.45 506-22A 0.34 0.67 ++ 506-23B 0.35 0.67 506-33B 0.34 0.67 506-38B 0.36 0.69 8.7 506-39A 0.37 0.70 506-40A 0.36 0.68 506-47A 0.32 0.68 506-48A 0.33 0.69 506-49A 0.33 0.69 534-8A 0.34 0.66 534-9A 0.36 0.67 534-22B 0.43 1.32 0.39 0.51 4.9 534-31 A 0.34 0.66 534-38A 0.35 1.49 0.42 0.33 534-39A 0.38 0.69 534-7A 0.34 0.67 534-25B 0.35 0.67 534-34B 0.80 1.13 0.42 0.70 534-35A 0.43 1.18 0.33 0.67 534-37B 0.42 1.58 0.37 0.68 534-43A 0.35 0.68 534-48A 0.46 1.24 0.35 0.68 6.2 EXAMPLE 11 Transformation of Tobacco with the 35S Promoter/cts/da A plus 35S Promoter/cts/lvsC-M4 Chimeric Genes The 35S promoter/Cab leader/cts/ecodapA/Nos 3', and 35S promoter/Cab leader/cts/lysC-M4/Nos 3' chimeric genes were combined in the binary vector pZS97K (Figure 5). The binary vector is described in Example 7. An oligonucleotide adaptor was synthesized to convert the BamH I site at the 5' end of the 35S promoter/Cab leader/cts/lysC-M4/Nos 3' chimeric gene (see Figure 4a) to an EcoR I site. The 35S promoter/Cab leader/cts/lvsC-M4/Nos 3' chimeric gene was then isolated as a 3.6 kb EcoR I fragment from plasmid pBT540 (Example 6) and inserted into pBT463 (Example 9) digested with EcoR I, yielding plasmid pBT564. This vector has both the 35S promoter/Cab leader/cts/ecodapA/Nos 3', and 35S promoter/Cab leader/cts/lysC-M4/Nos 3' chimeric genes inserted in the same orientation. The binary vector containing the chimeric ecodapA and lysC-M4 genes was transferred by tri-parental matings to Agrobacterium strain LB A4404/pAL4404, the Agrobacterium transformants used to inoculate tobacco leaf disks and the resulting transgenic plants regenerated by the methods set out in Example 7. To assay for expression of the chimeric genes in leaves of the transformed plants, protein was extracted as described in Example 7 for AKIII, and as described in Example 9 for DHDPS. The leaf extracts were assayed for DHDPS activity as described in Examples 4 and 9. E. coli DHDPS could be distinguished from tobacco DHDPS activity by its increased resistance to lysine; E. coli DHDPS retained 80-90% of its activity at 0.1 mM lysine, while tobacco DHDPS was completely inhibited at that concentration of lysine. Extracts were characterized immunologically for expression of AKIII and DHDPS proteins via Western blots as described in Examples 7 and 10. Ten of twelve transformants expressed E. coli DHDPS enzyme activity (Table 6). There was a good correlation between the level of enzyme activity and the amount of DHDPS protein detected immunologically. As described in Example 7, the AK assay was not sensitive enough to detect enzyme activity in these extracts. However, AKIII-M4 protein was detected immunologically in eight of the twelve extracts. In some transformants, 564-21A and 47A, there was a large disparity between the level of expression of DHDPS and AKIII -M4, but in 10 of 12 lines there was a good correlation. Free amino acids were extracted from leaves and analyzed for amino acid composition as described in Example 7. In the absence of significant AKIII-M4, the level of expression of the chimeric gene, 35S promoter/Cab leader/cts/ecodapA/Nos 3' determined the level of lysine accumulation (Table 6). Compare lines 564-21 A, 47 A and 39C, none of which expresses significant AKIII-M4. Line 564-21 A accumulates about 10-fold higher levels of lysine than line 564-47A which expresses a lower level of E. coli DHDPS and 40-fold higher levels of lysine than 564-39C which expresses no E. coli DHDPS. However, in transformants that all expressed similar amounts of E. coli DHDPS (564-18A, 56A, 36E, 55B, 47 A), the level of expression of the chimeric gene, 35S promoter/Cab leader/cts/lvsC-M4/Nos 3', controlled the level of lysine accumulation. Thus it is clear that although expression of 35S promoter/Cab leader/cts/lvsC-M4/Nos 3' has no effect on the free amino acid levels of leaves when expressed alone (see Example 7), it can increase lysine accumulation when expressed in concert with the 35S promoter/Cab leader/cts/ecodapA/Nos 3' chimeric gene. Expression of these genes together did not effect the level of any other free amino acid in the leaves. TABLE 6 BT564 Transformants: 35S promoter/Cab leader/cts/ecodapA/Nos 3' 35S promoter/Cab leader/cts/lusC-M4/Nos 3' E. COLI FREE AA LEAF DHDPS WESTERN WESTERN LINE nmol/4mg FREE AA LEAF U/MG/HR DHDPS AK-III TOT K K/L K/TOT 564-21 A 117 57 52 0.49 2.4 +++ +/- 564-18 A 99 56 69 0.57 1.1 ++ ++ 564-56A 104 58 58 0.56 1.5 ++ ++ 564-36E 85 17 17 0.20 1.5 ++ +++ 564-55B 54 5 9.1 0.10 1.0 -H- + 564-47A 18 1 4.8 0.06 0.8 -H- - 564-35A 37 7 13 0.18 0.3 + -H- 564-60D 61 3 4.5 0.06 0.2 + ++ 564-45A 46 4 8.1 0.09 0.4 + + 564-44B 50 1 1.7 0.02 0.1 +/- - 564-49A 53 1 1.0 0.02 0 +/- - 564-39C 62 1 1.4 0.02 0 . _ Free amino acids were extracted from mature seeds derived from self- pollinated plants and quantitated as described in Example 8. There was no significant difference in the free amino acid content of seeds from untransformed plants compared to that from the plants showing the highest free lysine accumulation in leaves, i.e. plants 564-18A, 564-21A, 564-36E, 564-56A. EXAMPLE 12 Transformation of Tobacco with the Phaseolin Promoter/cts/ecodapA plus Phaseolin Promoter/cts/lysC-M4 Chimeric Genes The chimeric gene cassettes, phaseolin 5' region/cts/ecodapA/phaseolin 3' region and phaseolin 5' region/cts/lvsC-M4/phaseolin 3' (Example 6) were combined in the binary vector pZS97 (Figure 6). The binary vector is described in Example 8. To accomplish this the phaseolin 5' region/cts/ecodapA/phaseolin 3' chimeric gene was isolated as a 2.7 kb Hind III fragment and inserted into the Hind III site of vector pUC 1318 [Kay et al (1987) Nucleic Acids Res. 6:2778], yielding pBT568. It was then possible to digest pBT568 with BamH I and isolate the chimeric gene on a 2.7 kb BamH I fragment. This fragment was inserted into BamH I digested pBT549 (Example 8), yielding pBT570. This binary vector has both chimeric genes, phaseolin 5' region/cts/ecodapA/phaseolin 3' gene and phaseolin 5' region/cts/lvsC-M4/phaseolin 3' inserted in the same orientation. The binary vector pBT570 was transferred by tri-parental mating to Agrobacterium strain LBA4404/pAL4404, the Agrobacterium transformants used to inoculate tobacco leaf disks and the resulting transgenic plants regenerated by the methods set out in Example 7. To assay for expression of the chimeric genes in the seeds of the transformed plants, the plants were allowed to flower, self-pollinate and go to seed. Total proteins were extracted from mature seeds and analyzed via western blots as described in Example 8. Twenty-one of twenty-five transformants expressed the DHDPS protein and nineteen of these also expressed the AKIII protein (Table 7). The amounts of the proteins expressed were related to the number of gene copies present in the transformants; the highest expressing lines, 570-4B, 570-12C, 570-59B and 570-23B, all had two or more sites of insertion of the gene cassette based on segregation of the kanamycin marker gene. Enzymatically active E. coli DHDPS was observed in mature seeds of all the lines tested wherein the protein was detected. To measure free amino acid composition of the seeds, free amino acids were extracted from mature seeds and analyzed as described in Example 8. There was a good correlation between transformants expressing higher levels of both DHDPS and AKIII protein and those having higher levels of free lysine and threonine. The highest expressing lines (marked by asterisk in Table 7) showed up to a 2-fold increase in free lysine levels and up to a 4-fold increase in the level of free threonine in the seeds. In the highest expressing lines it was possible to detect a high level of α-aminoadipic acid. This compound is known to be an intermediate in the catabolism of lysine in cereal seeds, but is normally detected only via radioactive tracer experiments due to its low level of accumulation. The build-up of high levels of this intermediate indicates that a large amount of lysine is being produced in the seeds of these transformed lines and is passing through the catabolic pathway. The build-up of α-aminoadipic acid was not observed in transformants expressing only E. coli DHDPS or only AKIII-M4 in seeds. These results show that it is necessary to express both enzymes simultaneously to produce high levels of free lysine. TABLE 7 BT570 Transformants: phaseolin 5'region/cts/lysC-M4/phaseolin 3' region phaseolin 5'region/cts/ecodapA phaseolin 3' region FREE AMINO TOTAL AMINO WESTERN WESTERN E. COLI ACIDS/SEED ACIDS/SEED E. COLI E. COLI DHDPS Progeny LINE K L T/L K/L T/L DHDPS AKIII U/MG/HR Kan r :Kan s NORMAL 0.49 1.3 0.35 0.68 - - 570-4B 0.31 2.6 0.34 0.64 +++ ++ 15:1 570-7C 0.39 2.3 0.34 0.64 ++ + 570-8B 0.29 2.1 0.34 0.63 + - 570-12C* 0.64 5.1 0.36 0.68 1 1 1 1 > 4.3 >15:1 570-18A 0.33 3.0 0.35 0.65 -H- -H- 15:1 570-24A 0.33 2.0 0.34 0.65 ++ - 570-37A 0.33 2.1 0.34 0.64 +/- +/- 570-44A 0.29 2.1 0.34 0.64 ++ + 570-46B 0.41 2.1 0.35 0.65 ++ + 570-5 IB 0.33 1.5 0.33 0.64 - - 0 570-59B* 0.46 3.0 0.35 0.65 +-H- +++ 2.6 >15:1 570-80A 0.31 2.2 0.34 0.64 -H- + 570-1 1 A 0.28 2.3 0.34 0.67 ++ ++ 3: 1 570- 17B 0.27 1.6 0.34 0.65 - - 570-20A 0.41 2.3 0.35 0.67 ++ + 570-2 IB 0.26 2.4 0.34 0.68 -H- + 570-23B* 0.40 3.6 0.34 0.68 -H-+ +++ 3.1 63:1 570-25D 0.30 2.3 0.35 0.66 ++ +/- 570-26A 0.28 1.5 0.34 0.64 - - 570-32A 0.25 2.5 0.34 0.67 ++ + 570-35A 0.25 2.5 0.34 0.63 ++ ++ 3:1 570-38 A- 1 0.25 2.6 0.34 0.64 -H- ++ 3:1 570-38A-3 0.33 1.6 0.35 0.63 - - 570-42A 0.27 2.5 0.34 0.62 ++ ++ 3: 1 570-45A 0.60 3.4 0.39 0.64 -H- ++ 3:1 * indicates free amino acid sample has α-aminoadipic acid EXAMPLE 13 Use of the cts/lvsC-M4 Chimeric Gene as a Selectable Marker for Tobacco Transformation The 35S promoter/Cab leader/cts/lysC-M4/Nos 3' chimeric gene in the binary vector pZS97K (pBT542, see Example 7) was used as a selectable genetic marker for transformation of tobacco. High concentrations of lysine plus threonine inhibit growth of shoots from tobacco leaf disks. Expression of active lysine and threonine insensitive AKIII-M4 reverses this growth inhibition (see Example 7). The binary vector pBT542 was transferred by tri-parental mating to Agrobacterium strain LB A4404/pAL4404, the Agrobacterium transformants used to inoculate tobacco leaf disks and the resulting transformed shoots were selected on shooting medium containing 3 mM lysine plus 3 mM threonine. Shoots were transferred to rooting media containing 3 mM lysine plus 3 mM threonine. Plants were grown from the rooted shoots. Leaf disks from the plants were placed on shooting medium containing 3 mM lysine plus 3 mM threonine. Transformed plants were identified by the shoot proliferation which occurred around the leaf disks on this medium. EXAMPLE 14 Transformation of Tobacco with the 35S Promoter/cts/cordapA Chimeric Gene The 35S promoter/Cab leader/cts/cordapA/Nos 3' chimeric gene was isolated as a 3.0 kb BamH I-Sal I fragment and inserted into BamH I-Sal I digested binary vector pZS97K (Figure 5), yielding plasmid pFS852. The binary vector is described in Example 7. The binary vector containing the chimeric cordapA gene was transferred by tri-parental mating to Agrobacterium strain LBA4404/pAL4404, the Agrobacterium transformant was used to inoculate tobacco leaf disks and the resulting transgenic plants were regenerated by the methods set out in Example 7. To assay for expression of the chimeric gene in leaves of the transformed plants, protein was extracted as described in Example 7, with the following modifications. The supernatant from the first ammonium sulfate precipitation, approximately 18 mL, was mixed with an additional 12 mL of cold, saturated ammonium sulfate. The mixture was set on ice for 30 min and centrifuged as described in Example 7. The supernatant was decanted and the pellet, which contained the DHDPS protein, was resuspended in 1 mL of TNE and desalted by passage over a Sephadex G-25 M column (Column PD-10, Pharmacia). The leaf extracts were assayed for DHDPS protein and enzyme activity as described in Example 4. Corynebacteria DHDPS enzyme activity could be distinguished from tobacco DHDPS activity by its insensitivity to lysine inhibition. Eight of eleven transformants showed Corynebacteria DHDPS expression, both as protein detected via western blot and as active enzyme. Free amino acids were extracted from leaves as described in Example 7. Expression of Corynebacteria DHDPS resulted in large increases in the level of free lysine in the leaves (Table 8). However, there was not a good correlation between the level of expression of DHDPS and the amount of free lysine accumulated. Free lysine levels from 2 to 50-fold higher than untransformed tobacco were observed. There was also a 2 to 2.5-fold increase in the level of total leaf lysine in the lines that showed high levels of free lysine. TABLE 8 FS586 transformant! J: 35S promoter/Cab leader/cts/cordapA/Nos 3' FREE AMINO TOTAL AMINO WESTERN CORYNE. ACIDS/LEAF ACIDS/LEAF CORYNE. DHDPS LINE K/L K L DHDPS U/MG/HR NORMAL 0.5 0.8 - - FS586-2A 1.0 0.8 - - FS586-4A 0.9 0.8 + 6.1 FS586-11B 3.6 0.8 + 3.4 FS586-11D 26 2.0 + 3.5 FS586-13A 2.4 0.8 + 3.5 FS586-19C 5.1 0.8 + 3.1 FS586-22B >15 1.5 + 2.3 FS586-30B 0.8 - - FS586-38B 18 1.5 ++ 3.9 FS586-51A 1.3 0.8 - - FS586-58C 1.2 0.8 + 5.1 The plants were allowed to flower, self-pollinate and go to seed. Mature seed was harvested and assayed for free amino acid composition as described in Example 8. There was no difference in the free lysine content of the transformants compared to untransformed tobacco seed. EXAMPLE 15 Transformation of Tobacco with the KTI3 promoter/cts/cordapA or Phaseolin Promoter/cts/cordapA plus Phaseolin Promoter/cts/lysC-M4 Chimeric Genes The chimeric gene cassettes, KTI3 5* region/cts/ cordapA/KTI3 3' region and phaseolin 5' region/cts/ lysC-M4/phaseolin 3' as well as phaseolin 5' region/cts/ cordapA/phaseolin 3' region and phaseolin 5' region/cts/ lysC-M4/phaseolin 3' (Example 6) were combined in the binary vector pZS97 (Figure 6). The binary vector is described in Example 8. To accomplish this the KTI3 5' region/cts/cordapA/ KTI3 3' region chimeric gene cassette was isolated as a 3.3 kb BamH I fragment and inserted into BamH I digested pBT549 (Example 8), yielding pFS883. This binary vector has the chimeric genes, KTI3 5' region/cts/cordapA/KTI3 3' region and phaseolin 5' region/cts/lvsC-M4/phaseolin 3' region inserted in opposite orientations. The phaseolin 5' region/cts/cordapA/phaseolin 3'region chimeric gene cassette was modified using oligonucleotide adaptors to convert the Hind HI sites at each end to BamH I sites. The gene cassette was then isolated as a 2.7 kb BamH I fragment and inserted into BamH I digested pBT549 (Example 8), yielding pFS903. This binary vector has both chimeric genes, phaseolin 5' region/cts/cordapA/phaseolin 3' region and phaseolin 5' region/cts/lysC-M4/phaseolin 3' region inserted in the same orientation. The binary vectors pFS883 and pFS903 were transferred by tri-parental mating to Agrobacterium strain LBA4404/pAL4404, the Agrobacterium transformants were used to inoculate tobacco leaf disks and the resulting transgenic plants were regenerated by the methods set out in Example 7. To assay for expression of the chimeric genes in the seeds of the transformed plants, the plants were allowed to flower, self-pollinate and go to seed. Total proteins were extracted from mature seeds and analyzed via western blots as described in Example 8. Twenty-one of twenty-two transformants tested expressed the DHDPS protein and eighteen of these also expressed the AKIII protein (Table 8). Enzymatically active Corynebacteria DHDPS was observed in mature seeds of all the lines tested wherein the protein was detected except one. To measure free amino acid composition of the seeds, free amino acids were extracted from mature seeds and analyzed as described in Example 8. There was a good correlation between transformants expressing higher levels of both DHDPS and AKIII protein and those having higher levels of free lysine and threonine. The highest expressing lines showed up to a 3 -fold increase in free lysine levels and up to a 8-fold increase in the level of free threonine in the seeds. As was described in Example 12, a high level of α-aminoadipic acid, indicative of lysine catabolism, was observed in many of the transformed lines (indicated by asterisk in Table 9). There was no major difference in the free amino acid composition or level of protein expression between the transformants which had the KTI3 or Phaseolin regulatory sequences driving expression of the Corynebacteria DHDPS gene. TABLE 9 FS883 Transformants: phaseolin 5' region/cts/lysC-M4/phaseolin 3' KTI3 5' region/cts/cordapA/KTI3 3' FS903 Transformants: phaseolin 5' region/cts/lysC-M4/phaseolin 3' phaseolin 5' region/cts/cordapA/phaseolin 3' FREE AMINO WESTERN WESTERN CORYNE. ACIDS/SEED CORYNE. E. COLI DHDPS Progeny LINE K/L T/L DHDPS AKIII U/MG/HR Kan r :Kan s NORMAL 0.5 1.3 - - FS883-4A 0.9 4.0 + + >15:1 FS883-11A 1.0 3.5 ++ ++ 3.1 3: 1 FS883-14B 0.5 2.5 ++ ++ FS883-16A* 0.7 10.5 + +++ 0 FS883-17A* 1.0 5.0 -H-+ +++ 7.0 FS883-18C* 1.2 3.5 ++ + 5.8 3:1 FS883-21A 0.5 1.5 + +/- FS883-26B* 1.1 3.6 ++ ++ 2.4 FS883-29B 0.5 1.5 + - 0.4 FS883-32B 0.7 2.4 ++ + 1.5 3:1 FS883-38B* 1.1 11.3 + ++ 2.0 FS883-59C* 1.4 6.1 + + 0.5 15:1 FS903-3C 0.5 1.8 + +++ FS903-8A* 0.8 2.1 -H-+ FS903-9B 0.6 1.8 ++ ++ 4.3 FS903-10A 0.5 1.5 - - FS903-22F 0.5 1.8 -H- ++ 0.9 FS903-35B* 0.8 2.1 ++ ++ FS903-36B 0.7 1.5 + - FS903-40A 0.6 1.8 + + FS903-41A* 1.2 2.0 -H- +++ FS903-42A 0.7 2.2 ++ +++ 5.4 FS903-44C 0.5 1.9 FS903-53B 0.6 1.9 * indicates free amino acid sample has α-aminoadipic acid Free amino acid composition and expression of bacterial DHDPS and AKIII proteins was also analyzed in developing seeds of two lines that segregated as single gene cassette insertions (see Table 10). Expression of the DHDPS protein under control of the KTI3 promoter was detected at earlier times than that of the AKIII protein under control of the Phaseolin promoter, as expected. At 14 days after flowering both proteins were expressed at a high level and there was about an 8-fold increase in the level of free lysine compared to normal seeds. These results confirm that simultaneous expression of lysine insensitive DHDPS and lysine-insensitive AK results in the production of high levels of free lysine in seeds. Free lysine does not continue to accumulate to even higher levels, however. In mature seeds free lysine is at a level 2 to 3 -fold higher than in normal mature seeds, and the lysine breakdown product α-aminoadipic acid accumulates. These results provide further evidence that lysine catabolism occurs in seeds and prevents accumulation of the high levels of free lysine produced in transformants expressing lysine insensitive DHDPS and lysine insensitive AK. TABLE 10 Developing seeds of FS883 Transformants: phaseolin 5' region/cts/lysC-M4/phaseolin 3' region KTI3 5' region/cts/cordapA/KTI3 3' region FREE / INO WESTERN WESTERN DAYS AFTER ACIDS/SEED CORYNE. E. COLI LINE FLOWERING K/L T/L DHDPS AKIII FS883-18C 9 1.1 2.1 - - FS883-18C 10 1.4 3.3 +/- - FS883-18C 11 1.4 2.5 + - FS883-18C 14 4.3 1.0 ++ ++ FS883-18C* MATURE 1.2 3.5 +++ ++ FS883-32B 9 1.3 2.9 + - FS883-32B 10 1.6 2.7 + - FS883-32B 11 1.4 2.3 + - FS883-32B* 14 3.9 1.3 ++ ++ FS883-32B* MATURE 0.7 2.4 T 1 T i T i ++ * indicates free amino acid sample has α-aminoadipic acid EXAMPLE 16 Transformation of Oilseed Rape with the Phaseolin Promoter/cts/cordapA and Phaseolin Promoter/cts/lvsC-M4 Chimeric Genes The chimeric gene cassettes, phaseolin 5' region/ cts/cordapA/phaseolin 3' region, phaseolin 5' region/ cts/lysC-M4/phaseolin 3', and phaseolin 5' region/ cts/cordapA/phaseolin 3' region plus phaseolin 5' region/cts/lysC-M4/phaseolin 3' (Example 6) were inserted into the binary vector pZS199 (Figure 7 A), which is similar to pSZ97K described in Example 8. In pZS199 the 35S promoter from Cauliflower Mosaic Vims replaced the Nos promoter driving expression of the NPT II to provide better expression of the marker gene, and the orientation of the polylinker containing the multiple restriction endonuclease sites was reversed. To insert the phaseolin 5' region/cts/cordapA/ phaseolin 3' region, the gene cassette was isolated as a 2.7 kb BamH I fragment (as described in Example 15) and inserted into BamH I digested pZS199, yielding plasmid pFS926 (Figure 7B). This binary vector has the chimeric gene, phaseolin 5' region/cts/cordapA/phaseolin 3' region inserted in the same orientation as the 35S/NPT II/nos 3' marker gene. To insert the phaseolin 5' region/cts/lvsC-M4/phaseolin 3' region, the gene cassette was isolated as a 3.3 kb EcoR I to Spe I fragment and inserted into EcoR I plus Xba I digested pZS199, yielding plasmid pBT593 (Figure 7C). This binary vector has the chimeric gene, phaseolin 5' region/cts/lvsC-M4/phaseolin 3' region inserted in the same orientation as the 35S/NPT II/nos 3' marker gene. To combine the two cassettes, the EcoR I site of pBT593 was converted to a BamH I site using oligonucleotide adaptors, the resulting vector was cut with BamH I and the phaseolin 5' region/cts/cordapA/ phaseolin 3' region gene cassette was isolated as a 2.7 kb BamH I fragment and inserted, yielding pBT597 (Figure 7D). This binary vector has both chimeric genes, phaseolin 5' region/cts/cordapA/phaseolin 3' region and phaseolin 5' region/cts/lysC- M4/phaseolin 3* region inserted in the same orientation as the 35S/NPT II/nos 3' marker gene. Brassica napus cultivar "Westar" was transformed by co-cultivation of seedling pieces with disarmed Agrobacterium tumefaciens strain LBA4404 carrying the appropriate binary vector. B. napus seeds were sterilized by stirring in 10% (v/v) Clorox, 0.1% SDS for thirty min, and then rinsed thoroughly with sterile distilled water. The seeds were germinated on sterile medium containing 30 mM CaCl 2 and 1.5% agar, and grown for 6 d in the dark at 24°. Liquid cultures of Agrobacterium for plant transformation were grown overnight at 28°C in Minimal A medium containing 100 mg/L kanamycin. The bacterial cells were pelleted by centrifugation and resuspended at a concentration of 10& cells/mL in liquid Murashige and Skoog Minimal Organic medium containing 100 uM acetosyringone. B. napus seedling hypocotyls were cut into 5 mm segments which were immediately placed into the bacterial suspension. After 30 min, the hypocotyl pieces were removed from the bacterial suspension and placed onto BC-35 callus medium containing 100 uM acetosyringone. The plant tissue and Agrobacteria were co-cultivated for 3 d at 24°C in dim light. The co-cultivation was terminated by transferring the hypocotyl pieces to BC-35 callus medium containing 200 mg/L carbenicillin to kill the Agrobacteria, and 25 mg/L kanamycin to select for transformed plant cell growth. The seedling pieces were incubated on this medium for three weeks at 24° under continuous light. After three weeks, the segments were transferred to BS-48 regeneration medium containing 200 mg/L carbenicillin and 25 mg/L kanamycin. Plant tissue was subcultured every two weeks onto fresh selective regeneration medium, under the same culture conditions described for the callus medium. Putatively transformed calli grew rapidly on regeneration medium; as calli reached a diameter of about 2 mm, they were removed from the hypocotyl pieces and placed on the same medium lacking kanamycin Shoots began to appear within several weeks after transfer to BS-48 regeneration medium. As soon as the shoots formed discernible stems, they were excised from the calli, transferred to MSV-1 A elongation medium, and moved to a 16:8-h photoperiod at 24°. Once shoots had elongated several intemodes, they were cut above the agar surface and the cut ends were dipped in Rootone. Treated shoots were planted directly into wet Metro-Mix 350 soiless potting medium. The pots were covered with plastic bags which were removed when the plants were clearly growing, after about 10 days. Results of the transformation are shown in Table 11. Transformed plants were obtained with each of the binary vectors. Minimal A Bacterial Growth Medium Dissolve in distilled water: 10.5 g potassium phosphate, dibasic 4.5 g potassium phosphate, monobasic 1.0 g ammonium sulfate 0.5 g sodium citrate, dihydrate Make up to 979 mL with distilled water Autoclave Add 20 mL filter-sterilized 10% sucrose Add 1 mL filter-sterilized 1 M MgS04 Brassica Callus Medium BC-35 Per liter: Murashige and Skoog Minimal Organic Medium (MS salts, 100 mg/L i-inositol, 0.4 mg/L thiamine; GIBCO #510-3118) 30 g sucrose 18 g mannitol 0.5 mg/L 2,4-D 0.3 mg/L kinetin 0.6% agarose pH 5.8 Brassica Regeneration Medium BS-48 Murashige and Skoog Minimal Organic Medium Gamborg B5 Vitamins (SIGMA #1019) 10 g glucose 250 mg xylose 600 mg MES 0.4% agarose pH 5.7 Filter-sterilize and add after autoclaving: 2.0 mg/L zeatin 0.1 mg/L IAA Brassica Shoot Elongation Medium MSV-1A Murashige and Skoog Minimal Organic Medium Gamborg B5 Vitamins 10 g sucrose 0.6% agarose pH 5.8 TABLE 11 Canola transformants NUMBER OF BINARY NUMBER OF NUMBER OF SHOOTING NUMBER OF VECTOR CUT ENDS KAN R CALLI CALLI PLANTS pZS199 120 41 5 2 pFS926 600 278 52 28 pBT593 600 70 10 3 pBT597 600 223 40 23 Plants were grown under a 16:8-h photoperiod, with a daytime temperature of 23° and a nighttime temperature of 17°. When the primary flowering stem began to elongate, it was covered with a mesh pollen-containment bag to prevent outcrossing. Self-pollination was facilitated by shaking the plants several times each day. Mature seeds derived from self-pollinations were harvested about three months after planting. A partially defatted seed meal was prepared as follows: 40 mg of mature dry seed was ground with a mortar and pestle under liquid nitrogen to a fine powder. One milliliter of hexane was added and the mixture was shaken at room temperature for 15 min. The meal was pelleted in an eppendorf centrifuge, the hexane was removed and the hexane extraction was repeated. Then the meal was dried at 65° for 10 min until the hexane was completely evaporated leaving a dry powder. Total proteins were extracted from mature seeds as follows. Approximately 30-40 mg of seeds were put into a 1.5 mL disposable plastic microfuge tube and ground in 0.25 mL of 50 mM Tris-HCl pH 6.8, 2 mM EDTA, 1% SDS, 1% (v/v) β-mercaptoethanol. The grinding was done using a motorized grinder with disposable plastic shafts designed to fit into the microfuge tube. The resultant suspensions were centrifuged for 5 min at room temperature in a microfuge to remove particulates. Three volumes of extract was mixed with 1 volume of 4 X SDS-gel sample buffer (0.1 M Tris-HCl pH6.8, 6.7% SDS, 16.7% (v/v) β-mercaptoethanol, 33% (v/v) glycerol) and 5 μL from each extract were run per lane on an SDS polyacrylamide gel, with bacterially produced DHDPS or AKIII serving as a size standard and protein extracted from untransformed tobacco seeds serving as a negative control. The proteins were then electrophoretically blotted onto a nitrocellulose membrane. The membranes were exposed to the DHDPS or AKIII antibodies at a 1 :5000 dilution of the rabbit serum using standard protocol provided by BioRad with their Immun-Blot Kit. Following rinsing to remove unbound primary antibody the membranes were exposed to the secondary antibody, donkey anti-rabbit Ig conjugated to horseradish peroxidase (Amersham) at a 1 :3000 dilution. Following rinsing to remove unbound secondary antibody, the membranes were exposed to Amersham chemiluminescence reagent and X-ray film. Eight of eight FS926 transformants and seven of seven BT597 transformants expressed the DHDPS protein. The single BT593 transformant and five of seven BT597 transformants expressed the AKHI-M4 protein (Table 12). Thus it is straightforward to express these proteins in oilseed rape seeds. To measure free amino acid composition of the seeds, free amino acids were extracted from 40 mg of the defatted meal in 0.6 mL of methanol/chloroform/water mixed in ratio of 12v/5v/3v (MCW) at room temperature. The mixture was vortexed and then centrifuged in an eppendorf microcentrifuge for about 3 min. Approximately 0.6 mL of supernatant was decanted and an additional 0.2 mL of MCW was added to the pellet which was then vortexed and centrifuged as above. The second supernatant, about 0.2 mL, was added to the first. To this, 0.2 mL of chloroform was added followed by 0.3 mL of water. The mixture was vortexed and then centrifuged in an eppendorf microcentrifuge for about 3 min, the upper aqueous phase, approximately 1.0 mL, was removed, and was dried down in a Savant Speed Vac Concentrator. The samples were hydrolyzed in 6 N hydrochloric acid, 0.4% (v/v) β-mercaptoethanol under nitrogen for 24 h at 110-120°; 1/4 of the sample was run on a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Relative free amino acid levels in the seeds were compared as ratios of lysine or threonine to leucine, thus using leucine as an internal standard. In contrast to tobacco seeds, expression of Corynebacterium DHDPS lead to large increases in accumulation of free lysine in rapeseed transformants. The highest expressing lines showed a greater than 100-fold increase in free lysine level in the seeds. The transformant that expressed AKIII-M4 in the absence of Corynebacteria DHDPS showed a 5-fold increase in the level of free threonine in the seeds. Concomitant expression of both enzymes resulted in accumulation of high levels of free lysine, but not threonine. A high level of α-aminoadipic acid, indicative of lysine catabolism, was observed in many of the transformed lines. Thus, prevention of lysine catabolism by inactivation of lysine ketoglutarate reductase should further increase the accumulation of free lysine in the seeds. Altematively, incorporation of lysine into a peptide or lysine-rich protein would prevent catabolism and lead to an increase in the accumulation of lysine in the seeds. To measure the total amino acid composition of mature seeds, 2 mg of the defatted meal were hydrolyzed in 6 N hydrochloric acid, 0.4% (v/v) β-mercaptoethanol under nitrogen for 24 h at 110-120°; 1/100 of the sample was run on a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Relative amino acid levels in the seeds were compared as percentages of lysine, threonine or α-aminoadipic acid to total amino acids. There was a good correlation between expression of DHDPS protein and accumulation of high levels of lysine in the seeds of transformants. Seeds with a 5-100% increase in the lysine level, compared to the untransformed control, were observed. In the transformant with the highest level, lysine makes up about 13% of the total seed amino acids, considerably higher than any previously known rapeseed seed. This transformant expresses high levels of both E. coli AKIII -M4 and Corynebacterium DHDPS. TABLE 12 FS926 Transformants: phaseolin 5' region/cts/cordapA/phaseolin 3' BT593 Transformants: : phaseolin 5' region/cts/lysC-M4/phaseolin 3' BT597 Transformants: : phaseolin 5' region/cts/lvsC-M4/phaseolin 3' phaseolin 5' region/cts/cordapA/phaseolin 3' % TOTAL AMINO WESTERN WESTERN FREE AMINO ACIDS ACIDS CORYNE. E. COLI K L T/L AA/L K T AA LINE DHDPS AKIII-M4 WESTAR 0.8 2.0 0 - - 6.5 5.6 0 ZS199 1.3 3.2 0 - - 6.3 5.4 0 FS926-3 140 2.0 16 1 1 1 1 - 12 5.1 1.0 FS926-9 110 1.7 12 1 1 1 1 - 11 5.0 0.8 FS926-11 7.9 2.0 5.2 ++ - 7.7 5.2 0 FS926-6 14 1.8 4.6 +++ - 8.2 5.9 0 FS926-22 3.1 1.3 0.3 + - 6.9 5.7 0 FS926-27 4.2 1.9 1.1 ++ - 7.1 5.6 0 FS926-29 38 1.8 4.7 1 1 1 1 - 12 5.2 1.6 FS926-68 4.2 1.8 0.9 ++ - 8.3 5.5 0 BT593-42 1.4 11 0 - ++ 6.3 6.0 0 BT597-14 6.0 2.6 4.3 ++ +/- 7.0 5.3 0 BT597-145 1.3 2.9 0 + - BT597-4 38 3.7 4.5 1 1 1 1 1 1 1 1 13 5.6 1.6 BT597-68 4.7 2.7 1.5 ++ + 6.9 5.8 0 BT597-100 9.1 1.9 1.7 -t-H- ++ 6.6 5.7 0 BT597-148 7.6 2.3 0.9 +++ + 7.3 5.7 0 BT597-169 5.6 2.6 1.7 +++ +-H- 6.6 5.7 0 AA is α-amino adipic acid EXAMPLE 17 Transformation of Maize Using a Chimeric lysC-M4 Gene as a Selectable Marker Embryogenic callus cultures were initiated from immature embryos (about 1.0 to 1.5 mm) dissected from kernels of a com line bred for giving a "type II callus" tissue culture response. The embryos were dissected 10 to 12 d after pollination and were placed with the axis-side down and in contact with agarose- solidified N6 medium [Chu et al. (1974) Sci Sin 75:659-668] supplemented with 0.5 mg/L 2,4-D (N6-0.5). The embryos were kept in the dark at 27°C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryos and somatic embryos borne on suspensor stmctures proliferated from the scutellum of the immature embryos. Clonal embryogenic calli isolated from individual embryos were identified and sub-cultured on N6-0.5 medium every 2 to 3 weeks. The particle bombardment method was used to transfer genes to the callus culture cells. A Biolistic™ PDS-1000/He (BioRAD Laboratories, Hercules, CA) was used for these experiments. The plasmid pBT573, containing the chimeric gene HH534 5' region/ mcts/lysC-M4/HH2- 1 3' region (see Example 6) designed for constitutive gene expression in com, was precipitated onto the surface of gold particles. To accomplish this 2.5 μg of pBT573 (in water at a concentration of about 1 mg/mL) was added to 25 mL of gold particles (average diameter of 1.5 μm) suspended in water (60 mg of gold per mL). Calcium chloride (25 mL of a 2.5 M solution) and spermidine (10 mL of a 1.0 M solution) were then added to the gold-DNA suspension as the tube was vortexing. The gold particles were centrifuged in a microfuge for 10 s and the supernatant removed. The gold particles were then resuspended in 200 mL of absolute ethanol, were centrifuged again and the supernatant removed. Finally, the gold particles were resuspended in 25 mL of absolute ethanol and sonicated twice for one sec. Five μL of the DNA-coated gold particles were then loaded on each macro carrier disk and the ethanol was allowed to evaporate away leaving the DNA-covered gold particles dried onto the disk. Embryogenic callus (from the callus line designated #132.2.2) was arranged in a circular area of about 6 cm in diameter in the center of a 100 X 20 mm petri dish containing N6-0.5 medium supplemented with 0.25M sorbitol and 0.25M mannitol. The tissue was placed on this medium for 2 h prior to bombardment as a pretreatment and remained on the medium during the bombardment procedure. At the end of the 2 h pretreatment period, the petri dish containing the tissue was placed in the chamber of the PDS-1000/He. The air in the chamber was then evacuated to a vacuum of 28 inch of Hg. The macrocarrier was accelerated with a helium shock wave using a mpture membrane that bursts when the He pressure in the shock tube reaches 1100 psi. The tissue was placed approximately 8 cm from the stopping screen. Four plates of tissue were bombarded with the DNA-coated gold particles. Immediately following bombardment, the callus tissue was transferred to N6-0.5 medium without supplemental sorbitol or mannitol. Seven d after bombardment small (2-4 mM diameter) clumps of callus tissue were transferred to N6-0.5 medium lacking casein or proline, but supplemented with 2mM each of lysine and threonine (LT). The tissue continued to grow slowly on this medium and was transferred to fresh N6-0.5 medium supplemented with LT every 2 weeks. After 12 weeks two clones of actively growing callus was identified on two separate plates containing LT-supplemented medium. These clones continued to grow when sub-cultured on the selective medium. The presence of the lysC-M4 gene in the selected clones was confirmed by PCR analysis. Callus was transferred to medium that promotes plant regeneration. EXAMPLE 18 Transformation of Com with the Constitutive Com Promoter/cts/ecodapA and Constitutive Com Promoter/cts/lvsC-M4 The chimeric gene cassettes, HH534 5' region/ mcts/ecodapA/HH2- 1 3' region plus HH534 5' region/ mcts/lvsC-M4/HH2- 1 3' region, (Example 6) were inserted into the vector pGem9z to generate a com transformation vector. Plasmid pBT583 (Example 6) was digested with Sal I and an 1850 bp fragment containing the HH534 5' region/mcts/ecodapA/HH2- 1 3' region gene cassette was isolated. This DNA fragment was inserted into pBT573 (Example 6), which carries the HH534 5' region/mcts/ lvsC-M4/HH2-l 3' region, digested with Xho I. The resulting vector with both chimeric genes in the same orientation was designated pBT586. Vector pBT586 was introduced into embryogenic com callus tissue using the particle bombardment method. The establishment of the embryogenic callus cultures and the parameters for particle bombardment were as described in Example 17. Either one of two plasmid vectors containing selectable markers were used in the transformations. One plasmid, pALSLUC [Frornm et al. (1990) Biotechnology 5:833-839], contained a cDNA of the maize acetolactate synthase (ALS) gene. The ALS cDNA had been mutated in vitro so that the enzyme coded by the gene would be resistant to chlorsulfuron. This plasmid also contains a gene that uses the 35S promoter from Cauliflower Mosaic Vims and the 3' region of the nopaline synthase gene to express a firefly luciferase coding region [de Wet et al. (1987) Molec. Cell Biol 7:725-737]. The other plasmid, pDETRIC, contained the bar gene from Streptomvces hygroscopicus that confers resistance to the herbicide glufosinate [Thompson et al. (1987 The EMBO Journal 6:2519-2523]. The bacterial gene had its translation codon changed from GTG to ATG for proper translation initiation in plants [De Block et al. (1987) The EMBO Journal 6:2513-2518]. The bar gene was driven by the 35S promoter from Cauliflower Mosaic Vims and uses the termination and polyadenylation signal from the octopine synthase gene from Agrobacterium tumefaciens. For bombardment, 2.5 μg of each plasmid, pBT586 and one of the two selectable marker plasmids, was co-precipitated onto the surface of gold particles as described in Example 17. Bombardment of the embryogenic tissue cultures was also as described in Example 17. Seven days after bombardment the tissue was transferred to selective medium. The tissue bombarded with the selectable marker pALSLUC was transferred to N6-0.5 medium that contained chlorsulfuron (30 ng/L) and lacked casein or proline. The tissue bombarded with the selectable marker, pDETRIC, was transferred to N6-0.5 medium that contained 2 mg/L glufosinate and lacked casein or proline. The tissue continued to grow slowly on these selective media. After an additional 2 weeks the tissue was transferred to fresh N6-0.5 medium containing the selective agents. Chlorsulfuron- and glufosinate-resistance callus clones could be identified after an additional 6-8 weeks. These clones continued to grow when transferred to the selective media. The presence of pBT586 in the transformed clones has been confirmed by PCR analysis. Functionality of the introduced AK enzyme was tested by plating out transformed clones on N6-0.5 media containing 2 mM each of lysine and threonine (LT selection; see Example 13). All of the clones were capable of growing on LT medium indicating that the E. coli aspartate kinase was expressed and was functioning properly. To test that the E. coli DHDPS enzyme was functional, transformed callus was plated on N6-0.5 media containing 2μM 2-aminoethylcysteine (AEC), a lysine analog and potent inhibitor of plant DHDPS. The transformed callus tissue was resistant to AEC indicating that the introduced DHDPS, which is about 16-fold less sensitive to AEC than the plant enzyme, was being produced and was functional. Plants have been regenerated from several transformed clones and are being grown to maturity. EXAMPLE 19 Transformation of Soybean with the Phaseolin Promoter/cts/cordapA and Phaseolin Promoter/cts/lvsC-M4 Chimeric Genes The chimeric gene cassettes, phaseolin 5' region/ cts/cordapA/phaseolin 3' region plus phaseolin 5' region/cts/lysC-M4/phaseolin 3', (Example 6) were inserted into the soybean transformation vector pBT603 (Figure 8A). This vector has a soybean transformation marker gene consisting of the 35S promoter from Cauliflower Mosaic Vims driving expression of the E. coli β-glucuronidase gene [Jefferson et al. (1986) Proc. Natl. Acad. Sci. USA 55:8447-8451] with the Nos 3' region in a modified pGEM9Z plasmid. To insert the phaseolin 5' region/cts/lysC-M4/ phaseolin 3' region, the gene cassette was isolated as a 3.3 kb Hind III fragment and inserted into Hind III digested pBT603, yielding plasmid pBT609. This binary vector has the chimeric gene, phaseolin 5' region/ cts/lysC-M4/phaseolin 3' region inserted in the opposite orientation from the 35S/GUS/Nos 3' marker gene. To insert the phaseolin 5' region/cts/cordapA/ phaseolin 3'region 3', the gene cassette was isolated as a 2.7 kb BamH I fragment (as described in Example 15) and inserted into BamH I digested pBT609, yielding plasmid pBT614 (Figure 8B). This vector has both chimeric genes, phaseolin 5' region/cts/lvsC-M4/phaseolin 3' region and phaseolin 5' region/cts/cordapA/phaseolin 3' region inserted in the same orientation, and both are in the opposite orientation from the 35S/GUS/Nos 3' marker gene. Soybean was transformed with plasmid pBT614 according to the procedure described in United States Patent No. 5,015,580. Soybean transformation was performed by Agracetus Company (Middleton, WI). Seeds from five transformed lines were obtained and analyzed. It was expected that the transgenes would be segregating in the Rl seeds of the transformed plants. To identify seeds that carried the transformation marker gene, a small chip of the seed was cut off with a razor and put into a well in a disposable plastic microtiter plate. A GUS assay mix consisting of 100 mM NaH 2 PO 4 , 10 mM EDTA, 0.5 mM K4Fe(CN) 6 , 0.1% Triton X-100, 0.5 mg/mL 5-Bromo-4-chloro-3-indolyl β-D-glucuronic acid was prepared and 0.15 mL was added to each microtiter well. The microtiter plate was incubated at 37° for 45 min. The development of blue color indicated the expression of GUS in the seed. Five of seven transformed lines showed approximately 3:1 segregation for GUS expression indicating that the GUS gene was inserted at a single site in the soybean genome. The other transformants showed 9:1 and 15:1 segregation, suggesting that the GUS gene was inserted at two sites. A meal was prepared from a fragment of individual seeds by grinding into a fine powder. Total proteins were extracted from the meal by adding 1 mg to 0.1 mL of 43 mM Tris-HCl pH 6.8, 1.7% SDS, 4.2% (v/v) β-mercaptoethanol, 8% (v/v) glycerol, vortexing the suspension, boiling for 2-3 min and vortexing again. The resultant suspensions were centrifuged for 5 min at room temperature in a microfuge to remove particulates and 10 μL from each extract were run per lane on an SDS polyacrylamide gel, with bacterially produced DHDPS or AKIII serving as a size standard. The proteins were then elecfrophoretically blotted onto a nitrocellulose membrane. The membranes were exposed to the DHDPS or AKIII antibodies, at a 1:5000 or 1:1000 dilution, respectively, of the rabbit serum using standard protocol provided by BioRad with their Immun-Blot Kit. Following rinsing to remove unbound primary antibody the membranes were exposed to the secondary antibody, donkey anti-rabbit Ig conjugated to horseradish peroxidase (Amersham) at a 1 :3000 dilution. Following rinsing to remove unbound secondary antibody, the membranes were exposed to Amersham chemiluminescence reagent and X-ray film. Six of seven transformants expressed the DHDPS protein. In the six transformants that expressed DHDPS, there was excellent correlation between expression of GUS and DHDPS in individual seeds (Table 13). Therefore, the GUS and DHDPS genes are integrated at the same site in the soybean genome. Four of seven transformants expressed the AKIII protein, and again there was excellent correlation between expression of AKIII, GUS and DHDPS in individual seeds (Table 13). Thus, in these four transformants the GUS, AKIII and DHDPS genes are integrated at the same site in the soybean genome. One transformant expressed only GUS in its seeds. To measure free amino acid composition of the seeds, free amino acids were extracted from 8-10 milligrams of the meal in 1.0 mL of methanol/chloro- form/water mixed in ratio of 12v/5v/3v (MCW) at room temperature. The mixture was vortexed and then centrifuged in an eppendorf microcentrifuge for about 3 min; approximately 0.8 mL of supernatant was decanted. To this supernatant, 0.2 mL of chloroform was added followed by 0.3 mL of water. The mixture was vortexed and then centrifuged in an eppendorf microcentrifuge for about 3 min, the upper aqueous phase, approximately 1.0 mL, was removed, and was dried down in a Savant Speed Vac Concentrator. The samples were hydrolyzed in 6 N hydrochloric acid, 0.4% (v/v) β-mercaptoethanol under nitrogen for 24 h at 110-120°; 1/10 of the sample was run on a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Relative free amino acid levels in the seeds were compared as ratios of lysine to leucine, thus using leucine as an internal standard. Soybean transformants expressing Corynebacteria DHDPS alone and in concert with E. coli AKIII-M4 accumulated high levels of free lysine in their seeds. From 20 fold to 120-fold increases in free lysine levels were observed (Table 13). A high level of saccharopine, indicative of lysine catabolism, was also observed in seeds that contained high levels of lysine. Thus, prevention of lysine catabolism by inactivation of lysine ketoglutarate reductase should further increase the accumulation of free lysine in the seeds. Altematively, incorporation of lysine into a peptide or lysine-rich protein would prevent catabolism and lead to an increase in the accumulation of lysine in the seeds. To measure the total amino acid composition of mature seeds, 1-1.4 milligrams of the seed meal was hydrolyzed in 6 N hydrochloric acid, 0.4% (v/v) β-mercaptoethanol under nitrogen for 24 h at 110-120°; 1/50 of the sample was run on a Beckman Model 6300 amino acid analyzer using post-column ninhydrin detection. Lysine (and other amino acid) levels in the seeds were compared as percentages of the total amino acids. The soybean seeds expressing Corynebacteria DHDPS showed substantial increases in accumulation of total seed lysine. Seeds with a 5-35% increase in total lysine content, compared to the untransformed control, were observed. In these seeds lysine makes up 7.5-7.7% of the total seed amino acids. Soybean seeds expressing Corynebacteria DHDPS in concert with E. coli AKHI-M4 showed much greater accumulation of total seed lysine than those expressing Corynebacteria DHDPS alone. Seeds with a more than four-fold increase in total lysine content were observed. In these seeds lysine makes up 20-25% of the total seed amino acids, considerably higher than any previously known soybean seed. TABLE 13 % TOTAL LINΕ-SΕΕD GUS Free LYS/LEU DHD AKIII SEED LYS A2396- 145-4 - 0.9 5.8 A2396-145-8 - 1.0 A2396-145-5 - 0.8 5.9 A2396- 145-3 - 1.0 A2396-145-9 + 2.0 A2396- 145-6 + 4.6 A2396-145-1 + 8.7 A2396-145-10 + 18.4 7.5 A2396-145-7 + 21.7 + 6.7 A2396-145-2 + 45.5 + 7.2 A5403-175-9 - 1.3 A5403- 175-4 - 1.2 6.0 A5403- 175-3 - 1.0 6.0 A5403-175-7 + 1.5 A5403-175-5 + 1.8 A5403- 175-1 + 6.2 A5403-175-2 + 6.5 6.3 A5403- 175-6 + 14.4 A5403-175-8 + 47.8 + - 7.7 A5403-175-10 + 124.3 + - 7.5 A5403-181-9 + 1.4 A5403-181-10 + 1.4 - - 5.7 A5403-181-8 + 0.9 A5403-181-6 + 1.5 A5403-181-4 - 0.7 - - 5.9 A5403-181-5 + 1.1 A5403-181-2 - 1.8 - - 5.6 A5403-181-3 + 2.7 - - 5.5 A5403-181-7 + 1.9 A5403-181-1 - 2.3 A5403- 183-9 - 0.8 A5403- 183-6 - 0.7 - - 6.0 A5403- 183-8 - 1.3 A5403-183-4 - 1.3 - - 6.0 A5403- 183-5 + 0.9 A5403-183-3 + 3.1 A5403-183-1 + 3.3 A5403-183-7 + 9.9 A5403-183-10 + 22.3 + + 6.7 A5403- 183-2 + 23.1 + + 7.3 A5403- 196-8 - 0.9 - - 5.9 A5403-196-6 + 8.3 A5403-196-1 + 16.1 + + 6.8 A5403- 196-7 + 27.9 A5403- 196-3 + 52.8 A5403- 196-5 + 26 A5403-196-2 + 16.2 + + A5403-196-10 + 29 + + 7.5 A5403- 196-4 + 58.2 + + 7.6 A5403- 196-9 + 47.1 A2396-233-1 + 25 A2396-233-2 + 18 A2396-233-3 + 23 A2396-233-4 + 20 A2396-233-5 - +/- 6.0 A2396-233-6 + 16 A2396-233-13 + 18 A2396-234-1 + + + 8.3 A2396-234-2 + + + 13 A2396-234-3 + 10 A2396-234-4 + 19 A2396-234-9 + 15 A2396-234-16 - 5.9 wild type - 0.9 5.6 control EXAMPLE 20 Isolation of a Plant Lysine Ketoglutarate Reductase Gene Lysine Ketoglutarate Reductase (LKR) enzyme activity has been observed in immature endosperm of developing maize seeds [Arruda et al. (1982) Plant Physiol. 69:988-989]. LKR activity increases sharply from the onset of endosperm development, reaches a peak level at about 20 d after pollination, and then declines [Arruda et al. (1983) Phytochemistry 22:2687-2689]. In order to clone the com LKR gene, RNA was isolated from developing seeds 19 days after pollination. This RNA was sent to Clontech Laboratories, Inc., (Palo Alto, CA) for the custom synthesis of a cDNA library in the vector Lambda Zap II. The conversion of the Lambda Zap II library into a phagemid library, then into a plasmid library was accomplished following the protocol provided by Clontech. Once converted into a plasmid library the ampicillin- resistant clones obtained carry the cDNA insert in the vector pBluescript SK(-). Expression of the cDNA is under control of the lacZ promoter on the vector. Two phagemid libraries were generated using the mixtures of the Lambda Zap II phage and the filamentous helper phage of 100 μL to 1 μL. Two additional libraries were generated using mixtures of 100 μL Lambda Zap II to 10 μL helper phage and 20 μL Lambda Zap II to 10 μL helper phage. The titers of the phagemid preparations were similar regardless of the mixture used and were about 2 x 10 3 ampicillin-resistant-transfectants per mL with E. coli strain XL 1 -Blue as the host and about 1 x 10 3 with DΕ126 (see below) as host. To select clones that carried the LKR gene a specially designed E. coli host, DEI 26 was constmcted. Constmction of DEI 26 occurred in several stages. (1) A generalized transducing stock of coliphage Plvir was produced by infection of a culture of TST1 [F"> araD139, Δ(argF-lac)205, flb5301, ptsF25, reJAl, rpsL150. malE52::TnlO. deoCl, λ"] (E. coli Genetic Stock Center #6137) using a standard method (for Methods see J. Miller, Experiments in Molecular Genetics). (2) This phage stock was used as a donor in a transductional cross (for Method see J. Miller, Experiments in Molecular Genetics) with strain GIF106M1 [F-, arg-, ilvA296. l sClOOl, thrAHOl, metL 1000. λ"> rpsL9, malTl. x l-7, mtl-2, thil(?). suρE44(?)l (E. coli Genetic Stock Center #5074) as the recipient. Recombinants were selected on rich medium [L supplemented with DAP] containing the antibiotic tetracycline. The transposon TnlO, conferring tetracycline resistance, is inserted in the malE gene of strain TST1. Tetracycline- resistant transductants derived from this cross are likely to contain up to 2 min of the E. coli chromosome in the vicinity ofmalE. The genes malE and lysC are separated by less than 0.5 minutes, well within cotransduction distance. (3) 200 tetracycline-resistant transductants were thoroughly phenotyped; appropriate fermentation and nutritional traits were scored. The recipient strain GIF106M1 is completely devoid of aspartokinase isozymes due to mutations in thrA. metL and IvsC. and therefore requires the presence of threonine, methionine, lysine and meso-diaminopimelic acid (DAP) for growth. Transductants that had inherited lysC + with malE::TnlQ from TST1 would be expected to grow on a minimal medium that contains vitamin Bl, L-arginine, L-isoleucine and L-valine in addition to glucose which serves as a carbon and energy source. Moreover strains having the genetic constitution of lysC + , metL- and thrA- will only express the lysine sensitive aspartokinase. Hence addition of lysine to the minimal medium should prevent the growth of the lvsC + recombinant by leading to starvation for threonine, methionine and DAP. Of the 200 tetracycline resistant transductants examined, 49 grew on the minimal medium devoid of threonine, methionine and DAP. Moreover, all 49 were inhibited by the addition of L-lysine to the minimal medium. One of these transductants was designated DEI 25. DEI 25 has the phenotype of tetracycline resistance, growth requirements for arginine, isoleucine and valine, and sensitivity to lysine. The genotype of this strain is F" malE52::TnlO arg- ilvA296 thrAl 101 metL 1000 lambda- rpsL9 malTl xχi-7 mtl-2 Jhil(?) SUPE44(?). (4) This step involves production of a male derivative of strain DEI 25. Strain DE125 was mated with the male strain AB1528 [F' 16/delta(gpt-proA)62. lacYl or lacZ4. glnV44. galK2 rac"(?), hisG4, rfbdl. mgl-51, kdgK51(?), ilvC7. argE3, ϋά-l] (E. coli Genetic Stock Center #1528) by the method of conjugation. F'16 carries the ilvGMEDAYC gene cluster. The two strains were cross streaked on rich medium permissive for the growth of each strain. After incubation, the plate was replica plated to a synthetic medium containing tetracycline, arginine, vitamin Bl and glucose. DEI 25 cannot grow on this medium because it cannot synthesize isoleucine. Growth of AB 1528 is prevented by the inclusion of the antibiotic tetracycline and the omission of proline and histidine from the synthetic medium. A patch of cells grew on this selective medium. These recombinant cells underwent single colony isolation on the same medium. The phenotype of one clone was determined to be Ilv + > Arg", TetR, Lysine-sensitive, male specific phage (MS2)-sensitive, consistent with the simple transfer of F'16 from AB1528 to DEI 25. This clone was designated DEI 26 and has the genotype F'16/malE52::TnlO, arg", ilvA296. thrAHOl, metL 100. lvsC+. λ", rpsL9. malTl. xyl-7. mtl-2. thi-1?. supE44?. It is inhibited by 20 μg/mL of L-lysine in a synthetic medium. To select for clones from the com cDNA library that carried the LKR gene, 100 μL of the phagemid library was mixed with 100 μL of an overnight culture of DEI 26 grown in L broth and the cells were plated on synthetic media containing vitamin Bl, L-arginine, glucose as a carbon and energy source, 100 μg/mL ampicillin and L-lysine at 20, 30 or 40 μg/mL. Four plates at each of the three different lysine concentrations were prepared. The amount of phagemid and DEI 26 cells was expected to yield about 1 x 10 5 ampicillin-resistant transfectants per plate. Ten to thirty lysine-resistant colonies grew per plate (about 1 lysine- resistant per 5000 ampicillin-resistant colonies). Plasmid DNA was isolated from 10 independent clones and retransformed into DE126. Seven of the ten DNAs yielded lysine-resistant clones demonstrating that the lysine-resistance trait was carried on the plasmid. Several of the cloned DNAs were sequenced and biochemically characterized. The inserted DNA fragments were found to be derived from the E. coli genome, rather than a com cDNA indicating that the cDNA library provided by Clontech was contaminated. Another method was used to identify plant cDNAs that encode LKR. This method was based upon expected homology between plant LKR and fungal genes encoding saccharopine dehydrogenase. Fungal saccharopine dehydrogenase (glutamate-forming) and saccharopine dehydrogenase (lysine-forming) catalyze the final two steps in the fungal lysine biosynthetic pathway. Plant LKR and fungal saccharopine dehydrogenase (lysine-forming) catalyze both forward and reverse reactions, use identical substrates and use similar co-factors. Similarly, plant saccharopine dehydrogenase (glutamate-forming), which catalyzes the second step in the lysine catabolic pathway, works in both forward and reverse reactions, uses identical substrates and uses similar co-factors as fungal saccharopine dehydrogenase (glutamate-forming). Biochemical and genetic evidence derived from human and bovine studies has demonstrated that mammalian LKR and saccharopine dehydrogenase (glutamate-forming) enzyme activities are present on a single protein with a monomer molecular weight of about 117,000. This contrasts with the fungal enzymes which are carried on separate proteins, saccharopine dehydrogenase (lysine-forming) with a molecular weight of about 44,000 and saccharopine dehydrogenase (glutamate-forming) with a molecular weight of about 51,000. Plant LKR has been reported to have a molecular weight of about 140,000 indicating that it is like the animal catabolic protein wherein both LKR and saccharopine dehydrogenase (glutamate-forming) enzyme activities are present on a single protein. Several genes for fungal saccharopine dehydrogenases have been isolated and sequenced [Xuan et al. (1990) Mol. Cell. Biol. 10:4795-4806, Feller et al. (1994) Mol. Cell. Biol. 74:6411-6418]. The fungal protein sequences, deduced from these gene sequences, were used to search plant cDNA databases for DNA fragments that encoded plant proteins homologous to the fungal saccharopine dehydrogenases. We discovered two plant cDNA fragments from Arabidopsis thaliana, SEQ ID NO: 102: and SEQ ID NO: 103:, that encoded polypeptides SEQ ID NO: 104: and SEQ ID NO: 105:, respectively, that are homologous to fungal saccharopine dehydrogenase (glutamate-forming). The sequence similarity between the fungal and plant polypeptides (see Figure 9) demonstrate that these cDNAs encode Arabidopsis saccharopine dehydrogenase. Oligonucleotides SEQ ID NO: 108: and SEQ ID NO: 109 were synthesized and used for PCR amplification of a 2.24 kb DNA fragment from genomic Arabidopsis. DNA. DNA sequencing of the fragment confirmed that it encoded LKR/SDH. The fragment was labeled with digoxigenin (DIG) using Boehringer Mannheim's Dig- High Prime kit and protocol. This probe was used to screen a CD4-8 Landsberg erecta genomic library by plaque hybridization. Approximately 2.7 X 10^ recombinant phage were plated on the host E. coli LE392, grown overnight at 37°. The protocol was as described in the DIG Wash and Block Set (Boehringer Mannheim) with the hybridization temperature set at 55°. Five positive clones were isolated; one was subcloned into plasmid vector pBluescript ® SK +/- (Stratagene), transformed into DH5α ™ competent cells (GibcoBRL) and sequenced. The complete genomic sequence of the Arabidopsis LKR/SDH gene is shown in SEQ ID NO:l 10. The sequence includes approximately 2 kb of 5' noncoding sequence and 500 bp of 3' noncoding sequence and 23 introns. Overlapping fragments of the corresponding cDNA were isolated from total Arabidopsis RNA by RT-PCR. Sequence analysis of the LKR-SDH cDNA revealed an ORF of 3.16 kb, which predicts a protein of 117 kd, and confirms that the LKR and SDH enzymes reside on one polypeptide. The complete protein coding sequence of Arabidopsis LKR/SDH gene, derived from the cDNA, is shown in SEQ ID NO: 111. The deduced amino acid sequence of Arabidopsis LKR/SDH protein is shown in SEQ ID NO: 112. The protein lacks an N-terminal targeting sequence implying that the lysine degradative pathway is located in the plant cell cytosol. Degenerate oligonucleotides, SEQ ID NO:l 13 and SEQ ID NO:l 14, were designed based upon comparison of the Arabidopsis LKR/SDH amino acid sequence with that of other LKR proteins. These were used to amplify soybean and com LKR/SDH cDNA fragments using PCR from mRNA, or cDNA synthesized from mRNA, isolated from developing soybean or com seeds. The soybean and com PCR-generated cDNA fragments were cloned and sequenced. The sequence of the soybean LKR/SDH cDNA fragment is shown in SEQ ID NO:l 15, and the sequence of the com cDNA fragment is shown in SEQ ID NO: 116. The deduced partial amino acid sequence of soybean LKR/SDH protein is shown in SEQ ID NO:l 17 and the deduced partial amino acid sequence of com LKR/SDH protein is shown in SEQ ID NO: 118. The partial cDNAs encoding com and soybean LKR/SDH obtained by PCR, above, were used in protocols that extended the sequence information for these functions. These protocols, which included RACE and direct DNA:DNA hybridization to cDNA libraries for the identification of overlapping clones, are well known to persons skilled in the art. From these efforts, more complete sequences for the com and soybean cDNAs for LKR/SDH were obtained. SEQ ID NOS: 119 and 120 list, respectively, near full- length sequences for the LKR/SDH coding regions from soybean and com. The deduced protein sequences encoded by these soybean and com cDNAs are shown in SEQ ID NOS: 121 and 122, respectively. Partial cDNA clones for LKR/SDH from rice and wheat were identifid in libraries prepared from rice roots and leafs and from wheat seedlings. cDNA libraries were prepared in Uni-ZAP™ XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA). Conversion of the Uni-ZAP™ XR libraries into plasmid libraries was accomplished according to the protocol provided by Stratagene. Upon conversion, cDNA inserts were contained in the plasmid vector pBluescript. cDNA inserts from randomly picked bacterial colonies containing recombinant pBluescript plasmids were amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences or plasmid DNA was prepared from cultured bacterial cells. Amplified insert DNAs or plasmid DNAs were sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or "ESTs"; see Adams, M. D. et al., (1991) Science 252: 1651). The resulting ESTs were analyzed using a Perkin Elmer Model 377 fluorescent sequencer. Possible protein products encoded by the ESTs were compared to the full-length sequence of Arabidopsis LKR/SDH (SEQ ID NO: 112). A contig for a partial cDNA from rice was constmcted and is presented in SEQ ID: 125. The predicted prtein fragment from the cDNA contig is shown in SEQ ID NO: 126. Another cDNA from rice was identified which corresponds to the 3' end of a LKR SDH coding region and this sequence is set forth in SEQ ID NO: 127. The predicted protein fragment is shown in SEQ ID NO: 128. A partial wheat clone was identified and possesses the sequence presented in SEQ ID NO: 129. The predicted protein fragment encoded by this cDNA is set forth isn SEQ ID NO: 130. The SDH coding region encompasses 1.4 kb on 3' end of the Arabidopsis cDNA clone (SEQ ID NO: 131), and encodes a protein of about 52 kD (SEQ ID NO: 132). A DNA fragment encoding SDH was generated using PCR primers, which added desired restriction enzyme sites, and ligated into prokaryotic expression vector pBT430 (see Example 2). Addition of the restriction enzyme cleavage site resulted in a change from thr to ala encoded by the second codon. High level expression of Arabidopsis SDH was achieved in E.coli BL21(DE3)LysS host which expressed T7 RNA polymerase. Extracts from IPTG-induced cells that were transformed with the vector carrying the 1.4 kb insert were analyzed by SDS-PAGE and a protein of the expected size was overproduced in these cells. Separation of the cell extracts into its supernatant (soluble) and pellet (insoluble) fractions showed that substantial amounts of protein were present in both. SDH activity was measured in the soluble fraction of the bacterial extracts. No SDH activity was observed in extracts from cells transformed with an unmodified vector. Extracts from cells containing the SDH cDNA insert converted substantial amounts of NAD+ to NADH. The reaction was specific for SDH because no significant activity was observed in the absence of the SDH substrate saccharopine. The SDH protein has been purified from these bacterial extracts and used to raise rabbit antibodies to the protein. In order to block expression of the LKR gene in transformed plants, a chimeric gene designed for cosuppression of LKR is constructed by linking the LKR gene or gene fragment to any of the plant promoter sequences described above. (See U.S. Patent No. 5,231,020 for methodology to block plant gene expression via cosuppression.) The com LKR gene, SEQ ID NO: 120, was modified by introducing an Nco I site at position 7 and a Kpn I site at position 1265 using PCR. This Nco I and Kpn I DNA fragment containing the com LKR gene fragment was inserted into a plasmid containing the glutelin 2 promoter and 10 kD zein 3' region (see Example 25) to create a chimeric gene for suppression of LKR expression in com endosperm. The soybean LKR gene, SEQ ID NO:l 19, was modified by introducing an Nco I site at position 2 and a Kpn I site at position 690 using PCR. This Nco I and Kpn I DNA fragment containing the soybean LKR gene fragment was inserted into a plasmid containing the KTI3 promoter and the KTI3 3' region (see Example 6) to create a chimeric gene for suppression of LKR expression in soybean seeds. Altematively, a chimeric gene designed to express antisense RNA for all or part of the LKR is constructed by linking the LKR gene or gene fragment in reverse orientation to any of the plant promoter sequences described above. (See U.S. patent 5,107,065 for methodology to block plant gene expression via antisense RNA.) Either the cosuppression or antisense chimeric gene is introduced into plants via transformation as described in other Examples, e.g. Example 18 or Example 19. Transformants wherein expression of the endogenous LKR gene is reduced or eliminated are selected. EXAMPLE 21 Construction of Synthetic Genes in Expression Vector pSK5 To facilitate the construction and expression of the synthetic genes described below, it was necessary to construct a plasmid vector with the following attributes: 1. No Ear I restriction endonuclease sites such that insertion of sequences would produce a unique site. 2. Containing a tetracycline resistance gene to avoid loss of plasmid during growth and expression of toxic proteins. 3. Containing approximately 290 bp from plasmid pBT430 including the T7 promoter and terminator segment for expression of inserted sequences in E. coli. 4. Containing unique ΕcoR I and Nco I restriction endonuclease recognition sites in proper location behind the T7 promoter to allow insertion of the oligonucleotide sequences. To obtain attributes 1 and 2 Applicants used plasmid pSKl which was a spontaneous mutant of pBR322 where the ampicillin gene and the Ear I site near that gene had been deleted. Plasmid pSKl retained the tetracycline resistance gene, the unique EcoR I restriction sites at base 1 and a single Ear I site at base 2353. To remove the Ear I site at base 2353 of pSKl a polymerase chain reaction (PCR) was performed using pSKl as the template. Approximately 10 femtomoles of pSKl were mixed with 1 μg each of oligonucleotides SM70 and SM71 which had been synthesized on an ABI1306B DNA synthesizer using the manufacturer's procedures. SM70 5'-CTGACTCGCTGCGCTCGGTC 3' SEQ ID NO: 16 SM71 5'-TATTTTCTCCTTACGCATCTGTGC-3' SEQ ID NO:17 The priming sites of these oligonucleotides on the pSKl template are depicted in Figure 10. The PCR was performed using a Perkin-Elmer Cetus kit (Emeryville, CA) according to the instructions of the vendor on a thermocycler manufactured by the same company. The 25 cycles were 1 min at 95°, 2 min at 42° and 12 min at 72°. The oligonucleotides were designed to prime replication of the entire pSKl plasmid excluding a 30 b fragment around the Ear I site (see Figure 10). Ten microliters of the 100 μL reaction product were run on a 1% agarose gel and stained with ethidium bromide to reveal a band of about 3.0 kb corresponding to the predicted size of the replicated plasmid. The remainder of the PCR reaction mix (90 μL) was mixed with 20 μL of 2.5 mM deoxynucleotide triphosphates (dATP, dTTP, dGTP, and dCTP), 30 units of Klenow enzyme added and the mixture incubated at 37° for 30 min followed by 65° for 10 min. The Klenow enzyme was used to fill in ragged ends generated by the PCR. The DNA was ethanol precipitated, washed with 70% ethanol, dried under vacuum and resuspended in water. The DNA was then treated with T4 DNA kinase in the presence of 1 mM ATP in kinase buffer. This mixture was incubated for 30 min at 37° followed by 10 min at 65°. To 10 μL of the kinase- treated preparation, 2 μL of 5X ligation buffer and 10 units of T4 DNA ligase were added. The ligation was carried out at 15° for 16 h. Following ligation, the DNA was divided in half and one half digested with Ear I enzyme. The Klenow, kinase, ligation and restriction endonuclease reactions were performed as described in Sambrook et al., [Molecular Cloning, A Laboratory Manual, 2nd ed. (1989) Cold Spring Harbor Laboratory Press]. Klenow, kinase, ligase and most restriction endonucleases were purchased from BRL. Some restriction endonucleases were purchased from NEN Biolabs (Beverly, MA) or Boehringer Mannheim (Indianapolis, IN). Both the ligated DNA samples were transformed separately into competent JM103 [supE thi Δ(lac-proAB) F' [traD36 proAB, lacl q lacZ ΔM15] restriction minus] cells using the CaCl method as described in Sambrook et al., [Molecular Cloning, A Laboratory Manual, 2nd ed. (1989) Cold Spring Harbor Laboratory Press] and plated onto media containing 12.5 μg/mL tetracycline. With or without Ear I digestion the same number of transformants were recovered suggesting that the Ear I site had been removed from these constructs. Clones were screened by preparing DNA by the alkaline lysis miniprep procedure as described in Sambrook et al., [Molecular Cloning, A Laboratory Manual, 2nd ed. (1989) Cold Spring Harbor Laboratory Press] followed by restriction endonuclease digest analysis. A single clone was chosen which was tetracycline-resistant and did not contain any Ear I sites. This vector was designated pSK2. The remaining EcoR I site of pSK2 was destroyed by digesting the plasmid with EcoR I to completion, filling in the ends with Klenow and ligating. A clone which did not contain an EcoR I site was designated pSK3. To obtain attributes 3 and 4 above, the bacteriophage T7 RNA polymerase promoter/terminator segment from plasmid pBT430 (see Example 2) was amplified by PCR. Oligonucleotide primers SM78 (SEQ ID NO: 18) and SM79 (SEQ ID NO: 19) were designed to prime a 300b fragment from pBT430 spanning the T7 promoter/terminator sequences (see Figure 10). SM785'-TTCATCGATAGGCGACCACACCCGTCC-3' SEQ IDNO:18 SM795'-AATATCGATGCCACGATGCGTCCGGCG-3* SEQ IDNO:19 The PCR reaction was carried out as described previously using pBT430 as the template and a 300 bp fragment was generated. The ends of the fragment were filled in using Klenow enzyme and phosphorylated as described above. DNA from plasmid pSK3 was digested to completion with PvuII enzyme and then treated with calf intestinal alkaline phosphatase (Boehringer Mannheim) to remove the 5' phosphate. The procedure was as described in Sambrook et al., [Molecular Cloning, A Laboratory Manual, 2nd ed. (1989) Cold Spring Harbor Laboratory Press]. The cut and dephosphorylated pSK3 DNA was purified by ethanol precipitation and a portion used in a ligation reaction with the PCR generated fragment containing the T7 promoter sequence. The ligation mix was transformed into JM103 [supE thi Δ(lac-proAB) F* [traD36 proAB, lacl q lacZ ΔM15] restriction minus] and tetracycline-resistant colonies were screened. Plasmid DNA was prepared via the alkaline lysis mini prep method and restriction endonuclease analysis was performed to detect insertion and orientation of the PCR product. Two clones were chosen for sequence analysis: Plasmid pSK5 had the fragment in the orientation shown in Figure 10. Sequence analysis performed on alkaline denatured double-stranded DNA using Sequenase® T7 DNA polymerase (US Biochemical Corp.) and manufacturer's suggested protocol revealed that pSK5 had no PCR replication errors within the T7 promoter/terminator sequence. The strategy for the constmction of repeated synthetic gene sequences based on the Ear I site is depicted in Figure 11. The first step was the insertion of an oligonucleotide sequence encoding a base gene of 14 amino acids. This oligonucleotide insert contained a unique Ear I restriction site for subsequent insertion of oligonucleotides encoding one or more heptad repeats and added an unique Asp 718 restriction site for use in transfer of gene sequences to plant vectors. The overhanging ends of the oligonucleotide set allowed insertion into the unique Nco I and EcoR I sites of vector pSK5. M E E K M K A M E E K SM81 5 ' -CATGGAGGAGAAGATGAAGGCGATGGAAGAGAAG SM80 3 ' -CTCCTCTTCTACTTCCGCTACCTTCTCTTC NCO I EAR I M K A (SEQ ID NO:22) SM81 ATGAAGGCGTGATAGGTACCG-3 ' (SEQ ID NO: 20) SM80 TACTTCCGCACTATCCATGGCTTAA-5 ' (SEQ ID NO: 21) ASP718 ECOR I DNA from plasmid pSK5 was digested to completion with Nco I and EcoR I restriction endonucleases and purified by agarose gel electrophoresis. Purified DNA (0.1 μg) was mixed with 1 μg of each oligonucleotide SM80 (SEQ ID NO: 14) and SM81 (SEQ ID NO:13) and ligated. The ligation mixture was transformed into E. coli strain JM103 [supE thi Δ(lac-proAB) F' [traD36 proAB, lacl q lacZ ΔM15] restriction minus] and tetracycline resistant transformants screened by rapid plasmid DNA preps followed by restriction digest analysis. A clone was chosen which had one each of Ear I, Nco I, Asp 718 and EcoR I sites indicating proper insertion of the oligonucleotides. This clone was designated pSK6 (Figure 12). Sequencing of the region of DNA following the T7 promoter confirmed insertion of oligonucleotides of the expected sequence. Repetitive heptad coding sequences were added to the base gene construct of described above by generating oligonucleotide pairs which could be directly ligated into the unique Ear I site of the base gene. Oligonucleotides SM84 (SEQ ID NO:23) and SM85 (SEQ ID NO:24) code for repeats of the SSP5 heptad. Oligonucleotides SM82 (SEQ ID NO:25) and SM83 (SEQ ID NO:26) code for repeats of the SSP7 heptad. SSP5 M E E K M K A (SEQ ID N0:28) SM84 5'-GATGGAGGAGAAGATGAAGGC-3' (SEQ ID NO: 23) SM85 3'- CCTCCTCTTCTACTTCCGCTA-5' (SEQ ID NO: 24) SSP7 M E E K L K A (SEQ ID NO:27) SM82 5'-GATGGAGGAGAAGCTGAAGGC-3' (SEQ ID NO:25) SM83 3'- CCTCCTCTTCGACTTCCGCTA-5' (SEQ ID NO: 26) Oligonucleotide sets were ligated and purified to obtain DNA fragments encoding multiple heptad repeats for insertion into the expression vector. Oligonucleotides from each set totaling about 2 μg were phosphorylated, and ligated for 2 h at room temperature. The ligated multimers of the oligonucleotide sets were separated on an 18% non-denaturing 20 X 20 X 0.015 cm polyacrylamide gel (Acrylamide: bis-acrylamide = 19:1). Multimeric forms which separated on the gel as 168 bp (8n) or larger were purified by cutting a small piece of polyacrylamide containing the band into fine pieces, adding 1.0 mL of 0.5 M ammonium acetate, 1 mM EDTA (pH 7.5) and rotating the tube at 37° overnight. The polyacrylamide was spun down by centrifugation, 1 μg of tRNA was added to the supernatant, the DNA fragments were precipitated with 2 volumes of ethanol at -70°, washed with 70% (v/v) ethanol, dried, and resuspended in 10 μL of water. Ten micrograms of pSK6 DNA were digested to completion with Ear I enzyme and treated with calf intestinal alkaline phosphatase. The cut and dephosphorylated vector DNA was isolated following electrophoresis in a low melting point agarose gel by cutting out the banded DNA, liquefying the agarose at 55°, and purifying over NACS PREP AC columns (BRL) following manufacturer's suggested procedures. Approximately 0.1 μg of purified Ear I digested and phosphatase treated pSK6 DNA was mixed with 5 μL of the gel purified multimeric oligonucleotide sets and ligated. The ligated mixture was transformed into E. coli strain JM103 [supΕ thi Δ(lac-proAB) F' [traD36 proAB, lacl q lacZ ΔM15] restriction minus] and tetracycline-resistant colonies selected. Clones were screened by restriction digests of rapid plasmid prep DNA to determine the length of the inserted DNA. Restriction endonuclease analyses were usually carried out by digesting the plasmid DNAs with Asp 718 and Bgl II, followed by separation of fragments on 18% non-denaturing polyacrylamide gels. Visualization of fragments with ethidium bromide, showed that a 150 bp fragment was generated when only the base gene segment was present. Inserts of the oligonucleotide fragments increased this size by multiples of 21 bases. From this screening several clones were chosen for DNA sequence analysis and expression of coded sequences in E. coli. Table 14 Sequence bv Heptad Clone # SΕO ID NO: Amino Acid Repeat (SSP) SΕO ID NO: C15 29 5.7.7.7.7.7.5 30 C20 31 5.7.7.7.7.7.5 32 C30 33 5.7.7.7.7.5 34 D16 35 5.5.5.5 36 D20 37 5.5.5.5.5 38 D33 39 5.5.5.5 40 The first and last SSP5 heptads flanking the sequence of each constmct are from the base gene described above. Inserts are designated by underlining. Because the gel purification of the oligomeric forms of the oligonucleotides did not give the expected enrichment of longer (i.e., >8n) inserts, Applicants used a different procedure for a subsequent round of insertion constmctions. For this series of constmcts four more sets of oligonucleotides were generated which code for SSP 8,9,10 and 11 amino acid sequences respectively: SSP8 M Ε Ε K L K K (SΕQ ID N0:49) SM86 5'-GATGGAGGAGAAGCTGAAGAA-3' (SΕQ ID NO: 41) SM87 3'- CCTCCTCTTCGACTTCTTCTA-5' (SΕQ ID NO: 42) SSP9 M E E K L K W (SEQ ID NO:50) SM88 5'-GATGGAGGAGAAGCTGAAGTG-3' (SEQ ID NO: 43) SM89 3'- CCTCCTCTTCGACTTCACCTA-5' (SEQ ID NO: 44) SSP10 M E E K M K K (SEQ ID N0:51) SM90 5'-GATGGAGGAGAAGATGAAGAA-3' (SEQ ID NO: 45) SM91 3'- CCTCCTCTTCTACTTCTTCTA-5' (SEQ ID N0:46) SSP11 M E E K M K (SEQ ID N0:52) SM92 5'-GATGGAGGAGAAGATGAAGTG-3' (SEQ ID NO: 47) SM93 3'- CCTCCTCTTCTACTTCACCTA-5' (SEQ ID NO: 48) The following HPLC procedure was used to purify multimeric forms of the oligonucleotide sets after phosphorylating and ligating the oligonucleotides as described above. Chromatography was performed on a Hewlett Packard Liquid Chromatograph instrument, Model 1090M. Effluent absorbance was monitored at 260 nm. Ligated oligonucleotides were centrifuged at 12,000xg for 5 min and injected onto a 2.5 micron TSK DEAE-NPR ion exchange column (35 cm x 4.6 mm i.d.) fitted with a 0.5 micron in-line filter (Supelco). The oligonucleotides were separated on the basis of length using a gradient elution and a two buffer mobile phase [Buffer A: 25 mM Tris-Cl, pH 9.0, and Buffer B: Buffer A + 1 M NaCl]. Both Buffers A and B were passed through 0.2 micron filters before use. The following gradient program was used with a flow rate of 1 mL per min at 30°: Time %A %B initial 75 25 0.5 min 55 45 5 min 50 50 20 min 38 62 23 min 0 100 30 min 0 100 31 min 75 25 Fractions (500 μL) were collected between 3 min and 9 min. Fractions corresponding to lengths between 120 bp and 2000 bp were pooled as determined from control separations of restriction digests of plasmid DNAs. The 4.5 mL of pooled fractions for each oligonucleotide set were precipitated by adding 10 μg of tRNA and 9.0 mL of ethanol, rinsed twice with 70% ethanol and resuspended in 50 μL of water. Ten μL of the resuspended HPLC purified oligonucleotides were added to 0.1 μg of the Ear I cut, dephosphorylated pSK6 DNA described above and ligated overnight at 15°. All six oligonucleotide sets described above which had been phosphorylated and self- ligated but not purified by gel or HPLC were also used in separate ligation reactions with the pSK6 vector. The ligation mixtures were transformed into E. coli strain DH5α [suρE44 ΔlacU169 (Φ80 lacZ ΔM15) hsdR17 recAl endAl gyrl96 thil relAl] and tetracycline-resistant colonies selected. Applicants chose to use the DH5α [supE44 ΔlacU169 (Φ80 lacZ ΔM15) hsdR17 recAl endAl gyrl96 thil relAl] strain for all subsequent work because this strain has a very high transformation rate and is recA-. The recA- phenotype eliminates concerns that these repetitive DNA stmctures may be substrates for homologous recombination leading to deletion of multimeric sequences. Clones were screened as described above. Several clones were chosen to represent insertions of each of the six oligonucleotide sets. Table 15 Sequence by Heptad Clone # SEQ ID NO: Amino Acid Repeat (SSP) SEQ ID NO: 82-4 53 7.7.7.7.7.7.5 54 84-H3 55 5.5,5.5 56 86-H23 57 5. - 58 88-2 59 5.9.9.9.5 60 90-H8 61 5.10.10.10.5 62 92-2 63 5.11.11.5 64 The first and last SSP5 heptads flanking the sequence represent the base gene sequence. Insert sequences are underlined. Clone numbers including the letter "H" designate HPLC-purified oligonucleotides. The loss of the first base gene repeat in clone 82-4 may have resulted from homologous recombination between the base gene repeats 5.5 before the vector pSK6 was transferred to the recA- strain. The HPLC procedure did not enhance insertion of longer multimeric forms of the oligonucleotide sets into the base gene but did serve as an efficient purification of the ligated oligonucleotides. Oligonucleotides were designed which coded for mixtures of the SSP sequences and which varied codon usage as much as possible. This was done to reduce the possibility of deletion of repetitive inserts by recombination once the synthetic genes were transformed into plants and to extend the length of the constmcted gene segments. These oligonucleotides encode four repeats of heptad coding units (28 amino acid residues) and can be inserted at the unique Ear I site in any of the previously constructed clones. SM96 and SM97 code for SSP(5)4, SM98 and SM99 code for SSP(7) 4 and SM100 plus SM101 code for SSP8.9.8.9. M E E K M K A M E E K M K SM96 5 ' -GATGGAGGAAAAGATGAAGGCGATGGAGGAGAAAATGAAA SM97 3 ' CCTCCTTTTCTACTTCCGCTACCTCCTCTTTTACTTT A M E E K M K A M E E K M K A (SEQ ID NO: 67) GCTATGGAGGAAAAGATGAAAGCGATGGAGGAGAAAATGAAGGC-3' (SEQ ID NO: 65) CGATACCTCCTTTTCTACTTTCGCTACCTCCTCTTTTACTTCCGCTA-5' (SEQ ID NO: 66) M E E K L K A M E E K L K SM98 5 ' -GATGGAGGAAAAGCTGAAAGCGATGGAGGAGAAACTCAAG SM99 3' CCTCCTTTTCGACTTTCGCTACCTCCTCTTTGAGTTC A M E E K L K A M E E K L K A (SEQ ID NO: 70) GCTATGGAAGAAAAGCTTAAAGCGATGGAGGAGAAACTGAAGGC-3' (SEQ ID NO: 68) CGATACCTTCTTTTCGAATTTCGCATCCTCCTCTTTGACTTCCGCTA-5' (SEQ ID NO: 69) M E E K L K K M E E K L K SM100 5 ' -GATGGAGGAAAAGCTTAAGAAGATGGAAGAAAAGCTGAAA SMI 01 3' CCTCCTTTTCGAATTCTTCTACCTTCTTTTCGACTTT M E E K L K K M E E K L K (SEQ ID N0:73) TGGATGGAGGAGAAACTCAAAAAGATGGAGGAAAAGCTTAAATG-3' (SEQ ID NO: 71) ACCTACCTCCTCTTTGAGTTTTTCATCCTCCTTTTCGAATTTACCTA-5' (SEQ ID NO: 72) DNA from clones 82-4 and 84-H3 were digested to completion with Ear I enzyme, treated with phosphatase and gel purified. About 0.2 μg of this DNA were mixed with 1.0 μg of each of the oligonucleotide sets SM96 and SM97, SM98 and SM99 or SM100 and SM101 which had been previously phosphorylated. The DNA and oligonucleotides were ligated overnight and then the ligation mixes transformed into E. coli strain DH5α. Tetracycline-resistant colonies were screened as described above for the presence of the oligonucleotide inserts. Clones were chosen for sequence analysis based on their restriction endonuclease digestion patterns. Table 16 Sequence by Heptad Clone # SEO ID NO: Amino Acid Repeat (SSP) SEO ID NO: 2-9 74 7.7.7.7.7.7.8.9.8.9.5 75 3-5 78 7.7.7.7.7.7.5.5 79 5-1 76 5.5.5.7.7.7.7.5 77 Inserted oligonucleotide segments are underlined Clone 2-9 was derived from oligonucleotides SM100 (SEQ ID NO:71) and SM101 (SEQ ID NO:72) ligated into the Ear I site of clone 82-4 (see above). Clone 3-5 (SEQ ID NO:78) was derived from the insertion of the first 22 bases of the oligonucleotide set SM96 (SEQ ID NO:65) and SM97 (SEQ ID NO:66) into the Ear I site of clone 82-4 (SEQ ID NO:53). This partial insertion may reflect improper annealing of these highly repetitive oligos. Clone 5-1 (SEQ ID NO:76) was derived from oligonucleotides SM98 (SEQ ID NO:68) and SM99 (SEQ ID NO:69) ligated into the Ear I site of clone 84-H3 (SEQ ID NO:55). Strategy II. A second strategy for constmction of synthetic gene sequences was implemented to allow more flexibility in both DNA and amino acid sequence. This strategy is depicted in Figure 13 and Figure 14. The first step was the insertion of an oligonucleotide sequence encoding a base gene of 16 amino acids into the original vector pSK5. This oligonucleotide insert contained an unique Ear I site as in the previous base gene constmct for use in subsequent insertion of oligonucleotides encoding one or more heptad repeats. The base gene also included a BspH I site at the 3' terminus. The overhanging ends of this cleavage site are designed to allow "in frame" protein fusions using Nco I overhanging ends. Therefore, gene segments can be multiplied using the duplication scheme described in Figure 14. The overhanging ends of the oligonucleotide set allowed insertion into the unique Nco I and EcoR I sites of vector pSK5. M E E K M K K L E E K SMI07 5 ' -CATGGAGGAGAAGATGAAAAAGCTCGAAGAGAAG SM106 3 ' -CTCCTCTTCTACTTTTTCGAGCTTCTCTTC NCO I EAR I M K V M K (SEQ ID NO:82) ATGAAGGTCATGAAGTGATAGGTACCG-3' (SEQ ID NO: 80) TACTTCCAGTACTTCACTATCCATGGCTTAA-5' (SEQ ID NO: 81) BSPH I ASP 718 The oligonucleotide set was inserted into pSK5 vector as described in Strategy I above. The resultant plasmid was designated pSK34. Oligonucleotide sets encoding 35 amino acid "segments" were ligated into the unique Ear I site of the pSK34 base gene using procedures as described above. In this case, the oligonucleotides were not gel or HPLC purified but simply annealed and used in the ligation reactions. The following oligonucleotide sets were used: SEG 3 L E E K M K A M E D K M K SMI 10 5 ' -GCTGGAAGAAAAGATGAAGGCTATGGAGGACAAGATGAAATGG SM111 3 ' -CCTTCTTTTCTACTTCCGATACCTCCTGTTCTACTTTACC L E E K M K K (SEQ ID NO:85) (amino acids 8-28) CTTGAGGAAAAGATGAAGAA-3' (SEQ ID NO: 83) GAACTCCTTTTCTACTTCTTCGA-5' (SEQ ID NO: 84) SEG 4 L E E K M K A M E D K M K W SMI 12 5 ' -GCTCGAAGAAAGATGAAGGCAATGGAAGACAAAATGAAGTGG SM113 3 ' -GCTTCTTTCTACTTCCGTTACCTTCTGTTTTACTTCACC L E E K M K K (SEQ ID NO:86) (amino acids 8-28) CTTGAGGAGAAAATGAAGAA-3' (SEQ ID NO: 87) GAACTCCTCTTTTACTTCTTCGA-5' (SEQ ID NO: 88) SEG 5 L K E E M A K M K D E M W K SMI 14 5 ' -GCTCAAGGAGGAAATGGCTAAGATGAAAGACGAAATGTGGAAA SMI 15 3 ' -GTTCCTCCTTTACCGATTCTACTTTCTGCTTTACACCTTT L K E E M K K (SEQ ID NO:89) (amino acids 8-28) CTGAAAGAGGAAATGAAGAA (SEQ ID NO: 90) GACTTTCTCCTTTACTTCTTCGA (SEQ ID NO: 91) Clones were screened for the presence of the inserted segments by restriction digestion followed by separation of fragments on 6% acrylamide gels. Correct insertion of oligonucleotides was confirmed by DNA sequence analyses. Clones containing segments 3, 4 and 5 respectively were designated pSKseg3, pSKseg4, and pSKseg5. These "segment" clones were used in a duplication scheme as shown in Figure 14. Ten μg of plasmid pSKseg3 were digested to completion with Nhe I and BspH I and the 1503 bp fragment isolated from an agarose gel using the Whatman paper technique. Ten μg of plasmid pSKseg4 were digested to completion with Nhe I and Nco I and the 2109 bp band gel isolated. Equal amounts of these fragments were ligated and recombinants selected on tetracycline. Clones were screened by restriction digestions and their sequences confirmed. The resultant plasmid was designated pSKseg34. pSKseg34 and pSKseg5 plasmid DNAs were digested, fragments isolated and ligated in a similar manner as above to create a plasmid containing DNA sequences encoding segment 5 fused to segments 3 and 4. This constmct was designated pSKseg534 and encodes the following amino acid sequence: SSP534 NH2-MEEKMKKLKEEMAKMKDEMWKLKEEMKKLEEKMKVMEEKMKKLEEKMKA MEDKMKWLEEKMKKLEEKMKVMEEKMKKLEEKMKAMEDKMKWLEEKMKK LEEKMKVMK-COOH (SEQ ID NO: 92) EXAMPLE 22 Constmction of SSP Chimeric Genes for Expression in the Seeds of Plants To express the synthetic gene products described in Example 21 in plant seeds, the sequences were transferred to the seed promoter vectors pCW108, pCW109 or pMLl 13 (Figure 15). The vectors pCW108 and pMLl 13 contain the bean phaseolin promoter (from base +1 to base -494),and 1191 bases of the 3' sequences from bean phaseolin gene. Plasmid pCW109 contains the soybean β-conglycinin promoter (from base +1 to base -619) and the same 1191 bases of 3' sequences from the bean phaseolin gene. These vectors were designed to allow direct cloning of coding sequences into unique Nco I and Asp 718 sites. These vectors also provide sites (Hind III or Sal I) at the 5' and 3' ends to allow transfer of the promoter/coding region/3' sequences directly to appropriate binary vectors. To insert the synthetic storage protein gene sequences, 10 μg of vector DNA were digested to completion with Asp 718 and Nco I restriction endonucleases. The linearized vector was purified via electrophoresis on a 1.0% agarose gel ovemight electrophoresis at 15 volts. The fragment was collected by cutting the agarose in front of the band, inserting a 10 X 5 mm piece of Whatman 3MM paper into the agarose and electrophoresing the fragment into the paper [Errington, (1990) Nucleic Acids Research, 18:17]. The fragment and buffer were spun out of the paper by centrifugation and the DNA in the -100 μL was precipitated by adding 10 mg of tRNA, 10 μL of 3 M sodium acetate and 200 μL of ethanol. The precipitated DNA was washed twice with 70% ethanol and dried under vacuum. The fragment DNA was resuspended in 20 μL of water and a portion diluted 10-fold for use in ligation reactions. Plasmid DNA (10 mg) from clone 3-5 (carrying the SSP3-5 coding sequence) and pSK534 (carrying the SSP534 coding sequence) was digested to completion with Asp 718 and Nco I restriction endonucleases. The digestion products were separated on an 18% polyacrylamide non-denaturing gel. Gel slices containing the desired fragments were cut from the gel and purified by inserting the gel slices into a 1% agarose gel and electrophoresing for 20 min at 100 volts. DNA fragments were collected on 10 X 5 mm pieces of Whatman 3 MM paper, the buffer and fragments spun out by centrifugation and the DNA precipitated with ethanol. The fragments were resuspended in 6 μL water. One microliter of the diluted vector fragment described above, 2 μL of 5X ligation buffer and 1 μL of T4 DNA ligase were added. The mixture was ligated overnight at 15°- The ligation mixes were transformed into E. coli strain DH5α [supΕ44 ΔlacU169 (Φ80 lacZ ΔM15) hsdR17 recAl endAl gyrl96 thil relAl] and ampicillin-resistant colonies selected. The clones were screened by restriction endonuclease digestion analyses of rapid plasmid DNAs and by DNA sequencing. EXAMPLE 23 Tobacco Plants Containing the Chimeric Genes Phaseolin Promoter/cts/lvsC-M4 and β-conglvcinin promoter/SSP3-5 The binary vector pZS97 was used to transfer the chimeric SSP3-5 gene of Example 22 and the chimeric E. coli dapA and lvsC-M4 genes of Example 4 to tobacco plants. Binary vector pZS97 (Figure 6) is part of a binary Ti plasmid vector system [Bevan, (1984) Nucl. Acids. Res. 72:8711-8720] of Agrobacterium tumefaciens. The vector contains: (1) the chimeric gene nopaline synthase ::neomycin phosphotransferase (nos::NPTII) as a selectable marker for transformed plant cells [Bevan et al., (1983) Nature 304:184-186], (2) the left and right borders of the T-DNA of the Ti plasmid [Bevan, (1984) Nucl. Acids. Res. 12:8711-8720], (3) the E. coli lacZ α-complementing segment [Viera et al., (1982) Gene 79:259-267] with a unique Sal I site(pSK97K) or unique Hind III site (pZS97) in the polylinker region, (4) the bacterial replication origin from the Pseudomonas plasmid pVSl [Itoh et al, (1984) Plasmid 77:206-220], and (5) the bacterial β-lactamase gene as a selectable marker for transformed A. tumefaciens. Plasmid pZS97 DNA was digested to completion with Hind III enzyme and the digested plasmid was gel purified. The Hind III digested pZS97 DNA was mixed with the Hind III digested and gel isolated chimeric SSP3-5 gene of Example 22, ligated, transformed and colonies selected on ampicillin. The binary vector containing the chimeric gene was transferred by tri- parental mating [Ruvkin et al., (1981) Nature 259:85-88] to Agrobacterium strain LBA4404/pAL4404 [Hockema et al., (1983), Nature 505:179-180] selecting for carbenicillin resistance. Cultures of Agrobacterium containing the binary vector was used to transform tobacco leaf disks [Horsch et al., (1985) Science 227: 1229- 1231]. Transgenic plants were regenerated in selective medium containing kanamycin. Transformed tobacco plants containing the chimeric gene, β-conglycinin promoter/SSP3-5/phaseolin 3' region, were thus obtained. Two transformed lines, pSK44-3A and pSK44-9A, which carried a single site insertion of the SSP3-5 gene were identified based upon 3:1 segregation of the marker gene for kanamycin resistance. Progeny of the primary transformants, which were homozygous for the transgene, pSK44-3A-6 and pSK44-9A-5, were then identified based upon 4:0 segregation of the kanamycin resistance in seeds of these plants. Similarly, transformed tobacco plants with the chimeric genes phaseolin 5' region/cts/lysC-M4/phaseolin 3' region and phaseolin 5' region/cts/ecodapA/phaseolin 3' region were obtained as described in Example 12. A transformed line, BT570-45A, which carried a single site insertion of the DHDPS and AK genes was identified based upon 3:1 segregation of the marker gene for kanamycin resistance. Progeny from the primary transformant which were homozygous for the transgene, BT570-45A-3 and BT570-45A-4, were then identified based upon 4:0 segregation of the kanamycin resistance in seeds of these plants. To generate plants carrying all three chimeric genes genetic crosses were performed using the homozygous parents. Plants were grown to maturity in greenhouse conditions. Flowers to be used as male and female were selected one day before opening and older flowers on the inflorescence removed. For crossing, female flowers were chosen at the point just before opening when the anthers were not dehiscent. The corolla was opened on one side and the anthers removed. Male flowers were chosen as flowers which had opened on the same day and had dehiscent anthers shedding mature pollen. The anthers were removed and used to pollinate the pistils of the anther-stripped female flowers. The pistils were then covered with plastic tubing to prevent further pollination. The seed pods were allowed to develop and dry for 4-6 weeks and harvested. Two to three separate pods were recovered from each cross. The following crosses were performed: Male X Female BT570-45A-3 pSK44-3A-6 BT570-45A-4 pSK44-3A-6 pSK44-3A-6 BT570-45A-4 BT570-45A-5 pSK44-9A-5 pSk44-9A-5 BT570-45A-5 Dried seed pods were broken open and seeds collected and pooled from each cross. Thirty seeds were counted out for each cross and for controls seeds from selfed flowers of each parent were used. Duplicate seed samples were hydrolyzed and assayed for total amino acid content as described in Example 8. The amount of increase in lysine as a percent of total seeds amino acids over wild type seeds, which contain 2.56% lysine, is presented in Table 16 along the copy number of each gene in the endosperm of the seed. TABLE 17 copy number AK & DHDPS copy number lysine male X female genes SSP gene increase BT570-45A X BT570-45A 1* 0 0 pSK44-9A X pSK44-9A 0 1* 0.12 pSK44-9A-5 X pSK44-9A-5 0 2 0.29 pSK44-9A-5 X BT570-45A-5 1 1 0.6 BT570-45A-5 X pSK44-9A-5 1 1 0.29 pSK44-3A X pSK44-3A 0 1* 0.28 pSK44-3A-6 X pSK44-3A-6 0 2 0.5 pSK44-3A-6 X BT570-45A-4 1 1 0.62 BT570-45A-3 X pSK44-3A-6 1 1 0.27 BT570-45A-4 X pSK44-3A-6 1 1 0.29 * copy number is average in population of seeds The results of these crosses demonstrate that the total lysine levels in seeds can be increased by the coordinate expression of the lysine biosynthesis genes and the high lysine protein SSP3-5. In seeds derived from hybrid tobacco plants, this synergism is strongest when the biosynthesis genes are derived from the female parent. It is expected that the lysine level would be further increased if the biosynthesis genes and the lysine-rich protein genes were all homozygous. EXAMPLE 24 Soybean Plants Containing the Chimeric Genes Phaseolin Promoter/cts/cordapA. Phaseolin Promoter/cts/lvsC-M4 and Phaseolin Promoter/SSP3-5 Transformed soybean plants that express the chimeric gene, phaseolin promoter/cts/cordapA/ phaseolin 3' region and phaseolin promoter/cts/lysC-M4/ phaseolin 3' region have been described in Example 19. Transformed soybean plants that express the chimeric gene, phaseolin promoter/SSP3-5/phaseolin 3' region, were obtained by inserting the chimeric gene as an isolated Hind III fragment into an equivalent soybean transformation vector plasmid pML63 (Figure 16) and carrying out transformation as described in Example 19. Seeds from primary transformants were sampled by cutting small chips from the sides of the seeds away from the embryonic axis. The chips were assayed for GUS activity as described in Example 19 to determine which of the segregating seeds carried the transgenes. Half seeds were ground to meal and assayed for expression of SSP3-5 protein by Enzyme Linked ImmunoSorbent Assay (ELISA). was performed as follows: A fusion protein of glutathione-S-transferase and the SSP3-5 gene product was generated through the use of the Pharmacia_ pGEX GST Gene Fusion System (Current Protocols in Molecular Biology, Vol. 2, pp 16.7.1-8, (1989) John Wiley and Sons). The fusion protein was purified by affinity chromatography on glutathione agarose (Sigma) or glutathione Sepharose (Pharmacia) beads, concentrated using Centricon 10 (Amicon) filters, and then subjected to SDS polyacrylamide electrophoresis (15% acrylamide, 19:1 acrylamide:bisacrylamide) for further purification. The gel was stained with Coomassie Blue for 30 min, destained in 50% (v/v) methanol, 10% (v/v) acetic acid and the protein bands electroeluted using an Amicon Centriluter Microelectroeluter (Paul T. Matsudaira ed., A Practical Guide to Protein and Peptide Purification for Microsequencing, Academic Press, Inc. New York, 1989). A second gel prepared and run in the same manner was stained in a non acetic acid containing stain [9 parts 0.1% Coomassie Blue G250 (Bio-Rad) in 50% (v/v) methanol and 1 part Serva Blue (Serva, Westbury, NY) in distilled water] for 1-2 h. The gel was briefly destained in 20%(v/v) methanol, 3%(v/v) glycerol for 0.5-1 h until the GST-SSP3-5 band was just barely visible. This band was excised from the gel and sent with the electroeluted material to Hazelton Laboratories for use as an antigen in immunizing a New Zealand Rabbit. A total of 1 mg of antigen was used (0.8 mg in gel, 0.2 mg in solution). Test bleeds were provided by Hazelton Laboratories every three weeks. The approximate titer was tested by westem blotting of E. coli extracts from cells containing the SSP-3-5 gene under the control of the T7 promoter at different dilutions of protein and of serum. IgG was isolated from the serum using a Protein A Sepharose column. The IgG was coated onto microtiter plates at 5 μg per well. A separate portion of the IgG was biotinylated. Aqueous extracts from transgenic plants were diluted and loaded into the wells usually starting with a sample containing 1 μg of total protein. The sample was diluted several more times to insure that at least one of the dilutions gave a result that was within the range of a standard curve generated on the same plate. The standard curve was generated using chemically synthesized SSP3-5 protein. The samples were incubated for 1 h at 37° and the plates washed. The biotinylated IgG was then added to the wells. The plate was incubated at 37° for 1 h and washed. Alkaline phosphatase conjugated to streptavidin was added to the wells, incubated at 37° for 1 h and washed. A substrate consisting of 1 mg/mL p mfrophenylphosphate in 1 M diethanolamine was added to the wells and the plates incubated at 37° for 1 h. A 5% EDTA stop solution was added to the wells and the absorbance read at 405 nm minus 650 nm reading. Transgenic soybean seeds contained 0.5 to 2.0% of water extractable protein as SSP3-5. The remaining half seeds positive for GUS and SSP3-5 protein were planted and grown to maturity in greenhouse conditions. To determine homozygotes for the GUS phenotype, seed from these Rl plants were screened for segregation of GUS activity as above. Plants homozygous for the phaseolin/SSP3-5 gene are then crossed with homozygous transgenic soybeans expressing the Corynebacterium dapA gene product or expressing the Corynebacterium dapA gene product plus the E. coli lysC-M4 gene product. As an preferred alternative to bringing the chimeric SSP gene and chimeric cordapA gene plus the E. coli lysC-M4 gene together via genetic crossing, a single soybean transformation vector carrying all the genes can be constmcted from the gene fragments described above and transformed into soybean as described in Example 19. EXAMPLE 25 Construction of Chimeric Genes for Expression of Corynebacterium DHDPS. lvs r -Corn DHDPS. E. co/tAKIH-M4 and SSP3-5 proteins in the Embryo and Endosperm of Transformed Com The following chimeric genes were made for transformation into com: globulin 1 promoter/mcts/lysC-M4/NOS 3' region globulin 1 promoter/mcts/cordapA/NOS 3 region glutelin 2 promoter/mcts/lysC-M4/NOS 3' region glutelin 2 promoter/mcts/cordapA/NOS 3' region globulin 1 promoter/SSP3-5/globulin 1 3' region glutelin 2 promoter/SSP3-5/10 kD 3' region globulin 1 promoter/com lys r -mutant DHDPS gene/globulin 1 3' region glutelin 2 promoter/com lys r -mutant DHDPS gene/10 kD 3' region The glutelin 2 promoter was cloned from com genomic DNA using PCR with primers based on the published sequence [Reina et al. (1990) Nucleic Acids Res. 75:6426-6426]. The promoter fragment includes 1020 nucleotides upstream from the ATG translation start codon. An Nco I site was introduced via PCR at the ATG start site to allow for direct translational fusions. A BamH I site was introduced on the 5' end of the promoter. The 1.02 kb BamH I to Nco I promoter fragment was cloned into the BamH I to Nco I sites of the plant expression vector pML63 (see Example 24) replacing the 35S promoter to create vector pML90. This vector contains the glutelin 2 promoter linked to the GUS coding region and the NOS 3'. The 10 kD zein 3' region was derived from a 10 kD zein gene clone generated by PCR from genomic DNA using oligonucleotide primers based on the published sequence [Kirihara et al. (1988) Gene 77:359-370]. The 3' region extends 940 nucleotides from the stop codon. Restriction endonuclease sites for Kpn I, Sma I and Xba I sites were added immediately following the TAG stop codon by oligonucleotide insertion to facilitate cloning. A Sma I to Hind III segment containing the 10 kD 3 'region was isolated and ligated into Sma I and Hind III digested pML90 to replace the NOS 3' sequence with the 10 kD 3 'region, thus creating plasmid pML103. pML103 contains the glutelin 2 promoter, an Nco I site at the ATG start codon of the GUS gene, Sma I and Xba I sites after the stop codon, and 940 nucleotides of the 10 kD zein 3' sequence. The globulin 1 promoter and 3' sequences were isolated from a Clontech com genomic DNA library using oligonucleotide probes based on the published sequence of the globulin 1 gene [Kriz et al. (1989) Plant Physiol. 97:636]. The cloned segment includes the promoter fragment extending 1078 nucleotides upstream from the ATG translation start codon, the entire globulin coding sequence including introns and the 3' sequence extending 803 bases from the translational stop. To allow replacement of the globulin 1 coding sequence with other coding sequences an Nco I site was introduced at the ATG start codon, and Kpn I and Xba I sites were introduced following the translational stop codon via PCR to create vector pCC50. There is a second Nco I site within the globulin 1 promoter fragment. The globulin 1 gene cassette is flanked by Hind III sites. The plant amino acid biosynthetic enzymes are known to be localized in the chloroplasts and therefore are synthesized with a chloroplast targeting signal. Bacterial proteins such as DHDPS and AKIII have no such signal. A chloroplast transit sequence (cts) was therefore fused to the cordapA and lvsC-M4 coding sequence in the chimeric genes described below. For com the cts used was based on the cts of the small subunit of ribulose 1,5-bisphosphate carboxylase from com [Lebrun et al. (1987) Nucleic Acids Res. 75:4360] and is designated mcts to distinguish it from the soybean cts. The oligonucleotides SEQ ID NOS:94-99 were synthesized and used as described in Example 6. To construct the chimeric gene: globulin 1 promoter/mcts/ly sC-M4/NO S 3' region an Nco I to Hpa I fragment containing the mcts/lysC-M4 coding sequence was isolated from plasmid pBT558 (see Example 6) and inserted into Nco I plus Sma I digested pCC50 creating plasmid pBT663. To construct the chimeric gene: globulin 1 promoter/mcts/cordapA/NOS 3 region an Nco I to Kpn I fragment containing the mcts/ecodapA coding sequence was isolated from plasmid pBT576 (see Example 6) and inserted into Nco I plus Kpn I digested pCC50 creating plasmid pBT662. Then the ecodapA coding sequence was replaced with the cordapA coding sequence as follows. An Afl II to Kpn I fragment containing the distal two thirds of the mcts fused to the cordapA coding sequence was inserted into Afl II to Kpn I digested pBT662 creating plasmid pBT677. To constmct the chimeric gene: glutelin 2 promoter/mcts/lvsC-M4/NOS 3' region an Nco I to Hpa I fragment containing the mcts/lvsC-M4 coding sequence was isolated from plasmid pBT558 (see Example 6) and inserted into Nco I plus Sma I digested pML90 creating plasmid pBT580. To construct the chimeric gene: glutelin 2 promoter/mcts/cordapA/NOS 3' region an Nco I to Kpn I fragment containing the mcts/cordapA coding sequence was isolated from plasmid pBT677 and inserted into Nco I to Kpn I digested pML90, creating plasmid pBT679. The chimeric genes: globulin 1 promoter/mcts/lvsC-M4/NOS 3' region and globulin 1 promoter/mcts/cordapA/NOS 3 region were linked on one plasmid as follows. pBT677 was partially digested with Hind III and full-length linearized plasmid DNA was isolated. A Hind III fragment carrying the globulin 1 promoter/mcts/lvsC-M4/NOS 3' region was isolated from pBT663 and ligated to the linearized pBT677 plasmid creating pBT680 (Figure 17). The chimeric genes: glutelin 2 promoter/mcts/lysC-M4/NOS 3' region and glutelin 2 promoter/mcts/cordapA/NOS 3' region were linked on one plasmid as follows. pBT580 was partially digested with Sal I and full-length linearized plasmid DNA was isolated. A Sal I fragment carrying the glutelin 2 promoter/mcts/cordapA/NOS 3' region was isolated from pBT679 and ligated to the linearized pBT580 plasmid creating pBT681 (Figure 18). To constmct the chimeric gene: glutelin 2 promoter/SSP3-5/10 kD 3' region the plasmid pML103 (above) containing the glutelin 2 promoter and 10 kD zein 3' region was cleaved at the Nco I and Sma I sites. The SSP3-5 coding region (Example 22) was isolated as an Nco I to blunt end fragment by cleaving with Xba I followed by filling in the sticky end using Klenow fragment of DNA polymerase, then cleaving with Nco I. The 193 base pair Nco I to blunt end fragment was ligated into the Nco I and Sma I cut pML103 to create pLH104 (Figure 19). To construct the chimeric gene: globulin 1 promoter/SSP3-5/globulin 1 3'region the 193 base pair Nco I and Xba I fragment containing the SSP3-5 coding region (Example 22) was inserted into plasmid pCC50 (above) between the globulin 1 5' and 3' regions creating pLH105 (Figure 20). The com DHDPS cDNA gene was cloned and sequenced previously [Frisch et al. (1991) Mol Gen Genet 225:287-293]. A mutation that rendered the protein insensitive to feedback inhibition by lysine was introduced into the gene. This mutation is a single nucleotide change that results in a single amino acid substitution in the protein; alal66 is changed to val. The lys r com DHDPS gene was obtained from Dr. Burle Gengenbach at the University of Minnesota. An Nco I site was introduced at the translation start codon of the gene and a Kpn I site was introduced immediately following the translation stop codon of the gene via PCR using the following primers: SEQ ID NO:106: 5'-ATTCCCCATG GTTTCGCCGA CGAAT SEQ ID NO: 107: 5'-CTCTCGGTAC CTAGTACCTA CTGATCAAC To construct the chimeric gene: globulin 1 promoter/lys r com DHDPS gene/globulin 1 3'region the 1144 base pair Nco I and Kpn I fragment containing the lys r com DHDPS gene was inserted into plasmid pCC50 (above) between the globulin 1 5' and 3' regions creating pBT739 (Figure 21). To constmct the chimeric gene: glutelin 2 promoter/lys r com DHDPS gene/ 10 kD 3' region the 1144 base pair Nco I and Kpn I fragment containing the lys r com DHDPS gene was inserted into a plasmid containing the glutelin 2 promoter and 10 kD zein 3' region creating plasmid pBT756 (Figure 22). Com transformations were done as described in Examples 17 and 18 with the following exceptions: 1) Embryogenic cell culture development was as described in Example 17 except the exact culture used for bombardment was designated LH132.5.X, or LH132.6.X. 2) The selectable marker used for these experiments was either the 35S/bar gene from pDETRIC as described in Example 18 or 35S/Ac, a synthetic phosphinothricin-N-acetyltransferase (pat) gene under the control of the 35S promoter and 3' terminator/ polyadenylation signal from Cauliflower Mosaic Vims [Eckes et al., (1989) J Cell Biochem Suppl 13 D] 3) The bombardment parameters were as described for Example 17 and 18 except that the bombardments were performed as "tribombardments" by co- precipitating 1.5 μg of each of the DNAs (35S/bar or 35S/Ac, pBT681 and pLH104 or 35S/Ac, pbt680 and pLH105) onto the gold particles. 4) Selection of transgenic cell lines was as described for glufosinate selection as in Example 18 except that the tissue was placed on the selection media within 24 h after bombardment. EXAMPLE 26 Com Plants Containing Chimeric Genes for Expression of Corynebacterium DHDPS and E. coli AKIII-M4 or lvs r -Corn DHDPS in the Embryo and Endosperm Com was transformed as described in Example 25 with the chimeric genes: • globulin 1 promoter/mcts/cordapA NOS 3 region along with or without globulin 1 promoter/mcts/lvsC-M4/NOS 3' region; or • glutelin 2 promoter/mcts/cordapA NOS 3' region along with or without glutelin 2 promoter/mcts/l sC-M4/NOS 3' region. Plants regenerated from transformed callus were analyzed for the presence of the intact transgenes via Southem blot or PCR. The plants were either selfed or outcrossed to an elite line to generate FI seeds. Six to eight seeds were pooled and assayed for expression of the Corynebacterium DHDPS protein and the E. coli AKIII-M4 protein by westem blot analysis. The free amino acid composition and total amino acid composition of the seeds were determined as described in previous examples. Expression of the Corynebacterium DHDPS protein, driven by either the globulin 1 or glutelin 2 promoter, was observed in the com seeds (Table 12). Expression of the E. coli AKIII-M4 protein, driven by the glutelin promoter was also observed in the com seeds. Free lysine levels in the seeds increased from about 1.4% of free amino acids in control seeds to 15-27% in seeds of three different transformants expressing Corynebacterium DHDPS from the globulin 1 promoter. The increased free lysine, and a high level of saccharopine, indicative of lysine catabolism, were both localized to the embryo in seeds expressing Corynebacterium DHDPS from the globulin 1 promoter. No increase in free lysine was observed in seeds expressing Corynebacterium DHDPS from the glutelin 2 promoter with or without E. coli AKIII-M4. Lysine catabolism is expected to be much greater in the endosperm than the embryo and this probably prevents the accumulation of increased levels of lysine in seeds expressing Corynebacterium DHDPS plus E. coli AKIII-M4 from the glutelin 2 promoter. Lysine normally represents about 2.3% of the seed amino acid content. It is therefore apparent from Table 12 that a 130% increase in lysine as a percent of total seed amino acids was found in seeds expressing Corynebacterium DHDPS from the globulin 1 promoter. TABLE 12 % LYS OF % LYS OF WESTERN WESTERN FREE SEED TOTAL SEED TRANSGENIC CORYNE. E. COLI AMINO ACIDS AMINO ACIDS LINE PROMOTER DHDPS AKIII-M4 1088.1.2 x elite globulin 1 + - 15 3.6 1089.4.2 x elite globulin 1 + - 21 5.1 1099.2.1 x self globulin 1 + - 27 5.3 1090.2.1 x elite glutelin 2 + - 1.2 1.7 1092.2.1 x elite glutelin 2 + + 1.1 2.2 SEQUENCE LISTING GENERAL INFORMATION : (i) APPLICANT: (A) ADDRESSEE: E. I. DU PONT DE NEMOURS AND COMPANY (B) STREET: 1007 MARKET STREET (C) CITY: WILMINGTON (D) STATE: DELAWARE (E) COUNTRY: U.S.A. (F) ZIP: 19898 (A) TELEPHONE: 302-992-5481 (B) TELEFAX: 302-892-7949 (C) TELEX: 835420 (ii) TITLE OF INVENTION: CHIMERIC GENES AND METHODS FOR INCREASING THE LYSINE CONTENT OF THE SEEDS OF PLANTS (iii) NUMBER OF SEQUENCES: 132 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: DISKETTE, 3.50 INCH (B) COMPUTER: IBM PC COMPATIBLE (C) OPERATING SYSTEM: MICROSOFT WINDOWS 95 (D) SOFTWARE: MICROSOFT WORD FOR WINDOWS 95 (7.0) (v) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: (B) FILING DATE: (C) CLASSIFICATION: (vi) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: 08/824,627 (B) FILING DATE: MARCH 27, 1997 (vii) ATTORNEY/AGENT INFORMATION: (A) NAME: CHRISTENBURY, LYNNE M. (B) REGISTRATION NUMBER: 30,971 (C) REFERENCE/DOCKET NUMBER: BB-1037-F (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1350 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS : single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..1350 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: ATG GCT GAA ATT GTT GTC TCC AAA TTT GGC GGT ACC AGC GTA GCT GAT 48 Met Ala Glu He Val Val Ser Lys Phe Gly Gly Thr Ser Val Ala Asp 1 5 10 15 TTT GAC GCC ATG AAC CGC AGC GCT GAT ATT GTG CTT TCT GAT GCC AAC 96 Phe Asp Ala Met Asn Arg Ser Ala Asp He Val Leu Ser Asp Ala Asn 20 25 30 GTG CGT TTA GTT GTC CTC TCG GCT TCT GCT GGT ATC ACT AAT CTG CTG 144 Val Arg Leu Val Val Leu Ser Ala Ser Ala Gly He Thr Asn Leu Leu 35 40 45 GTC GCT TTA GCT GAA GGA CTG GAA CCT GGC GAG CGA TTC GAA AAA CTC 192 Val Ala Leu Ala Glu Gly Leu Glu Pro Gly Glu Arg Phe Glu Lys Leu 50 55 60 GAC GCT ATC CGC AAC ATC CAG TTT GCC ATT CTG GAA CGT CTG CGT TAC 240 Asp Ala He Arg Asn He Gin Phe Ala He Leu Glu Arg Leu Arg Tyr 65 70 75 80 CCG AAC GTT ATC CGT GAA GAG ATT GAA CGT CTG CTG GAG AAC ATT ACT 288 Pro Asn Val He Arg Glu Glu He Glu Arg Leu Leu Glu Asn He Thr 85 90 95 GTT CTG GCA GAA GCG GCG GCG CTG GCA ACG TCT CCG GCG CTG ACA GAT 336 Val Leu Ala Glu Ala Ala Ala Leu Ala Thr Ser Pro Ala Leu Thr Asp 100 105 HO GAG CTG GTC AGC CAC GGC GAG CTG ATG TCG ACC CTG CTG TTT GTT GAG 384 Glu Leu Val Ser His Gly Glu Leu Met Ser Thr Leu Leu Phe Val Glu 115 120 125 ATC CTG CGC GAA CGC GAT GTT CAG GCA CAG TGG TTT GAT GTA CGT AAA 432 He Leu Arg Glu Arg Asp Val Gin Ala Gin Trp Phe Asp Val Arg Lys 130 135 140 GTG ATG CGT ACC AAC GAC CGA TTT GGT CGT GCA GAG CCA GAT ATA GCC 480 Val Met Arg Thr Asn Asp Arg Phe Gly Arg Ala Glu Pro Asp He Ala 145 150 155 160 GCG CTG GCG GAA CTG GCC GCG CTG CAG CTG CTC CCA CGT CTC AAT GAA 528 Ala Leu Ala Glu Leu Ala Ala Leu Gin Leu Leu Pro Arg Leu Asn Glu 165 170 175 GGC TTA GTG ATC ACC CAG GGA TTT ATC GGT AGC GAA AAT AAA GGT CGT 576 Gly Leu Val He Thr Gin Gly Phe He Gly Ser Glu Asn Lys Gly Arg 180 185 190 ACA ACG ACG CTT GGC CGT GGA GGC AGC GAT TAT ACG GCA GCC TTG CTG 624 Thr Thr Thr Leu Gly Arg Gly Gly Ser Asp Tyr Thr Ala Ala Leu Leu 195 200 205 GCG GAG GCT TTA CAC GCA TCT CGT GTT GAT ATC TGG ACC GAC GTC CCG 672 Ala Glu Ala Leu His Ala Ser Arg Val Asp He Trp Thr Asp Val Pro 210 215 220 GGC ATC TAC ACC ACC GAT CCA CGC GTA GTT TCC GCA GCA AAA CGC ATT 720 Gly He Tyr Thr Thr Asp Pro Arg Val Val Ser Ala Ala Lys Arg He 225 230 235 240 GAT GAA ATC GCG TTT GCC GAA GCG GCA GAG ATG GCA ACT TTT GGT GCA 768 Asp Glu He Ala Phe Ala Glu Ala Ala Glu Met Ala Thr Phe Gly Ala 245 250 255 AAA GTA CTG CAT CCG GCA ACG TTG CTA CCC GCA GTA CGC AGC GAT ATC 816 Lys Val Leu His Pro Ala Thr Leu Leu Pro Ala Val Arg Ser Asp He 260 265 270 CCG GTC TTT GTC GGC TCC AGC AAA GAC CCA CGC GCA GGT GGT ACG CTG 864 Pro Val Phe Val Gly Ser Ser Lys Asp Pro Arg Ala Gly Gly Thr Leu 275 280 285 GTG TGC AAT AAA ACT GAA AAT CCG CCG CTG TTC CGC GCT CTG GCG CTT 912 Val Cys Asn Lys Thr Glu Asn Pro Pro Leu Phe Arg Ala Leu Ala Leu 290 295 300 CGT CGC AAT CAG ACT CTG CTC ACT TTG CAC AGC CTG AAT ATG CTG CAT 960 Arg Arg Asn Gin Thr Leu Leu Thr Leu His Ser Leu Asn Met Leu His 305 310 315 320 TCT CGC GGT TTC CTC GCG GAA GTT TTC GGC ATC CTC GCG CGG CAT AAT 1008 Ser Arg Gly Phe Leu Ala Glu Val Phe Gly He Leu Ala Arg His Asn 325 330 335 ATT TCG GTA GAC TTA ATC ACC ACG TCA GAA GTG AGC GTG GCA TTA ACC 1056 He Ser Val Asp Leu He Thr Thr Ser Glu Val Ser Val Ala Leu Thr 340 345 350 CTT GAT ACC ACC GGT TCA ACC TCC ACT GGC GAT ACG TTG CTG ACG CAA 1104 Leu Asp Thr Thr Gly Ser Thr Ser Thr Gly Asp Thr Leu Leu Thr Gin 355 360 365 TCT CTG CTG ATG GAG CTT TCC GCA CTG TGT CGG GTG GAG GTG GAA GAA 1152 Ser Leu Leu Met Glu Leu Ser Ala Leu Cys Arg Val Glu Val Glu Glu 370 375 380 GGT CTG GCG CTG GTC GCG TTG ATT GGC AAT GAC CTG TCA AAA GCC TGC 1200 Gly Leu Ala Leu Val Ala Leu He Gly Asn Asp Leu Ser Lys Ala Cys 385 390 395 400 GCC GTT GGC AAA GAG GTA TTC GGC GTA CTG GAA CCG TTC AAC ATT CGC 1248 Ala Val Gly Lys Glu Val Phe Gly Val Leu Glu Pro Phe Asn He Arg 405 410 415 ATG ATT TGT TAT GGC GCA TCC AGC CAT AAC CTG TGC TTC CTG GTG CCC 1296 Met He Cys Tyr Gly Ala Ser Ser His Asn Leu Cys Phe Leu Val Pro 420 425 430 GGC GAA GAT GCC GAG CAG GTG GTG CAA AAA CTG CAT AGT AAT TTG TTT 1344 Gly Glu Asp Ala Glu Gin Val Val Gin Lys Leu His Ser Asn Leu Phe 435 440 445 GAG TAA 1350 Glu * 450 (2) INFORMATION FOR SEQ ID NO : 2 : (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: GATCCATGGC TGAAATTGTT GTCTCCAAAT TTGGCG 36 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: GTACCGCCAA ATTTGGAGAC AACAATTTCA GCCATG 36 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 48 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: CCCGGGCCAT GGCTACAGGT TTAACAGCTA AGACCGGAGT AGAGCACT 48 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 37 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: GATATCGAAT TCTCATTATA GAACTCCAGC TTTTTTC 37 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 917 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3..911 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: CC ATG GCT ACA GGT TTA ACA GCT AAG ACC GGA GTA GAG CAC TTC GGC 47 Met Ala Thr Gly Leu Thr Ala Lys Thr Gly Val Glu His Phe Gly 1 5 10 15 ACC GTT GGA GTA GCA ATG GTT ACT CCA TTC ACG GAA TCC GGA GAC ATC 95 Thr Val Gly Val Ala Met Val Thr Pro Phe Thr Glu Ser Gly Asp He 20 25 30 GAT ATC GCT GCT GGC CGC GAA GTC GCG GCT TAT TTG GTT GAT AAG GGC 143 Asp He Ala Ala Gly Arg Glu Val Ala Ala Tyr Leu Val Asp Lys Gly 35 40 45 TTG GAT TCT TTG GTT CTC GCG GGC ACC ACT GGT GAA TCC CCA ACG ACA 191 Leu Asp Ser Leu Val Leu Ala Gly Thr Thr Gly Glu Ser Pro Thr Thr 50 55 60 ACC GCC GCT GAA AAA CTA GAA CTG CTC AAG GCC GTT CGT GAG GAA GTT 239 Thr Ala Ala Glu Lys Leu Glu Leu Leu Lys Ala Val Arg Glu Glu Val 65 70 75 GGG GAT CGG GCG AAG CTC ATC GCC GGT GTC GGA ACC AAC AAC ACG CGG 287 Gly Asp Arg Ala Lys Leu He Ala Gly Val Gly Thr Asn Asn Thr Arg 80 85 90 95 ACA TCT GTG GAA CTT GCG GAA GCT GCT GCT TCT GCT GGC GCA GAC GGC 335 Thr Ser Val Glu Leu Ala Glu Ala Ala Ala Ser Ala Gly Ala Asp Gly 100 105 110 CTT TTA GTT GTA ACT CCT TAT TAC TCC AAG CCG AGC CAA GAG GGA TTG 383 Leu Leu Val Val Thr Pro Tyr Tyr Ser Lys Pro Ser Gin Glu Gly Leu 115 120 125 CTG GCG CAC TTC GGT GCA ATT GCT GCA GCA ACA GAG GTT CCA ATT TGT 431 Leu Ala His Phe Gly Ala He Ala Ala Ala Thr Glu Val Pro He Cys 130 135 140 CTC TAT GAC ATT CCT GGT CGG TCA GGT ATT CCA ATT GAG TCT GAT ACC 479 Leu Tyr Asp He Pro Gly Arg Ser Gly He Pro He Glu Ser Asp Thr 145 150 155 ATG AGA CGC CTG AGT GAA TTA CCT ACG ATT TTG GCG GTC AAG GAC GCC 527 Met Arg Arg Leu Ser Glu Leu Pro Thr He Leu Ala Val Lys Asp Ala 160 165 170 175 AAG GGT GAC CTC GTT GCA GCC ACG TCA TTG ATC AAA GAA ACG GGA CTT 575 Lys Gly Asp Leu Val Ala Ala Thr Ser Leu He Lys Glu Thr Gly Leu 180 185 190 GCC TGG TAT TCA GGC GAT GAC CCA CTA AAC CTT GTT TGG CTT GCT TTG 623 Ala Trp Tyr Ser Gly Asp Asp Pro Leu Asn Leu Val Trp Leu Ala Leu 195 200 205 GGC GGA TCA GGT TTC ATT TCC GTA ATT GGA CAT GCA GCC CCC ACA GCA 671 Gly Gly Ser Gly Phe He Ser Val He Gly His Ala Ala Pro Thr Ala 210 215 220 TTA CGT GAG TTG TAC ACA AGC TTC GAG GAA GGC GAC CTC GTC CGT GCG 719 Leu Arg Glu Leu Tyr Thr Ser Phe Glu Glu Gly Asp Leu Val Arg Ala 225 230 235 CGG GAA ATC AAC GCC AAA CTA TCA CCG CTG GTA GCT GCC CAA GGT CGC 767 Arg Glu He Asn Ala Lys Leu Ser Pro Leu Val Ala Ala Gin Gly Arg 240 245 250 255 TTG GGT GGA GTC AGC TTG GCA AAA GCT GCT CTG CGT CTG CAG GGC ATC 815 Leu Gly Gly Val Ser Leu Ala Lys Ala Ala Leu Arg Leu Gin Gly He 260 265 270 AAC GTA GGA GAT CCT CGA CTT CCA ATT ATG GCT CCA AAT GAG CAG GAA 863 Asn Val Gly Asp Pro Arg Leu Pro He Met Ala Pro Asn Glu Gin Glu 275 280 285 CTT GAG GCT CTC CGA GAA GAC ATG AAA AAA GCT GGA GTT CTA TAA TGAGAATTC 918 Leu Glu Ala Leu Arg Glu Asp Met Lys Lys Ala Gly Val Leu * 290 295 300 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: CTTCCCGTGA CCATGGGCCA TC 22 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 75 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: CATGGCTGGC TTCCCCACGA GGAAGACCAA CAATGACATT ACCTCCATTG CTAGCAACGG 60 TGGAAGAGTA CAATG 75 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 75 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: CATGCATTGT ACTCTTCCAC CGTTGCTAGC AATGGAGGTA ATGTCATTGT TGGTCTTCCT 60 CGTGGGGAAG CCAGC 75 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 90 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: CATGGCTTCC TCAATGATCT CCTCCCCAGC TGTTACCACC GTCAACCGTG CCGGTGCCGG 60 CATGGTTGCT CCATTCACCG GCCTCAAAAG 90 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 90 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11: CATGCTTTTG AGGCCGGTGA ATGGAGCAAC CATGCCGGCA CCGGCACGGT TGACGGTGGT 60 AACAGCTGGG GAGGAGATCA TTGAGGAAGC 90 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: CCGGTTTGCT GTAATAGGTA CCA 23 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 31 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: AGCTTGGTAC CTATTACAGC AAACCGGCAT G 31 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: GCTTCCTCAA TGATCTCCTC CCCAGCT 27 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: CATTGTACTC TTCCACCGTT GCTAGCAA 28 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..20 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 70" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: CTGACTCGCT GCGCTCGGTC 20 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..24 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 71" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: TATTTTCTCC TTACGCATCT GTGC 24 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..27 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 78" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: TTCATCGATA GGCGACCACA CCCGTCC 27 (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 27 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..27 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard__name= "SM 79" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: AATATCGATG CCACGATGCG TCCGGCG 27 (2) INFORMATION FOR SEQ ID NO: 20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 55 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..55 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 81" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: CATGGAGGAG AAGATGAAGG CGATGGAAGA GAAGATGAAG GCGTGATAGG TACCG 55 (2) INFORMATION FOR SEQ ID NO: 21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 55 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..55 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 80" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: AATTCGGTAC CTATCACGCC TTCATCTTCT CTTCCATCGC CTTCATCTTC TCCTC 55 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 14 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (ix) FEATURE: (A) NAME/KEY: Protein (B) LOCATION: 1..14 (D) OTHER INFORMATION: /label= name /note= "base gene [(SSP5)2] " (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 1 5 10 (2) INFORMATION FOR SEQ ID NO: 23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE : (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION /product= "synthetic oligonucleotide" /standard_name= "SM 84" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: GATGGAGGAG AAGATGAAGG C 21 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 85" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: ATCGCCTTCA TCTTCTCCTC C 21 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 82" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25: GATGGAGGAG AAGCTGAAGG C 21 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide " /standard_name= "SM 83" (xi) SEQUENCE DESCRIPTION: SEQ ID NO:26: ATCGCCTTCA GCTTCTCCTC C 21 (2) INFORMATION FOR SEQ ID NO: 27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 27: Met Glu Glu Lys Leu Lys Ala 1 5 (2) INFORMATION FOR SEQ ID NO: 28: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown ( ii ) MOLECULE TYPE : protein ( xi ) SEQUENCE DESCRI PTION : SEQ ID NO : 28 : Met Glu Glu Lys Met Lys Ala 1 5 (2) INFORMATION FOR SEQ ID NO: 29: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 160 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii ) IMMEDIATE SOURCE : ( B ) CLONE : C15 ( ix ) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 2..151 (D) OTHER INFORMATION: /function= "synthetic storage protein" /product= "protein" /gene= "ssp" /standard_name= "5.7.7.7.7.7.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 29: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met 1 5 10 15 GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG 94 Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu 20 25 30 AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAA GAG AAG ATG 142 Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met 35 40 45 AAG GCG TGATAGGTAC CG 160 Lys Ala 50 (2) INFORMATION FOR SEQ ID NO: 30: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 49 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 30: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu 1 5 10 15 Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys 20 25 30 Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met Lys 35 40 45 Ala (2) INFORMATION FOR SEQ ID NO: 31: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 160 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: C20 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..151 (D) OTHER INFORMATION: /function= "synthetic storage protein" /product= "protein" /gene= "ssp" /standard_name= "5.7.7.7.7.7.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 31: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met 1 5 10 15 GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG 94 Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu 20 25 30 AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAA GAG AAG ATG 142 Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met 35 40 45 AAG GCG TGATAGGTAC CG 160 Lys Ala 50 (2) INFORMATION FOR SEQ ID NO: 32: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 49 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 32: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu 1 5 10 15 Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys 20 25 30 Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met Lys 35 40 45 Ala (2) INFORMATION FOR SEQ ID NO: 33: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 139 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: C30 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..130 (D) OTHER INFORMATION: /function= "synthetic storage protein" /product= "protein" /gene= "ssp" /standard_name= "5.7.7.7.7.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 33: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met 1 5 10 15 GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG 94 Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu 20 25 30 AAG CTG AAG GCG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC CG 139 Lys Leu Lys Ala Met Glu Glu Lys Met Lys Ala 35 40 (2) INFORMATION FOR SEQ ID NO: 34: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 42 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 34: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu 1 5 10 15 Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys 20 25 30 Leu Lys Ala Met Glu Glu Lys Met Lys Ala 35 40 (2) INFORMATION FOR SEQ ID NO: 35: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 97 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: D16 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..88 ( D) OTHER INFORMATION : /function= " synthetic storage protein" /product= "protein" /gene= "ssp" /standard_name= "5 . 5 . 5 . 5 " (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 35 : C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met 1 5 10 15 GAG GAG AAG ATG AAG GCG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC 95 Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 20 25 CG 97 (2) INFORMATION FOR SEQ ID NO: 36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 36: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 20 25 (2) INFORMATION FOR SEQ ID NO: 37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 118 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: D20 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..109 (D) OTHER INFORMATION: /function= "synthetic storage protein" /product= "protein" /gene= "ssp" /standard_name= "5.5.5.5.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 37: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met 1 5 10 15 GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG GCG ATG GAA GAG 94 Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu Glu 20 25 30 AAG ATG AAG GCG TGATAGGTAC CG 118 Lys Met Lys Ala 35 (2) INFORMATION FOR SEQ ID NO: 38: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 38: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys 20 25 30 Met Lys Ala 35 (2) INFORMATION FOR SEQ ID NO: 39: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 97 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: D33 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..88 (D) OTHER INFORMATION: /function= "synthetic storage protein" /product= "protein" /gene= "ssp" /standard_name= "5.5.5.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 39: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met 1 5 10 15 GAG GAG AAG ATG AAG GCG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC 95 Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 20 25 CG 97 (2) INFORMATION FOR SEQ ID NO: 40: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 40: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 20 25 (2) INFORMATION FOR SEQ ID NO: 41: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 86" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 41: GATGGAGGAG AAGCTGAAGA A 21 (2) INFORMATION FOR SEQ ID NO: 42: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 87" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 42: ATCTTCTTCA GCTTCTCCTC C 21 (2) INFORMATION FOR SEQ ID NO: 43: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 88" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 43: GATGGAGGAG AAGCTGAAGT G 21 (2) INFORMATION FOR SEQ ID NO: 44: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 89" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 44: ATCCACTTCA GCTTCTCCTC C 21 (2) INFORMATION FOR SEQ ID NO: 45: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 90" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 45: GATGGAGGAG AAGATGAAGA A 21 (2) INFORMATION FOR SEQ ID NO: 46: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 91" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 46: ATCTTCTTCA TCTTCTCCTC C 21 (2) INFORMATION FOR SEQ ID NO: 47: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 92" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 47: GATGGAGGAG AAGATGAAGT G 21 (2) INFORMATION FOR SEQ ID NO: 48: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..21 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 93" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 48: ATCCACTTCA TCTTCTCCTC C 21 (2) INFORMATION FOR SEQ ID NO: 49: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 49: Met Glu Glu Lys Leu Lys Lys 1 5 (2) INFORMATION FOR SEQ ID NO: 50: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown ( ii ) MOLECULE TYPE : protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 50: Met Glu Glu Lys Leu Lys Trp 1 5 (2) INFORMATION FOR SEQ ID NO: 51: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 51: Met Glu Glu Lys Met Lys Lys 1 5 (2) INFORMATION FOR SEQ ID NO: 52: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 52: Met Glu Glu Lys Met Lys Trp 1 5 (2) INFORMATION FOR SEQ ID NO: 53: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 160 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: 82-4 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..151 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "7.7.7.7.7.7.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 53: C ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG 46 Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met 1 5 10 15 GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG 94 Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu 20 25 30 AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAA GAG AAG ATG 142 Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met 35 40 45 AAG GCG TGATAGGTAC CG 160 Lys Ala 50 (2) INFORMATION FOR SEQ ID NO: 54: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 49 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:54: Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu 1 5 10 15 Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys 20 25 30 Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met Lys 35 40 45 Ala (2) INFORMATION FOR SEQ ID NO: 55: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 97 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha ( vii ) IMMEDIATE SOURCE : ( B ) CLONE : 84 -H3 ( ix ) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 2..88 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "5.5.5.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO:55: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met 1 5 10 15 GAG GAG AAG ATG AAG GCG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC 95 Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 20 25 CG 97 (2) INFORMATION FOR SEQ ID NO: 56: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 56: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 20 25 (2) INFORMATION FOR SEQ ID NO: 57: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 97 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: 86-H23 ( ix ) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 2..88 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "5.8.8.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 57: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG CTG AAG AAG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Lys Met 1 5 10 15 GAG GAG AAG CTG AAG AAG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC 95 Glu Glu Lys Leu Lys Lys Met Glu Glu Lys Met Lys Ala 20 25 CG 97 (2) INFORMATION FOR SEQ ID NO: 58: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 58: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Lys Met Glu 1 5 10 15 Glu Lys Leu Lys Lys Met Glu Glu Lys Met Lys Ala 20 25 (2) INFORMATION FOR SEQ ID NO: 59: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 112 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: 88-2 ( ix) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 2..103 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "5.9.9.9.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 59: C ATG GAG GAG AAG ATG AAG GCG AAG AAG CTG AAG TGG ATG GAG GAG 46 Met Glu Glu Lys Met Lys Ala Lys Lys Leu Lys Trp Met Glu Glu 1 5 10 15 AAG CTG AAG TGG ATG GAG GAG AAG CTG AAG TGG ATG GAA GAG AAG ATG 94 Lys Leu Lys Trp Met Glu Glu Lys Leu Lys Trp Met Glu Glu Lys Met 20 25 30 AAG GCG TGATAGGTAC CG 112 Lys Ala (2) INFORMATION FOR SEQ ID NO: 60: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 33 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 60: Met Glu Glu Lys Met Lys Ala Lys Lys Leu Lys Trp Met Glu Glu Lys 1 5 10 15 Leu Lys Trp Met Glu Glu Lys Leu Lys Trp Met Glu Glu Lys Met Lys 20 25 30 Ala (2) INFORMATION FOR SEQ ID NO: 61: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 118 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: 90-H8 ( ix) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 2..109 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "5.10.10.10.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 61: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG AAG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Lys Met 1 5 10 15 GAG GAG AAG ATG AAG AAG ATG GAG GAG AAG ATG AAG AAG ATG GAA GAG 94 Glu Glu Lys Met Lys Lys Met Glu Glu Lys Met Lys Lys Met Glu Glu 20 25 30 AAG ATG AAG GCG TGATAGGTAC CG 118 Lys Met Lys Ala 35 (2) INFORMATION FOR SEQ ID NO: 62: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 62: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Lys Met Glu 1 5 10 15 Glu Lys Met Lys Lys Met Glu Glu Lys Met Lys Lys Met Glu Glu Lys 20 25 30 Met Lys Ala 35 (2) INFORMATION FOR SEQ ID NO: 63: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 97 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii ) IMMEDIATE SOURCE : (B ) CLONE : 92-2 ( ix) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 2..88 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "5.11.11.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 63: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG TGG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Trp Met 1 5 10 15 GAG GAG AAG ATG AAG TGG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC 95 Glu Glu Lys Met Lys Trp Met Glu Glu Lys Met Lys Ala 20 25 CG 97 (2) INFORMATION FOR SEQ ID NO: 64; (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 64: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Trp Met Glu 10 15 Glu Lys Met Lys Trp Met Glu Glu Lys Met Lys Ala 20 25 (2) INFORMATION FOR SEQ ID NO: 65: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 84 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..84 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide " /standard_name= "SM 96" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 65: GATGGAGGAA AAGATGAAGG CGATGGAGGA GAAAATGAAA GCTATGGAGG AAAAGATGAA 60 AGCGATGGAG GAGAAAATGA AGGC 84 (2) INFORMATION FOR SEQ ID NO: 66: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 84 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..84 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 97" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 66: ATCGCCTTCA TTTTCTCCTC CATCGCTTTC ATCTTTTCCT CCATAGCTTT CATTTTCTCC 60 TCCATCGCCT TCATCTTTTC CTCC 84 (2) INFORMATION FOR SEQ ID NO: 67: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (ix) FEATURE: (A) NAME/KEY: Protein (B) LOCATION: 1..28 (D) OTHER INFORMATION: /label= name /note= " (SSP 5)4" (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 67 : Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala 20 25 (2) INFORMATION FOR SEQ ID NO: 68: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 84 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..84 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 98" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 68: GATGGAGGAA AAGCTGAAAG CGATGGAGGA GAAACTCAAG GCTATGGAAG AAAAGCTTAA 60 AGCGATGGAG GAGAAACTGA AGGC 84 (2) INFORMATION FOR SEQ ID NO: 69: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 84 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..84 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 99" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 69: ATCGCCTTCA GTTTCTCCTC CTACGCTTTA AGCTTTTCTT CCATAGCCTT GAGTTTCTCC 60 TCCATCGCTT TCAGCTTTTC CTCC 84 (2) INFORMATION FOR SEQ ID NO:70: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein ( ix ) FEATURE : (A) NAME/KEY: Protein (B) LOCATION: 1..28 (D) OTHER INFORMATION: /label= name /note= " (SSP 7)4" (xi) SEQUENCE DESCRIPTION: SEQ ID NO:70: Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu 1 5 10 15 Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala 20 25 (2) INFORMATION FOR SEQ ID NO: 71: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 84 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..84 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 100" (xi) SEQUENCE DESCRIPTION: SEQ ID NO:71: GATGGAGGAA AAGCTTAAGA AGATGGAAGA AAAGCTGAAA TGGATGGAGG AGAAACTCAA 60 AAAGATGGAG GAAAAGCTTA AATG 84 (2) INFORMATION FOR SEQ ID NO: 72: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 84 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..84 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 101" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 72: ATCCATTTAA GCTTTTCCTC CTACTTTTTG AGTTTCTCCT CCATCCATTT CAGCTTTTCT 60 TCCATCTTCT TAAGCTTTTC CTCC 84 (2) INFORMATION FOR SEQ ID NO: 73: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 28 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 73: Met Glu Glu Lys Leu Lys Lys Met Glu Glu Lys Leu Lys Trp Met Glu 1 5 10 15 Glu Lys Leu Lys Lys Met Glu Glu Lys Leu Lys Trp 20 25 (2) INFORMATION FOR SEQ ID NO: 74: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 243 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii) IMMEDIATE SOURCE: (B) CLONE: 2-9 (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..235 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "7.7.7.7.7.7.8.9.8.9.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 74: C ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG 46 Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met 1 5 10 15 GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG 94 Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu 20 25 30 AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAA AAG CTT 142 Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu 35 40 45 AAG AAG ATG GAA GAA AAG CTG AAA TGG ATG GAG GAG AAA CTC AAA AAG 190 Lys Lys Met Glu Glu Lys Leu Lys Trp Met Glu Glu Lys Leu Lys Lys 50 55 60 ATG GAG GAA AAG CTT AAA TGG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC 242 Met Glu Glu Lys Leu Lys Trp Met Glu Glu Lys Met Lys Ala 65 70 75 243 (2) INFORMATION FOR SEQ ID NO: 75: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 77 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 75: Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu 1 5 10 15 Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys 20 25 30 Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys 35 40 45 Lys Met Glu Glu Lys Leu Lys Trp Met Glu Glu Lys Leu Lys Lys Met 50 55 60 Glu Glu Lys Leu Lys Trp Met Glu Glu Lys Met Lys Ala 65 70 75 (2) INFORMATION FOR SEQ ID NO: 76: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 175 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (vii ) IMMEDIATE SOURCE : ( B ) CLONE : 5-1 ( ix) FEATURE : (A) NAME/KEY: CDS (B) LOCATION: 2..172 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "5.5.5.7.7.7.7.5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 76: C ATG GAG GAG AAG ATG AAG GCG ATG GAG GAG AAG ATG AAG GCG ATG 46 Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met 1 5 10 15 GAG GAG AAG ATG AAG GCG ATG GAG GAA AAG CTG AAA GCG ATG GAG GAG 94 Glu Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu 20 25 30 AAA CTC AAG GCT ATG GAA GAA AAG CTT AAA GCG ATG GAG GAG AAA CTG 142 Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu 35 40 45 AAG GCC ATG GAA GAG AAG ATG AAG GCG TGATAG 179 Lys Ala Met Glu Glu Lys Met Lys Ala 50 55 (2) INFORMATION FOR SEQ ID NO: 77: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 56 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:77: Met Glu Glu Lys Met Lys Ala Met Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Glu Lys Met Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys 20 25 30 Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys 35 40 45 Ala Met Glu Glu Lys Met Lys Ala 50 55 (2) INFORMATION FOR SEQ ID NO: 78: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 187 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear ( ii ) MOLECULE TYPE : DNA ( genomic ) (vi) ORIGINAL SOURCE: (B) STRAIN: E. coli (G) CELL TYPE: DH5 alpha (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3..173 (D) OTHER INFORMATION: /function= "synthetic storage protein /product= "protein" /gene= "ssp" /standard_name= "SSP-3-5" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 78: CC ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG 47 Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met 1 5 10 15 GAG GAG AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAG 95 Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu 20 25 30 AAG CTG AAG GCG ATG GAG GAG AAG CTG AAG GCG ATG GAG GAA AAG ATG 143 Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met 35 40 45 AAG GCG ATG GAA GAG AAG ATG AAG GCG TGATAGGTAC CGAATTC 187 Lys Ala Met Glu Glu Lys Met Lys Ala 50 55 (2) INFORMATION FOR SEQ ID NO: 79: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 56 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:79: Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu 1 5 10 15 Glu Lys Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys 20 25 30 Leu Lys Ala Met Glu Glu Lys Leu Lys Ala Met Glu Glu Lys Met Lys 35 40 45 Ala Met Glu Glu Lys Met Lys Ala 50 55 (2) INFORMATION FOR SEQ ID NO: 80: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 61 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..61 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 107" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 80: CATGGAGGAG AAGATGAAAA AGCTCGAAGA GAAGATGAAG GTCATGAAGT GATAGGTACC 60 G 61 (2) INFORMATION FOR SEQ ID NO: 81: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 61 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..61 (D) OTHER INFORMATION: /product= "synthetic ligonucleotide" /standard_name= "SM 106" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 81: AATTCGGTAC CTATCACTTC ATGACCTTCA TCTTCTCTTC GAGCTTTTTC ATCTTCTCCT 60 C 61 (2) INFORMATION FOR SEQ ID NO: 82: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: unknown (ii) MOLECULE TYPE: protein (ix) FEATURE: (A) NAME/KEY: Protein (B) LOCATION: 1..16 (D) OTHER INFORMATION: /label= name /note= "pSK34 base gene" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 82: Met Glu Glu Lys Met Lys Lys Leu Glu Glu Lys Met Lys Val Met Lys 1 5 10 15 (2) INFORMATION FOR SEQ ID NO: 83: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 63 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..63 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 110" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 83: GCTGGAAGAA AAGATGAAGG CTATGGAGGA CAAGATGAAA TGGCTTGAGG AAAAGATGAA 60 GAA 63 (2) INFORMATION FOR SEQ ID NO: 84: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 63 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear ( ii ) MOLECULE TYPE : DNA ( genomic ) ( ix ) FEATURE : (A) NAME/KEY: misc_feature (B) LOCATION: 1..63 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard__name= "SM 111" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 84: AGCTTCTTCA TCTTTTCCTC AAGCCATTTC ATCTTGTCCT CCATAGCCTT CATCTTTTCT 60 TCC 63 (2) INFORMATION FOR SEQ ID NO: 85: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 37 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 85: Met Glu Glu Lys Met Lys Lys Leu Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Asp Lys Met Lys Trp Leu Glu Glu Lys Met Lys Lys Leu Glu Glu Lys 20 25 30 Met Lys Val Met Lys 35 (2) INFORMATION FOR SEQ ID NO: 86: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 37 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 86: Met Glu Glu Lys Met Lys Lys Leu Glu Glu Lys Met Lys Ala Met Glu 1 5 10 15 Asp Lys Met Lys Trp Leu Glu Glu Lys Met Lys Lys Leu Glu Glu Lys 20 25 30 Met Lys Val Met Lys 35 (2) INFORMATION FOR SEQ ID NO: 87: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 62 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..62 (D) OTHER INFORMATION: /product= "synthetic oligonucletide" /standard_name= "SM 112" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 87: GCTCGAAGAA AGATGAAGGC AATGGAAGAC AAAATGAAGT GGCTTGAGGA GAAAATGAAG 60 AA 62 (2) INFORMATION FOR SEQ ID NO: 88: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 62 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..62 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 113" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 88: AGCTTCTTCA TTTTCTCCTC AAGCCACTTC ATTTTGTCTT CCATTGCCTT CATCTTTCTT 60 CG 62 (2) INFORMATION FOR SEQ ID NO: 89: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 37 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 89: Met Glu Glu Lys Met Lys Lys Leu Lys Glu Glu Met Ala Lys Met Lys 1 5 10 15 Asp Glu Met Trp Lys Leu Lys Glu Glu Met Lys Lys Leu Glu Glu Lys 20 25 30 Met Lys Val Met Lys 35 (2) INFORMATION FOR SEQ ID NO: 90: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 63 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..63 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 114" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 90: GCTCAAGGAG GAAATGGCTA AGATGAAAGA CGAAATCTGG AAACTGAAAG AGGAAATGAA 60 GAA 63 (2) INFORMATION FOR SEQ ID NO: 91: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 63 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 1..63 (D) OTHER INFORMATION: /product= "synthetic oligonucleotide" /standard_name= "SM 115" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 91: AGCTTCTTCA TTTCCTCTTT CAGTTTCCAC ATTTCGTCTT TCATCTTAGC CATTTCCTCC 60 TTG 63 (2) INFORMATION FOR SEQ ID NO: 92: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 107 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 92: Met Glu Glu Lys Met Lys Lys Leu Lys Glu Glu Met Ala Lys Met Lys 1 5 10 15 Asp Glu Met Trp Lys Leu Lys Glu Glu Met Lys Lys Leu Glu Glu Lys 20 25 30 Met Lys Val Met Glu Glu Lys Met Lys Lys Leu Glu Glu Lys Met Lys 35 40 45 Ala Met Glu Asp Lys Met Lys Trp Leu Glu Glu Lys Met Lys Lys Leu 50 55 60 Glu Glu Lys Met Lys Val Met Glu Glu Lys Met Lys Lys Leu Glu Glu 65 70 75 80 Lys Met Lys Ala Met Glu Asp Lys Met Lys Trp Leu Glu Glu Lys Met 85 90 95 Lys Lys Leu Glu Glu Lys Met Lys Val Met Lys 100 105 (2) INFORMATION FOR SEQ ID NO: 93: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 839 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 93: GGATCCCCCG GGCTGCAGGA ATTCTACGTA CCATATAGTA AGACTTTGTA TATAAGACGT 60 CACCTCTTAC GTGCATGGTT ATATGTGACA TGTGCAGTGA CGTTGTACCA TATAGTAAGA 120 CTTTGTATAT AAGACGTCAC CTCTTACGTG CATGGTTATA TGTGACATGT GCAGTGACGT 180 TAACCGCACC CTCCTTCCCG TCGTTTCCCA TCTCTTCCTC CTTTAGAGCT ACCACTATAT 240 AAATCAGGGC TCATTTTCTC GCTCCTCACA GGCTCATCAG CACCCCGGCA GTGCCACCCC 300 GACTCCCTGC ACCTGCCATG GGTACGCTAG CCCGGGAGAT CTGACAAAGC AGCATTAGTC 360 CGTTGATCGG TGGAAGACCA CTCGTCAGTG TTGAGTTGAA TGTTTGATCA ATAAAATACG 420 GCAATGCTGT AAGGGTTGTT TTTTATGCCA TTGATAATAC ACTGTACTGT TCAGTTGTTG 480 AACTCTATTT CTTAGCCATG CCAGTGCTTT TCTTATTTTG AATAACATTA CAGCAAAAAG 540 TTGAAAGACA AAAAAANNNN NCCCCGAACA GAGTGCTTTG GGTCCCAAGC TTCTTTAGAC 600 TGTGTTCGGC GTTCCCCCTA AATTTCTCCC CTATATCTCA CTCACTTGTC ACATCAGCGT 660 TCTCTTTCCC CTATATCTCC ACGCTCTACA GCAGTTCCAC CTATATCAAA CCTCTATACC 720 CCACCACAAC AATATTATAT ACTTTCATCT TCACCTAACT CATGTACCTT CCAATTTTTT 780 TCTACTAATA ATTATTTACG TGCACAGAAA CTTAGGCAAG GGAGAGAGAG AGCGGTACC 839 (2) INFORMATION FOR SEQ ID NO: 94: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 43 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 94: CTAGAAGCCT CGGCAACGTC AGCAACGGCG GAAGAATCCG GTG 43 (2) INFORMATION FOR SEQ ID NO: 95: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 43 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 95: CATGCACCGG ATTCTTCCGC CGTTGCTGAC GTTGCCGAGG CTT 43 (2) INFORMATION FOR SEQ ID NO: 96: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 55 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 96: GATCCCATGG CGCCCCTTAA GTCCACCGCC AGCCTCCCCG TCGCCCGCCG CTCCT 55 (2) INFORMATION FOR SEQ ID NO: 97: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 55 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 97: CTAGAGGAGC GGCGGGCGAC GGGGAGGCTG GCGGTGGACT TAAGGGGCGC CATGG 55 (2) INFORMATION FOR SEQ ID NO: 98: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 59 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 98: CATGGCGCCC ACCGTGATGA TGGCCTCGTC GGCCACCGCC GTCGCTCCGT TCCAGGGGC 59 (2) INFORMATION FOR SEQ ID NO: 99: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 59 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 99: TTAAGCCCCT GGAACGGAGC GACGGCGGTG GCCGACGAGG CCATCATCAC GGTGGGCGC 59 (2) INFORMATION FOR SEQ ID NO: 100: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 100: GCGCCCACCG TGATGA 16 (2) INFORMATION FOR SEQ ID NO: 101: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 101: CACCGGATTC TTCCGC 16 (2) INFORMATION FOR SEQ ID NO: 102: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 372 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 102: GTAAGATTGG TAAAGTCCAG CAAGAAAATG AGATAAAAGA GAAGCCTGAA ATGACGAAAA 60 AATCAGGTGT TTTGATTCTT GGTGCTGGAC GTGTGTNTCG CCCAGCTGCT GATTTCCTAG 120 CTTCAGTTAG AACCATTTCG TCACAGCAAT GGTACAAAAC ATATTTCGGA GCAGACTCTG 180 AAGAGAAAAC AGATGTTCAT GTGATTGTCG CGTCTCTGTA TCTTAAGGAT GCCAAAGAGA 240 CGGTTGAAGG TATTTCAGAT GTAGAAGCAG TTCGGCTAGA TGTATCTGAT AGTGAAAGTC 300 TCCTTAAGTA TGTTTCTCAG GTTGATGTTG TCCTAAGTTT ATTACCTGCA AGTTGTCATG 360 CTTGTTGTAG CA 372 (2) INFORMATION FOR SEQ ID NO: 103: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 323 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 103: GGAAGCACAC TGCGACTCTT TTGGAATTCG GGGACATCAA GAATGGACAA ACAACAACCG 60 CTATGGCCAA GACTGTTGGG ATCCCTGCAG CCATTGGAGC TCTGCTGTTA ATTGAAGACA 120 AGATCAAGAC AAGAGGAGTC TTAAGGCCTC TCGAAGCAGA GGTGTATTTG CCAGCTTTGG 180 ATATATTGCA AGCATATGGT ATAAAGCTGA TGGAGAAGGC AGAATGATCA AAGAACTCTG 240 TATATTGTTT CTNTCTATAA CTTGGAGTTG GAGACAAAGC TGAAGGAGNC AGNGCCATTA 300 GACCAGCAAA AAAAGGAGGA GGA 323 (2) INFORMATION FOR SEQ ID NO: 104: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 123 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear ( ii ) MOLECULE TYPE : protein (xi ) SEQUENCE DESCRIPTION : SEQ ID NO : 104 : Lys He Gly Lys Val Gin Gin Glu Asn Glu He Lys Glu Lys Pro Glu 1 5 10 15 Met Thr Lys Lys Ser Gly Val Leu He Leu Gly Ala Gly Arg Val Xaa 20 25 30 Arg Pro Ala Ala Asp Phe Leu Ala Ser Val Arg Thr He Ser Ser Gin 35 40 45 Gin Trp Tyr Lys Thr Tyr Phe Gly Ala Asp Ser Glu Glu Lys Thr Asp 50 55 60 Val His Val He Val Ala Ser Leu Tyr Leu Lys Asp Ala Lys Glu Thr 65 70 75 80 Val Glu Gly He Ser Asp Val Glu Ala Val Arg Leu Asp Val Ser Asp 85 90 95 Ser Glu Ser Leu Leu Lys Tyr Val Ser Gin Val Asp Val Val Leu Ser 100 105 110 Leu Leu Pro Ala Ser Cys His Ala Cys Cys Ser 115 120 (2) INFORMATION FOR SEQ ID NO: 105: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 74 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 105: Lys His Thr Ala Thr Leu Leu Glu Phe Gly Asp He Lys Asn Gly Gin 1 5 10 15 Thr Thr Thr Ala Met Ala Lys Thr Val Gly He Pro Ala Ala He Gly 20 25 30 Ala Leu Leu Leu He Glu Asp Lys He Lys Thr Arg Gly Val Leu Arg 35 40 45 Pro Leu Glu Ala Glu Val Tyr Leu Pro Ala Leu Asp He Leu Gin Ala 50 55 60 Tyr Gly He Lys Leu Met Glu Lys Ala Glu 65 70 (2) INFORMATION FOR SEQ ID NO: 106: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 106: ATTCCCCATG GTTTCGCCGA CGAAT 25 (2) INFORMATION FOR SEQ ID NO: 107: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 29 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 107: CTCTCGGTAC CTAGTACCTA CTGATCAAC 29 (2) INFORMATION FOR SEQ ID NO: 108: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 108: AGAGAAGCCT GAAATGACGA AAAA 24 (2) INFORMATION FOR SEQ ID NO:109: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 109: GTCTTGGCCA TAGCGGTTGT TGTT 24 (2) INFORMATION FOR SEQ ID NO: 110: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8160 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 110: TCTAGATGCA CATTCAACTC GAGGTTGTTG CATGATGTTT CATTTACCAA AAAAATCATA 60 GTCAAATTAT GTAAGCAAAT GATATTACAG AAAAGTTTTA CTAGAGAGTT TCAGATTTAC 120 ACATGCACAA CGTTAAAAAA AATAGCAGAA AAAAGAAAGA AGAAAAGTTC TTTATTTGTG 180 AGAAAAATGT ATGAAAAAAA AAGAGATGGG TGTAAAAAGC AAAAGGATAG GACCACTGTT 240 ACTTTGTAGC CTCGTTGAGG AATCTCTTCT CGCATCTCGA CTTTTGTGCC ATTGCAAAGT 300 CAATGCCCAG AACTTGTTCC CAGGCCATCT CCAATTAACT ACGTCTATTT AATTAAACTT 360 TTAAAAGAAA ACCTAATAAA TTAAACAAAA GAAAAGCCGT CAACGAAATC TAAGCTTGCA 420 GCGATATCGA TGAACTGATA CCAAAACAAT GTTCAAGTTT CACTTTCAAA TTGTTTTTTC 480 TTGAAATAGT TTATTGGGTA AGGCCCATAG ATATTTCATA AGAAGAACAC TTGTCGAGGT 540 TGAATCGTAT GTCTGCCCAC CGCGGCCCAT GCATCCTCTG TTGGTAGCAT AATCGTTTTA 600 GGCCATACTA TTGTTCGTAC ACACTGATTT TGAAGTCACC TTTGTGCACT CCTTAATTCC 660 TAAATTGAAG AAGCTTGTTC TCATTCTTCT TTGGGTTACA AATGCCAAGG CAAAAGGAAC 720 TTGGGCCAAA TTAAGACAAC AACTCAAGCC CACTCTCTGC AAATAATACT TGGGAATTTT 780 TACTAAAACG GTGCGTTTCA TCCAAGAATC TATTAATATC CCTAACTTGA AATCATCATA 840 TACGTAACCC AACATATTAA AGAGTTAATA ATGTTAAAAA AAGTCTCAGA AGAGAGAGAC 900 GTAGAGAACA CGGAAAGTGG TAACTGGTAA GCGTCGTCAT CGAGGATATA GTAGCTACGT 960 GAGCAAACGT CTTCACTCAT CTCTGTCTAT TTCTCTTCGA ATACACGTAA TACATTTTCG 1020 ATTGGATTGA TCCTCCCTCG GTCCTATCCA AGTATCCATC CACGTAAACA AGAGCTTGTT 1080 CCTTTCTTGT TTTTTCTTTC TTTAAATAGT AAAAATACTT ATTTCATTTG TTTCGTTTGA 1140 TTTCATTATT ATTGTCTATG GCATTATATA CTATATATAT TATTTCTACA ACATTGGCTG 1200 GCTCACGTTG TTCTCGTGTA TACAACAAAC TTAATTAATG TCTCTCTATT GCATTAGATA 1260 GTTTCGGAGC ATATCCATTA TGTGAAAGCC ACATTAAGTT ATAACTAAAA GTAGTTTTCG 1320 AAAGAGCTTA ATTAAGTTAT GTTCTGTTTC AAATAAAAAT GAACACGAGG GATTTTTTTT 1380 TTTTTTGACA GATCATTATT AACAAAAATG ATTACCTGAA GAAAGGGGAA AATAATTATA 1440 GCTGATTACA GATCATTATT AACAAAAAGA ATTCTTGTCA CATCATTCAT TATAACAAGA 1500 AATATTATAT TATATTAATT TAATCTTTCG CTAACACGCC CACAATATAT TAATCATATA 1560 CGTAATTTAG CTTATAAAAA GGACGGAAAG AGATTATTAC TGCGCCTAAA AAACTCACTA 1620 ATTCCAAAGA AAAAAAAAAG CTTGTATTTT TTCTTGACAA ACCAGCTCAC AGGCATTGCA 1680 TGATCAAACT CATCAGGTAC GTTTTGATTC CTTCTTCCAT AATTTTCCCA TCTTGAGGAA 1740 TGCAAATTTG GAGAGCGCTT TAGCTAAATC ACTGCCTTCA TTTTTTCACT TTGGATTTAA 1800 TAATTTGCAT TCCTCTCTTC CTCTCTGCTC TGTTCTGTTC TGTTCTGTTC TGATTTGAGT 1860 TTTCAATTAA TCGCTCGAGC AAAAGCTATT TCTCAACTCG TTAAATTTCT GTTCCCAGTT 1920 TGTTCGATTT TCAACAGTTT CACATTAAAG TTTGGGTTTT TGATGTTTGG TTGATGAAAC 1980 TCGAAATATG AAATGTTTGT GAATCTATTC CAGGGTGTTT AAAATAAGGG TTTGTTGTTC 2040 ATCTGCAGAG ATTATATGTT TTTACATGAA AGATGAATTC AAATGGCCAT GAGGAGGAGA 2100 AGAAGTTGGG GAATGGAGTT GTGGGGATTC TAGCTGAAAC AGTTAACAAA TGGGAGAGAC 2160 GAACACCATT GACGCCATCG CATTGCGCTC GCCTTTTACA CGGTGGGAAA GACAGAACCG 2220 GCATTTCCCG CATTGTGGTT CAGCCATCTG CTAAGCGTAT CCATCATGAT GCCTTGTATG 2280 AAGATGTTGG GTGTGAAATT TCTGATGATT TGTCTGATTG TGGGCTTATA CTTGGAATCA 2340 AACAACCTGA GGTGTGGGAA TTTGCATTAA AAAGAGTTCC TTTTTTTCTT CTATATATAT 2400 ATCAGTTTAT GAGATTTGAT TCTGTTTGCA GCTAGAAATG ATTCTTCCAG AGAGAGCATA 2460 CGCTTTCTTT TCACATACTC ATAAGGCACA GAAAGAGAAC ATGCCTTTGT TGGATAAAGT 2520 ATTACACTTT TCATTTATCC TTTTAGTCCT ATCTAAGATA CTGAGGAATG TTGACAAAAG 2580 GGGTATCCAA TTGCAGATTC TTTCTGAGAG AGTGACTTTG TGTGATTATG AGCTCATTGT 2640 TGGGGATCAT GGGAAACGAT TATTGGCGTT TGGTAAATAT GCAGGCAGAG CTGGTCTTGT 2700 TGACTTCTTA CACGGACTTG GACAGCGTAA GCTCATGTTA TAATTCTGAT GATCAGGACA 2760 TGTTTCTGTG CAGAACAAGA TGAGATGTAA TTTTCCATGT TTGATGCAGG ATATCTAAGT 2820 CTAGGATACT CAACACCTTT CCTCTCGCTC GGTGCATCGT ATATGTATTC CTCATTGGCT 2880 GCTGCAAAAG CCGCTGTAAT TTCTGTTGGT GAAGAAATTG CAAGCCAGGG ACTGCCATTA 2940 GGAATCTGCC CTCTTGTATT TGTCTTCACC GGAACAGGAA ATGGTATCTT CTTTAGTTCT 3000 ACTGCGAGTT CTTTGAATCC TTCTGCATAT GTTTCATCTC ATTAAAAAAT TTCTCATCCG 3060 CAGTTTCTCT GGGGGCGCAA GAAATTTTCA AGCTTCTTCC TCACACTTTT GTTGAACCAA 3120 GCAAACTTCC TGAACTATTT GTAAAAGTAA GTCACGCTTT GCTTTTTATT TGGTTTCAGA 3180 GTTTTGAAGA TTCTGAAATG TATATTTCTC ACAGGACAAA GGAATTAGTC AAAATGGGAT 3240 TTCAACAAAG CGAGTCTATC AAGTATATGG TTGTATTATT ACCAGCCAAG ACATGGTTGA 3300 ACACAAAGAT CCATCAAAGT CATTCGACAA AGTAACACTT ACCTTCTTAG CTCCTTGGCT 3360 GTGACTTTTG TTCCACTACG CTAAAGTAGA ATACCTATTA ATTCTTCAAG CTTATGATGT 3420 TTAGGCCGAC TATTATGCAC ACCCGGAACA TTACAATCCA GTTTTCCACG AAAAGATATC 3480 GCCATATACG TCTGTTCTTG GTAGATCCTG ATCACTGTTT TACCTTTAAA GCTCAAGAGT 3540 TTACATATAA GCAAATCCTC TGTCCACTCC GTGACTGTGA CCATCTCATT TTGGTTAGTT 3600 CCAGTGTGTA ACCCCTATGA CTTTCTGTGC AGTAAACTGT ATGTACTGGG AGAAGAGGTT 3660 TCCCTGTCTT CTGAGCACAA AACAGCTTCA AGATTTAACA AAAAAAGGAC TCCCACTAGT 3720 AGGCATATGT GATATAACTT GTGACATCGG TGGCTCCATT GAATTTGTTA ACCGAGCTAC 3780 TTTAATCGAT TCCCCTTTCT TCAGGTAATA TATACTTAGG AAGAGCTTTC TTTTGAGTCA 3840 TCTACGTTTA CTATGATGAA ACTCGTCGAG CTAAACACTA TCTCTAGGTT TAATCCCTCG 3900 AACAATTCAT ACTACGATGA CATGGATGGG GATGGCGTAC TATGCATGGC TGTTGACATT 3960 TTACCCACAG AATTTGCAAA AGAGGTATGT ATGAAGGTTA CAGTTATAGT ACTTAAGATT 4020 AAATCTAAAG TTAAAAACCT TGTATTGAGT GGGAGTTCTT GTGTCCTGAA AAAGGCATCC 4080 CAGCATTTTG GAGATATTCT TTCCGGATTT GTCGGTAGTT TGGCTTCAAT GACTGAAATT 4140 TCAGATCTAC CAGCACATCT GAAGAGGGCT TGCATAAGCT ATAGGGGAGA ATTGACATCT 4200 TTGTATGAGT ATATTCCACG TATGAGGAAG TCAAATCCAG AGTATGTTCT GCTTCGAGCG 4260 TTACTTCATC TGAAATATTT AGGCCTCTTC TCTAAACTAT GTTTTCATCT TTACCCACTT 4320 TAACTGCAGA GAGGCACAAG ATAATATTAT CGCCAACGGG GTTTCCAGCC AGAGAACATT 4380 CAACATATTG GTTAGTTTTG ATGAAGAAAG TATATATAAC TAGTTTCCGA ATCATATGAT 4440 TTAAGCTAAT GAATTAAGAA AATATATAGT TCAAGACTTA TGATTCATAT CTCTATCAAC 4500 TTTTTGACCA AAGATTGATA CTTTTTCGAC ATCTGTCACA GCATTTTGTG ATGATTTTGA 4560 TTGAGACAAA TCATTTGTAG GTATCTCTGA GCGGACACCT ATTTGATAAG TTTCTGATAA 4620 ACGAAGCTCT TGATATGATC GAAGCGGCTG GTGGCTCATT TCATTTGGCT AAATGTGAAC 4680 TGGGGCAGAG CGCTGATGCT GAATCGTACT CAGAACTTGA AGTAAGTTTC TTTCTGGATA 4740 AAACCTAATC ATTCACATGG AACAACTGTC AAGAGTTTTT AATGTCACGT TTAGGTTCAA 4800 TGTCCTTTTC ACTAAGTCTC GTAAGTTTTT AAAACAAGTA AACAAACTAC AAGCCAAAAA 4860 CATTCTGGCC CCACATTAAC CTATTCCCAC TTGTTAAAGA ACCCATCTTG CATTATCTTG 4920 GTAGGTTGGT GCGGATGATA AGAGAGTATT GGATCAAATC ATTGATTCAT TAACTCGGTT 4980 AGCTAATCCA AATGAAGATT ATATATCCCC ACATAGAGAA GCAAATAAGA TCTCACTGAA 5040 GATTGGTAAA GTCCAGCAAG AAAATGAGAT AAAAGAGAAG CCTGAAATGA CGAAAAAATC 5100 AGGCGTTTTG ATTCTTGGTG CTGGACGTGT GTGTCGCCCA GCTGCTGATT TCCTAGCTTC 5160 AGTTAGAACC ATTTCGTCAC AGCAATGGTA CAAAACATAT TTCGGAGCAG ACTCTGAAGA 5220 GAAAACAGAT GTTCATGTGA TTGTCGCGTC TCTGTATCTT AAGGATGCCA AAGAGGTAGG 5280 AGAAGCCTTT GGGCTTCATC TGAGTAATTC AGTGTATACG ATGAACTATC AATCTTTTAA 5340 AGTTTTACTG ATGATCAAAT TTTCCGCAGA CGGTTGAAGG TATTTCAGAT GTAGAAGCAG 5400 TTCGGCTAGA TGTATCTGAT AGTGAAAGTC TCCTTAAGTA TGTTTCTCAG GTATTTTCCT 5460 AACTTCTCTG TTCTTAGATC ACCTTTACTT CAAACTCCAC TGTTCAAATC CATGATCTTA 5520 TATTTTTTTT TCATTGCACG CAGGTTGATG TTGTCCTAAG TTTATTACCT GCAAGTTGTC 5580 ATGCTGTTGT AGCAAAGACA TGCATTGAGG TAAATTCCTA ACGTTTAATG CGTTTTCCGA 5640 GTGAAGTTAT GAAATTTGCA AATGTTATTC GACATAGAGG TTAAACTTCC TCTGCATAAC 5700 ACATTCTTTC AGTAGTTTCC GGTTCCTAAA TGTCTCTGTT TCTTCTTTCT GATTCACTCA 5760 GCTGAAGAAG CATCTCGTCA CTGCTAGCTA TGTTGATGAT GAAACGTCCA TGTTACATGA 5820 GAAGGCTAAG AGTGCTGGGA TAACGATTCT AGGCGAAATG GGACTGGACC CTGGAATCGG 5880 TATGATATCT CACAACATAG TATCTCTTAA GATCATTTGT TCACTTGATT TAACTTAAGT 5940 GCATTTATCT TCAAAATATT TCCCGGATAA CTGAGAAGGT GATCCTACAA TGAATCTTTC 6000 AGATCACATG ATGGCGATGA AAATGATCAA CGATGCTCAT ATCAAAAAAG GGAAAGTGAA 6060 GTCTTTTACC TCTTATTGTG GAGGGCTTCC CTCTCCTGCT GCAGCAAATA ATCCATTAGC 6120 ATATAAATTT AGGTACGGTA GTCCTTTACG CCATTAACAT ATTTTGTTTT GTTTAACTCA 6180 TTTAGACATC CTTTCAGAAT TTCGCTTACT CAATTACATC TCGGTATTTT CAGCTGGAAC 6240 CCTGCTGGAG CAATTCGAGC TGGTCAAAAC CCCGCCAAAT ACAAAAGCAA CGGCGACATA 6300 ATACATGTTG ATGGTATGAA AAACAAAATA TGTCTACATG CAGGAGAGGT TGGAGTAGTT 6360 TAGCTTCACT ACACATCATT TTTGTTTAAC CGAGCAATGT AAATCGCAGG GAAGAATCTC 6420 TATGATTCCG CGGCAAGATT CCGAGTACCT AATCTTCCAG CTTTTGCATT GGAGTGTCTT 6480 CCAAATCGTG ACTCCTTGGT TTACGGGGAA CATTATGGCA TCGAGAGCGA AGCAACAACG 6540 ATATTTCGTG GAACACTCAG ATATGAAGGC ATGAATTCCA TAATCACAAC TCACGACTCA 6600 CTTCTCCATA TCTGAAGGCT TAACACTTGT TTTCTTTTGG CTTGTACAGG GTTTAGTATG 6660 ATAATGGCAA CACTTTCGAA ACTTGGATTC TTTGACAGTG AAGCAAATCA AGTACTCTCC 6720 ACTGGAAAGA GGATTACGTT TGGTGCTCTT TTAAGTAACA TTCTAAATAA GGATGCCGAC 6780 AATGAATCAG AGCCCCTAGC GGGAGAAGAA GAGATAAGCA AGAGAATTAT CAAGCTTGGA 6840 CATTCCAAGG AGACTGCAGC CAAAGCTGCC AAAACAATTG TGTAAGCTTC TCCATGAAGA 6900 TATATAATCT GAATGTTGCA GTGTGATTCC AATTCTTCTA CGAAACTCCT AACCCCAATT 6960 CTTTTGTGGT GTCTTAGATT CTTGGGGTTC AACGAAGAGA GGGAGGTTCC ATCACTGTGT 7020 AAAAGCGTAT TTGATGCAAC TTGTTACCTA ATGGAAGAGA AACTAGCTTA TTCCGGAAAT 7080 GAACAGGTCT CTGTTTCATG TGAAAGCATT AGTTTTCTTC TCTCACTTGT ATTTGGTGTT 7140 ACTTACTGAC ATAAACTTTG GACAATCTTT TGCATTATGT TTTCAGGACA TGGTGCTTTT 7200 GCATCACGAA GTAGAAGTGG AATTCCTTGA AAGCAAACGT ATAGAGAAGC ACACTGCGAC 7260 TCTTTTGGAA TTCGGGGACA TCAAGAATGG GCAAACAACA ACCGCTATGG CCAAGACTGT 7320 TGGGATCCCT GCAGCCATTG GAGCTCTGGT CCTTACTAAG ACTTTGATCA CCACTTTTTC 7380 CTGTCTATAT TTCTCTAAAA TGAAAGTTTT AAGCGTTTGT TTTATGATGT TGTGTGTTGC 7440 AGCTGTTAAT TGAAGACAAG ATCAAGACAA GAGGAGTCTT AAGGCCTTTC GAAGCAGAGG 7500 TGTATTTGCC AGGTAAATTA GAATTCCGCT TCAAAAGGAT GTGTGTTGCA GATAAAGACA 7560 ATGATGTTGA TTTGTTGTGT GTTTGGGATA TGTGGTGTTA TACATACAGC TTTGGATATA 7620 TTGCAAGCAT ATGGTATAAA GCTGATGGAG AAGGCAGAAT GATCAAAGAA CTCTGTATAT 7680 TGTTTCTCTC TATAACTTGG AGTTGGAGAC AAAGCTGAAG AAGACAGAGA CATTAGACCA 7740 GCAAAAAAAG AAGAAGAAGG AAGAAGATAA GCCTCGATCC TTGGGTGACG AGTATCTATA 7800 TGTTTATATG TACTATATGT TATGTTGTAC AGAAGAAGTC GTGTCCACAA ATATCAATTG 7860 ATGTCAGATG TCTAGTAAGT GATCATGTGT AGCATACAAA CTGGAGTAAT TTAAAAAGTG 7920 AATAAACAAA AATAATTACT AAACGTTATT CCAAGTAGCT TTCCAAGACA GTCACTTGCC 7980 CTTTTCCAAT TTCCCTTGCA ATTAACTAAA TTGCTCTTCA CGATATGATA TTATACCAAA 8040 ATGGTGATAC CTTGGGAATT GTTAATTTGA CTCATTTGAA CAAATCTCAT CTATAAAATC 8100 ATCCCACCTC TCCACCACAT TTGTTCTCAC TACCAATCAA AAAATAATCT AGTCTTAAAC 8160 (2) INFORMATION FOR SEQ ID NO: 111: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3194 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 111: ATGAATTCAA ATGGCCATGA GGAGGAGAAG AAGTTGGGGA ATGGAGTTGT GGGGATTCTA 60 TCTGAAACAG TTAACAAATG GGAGAGACGA ACACCATTGA CGCCATCGCA TTGCGCTCGC 120 CTTTTACACG GTGGGAAAGA CAGAACCGGC ATTTCCCGCA TTGTGGTTCA GCCATCTGCT 180 AAGCGTATCC ATCATGATGC CTTGTATGAA CATGTTGGGT GTGAAATTTC TGATGATTTG 240 TCTGATTGTG GGCTTATACT TGGAATCAAA CAACCTGAGC TAGAAATGAT TCTTCCAGAG 300 AGAGCATACG CTTTCTTTTC ACATACTCAT AAGGCACAGA AAGAGAACAT GCCTTTGTTG 360 GATAAAATTC TTTCTGAGAG AGTGACTTTG TGTGATTATG AGCTCATTGT TGGGGATCAT 420 GGGAAACGAT TATTGGCGTT TGGTAAATAT GCAGGCAGAG CTGGTCTTGT TGACTTCTTA 480 CACGGACTTG GACAGCGATA TCTAAGTCTA GGATACTCAA CACCTTTCCT CTCGCTCGGT 540 GCATCGTATA TGTATTCCTC ATTGGCTGCT GCAAAAGCCG CTGTAATTTC TGTTGGTGAA 600 GAAATTGCAA GCCAGGGACT GCCATTAGGA ATCTGCCCTC TTGTATTTGT CTTCACCGGA 660 ACAGGAAATG TTTCTCTGGG GGCGCAAGAA ATTTTCAAGC TTCTTCCTCA CACTTTTGTT 720 GAACCAAGCA AACTTCCTGA ACTATTTGTA AAAGACAAAG GAATTAGTCA AAATGGGATT 780 TCAACAAAGC GAGTCTATCA AGTATATGGT TGTATTATTA CCAGCCAAGA CATGGTTGAA 840 CACAAAGATC CATCAAAGTC ATTCGACAAA GCCGACTATT ATGCACACCC GGAACATTAC 900 AATCCAGTTT TCCACGAAAA GATATCGCCA TATACGTCTG TTCTTGTAAA CTGTATGTAC 960 TGGGAGAAGA GGTTTCCCTG TCTTCTGAGC ACAAAACAGC TTCAAGATTT AACAAAAAAA 1020 GGACTCCCAC TAGTAGGCAT ATGTGATATA ACTTGTGACA TCGGTGGCTC CATTGAATTT 1080 GTTAACCGAG CTACTTTAAT CGATTCCCCT TTCTTCAGGT TTAATCCCTC GAACAATTCA 1140 TACTACGATG ACATGGATGG GGATGGCGTA CTATGCATGG CTGTTGACAT TTTACCCACA 1200 GAATTTGCAA AAGAGGCATC CCAGCATTTT GGAGATATTC TTTCCGGATT TGTCGGTAGT 1260 TTGGCTTCAA TGACTGAAAT TTCAGATCTA CCAGCACATC TGAAGAGGGC TTGCATAAGC 1320 TATAGGGGAG AATTGACATC TTTGTATGAG TATATTCCAC GTATGAGGAA GTCAAATCCA 1380 GAAGAGGCAC AAGATAATAT TATCGCCAAC GGGGTTTCCA GCCAGAGAAC ATTCAACATA 1440 TTGGTATCTC TGAGCGGACA CCTATTTGAT AAGTTTCTGA TAAACGAAGC TCTTGATATG 1500 ATCGAAGCGG CTGGTGGCTC ATTTCATTTG GCTAAATGTG AACTGGGGCA GAGCGCTGAT 1560 GCTGAATCGT ACTCAGAACT TGAAGTTGGT GCGGATGATA AGAGAGTATT GGATCAAATC 1620 ATTGATTCAT TAACTCGGTT AGCTAATCCA AATGAAGATT ATATATCCCC ACATAGAGAA 1680 GCAAATAAGA TCTCACTGAA GATTGGTAAA GTCCAGCAAG AAAATGAGAT AAAAGAGAAG 1740 CCTGAAATGA CGAAAAAATC AGGTGTTTTG ATTCTTGGTG CTGGACGTGT GTGTCGCCCA 1800 GCTGCTGATT TCCTAGCTTC AGTTAGAACC ATTTCGTCAC AGCAATGGTA CAAAACATAT 1860 TTCGGAGCAG ACTCTGAAGA GAAAACAGAT GTTCATGTGA TTGTCGCGTC TCTGTATCTT 1920 AAGGATGCCA AAGAGACGGT TGAAGGTATT TCAGATGTAG AAGCAGTTCG GCTAGATGTA 1980 TCTGATAGTG AAAGTCTCCT TAAGTATGTT TCTCAGGTTG ATGTTGTCCT AAGTTTATTA 2040 CCTGCAAGTT GTCATGCTGT TGTAGCAAAG ACATGCATTG AGCTGAAGAA GCATCTCGTC 2100 ACTGCTAGCT ATGTTGATGA TGAAACGTCC ATGTTACATG AGAAGGCTAA GAGTGCTGGG 2160 ATAACGATTC TAGGCGAAAT GGGACTGGAC CCTGGAATCG ATCACATGAT GGCGATGAAA 2220 ATGATCAACG ATGCTCATAT CAAAAAAGGG AAAGTGAAGT CTTTTACCTC TTATTGTGGA 2280 GGGCTTCCCT CTCCTGCTGC AGCAAATAAT CCATTAGCAT ATAAATTTAG CTGGAACCCT 2340 GCTGGAGCAA TTCGAGCTGG TCAAAACCCC GCCAAATACA AAAGCAACGG CGACATAATA 2400 CATGTTGATG GGAAGAATCT CTATGATTCC GCGGCAAGAT TCCGAGTACC TAATCTTCCA 2460 GCTTTTGCAT TGGAGTGTTT TCCAAATCGT GACTCCTTGG TTTACGGGGA ACATTATGGC 2520 ATCGAGAGCG AAGCAACAAC GATATTTCGT GGAACACTCA GATATGAAGG GTTTAGTATG 2580 ATAATGGCAA CACTTTCGAA ACTTGGATTC TTTGACAGTG AAGCAAATCA AGTACTCTCC 2640 ACTGGAAAGA GGATTACGTT TGGTGCTCTT TTAAGTAACA TTCTAAATAA GGATGCAGAC 2700 AATGAATCAG AGCCCCTAGC GGGAGAAGAA GAGATAAGCA AGAGAATTAT CAAGCTTGGA 2760 CATTCCAAGG AGACTGCAGC CAAAGCTGCC AAAACAATTG TATTCTTGGG GTTCAACGAA 2820 GAGAGGGAGG TTCCATCACT GTGTAAAAGC GTATTTGATG CAACTTGTTA CCTAATGGAA 2880 GAGAAACTAG CTTATTCCGG AAATGAACAG GACATGGTGC TTTTGCATCA CGAAGTAGAA 2940 GTGGAATTCC TTGAAAGCAA ACGTATAGAG AAGCACACTG CGACTCTTTT GGAATTCGGG 3000 GACATCAAGA ATGGACAAAC AACAACCGCT ATGGCCAAGA CTGTTGGGAT CCCTGCAGCC 3060 ATTGGAGCTC TGGTGTTAAT TGAAGACAAG ATCAAGACAA GAGGAGTCTT AAGGCCTCTC 3120 GAAGCAGAGG TGTATTTGCC AGCTTTGGAT ATATTGCAAG CATATGGTAT AAAGCTGATG 3180 GAGAAGGCAG AATGA 3195 (2) INFORMATION FOR SEQ ID NO: 112: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1064 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 112: Met Asn Ser Asn Gly His Glu Glu Glu Lys Lys Leu Gly Asn Gly Val 1 5 10 15 Val Gly He Leu Ser Glu Thr Val Asn Lys Trp Glu Arg Arg Thr Pro 20 25 30 Leu Thr Pro Ser His Cys Ala Arg Leu Leu His Gly Gly Lys Asp Arg 35 40 45 Thr Gly He Ser Arg He Val Val Gin Pro Ser Ala Lys Arg He His 50 55 60 His Asp Ala Leu Tyr Glu His Val Gly Cys Glu He Ser Asp Asp Leu 65 70 75 80 Ser Asp Cys Gly Leu He Leu Gly He Lys Gin Pro Glu Leu Glu Met 85 90 95 He Leu Pro Glu Arg Ala Tyr Ala Phe Phe Ser His Thr His Lys Ala 100 105 110 Gin Lys Glu Asn Met Pro Leu Leu Asp Lys He Leu Ser Glu Arg Val 115 120 125 Thr Leu Cys Asp Tyr Glu Leu He Val Gly Asp His Gly Lys Arg Leu 130 135 140 Leu Ala Phe Gly Lys Tyr Ala Gly Arg Ala Gly Leu Val Asp Phe Leu 145 150 155 160 His Gly Leu Gly Gin Arg Tyr Leu Ser Leu Gly Tyr Ser Thr Pro Phe 165 170 175 Leu Ser Leu Gly Ala Ser Tyr Met Tyr Ser Ser Leu Ala Ala Ala Lys 180 185 190 Ala Ala Val He Ser Val Gly Glu Glu He Ala Ser Gin Gly Leu Pro 195 200 205 Leu Gly He Cys Pro Leu Val Phe Val Phe Thr Gly Thr Gly Asn Val 210 215 220 Ser Leu Gly Ala Gin Glu He Phe Lys Leu Leu Pro His Thr Phe Val 225 230 235 240 Glu Pro Ser Lys Leu Pro Glu Leu Phe Val Lys Asp Lys Gly He Ser 245 250 255 Gin Asn Gly He Ser Thr Lys Arg Val Tyr Gin Val Tyr Gly Cys He 260 265 270 He Thr Ser Gin Asp Met Val Glu His Lys Asp Pro Ser Lys Ser Phe 275 280 285 Asp Lys Ala Asp Tyr Tyr Ala His Pro Glu His Tyr Asn Pro Val Phe 290 295 300 His Glu Lys He Ser Pro Tyr Thr Ser Val Leu Val Asn Cys Met Tyr 305 310 315 320 Trp Glu Lys Arg Phe Pro Cys Leu Leu Ser Thr Lys Gin Leu Gin Asp 325 330 335 Leu Thr Lys Lys Gly Leu Pro Leu Val Gly He Cys Asp He Thr Cys 340 345 350 Asp He Gly Gly Ser He Glu Phe Val Asn Arg Ala Thr Leu He Asp 355 360 365 Ser Pro Phe Phe Arg Phe Asn Pro Ser Asn Asn Ser Tyr Tyr Asp Asp 370 375 380 Met Asp Gly Asp Gly Val Leu Cys Met Ala Val Asp He Leu Pro Thr 385 390 395 400 Glu Phe Ala Lys Glu Ala Ser Gin His Phe Gly Asp He Leu Ser Gly 405 410 415 Phe Val Gly Ser Leu Ala Ser Met Thr Glu He Ser Asp Leu Pro Ala 420 425 430 His Leu Lys Arg Ala Cys He Ser Tyr Arg Gly Glu Leu Thr Ser Leu 435 440 445 Tyr Glu Tyr He Pro Arg Met Arg Lys Ser Asn Pro Glu Glu Ala Gin 450 455 460 Asp Asn He He Ala Asn Gly Val Ser Ser Gin Arg Thr Phe Asn He 465 470 475 480 Leu Val Ser Leu Ser Gly His Leu Phe Asp Lys Phe Leu He Asn Glu 485 490 495 Ala Leu Asp Met He Glu Ala Ala Gly Gly Ser Phe His Leu Ala Lys 500 505 510 Cys Glu Leu Gly Gin Ser Ala Asp Ala Glu Ser Tyr Ser Glu Leu Glu 515 520 525 Val Gly Ala Asp Asp Lys Arg Val Leu Asp Gin He He Asp Ser Leu 530 535 540 Thr Arg Leu Ala Asn Pro Asn Glu Asp Tyr He Ser Pro His Arg Glu 545 550 555 560 Ala Asn Lys He Ser Leu Lys He Gly Lys Val Gin Gin Glu Asn Glu 565 570 575 He Lys Glu Lys Pro Glu Met Thr Lys Lys Ser Gly Val Leu He Leu 580 585 590 Gly Ala Gly Arg Val Cys Arg Pro Ala Ala Asp Phe Leu Ala Ser Val 595 600 605 Arg Thr He Ser Ser Gin Gin Trp Tyr Lys Thr Tyr Phe Gly Ala Asp 610 615 620 Ser Glu Glu Lys Thr Asp Val His Val He Val Ala Ser Leu Tyr Leu 625 630 635 640 Lys Asp Ala Lys Glu Thr Val Glu Gly He Ser Asp Val Glu Ala Val 645 650 655 Arg Leu Asp Val Ser Asp Ser Glu Ser Leu Leu Lys Tyr Val Ser Gin 660 665 670 Val Asp Val Val Leu Ser Leu Leu Pro Ala Ser Cys His Ala Val Val 675 680 685 Ala Lys Thr Cys He Glu Leu Lys Lys His Leu Val Thr Ala Ser Tyr 690 695 700 Val Asp Asp Glu Thr Ser Met Leu His Glu Lys Ala Lys Ser Ala Gly 705 710 715 720 He Thr He Leu Gly Glu Met Gly Leu Asp Pro Gly He Asp His Met 725 730 735 Met Ala Met Lys Met He Asn Asp Ala His He Lys Lys Gly Lys Val 740 745 750 Lys Ser Phe Thr Ser Tyr Cys Gly Gly Leu Pro Ser Pro Ala Ala Ala 755 760 765 Asn Asn Pro Leu Ala Tyr Lys Phe Ser Trp Asn Pro Ala Gly Ala He 770 775 780 Arg Ala Gly Gin Asn Pro Ala Lys Tyr Lys Ser Asn Gly Asp He He 785 790 795 800 His Val Asp Gly Lys Asn Leu Tyr Asp Ser Ala Ala Arg Phe Arg Val 805 810 815 Pro Asn Leu Pro Ala Phe Ala Leu Glu Cys Phe Pro Asn Arg Asp Ser 820 825 830 Leu Val Tyr Gly Glu His Tyr Gly He Glu Ser Glu Ala Thr Thr He 835 840 845 Phe Arg Gly Thr Leu Arg Tyr Glu Gly Phe Ser Met He Met Ala Thr 850 855 860 Leu Ser Lys Leu Gly Phe Phe Asp Ser Glu Ala Asn Gin Val Leu Ser 865 870 875 880 Thr Gly Lys Arg He Thr Phe Gly Ala Leu Leu Ser Asn He Leu Asn 885 890 895 Lys Asp Ala Asp Asn Glu Ser Glu Pro Leu Ala Gly Glu Glu Glu He 900 905 910 Ser Lys Arg He He Lys Leu Gly His Ser Lys Glu Thr Ala Ala Lys 915 920 925 Ala Ala Lys Thr He Val Phe Leu Gly Phe Asn Glu Glu Arg Glu Val 930 935 940 Pro Ser Leu Cys Lys Ser Val Phe Asp Ala Thr Cys Tyr Leu Met Glu 945 950 955 960 Glu Lys Leu Ala Tyr Ser Gly Asn Glu Gin Asp Met Val Leu Leu His 965 970 975 His Glu Val Glu Val Glu Phe Leu Glu Ser Lys Arg He Glu Lys His 980 985 990 Thr Ala Thr Leu Leu Glu Phe Gly Asp He Lys Asn Gly Gin Thr Thr 995 1000 1005 Thr Ala Met Ala Lys Thr Val Gly He Pro Ala Ala He Gly Ala Leu 1010 1015 1020 Val Leu He Glu Asp Lys He Lys Thr Arg Gly Val Leu Arg Pro Leu 1025 1030 1035 1040 Glu Ala Glu Val Tyr Leu Pro Ala Leu Asp He Leu Gin Ala Tyr Gly 1045 1050 1055 He Lys Leu Met Glu Lys Ala Glu 1060 (2) INFORMATION FOR SEQ ID NO: 113: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 113: TTYTCICAYA CICAYAARGC ICA 23 (2) INFORMATION FOR SEQ ID NO: 114: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 114: TTYTCCCART ACATRCARTT 20 (2) INFORMATION FOR SEQ ID NO: 115: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 619 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 115: GAAAACATGC CTTTGCTGGA TAAGATTCTA GCTGAGAGGG CATCGTTATA TGACTATGAA 60 TTAATTGTTG GGGACACTGG GAAAAGGTTA CTTGCATTTG GAAAATTCGC TGGTAGGGCT 120 GGAATGATCG ACTTTTTGCG CGGATTAGGA CAGCGGTTTT TAAGTCTTGG ATATTCAACA 180 CCTTTCTTGT CACTTGGATC ATCTTACATG TACCCTTCCC TGGCTGCTGC TAAGGCTGCT 240 GTGATTTCTG TTGGTGAAAA ATTGCGACGC AGGGATTGCC ATTGGGGATT TGTCCCCTGG 300 TTTGTTTATT TACTGGTTCA GGAAATGTTT GTTCTGGTGC ACAGGAGATA TTTAAGCTTC 360 TTCCTCATAC CTTTGTTGAT CCATCTAAAC TACGCGACCT ACATAGAACG GACCCAGATC 420 AACCAAGGCA TGCTTCAAAA AGAGTTTTCC AAGTTTATGG TTGTGTTGTG ACTGCCCAAG 480 ACATGGTTGA ACCCAAAGAT CACGTGATAG TGTTTGACAA AGCAGACTAC TATGCACATC 540 CTGAGCATTA CAATCCCACT TTCCATGAAA AAATAGCACC ATATGCATCT GTTATTGTCA 600 ATTGCATGTA TTGGGAAAA 619 (2) INFORMATION FOR SEQ ID NO: 116: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 620 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 116: GAGAATATGC CACTGTTAGA CAAGATCCTT GAAGAAAGGG TGTCCTTGTT TGATTATGAG 60 CTAATTGTTG GAGATGATGG GAAAAGATCA CTAGCATTTG GGAAATTTGC TGGTAGAGCT 120 GGACTGATAG ATTTCTTACA TGGTCTCGGA CAGCGATATT TGAGCCTTGG ATACTCCACT 180 CCATTTCTCT CTCTGGGACA TCTCATATGT TCCTTCGCTC GCTGCAGCCA AGGCTGCAGT 240 CATTGTCGTT GCAGAAGAGA TAGCAACATT TGGACTTCCA TCCGGAATTT GTCCGATAGT 300 GTTTGTGTTC ACTGGAGTTG GAAACGTCTC TCAGGGTGCG CAGGAGATAT TCAAGTTATT 360 GCCCCATACC TTTGTTGATG CTGAGAAGCT TCCCGAAATT TTTCAGGCCA GGAATCTGTC 420 TAAGCAATCT CAGTCGACCA AGAGAGTATT TCAACTTTAT GGTTGTGTTG TGACCTCTAG 480 AGACATAGTT TCTCACAAGG ATCCCACCAG ACAATTTGAC AAAGGTGACT ATTATGCTCA 540 TCCAGAACAC TACACCCCTG TTTTTCATGA AAGAATTGCT CCATATGCAT CTGTCATCGT 600 AAACTGCATG TATTGGGAAA 620 (2) INFORMATION FOR SEQ ID NO: 117: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 206 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 117: Glu Asn Met Pro Leu Leu Asp Lys He Leu Ala Glu Arg Ala Ser Leu 1 5 10 15 Tyr Asp Tyr Glu Leu He Val Gly Asp Thr Gly Lys Arg Leu Leu Ala 20 25 30 Phe Gly Lys Phe Ala Gly Arg Ala Gly Met He Asp Phe Leu Arg Gly 35 40 45 Leu Gly Gin Arg Phe Leu Ser Leu Gly Tyr Ser Thr Pro Phe Leu Ser 50 55 60 Leu Gly Ser Ser Tyr Met Tyr Pro Ser Leu Ala Ala Ala Lys Ala Ala 65 70 75 80 Val He Ser Val Gly Glu Xaa He Ala Thr Gin Gly Leu Pro Leu Gly 85 90 95 He Cys Pro Leu Val Cys Leu Phe Thr Gly Ser Gly Asn Val Cys Ser 100 105 110 Gly Ala Gin Glu He Phe Lys Leu Leu Pro His Thr Phe Val Asp Pro 115 120 125 Ser Lys Leu Arg Asp Leu His Arg Thr Asp Pro Asp Gin Pro Arg His 130 135 140 Ala Ser Lys Arg Val Phe Gin Val Tyr Gly Cys Val Val Thr Ala Gin 145 150 155 160 Asp Met Val Glu Pro Lys Asp His Val He Val Phe Asp Lys Ala Asp 165 170 175 Tyr Tyr Ala His Pro Glu His Tyr Asn Pro Thr Phe His Glu Lys He 180 185 190 Ala Pro Tyr Ala Ser Val He Val Asn Cys Met Tyr Trp Glu 195 200 205 (2) INFORMATION FOR SEQ ID NO: 118: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 207 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 118: Glu Asn Met Pro Leu Leu Asp Lys He Leu Glu Glu Arg Val Ser Leu 1 5 10 15 Phe Asp Tyr Glu Leu He Val Gly Asp Asp Gly Lys Arg Ser Leu Ala 20 25 30 Phe Gly Lys Phe Ala Gly Arg Ala Gly Leu He Asp Phe Leu His Gly 35 40 45 Leu Gly Gin Arg Tyr Leu Ser Leu Gly Tyr Ser Thr Pro Phe Leu Ser 50 55 60 Leu Gly Xaa Ser His Met Xaa Pro Ser Leu Ala Ala Ala Lys Ala Ala 65 70 75 80 Val He Val Val Ala Glu Glu He Ala Thr Phe Gly Leu Pro Ser Gly 85 90 95 He Cys Pro He Val Phe Val Phe Thr Gly Val Gly Asn Val Ser Gin 100 105 110 Gly Ala Gin Glu He Phe Lys Leu Leu Pro His Thr Phe Val Asp Ala 115 120 125 Glu Lys Leu Pro Glu He Phe Gin Ala Arg Asn Leu Ser Lys Gin Ser 130 135 140 Gin Ser Thr Lys Arg Val Phe Gin Leu Tyr Gly Cys Val Val Thr Ser 145 150 155 160 Arg Asp He Val Ser His Lys Asp Pro Thr Arg Gin Phe Asp Lys Gly 165 170 175 Asp Tyr Tyr Ala His Pro Glu His Tyr Thr Pro Val Phe His Glu Arg 180 185 190 He Ala Pro Tyr Ala Ser Val He Val Asn Cys Met Tyr Trp Glu 195 200 205 (2) INFORMATION FOR SEQ ID NO: 119: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2582 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Glycine max (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3..2357 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 119: TTGAACCCAA AGATCACGTG ATAGTGTTTG ACAAAGCAGA CTACTATTCA CACCCTGAGC 60 ATTACAATCC CACTTTCCAT GAAAAAATAG CACCATATGC ATCTGTTATT GTCAATTGCA 120 TGTATTGGGA GAAAAGATTT CCTCAATTGC CGAGCTATAA GCAGATGCAA GACTTAATGG 180 GCCGGGGGAG CCCCCTTGTT GGAATAGCTG ACATAACGTG TGATATAGGG GGTTCAATTG 240 AGTTTGTTAA CCGCGGTACT TCAATTGATT CACCCTTCTT CAGATATGAT CCCTTAACAA 300 ATTCCTACCA TGATGATATG GAGGGGAATG GAGTGATATG CTTAGCTGTT GACATTCTTC 360 CAACAGAATT TGCAAAGGAG GCTTCCCAAC ATTTTGGAAA CATACTTTCC CAATTTGTTG 420 TAAATTTGGC TTCTGCTACA GACATTACAA AGTTGCCTGC TCACTTAAGG AGAGCTTGCA 480 TAGCCCATAA AGGAGTGCTA ACCTCCTTAT ATGATTATAT CCCACGCATG CGGAGTTCTG 540 ATTCAGAGGA AGTATCAGAA AACGCAGAAA ATTCTCTATC CAACAAAAGG AAGTACAATA 600 TATCGGTGTC TCTGAGTGGT CACTTATTTG ATCAGTTTCT GATAAATGAG GCCTTAGATA 660 TTATTGAAGC TGCAGGAGGC TCCTTCCACT TAGTCAACTG CCATGTGGGT CAGAGCATTG 720 AAGCCGTATC ATTCTCTGAA CTTGAAGTTG GTGCAGATAA CAGGGCTGTT CTGGATCAAA 780 TCATTGATTC TTTAACTGCT ATTGCTAGTC CAACTGAACA TGATAGATTT TCAAATCAAG 840 ATTCAAGTAA AATTTCACTT AAGCTTGGTA AAGTTGAAGA GAATGGCATA GAGAAGGAAT 900 CTGACCCCAG AAAGAAGGCT GCGGTTTTAA TTCTTGGAGC TGGTCGGGTC TGTCAACCAG 960 CTGCTGAAAT GTTATCATCA TTTGGAAGGC CATCATCGAG CCAATGGTAT AAAACATTGT 1020 TGGAAGATGA TTTTGAATGT CAAACTGATG TAGAAGTCAT TGTGGGATCT CTGTACCTGA 1080 AGGATGCAGA GCAGACTGTT GAGGGCATTC CAAATGTAAC CGGAATTCAG CTTGATGTGA 1140 TGGATCGTGC CAATTTGTGT AAGTACATTT CACAGGTTGA CGTTGTTATA AGTTTGCTGC 1200 CCCCAAGTTG TCATATTATT GTAGCAAATG CTTGCATTGA GCTGAAAAAA CATCTTGTCA 1260 CTGCTAGCTA TGTTGATAGC TCCATGTCAA TGCTAAATGA TAAGGCTAAA GATGCTGGCA 1320 TAACAATTCT TGGAGAGATG GGCTTGGACC CAGGAATTGG TCATATGATG GCAATGAAGA 1380 TGATCAACCA AGCACATGTG AGGAAGGGGA AAATAAAGTC TTTCACTTCT TATTGTGGTG 1440 GACTTCCATC TCCTGAAGCT GCTAACAATC CATTAGCATA TAAATTCAGT TGGAATCCTG 1500 CAGGAGCCAT CCGAGCTGGG CGCAATCCTG CCACCTACAA ATGGGGTGGT GAAACTGTAC 1560 ATATTGATGG GGACGATCTT TATGATTCGG CTACAAGACT AAGGCTACCG GACCTTCCTG 1620 CTTTTGCTTT GGAATGTCTC CCAAATCGCA ATTCATTACT TTATGGGGAT TTGTATGGAA 1680 TAACTGAAGC ATCAACCATT TTCCGTGGAA CCCTCCGCTA TGAAGGATTT AGTGAGATCA 1740 TGGGGACACT GTCTAGGATT AGCTTATTTA ACAATGAAGC CCATTCGTTG CTAATGAATG 1800 GACAAAGACC AACTTTCAAA AAATTCTTAT TTGAACTTCT CAAAGTTGTT GGTGATAATC 1860 CAGATGAACT ATTGATAGGA GAGAATGACA TCATGGAGCA AATATTAATA CAAGGGCACT 1920 GCAAAGATCA AAGAACGGCA ATGGAGACAG CAAAAACAAT CATTTTCTTG GGACTTCTTG 1980 ACCAAACTGA AATCCCTGCT TCCTGCAAAA GTGCTTTTGA TGTTGCTTGT TTCCGCATGG 2040 AGGAGAGGTT ATCATACACC AGCACAGAAA AGGATATGGT GCTTTTGCAT CATGAAGTGG 2100 AAATAGAATA CCCAGATAGC CAAATTACAG AGAAGCATAG AGCTACTTTA CTTGAATTTG 2160 GGAAGACTCT TGATGAAAAA ACCACAACTG CCATGGCCCT TACTGTTGGT ATTCCAGCTG 2220 CTGTTGGAGC TTTGCTTTTA TTGACAAACA AAATTCAGAC AAGAGGAGTC TTAAGGCCTA 2280 TCGAACCTGA AGTATACAAT CCAGCACTGG ATATTATAGA AGCTTATGGG ATCAAGTTGA 2340 TAGAGAAGAC CGAGTAATTT GCATYTATGA ATTGATGTAT AGGTGTACAT TAATGTACAC 2400 CATGCAATGT TTGATTTGAA TAAGATAAAA TATAATAATT ACTGCAGTCA TGGAATTGCA 2460 ACTGCCATTC TATGCAACTG TCAGAAATGG ACCACACGGT ACCAGCATAG TTAAAACACT 2520 TAGGCAGATA CCAATTTCAA TTGCAGCAGT ACAATCCAAC CAGTTATGAA GTATGGTTCT 2580 AG 2582 (2) INFORMATION FOR SEQ ID NO:120: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3265 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3..3071 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 120: ATTGTGCCCG CCTTCTGCTA GGAGGAGGCA AGAACGGACC TCGAGTAAAC CGGATTATTG 60 TGCAGCCAAG CACAAGGAGG ATCCATCATG ACGCTCAGTA TGAGGATGCA GGATGCGAGA 120 TTTCAGAAGA CCTGTCAGAA TGCGGCCTTA TCATAGGCAT CAAACAACCC AAGCTGCAGA 180 TGATTCTTTC AGATAGAGCG TACGCTTTCT TTTCACACAC ACACAAAGCC CAAAAAGAGA 240 ATATGCCACT GTTAGACAAG ATCCTTGAAG AAAGGGTGTC CTTGTTTGAT TATGAGCTAA 300 TTGTTGGAGA TGATGGGAAA AGATCACTAG CATTTGGGAA ATTTGCTGGT AGAGCTGGAC 360 TGATAGATTT CTTACATGGT CTCGGACAGC GATATTTGAG CCTTGGATAC TCGACTCCAT 420 TTCTCTCTCT GGGACAATCT CATATGTATC CTTCGCTCGC TGCAGCCAAG GCTGCAGTCA 480 TTGTCGTTGC AGAAGAGATA GCAACATTTG GACTTCCATC CGGAATTTGT CCGATAGTGT 540 TTGTGTTCAC TGGAGTTGGA AACGTCTCTC AGGGTGCGCA GGAGATATTC AAGTTATTGC 600 CCCATACCTT TGTTGATGCT GAGAAGCTTC CCGAAATTTT TCAGGCCAGG AATCTGTCTA 660 AGCAATCTCA GTCGACCAAG AGAGTATTTC AACTTTATGG TTGTGTTGTG ACCTCTAGAG 720 ACATAGTTTC TCACAAGGAT CCCACCAGAC AATTTGACAA AGGTGACTAT TATGCTCATC 780 CAGAACACTA CACCCCTGTT TTTCATGAAA GAATTGCTCC ATATGCATCT GTCATCGTAA 840 ACTGTATGTA TTGGGAGAAG AGGTTTCCAC CATTACTAAA TATGGATCAG TTACAGCAAT 900 TGATGGAGAC TGGTTGTCCT TTAGTCGGCG TTTGTGACAT AACTTGTGAT ATTGGAGGTT 960 CCATTGAATT TATCAACAAG AGTACATCAA TAGAGAGGCC TTTCTTTCGG TATGATCCTT 1020 CTAAGAATTC ATACCATGAT GATATGGAAG GTGCCGGAGT GGTCTGCTTG GCTGTTGACA 1080 TTCTCCCTAC AGAATTCTCT AAAGAGGCCT CCCAACATTT TGGAAACATA CTATCTAGAC 1140 TTGTTGCTAG TTTGGCCTCA GTGAAGCAAC CGGCAGAACT TCCTTCCTAC TTGAGAAGAG 1200 CTTGCATTGC ACATGCTGGC AGATTAACTC CTTTGTATGA ATATATCCCT AGGATGAGAA 1260 ATACTATGAT AGATTTGGCA CCCGCAAAAA CAAATCCATT GCCTGACAAG AAGTATAGCA 1320 CCCTGGTATC TCTCAGTGGG CACCTATTTG ATAAGTTCCT TATAAATGAA GCTTTGGACA 1380 TCATTGAGAC AGCTGGAGGT TCATTTCACT TGGTTAGATG TGAAGTTGGA CAAAGCACGG 1440 ATGATATGTC ATACTCAGAG CTTGAAGTAG GAGCAGATGA TACTGCCACA TTGGATAAAA 1500 TTATTGATTC CTTGACTTCT TTAGCTAATG AACATGGTGG AGATCACGAT GCCGGGCAAG 1560 AAATTGAATT AGCTCTGAAG ATAGGAAAAG TCAATGAGTA TGAAACTGAC GTCACAATTG 1620 ATAAAGGAGG GCCAAAGATT TTAATTCTTG GAGCTGGAAG AGTCTGTCGG CCAGCTGCTG 1680 AGTTTCTGGC ATCTTACCCA GACATATGTA CCTATGGTGT TGATGACCAT GATGCAGATC 1740 AAATTCATGT TATCGTGGCA TCTTTGTATC AAAAAGATGC AGAAGAGACA GTTGATGGTA 1800 TTGAAAATAC AACTGCTACC CAGCTTGATG TTGCTGATAT TGGAAGCCTT TCAGATCTTG 1860 TTTCTCAGGT TGAGGTTGTA ATTAGCTTGC TGCCTGCTAG TTTTCATGCT GCCATTGCAG 1920 GAGTATGCAT AGAGTTGAAG AAGCACATGG TAACGGCAAG CTATGTTGAT GAATCCATGT 1980 CAAACTTGAG CCAAGCTGCC AAAGATGCAG GTGTAACTAT ACTTTGTGAA ATGGGCCTAG 2040 ATCCTGGCAT AGATCACTTG ATGTCAATGA AGATGATTGA TGAAGCTCAT GCACGAAAGG 2100 GAAAAATAAA GGCATTTACA TCTTACTGTG GTGGATTGCC ATCTCCAGCT GCAGCAAACA 2160 ATCCGCTTGC CTATAAATTC AGTTGGAACC CAGCTGGTGC ACTCCGGTCA GGGAAAAATC 2220 CTGCAGTCTA CAAATTTCTT GGTGAGACGA TCCATGTAGA TGGTCATAAC TTGTATGAAT 2280 CAGCAAAGAG GCTCAGACTA CGAGAGCTTC CAGCTTTTGC TCTGGAACAC TTGCCAAATC 2340 GGAATTCCTT GATATATGGT GACCTTTATG GTATCTCCAA AGAAGCATCC ACCATATATA 2400 GGGCTACTYT TCGTTACGAA GGTTTTAGTG AGATTATGGT AACCCTTTCC AAAACTGGGT 2460 TCTTTGATGC TGCAAATCAT CCACTGCTGC AAGATACTAG TCGTCCAACA TATAAGGGTT 2520 TCCTTGATGA ACTACTGAAT AATATCTCCA CAATTAACAC GGACTTAGAT ATTGAAGCTT 2580 CTGGTGGATA CGATGATGAC CTGATTGCCA GACTGTTGAA GCTCGGGTGT TGCAAAAATA 2640 AGGAAATAGC TGTTAAGACA GTCAAAACCA TCAAGTTCTT GGGACTACAT GAAGAGACTC 2700 AAATACCTAA GGGTTGTTCG AGCCCATTTG ATGTGATTTG CCAGCGAATG GAACAGAGGA 2760 TGGCCTATGG CCACAATGAG CAAGACATGG TACTGCTCCA CCACGAAGTC GAGGTGGAAT 2820 ACCCGGACGG GCAACCCGCC GAAAAGCACC AAGCGACGCT ACTGGAGTTC GGGAAGGTTG 2880 AAAATGGCAG GTCCACCACT GCCATGGCGC TGACCGTCGG CATTCCAGCA GCAATAGGGG 2940 CCCTGCTATT GCTAAAGAAT AAGGTCCAGA CGAAAGGAGT GATCAGGCCT CTGCAACCGG 3000 AAATCTACGT TCCAGCATTG GAGATCTTGG AGTCGTCGGG CATCAAGCTG GTTGAGAAAG 3060 TGGAGACTTG AAAGTTCCCT GATACACAGA TAAAGATAGT ATGATATAGC AGGGCACATG 3120 TATCTTTTGT ATTAACTCCG TTCTGGAATA TATATTTGTG AACTAAAATG TGACAAATAA 3180 AAAGAACGGG TGGAGTATAT TGTAAGAGAC GGCAAAGAAA CCTCTGTATA TATGACCTGT 3240 CGATATCAAA TAATGCCGAT CAGTT 3265 (2) INFORMATION FOR SEQ ID NO: 121: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 784 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Glycine max (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 121: Glu Pro Lys Asp His Val He Val Phe Asp Lys Ala Asp Tyr Tyr Ser 1 5 10 15 His Pro Glu His Tyr Asn Pro Thr Phe His Glu Lys He Ala Pro Tyr 20 25 30 Ala Ser Val He Val Asn Cys Met Tyr Trp Glu Lys Arg Phe Pro Gin 35 40 45 Leu Pro Ser Tyr Lys Gin Met Gin Asp Leu Met Gly Arg Gly Ser Pro 50 55 60 Leu Val Gly He Ala Asp He Thr Cys Asp He Gly Gly Ser He Glu 65 70 75 80 Phe Val Asn Arg Gly Thr Ser He Asp Ser Pro Phe Phe Arg Tyr Asp 85 90 95 Pro Leu Thr Asn Ser Tyr His Asp Asp Met Glu Gly Asn Gly Val He 100 105 110 Cys Leu Ala Val Asp He Leu Pro Thr Glu Phe Ala Lys Glu Ala Ser 115 120 125 Gin His Phe Gly Asn He Leu Ser Gin Phe Val Val Asn Leu Ala Ser 130 135 140 Ala Thr Asp He Thr Lys Leu Pro Ala His Leu Arg Arg Ala Cys He 145 150 155 160 Ala His Lys Gly Val Leu Thr Ser Leu Tyr Asp Tyr He Pro Arg Met 165 170 175 Arg Ser Ser Asp Ser Glu Glu Val Ser Glu Asn Ala Glu Asn Ser Leu 180 185 190 Ser Asn Lys Arg Lys Tyr Asn He Ser Val Ser Leu Ser Gly His Leu 195 200 205 Phe Asp Gin Phe Leu He Asn Glu Ala Leu Asp He He Glu Ala Ala 210 215 220 Gly Gly Ser Phe His Leu Val Asn Cys His Val Gly Gin Ser He Glu 225 230 235 240 Ala Val Ser Phe Ser Glu Leu Glu Val Gly Ala Asp Asn Arg Ala Val 245 250 255 Leu Asp Gin He He Asp Ser Leu Thr Ala He Ala Ser Pro Thr Glu 260 265 270 His Asp Arg Phe Ser Asn Gin Asp Ser Ser Lys He Ser Leu Lys Leu 275 280 285 Gly Lys Val Glu Glu Asn Gly He Glu Lys Glu Ser Asp Pro Arg Lys 290 295 300 Lys Ala Ala Val Leu He Leu Gly Ala Gly Arg Val Cys Gin Pro Ala 305 310 315 320 Ala Glu Met Leu Ser Ser Phe Gly Arg Pro Ser Ser Ser Gin Trp Tyr 325 330 335 Lys Thr Leu Leu Glu Asp Asp Phe Glu Cys Gin Thr Asp Val Glu Val 340 345 350 He Val Gly Ser Leu Tyr Leu Lys Asp Ala Glu Gin Thr Val Glu Gly 355 360 365 He Pro Asn Val Thr Gly He Gin Leu Asp Val Met Asp Arg Ala Asn 370 375 380 Leu Cys Lys Tyr He Ser Gin Val Asp Val Val He Ser Leu Leu Pro 385 390 395 400 Pro Ser Cys His He He Val Ala Asn Ala Cys He Glu Leu Lys Lys 405 410 415 His Leu Val Thr Ala Ser Tyr Val Asp Ser Ser Met Ser Met Leu Asn 420 425 430 Asp Lys Ala Lys Asp Ala Gly He Thr He Leu Gly Glu Met Gly Leu 435 440 445 Asp Pro Gly He Gly His Met Met Ala Met Lys Met He Asn Gin Ala 450 455 460 His Val Arg Lys Gly Lys He Lys Ser Phe Thr Ser Tyr Cys Gly Gly 465 470 475 480 Leu Pro Ser Pro Glu Ala Ala Asn Asn Pro Leu Ala Tyr Lys Phe Ser 485 490 495 Trp Asn Pro Ala Gly Ala He Arg Ala Gly Arg Asn Pro Ala Thr Tyr 500 505 510 Lys Trp Gly Gly Glu Thr Val His He Asp Gly Asp Asp Leu Tyr Asp 515 520 525 Ser Ala Thr Arg Leu Arg Leu Pro Asp Leu Pro Ala Phe Ala Leu Glu 530 535 540 Cys Leu Pro Asn Arg Asn Ser Leu Leu Tyr Gly Asp Leu Tyr Gly He 545 550 555 560 Thr Glu Ala Ser Thr He Phe Arg Gly Thr Leu Arg Tyr Glu Gly Phe 565 570 575 Ser Glu He Met Gly Thr Leu Ser Arg He Ser Leu Phe Asn Asn Glu 580 585 590 Ala His Ser Leu Leu Met Asn Gly Gin Arg Pro Thr Phe Lys Lys Phe 595 600 605 Leu Phe Glu Leu Leu Lys Val Val Gly Asp Asn Pro Asp Glu Leu Leu 610 615 620 He Gly Glu Asn Asp He Met Glu Gin He Leu He Gin Gly His Cys 625 630 635 640 Lys Asp Gin Arg Thr Ala Met Glu Thr Ala Lys Thr He He Phe Leu 645 650 655 Gly Leu Leu Asp Gin Thr Glu He Pro Ala Ser Cys Lys Ser Ala Phe 660 665 670 Asp Val Ala Cys Phe Arg Met Glu Glu Arg Leu Ser Tyr Thr Ser Thr 675 680 685 Glu Lys Asp Met Val Leu Leu His His Glu Val Glu He Glu Tyr Pro 690 695 700 Asp Ser Gin He Thr Glu Lys His Arg Ala Thr Leu Leu Glu Phe Gly 705 710 715 720 Lys Thr Leu Asp Glu Lys Thr Thr Thr Ala Met Ala Leu Thr Val Gly 725 730 735 He Pro Ala Ala Val Gly Ala Leu Leu Leu Leu Thr Asn Lys He Gin 740 745 750 Thr Arg Gly Val Leu Arg Pro He Glu Pro Glu Val Tyr Asn Pro Ala 755 760 765 Leu Asp He He Glu Ala Tyr Gly He Lys Leu He Glu Lys Thr Glu 770 775 780 (2) INFORMATION FOR SEQ ID NO: 122: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1022 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (iii) HYPOTHETICAL: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 122: Cys Ala Arg Leu Leu Leu Gly Gly Gly Lys Asn Gly Pro Arg Val Asn 1 5 10 15 Arg He He Val Gin Pro Ser Thr Arg Arg He His His Asp Ala Gin 20 25 30 Tyr Glu Asp Ala Gly Cys Glu He Ser Glu Asp Leu Ser Glu Cys Gly 35 40 45 Leu He He Gly He Lys Gin Pro Lys Leu Gin Met He Leu Ser Asp 50 55 60 Arg Ala Tyr Ala Phe Phe Ser His Thr His Lys Ala Gin Lys Glu Asn 65 70 75 80 Met Pro Leu Leu Asp Lys He Leu Glu Glu Arg Val Ser Leu Phe Asp 85 90 95 Tyr Glu Leu He Val Gly Asp Asp Gly Lys Arg Ser Leu Ala Phe Gly 100 105 110 Lys Phe Ala Gly Arg Ala Gly Leu He Asp Phe Leu His Gly Leu Gly 115 120 125 Gin Arg Tyr Leu Ser Leu Gly Tyr Ser Thr Pro Phe Leu Ser Leu Gly 130 135 140 Gin Ser His Met Tyr Pro Ser Leu Ala Ala Ala Lys Ala Ala Val He 145 150 155 160 Val Val Ala Glu Glu He Ala Thr Phe Gly Leu Pro Ser Gly He Cys 165 170 175 Pro He Val Phe Val Phe Thr Gly Val Gly Asn Val Ser Gin Gly Ala 180 185 190 Gin Glu He Phe Lys Leu Leu Pro His Thr Phe Val Asp Ala Glu Lys 195 200 205 Leu Pro Glu He Phe Gin Ala Arg Asn Leu Ser Lys Gin Ser Gin Ser 210 215 220 Thr Lys Arg Val Phe Gin Leu Tyr Gly Cys Val Val Thr Ser Arg Asp 225 230 235 240 He Val Ser His Lys Asp Pro Thr Arg Gin Phe Asp Lys Gly Asp Tyr 245 250 255 Tyr Ala His Pro Glu His Tyr Thr Pro Val Phe His Glu Arg He Ala 260 265 270 Pro Tyr Ala Ser Val He Val Asn Cys Met Tyr Trp Glu Lys Arg Phe 275 280 285 Pro Pro Leu Leu Asn Met Asp Gin Leu Gin Gin Leu Met Glu Thr Gly 290 295 300 Cys Pro Leu Val Gly Val Cys Asp He Thr Cys Asp He Gly Gly Ser 305 310 315 320 He Glu Phe He Asn Lys Ser Thr Ser He Glu Arg Pro Phe Phe Arg 325 330 335 Tyr Asp Pro Ser Lys Asn Ser Tyr His Asp Asp Met Glu Gly Ala Gly 340 345 350 Val Val Cys Leu Ala Val Asp He Leu Pro Thr Glu Phe Ser Lys Glu 355 360 365 Ala Ser Gin His Phe Gly Asn He Leu Ser Arg Leu Val Ala Ser Leu 370 375 380 Ala Ser Val Lys Gin Pro Ala Glu Leu Pro Ser Tyr Leu Arg Arg Ala 385 390 395 400 Cys He Ala His Ala Gly Arg Leu Thr Pro Leu Tyr Glu Tyr He Pro 405 410 415 Arg Met Arg Asn Thr Met He Asp Leu Ala Pro Ala Lys Thr Asn Pro 420 425 430 Leu Pro Asp Lys Lys Tyr Ser Thr Leu Val Ser Leu Ser Gly His Leu 435 440 445 Phe Asp Lys Phe Leu He Asn Glu Ala Leu Asp He He Glu Thr Ala 450 455 460 Gly Gly Ser Phe His Leu Val Arg Cys Glu Val Gly Gin Ser Thr Asp 465 470 475 480 Asp Met Ser Tyr Ser Glu Leu Glu Val Gly Ala Asp Asp Thr Ala Thr 485 490 495 Leu Asp Lys He He Asp Ser Leu Thr Ser Leu Ala Asn Glu His Gly 500 505 510 Gly Asp His Asp Ala Gly Gin Glu He Glu Leu Ala Leu Lys He Gly 515 520 525 Lys Val Asn Glu Tyr Glu Thr Asp Val Thr He Asp Lys Gly Gly Pro 530 535 540 Lys He Leu He Leu Gly Ala Gly Arg Val Cys Arg Pro Ala Ala Glu 545 550 555 560 Phe Leu Ala Ser Tyr Pro Asp He Cys Thr Tyr Gly Val Asp Asp His 565 570 575 Asp Ala Asp Gin He His Val He Val Ala Ser Leu Tyr Gin Lys Asp 580 585 590 Ala Glu Glu Thr Val Asp Gly He Glu Asn Thr Thr Ala Thr Gin Leu 595 600 605 Asp Val Ala Asp He Gly Ser Leu Ser Asp Leu Val Ser Gin Val Glu 610 615 620 Val Val He Ser Leu Leu Pro Ala Ser Phe His Ala Ala He Ala Gly 625 630 635 640 Val Cys He Glu Leu Lys Lys His Met Val Thr Ala Ser Tyr Val Asp 645 650 655 Glu Ser Met Ser Asn Leu Ser Gin Ala Ala Lys Asp Ala Gly Val Thr 660 665 670 He Leu Cys Glu Met Gly Leu Asp Pro Gly He Asp His Leu Met Ser 675 680 685 Met Lys Met He Asp Glu Ala His Ala Arg Lys Gly Lys He Lys Ala 690 695 700 Phe Thr Ser Tyr Cys Gly Gly Leu Pro Ser Pro Ala Ala Ala Asn Asn 705 710 715 720 Pro Leu Ala Tyr Lys Phe Ser Trp Asn Pro Ala Gly Ala Leu Arg Ser 725 730 735 Gly Lys Asn Pro Ala Val Tyr Lys Phe Leu Gly Glu Thr He His Val 740 745 750 Asp Gly His Asn Leu Tyr Glu Ser Ala Lys Arg Leu Arg Leu Arg Glu 755 760 765 Leu Pro Ala Phe Ala Leu Glu His Leu Pro Asn Arg Asn Ser Leu He 770 775 780 Tyr Gly Asp Leu Tyr Gly He Ser Lys Glu Ala Ser Thr He Tyr Arg 785 790 795 800 Ala Thr Xaa Arg Tyr Glu Gly Phe Ser Glu He Met Val Thr Leu Ser 805 810 815 Lys Thr Gly Phe Phe Asp Ala Ala Asn His Pro Leu Leu Gin Asp Thr 820 825 830 Ser Arg Pro Thr Tyr Lys Gly Phe Leu Asp Glu Leu Leu Asn Asn He 835 840 845 Ser Thr He Asn Thr Asp Leu Asp He Glu Ala Ser Gly Gly Tyr Asp 850 855 860 Asp Asp Leu He Ala Arg Leu Leu Lys Leu Gly Cys Cys Lys Asn Lys 865 870 875 880 Glu He Ala Val Lys Thr Val Lys Thr He Lys Phe Leu Gly Leu His 885 890 895 Glu Glu Thr Gin He Pro Lys Gly Cys Ser Ser Pro Phe Asp Val He 900 905 910 Cys Gin Arg Met Glu Gin Arg Met Ala Tyr Gly His Asn Glu Gin Asp 915 920 925 Met Val Leu Leu His His Glu Val Glu Val Glu Tyr Pro Asp Gly Gin 930 935 940 Pro Ala Glu Lys His Gin Ala Thr Leu Leu Glu Phe Gly Lys Val Glu 945 950 955 960 Asn Gly Arg Ser Thr Thr Ala Met Ala Leu Thr Val Gly He Pro Ala 965 970 975 Ala He Gly Ala Leu Leu Leu Leu Lys Asn Lys Val Gin Thr Lys Gly 980 985 990 Val He Arg Pro Leu Gin Pro Glu He Tyr Val Pro Ala Leu Glu He 995 1000 1005 Leu Glu Ser Ser Gly He Lys Leu Val Glu Lys Val Glu Thr 1010 1015 1020 (2) INFORMATION FOR SEQ ID NO: 123: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1908 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 3..1908 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 123: ATTGTGCCCG CCTTCTGCTA GGAGGAGGCA AGAACGGACC TCGAGTAAAC CGGATTATTG 60 TGCAGCCAAG CACAAGGAGG ATCCATCATG ACGCTCAGTA TGAGGATGCA GGATGCGAGA 120 TTTCAGAAGA CCTGTCAGAA TGCGGCCTTA TCATAGGCAT CAAACAACCC AAGCTGCAGA 180 TGATTCTTTC AGATAGAGCG TACGCTTTCT TTTCACACAC ACACAAAGCC CAAAAAGAGA 240 ATATGCCACT GTTAGACAAG ATCCTTGAAG AAAGGGTGTC CTTGTTTGAT TATGAGCTAA 300 TTGTTGGAGA TGATGGGAAA AGATCACTAG CATTTGGGAA ATTTGCTGGT AGAGCTGGAC 360 TGATAGATTT CTTACATGGT CTCGGACAGC GATATTTGAG CCTTGGATAC TCGACTCCAT 420 TTCTCTCTCT GGGACAATCT CATATGTATC CTTCGCTCGC TGCAGCCAAG GCTGCAGTCA 480 TTGTCGTTGC AGAAGAGATA GCAACATTTG GACTTCCATC CGGAATTTGT CCGATAGTGT 540 TTGTGTTCAC TGGAGTTGGA AACGTCTCTC AGGGTGCGCA GGAGATATTC AAGTTATTGC 600 CCCATACCTT TGTTGATGCT GAGAAGCTTC CCGAAATTTT TCAGGCCAGG AATCTGTCTA 660 AGCAATCTCA GTCGACCAAG AGAGTATTTC AACTTTATGG TTGTGTTGTG ACCTCTAGAG 720 ACATAGTTTC TCACAAGGAT CCCACCAGAC AATTTGACAA AGGTGACTAT TATGCTCATC 780 CAGAACACTA CACCCCTGTT TTTCATGAAA GAATTGCTCC ATATGCATCT GTCATCGTAA 840 ACTGTATGTA TTGGGAGAAG AGGTTTCCAC CATTACTAAA TATGGATCAG TTACAGCAAT 900 TGATGGAGAC TGGTTGTCCT TTAGTCGGCG TTTGTGACAT AACTTGTGAT ATTGGAGGTT 960 CCATTGAATT TATCAACAAG AGTACATCAA TAGAGAGGCC TTTCTTTCGG TATGATCCTT 1020 CTAAGAATTC ATACCATGAT GATATGGAAG GTGCCGGAGT GGTCTGCTTG GCTGTTGACA 1080 TTCTCCCTAC AGAATTCTCT AAAGAGGCCT CCCAACATTT TGGAAACATA CTATCTAGAC 1140 TTGTTGCTAG TTTGGCCTCA GTGAAGCAAC CGGCAGAACT TCCTTCCTAC TTGAGAAGAG 1200 CTTGCATTGC ACATGCTGGC AGATTAACTC CTTTGTATGA ATATATCCCT AGGATGAGAA 1260 ATACTATGAT AGATTTGGCA CCCGCAAAAA CAAATCCATT GCCTGACAAG AAGTATAGCA 1320 CCCTGGTATC TCTCAGTGGG CACCTATTTG ATAAGTTCCT TATAAATGAA GCTTTGGACA 1380 TCATTGAGAC AGCTGGAGGT TCATTTCACT TGGTTAGATG TGAAGTTGGA CAAAGCACGG 1440 ATGATATGTC ATACTCAGAG CTTGAAGTAG GAGCAGATGA TACTGCCACA TTGGATAAAA 1500 TTATTGATTC CTTGACTTCT TTAGCTAATG AACATGGTGG AGATCACGAT GCCGGGCAAG 1560 AAATTGAATT AGCTCTGAAG ATAGGAAAAG TCAATGAGTA TGAAACTGAC GTCACAATTG 1620 ATAAAGGAGG GCCAAAGATT TTAATTCTTG GAGCTGGAAG AGTCTGTCGG CCAGCTGCTG 1680 AGTTTCTGGC ATCTTACCCA GACATATGTA CCTATGGTGT TGATGACCAT GATGCAGATC 1740 AAATTCATGT TATCGTGGCA TCTTTGTATC AAAAAGATGC AGAAGAGACA GTTGATGGTA 1800 TTGAAAATAC AACTGCTACC CAGCTTGATG TTGCTGATAT TGGAAGCCTT TCAGATCTTG 1860 TTTCTCAGGT TGAGGTTGTA ATTAGCTTGC TGCCTGCTAG TTTTCATG 1908 (2) INFORMATION FOR SEQ ID NO: 124: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 640 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Zea mays (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 124: Cys Ala Arg Leu Leu Leu Gly Gly Gly Lys Asn Gly Pro Arg Val Asn 1 5 10 15 Arg He He Val Gin Pro Ser Thr Arg Arg He His His Asp Ala Gin 20 25 30 Tyr Glu Asp Ala Gly Cys Glu He Ser Glu Asp Leu Ser Glu Cys Gly 35 40 45 Leu He He Gly He Lys Gin Pro Lys Leu Gin Met He Leu Ser Asp 50 55 60 Arg Ala Tyr Ala Phe Phe Ser His Thr His Lys Ala Gin Lys Glu Asn 65 70 75 80 Met Pro Leu Leu Asp Lys He Leu Glu Glu Arg Val Ser Leu Phe Asp 85 90 95 Tyr Glu Leu He Val Gly Asp Asp Gly Lys Arg Ser Leu Ala Phe Gly 100 105 110 Lys Phe Ala Gly Arg Ala Gly Leu He Asp Phe Leu His Gly Leu Gly 115 120 125 Gin Arg Tyr Leu Ser Leu Gly Tyr Ser Thr Pro Phe Leu Ser Leu Gly 130 135 140 Gin Ser His Met Tyr Pro Ser Leu Ala Ala Ala Lys Ala Ala Val He 145 150 155 160 Val Val Ala Glu Glu He Ala Thr Phe Gly Leu Pro Ser Gly He Cys 165 170 175 Pro He Val Phe Val Phe Thr Gly Val Gly Asn Val Ser Gin Gly Ala 180 185 190 Gin Glu He Phe Lys Leu Leu Pro His Thr Phe Val Asp Ala Glu Lys 195 200 205 Leu Pro Glu He Phe Gin Ala Arg Asn Leu Ser Lys Gin Ser Gin Ser 210 215 220 Thr Lys Arg Val Phe Gin Leu Tyr Gly Cys Val Val Thr Ser Arg Asp 225 230 235 240 He Val Ser His Lys Asp Pro Thr Arg Gin Phe Asp Lys Gly Asp Tyr 245 250 255 Tyr Ala His Pro Glu His Tyr Thr Pro Val Phe His Glu Arg He Ala 260 265 270 Pro Tyr Ala Ser Val He Val Asn Cys Met Tyr Trp Glu Lys Arg Phe 275 280 285 Pro Pro Leu Leu Asn Met Asp Gin Leu Gin Gin Leu Met Glu Thr Gly 290 295 300 Cys Pro Leu Val Gly Val Cys Asp He Thr Cys Asp He Gly Gly Ser 305 310 315 320 He Glu Phe He Asn Lys Ser Thr Ser He Glu Arg Pro Phe Phe Arg 325 330 335 Tyr Asp Pro Ser Lys Asn Ser Tyr His Asp Asp Met Glu Gly Ala Gly 340 345 350 Val Val Cys Leu Ala Val Asp He Leu Pro Thr Glu Phe Ser Lys Glu 355 360 365 Ala Ser Gin His Phe Gly Asn He Leu Ser Arg Leu Val Ala Ser Leu 370 375 380 Ala Ser Val Lys Gin Pro Ala Glu Leu Pro Ser Tyr Leu Arg Arg Ala 385 390 395 400 Cys He Ala His Ala Gly Arg Leu Thr Pro Leu Tyr Glu Tyr He Pro 405 410 415 Arg Met Arg Asn Thr Met He Asp Leu Ala Pro Ala Lys Thr Asn Pro 420 425 430 Leu Pro Asp Lys Lys Tyr Ser Thr Leu Val Ser Leu Ser Gly His Leu 435 440 445 Phe Asp Lys Phe Leu He Asn Glu Ala Leu Asp He He Glu Thr Ala 450 455 460 Gly Gly Ser Phe His Leu Val Arg Cys Glu Val Gly Gin Ser Thr Asp 465 470 475 480 Asp Met Ser Tyr Ser Glu Leu Glu Val Gly Ala Asp Asp Thr Ala Thr 485 490 495 Leu Asp Lys He He Asp Ser Leu Thr Ser Leu Ala Asn Glu His Gly 500 505 510 Gly Asp His Asp Ala Gly Gin Glu He Glu Leu Ala Leu Lys He Gly 515 520 525 Lys Val Asn Glu Tyr Glu Thr Asp Val Thr He Asp Lys Gly Gly Pro 530 535 540 Lys He Leu He Leu Gly Ala Gly Arg Val Cys Arg Pro Ala Ala Glu 545 550 555 560 Phe Leu Ala Ser Tyr Pro Asp He Cys Thr Tyr Gly Val Asp Asp His 565 570 575 Asp Ala Asp Gin He His Val He Val Ala Ser Leu Tyr Gin Lys Asp 580 585 590 Ala Glu Glu Thr Val Asp Gly He Glu Asn Thr Thr Ala Thr Gin Leu 595 600 605 Asp Val Ala Asp He Gly Ser Leu Ser Asp Leu Val Ser Gin Val Glu 610 615 620 Val Val He Ser Leu Leu Pro Ala Ser Phe His Ala Ala He Ala Gly 625 630 635 640 (2) INFORMATION FOR SEQ ID NO: 125: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 720 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Oryza sativa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 2..720 (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 215 (D) OTHER INFORMATION: /label= unknown (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 678 (D) OTHER INFORMATION: /label= unknown (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 125: GTTTAAACAT CTTTCCAATC TTGTTTCTCA GGTTGAAGTA GTAGTTAGCT TGCTGCCTGC 60 CAGTTTTCAT GCTGCCATAG CAAGAGTATG CATAGAGATG AAGAAGCACT TGGTCACTGC 120 AAGCTATGTT GATGAGTCCA TGTCAAAGTT GGAACAATCT GCAGAAGGTG CTGGTGTAAC 180 TATTCTCTGT GAAATGGGCC TGGATCCTGG CATANATCAT ATGATGTCAA TGAAGATGAT 240 TGACGAAGCA CATTCACGGA AGGGGAAAAT AAAGTCATTT ACATCCTTTT GTGGAGGACT 300 TCCATCTCCA GCTTCTGCAA ACAATCCACT TGCTTATAAG TTCAGTTGGA GTCCAGCTGG 360 TGCCATCCGT GCAGGGAGAA ACCCTGCTGT CTACAAATTT CATGGAGAAA TCATCCATGT 420 AGATGGTGAT AAATTGTATG AATCCGCAAA GAGGCTCAGA TTACMAGAAC TTCCAGCTTT 480 TGCACTGGAA CACTTGCCAA ACCGGAATTC CTTGATGTAT GGAGACCTGT ATGGGATCTC 540 CAAAGAAGCA TCTACTGTGT ACAGGGCTAC TCTTCGTTAT GAAGGATTTA ATGAGATAAT 600 GGCAACCTTC GCGAAAATTG GGTTTTTTGA TGCTGCAAGT CATCCACTGT TGCAACAAAC 660 TACTCGCCCT ACATACANGG ATTTCCTGTT GAACCCTCAA TGCTTGTACA TCTCCAAAAC 720 (2) INFORMATION FOR SEQ ID NO: 126: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 239 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Oryza sativa (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 126: Phe Lys His Leu Ser Asn Leu Val Ser Gin Val Glu Val Val Val Ser 1 5 10 15 Leu Leu Pro Ala Ser Phe His Ala Ala He Ala Arg Val Cys He Glu 20 25 30 Met Lys Lys His Leu Val Thr Ala Ser Tyr Val Asp Glu Ser Met Ser 35 40 45 Lys Leu Glu Gin Ser Ala Glu Gly Ala Gly Val Thr He Leu Cys Glu 50 55 60 Met Gly Leu Asp Pro Gly He Xaa His Met Met Ser Met Lys Met He 65 70 75 80 Asp Glu Ala His Ser Arg Lys Gly Lys He Lys Ser Phe Thr Ser Phe 85 90 95 Cys Gly Gly Leu Pro Ser Pro Ala Ser Ala Asn Asn Pro Leu Ala Tyr 100 105 110 Lys Phe Ser Trp Ser Pro Ala Gly Ala He Arg Ala Gly Arg Asn Pro 115 120 125 Ala Val Tyr Lys Phe His Gly Glu He He His Val Asp Gly Asp Lys 130 135 140 Leu Tyr Glu Ser Ala Lys Arg Leu Arg Leu Xaa Glu Leu Pro Ala Phe 145 150 155 160 Ala Leu Glu His Leu Pro Asn Arg Asn Ser Leu Met Tyr Gly Asp Leu 165 170 175 Tyr Gly He Ser Lys Glu Ala Ser Thr Val Tyr Arg Ala Thr Leu Arg 180 185 190 Tyr Glu Gly Phe Asn Glu He Met Ala Thr Phe Ala Lys He Gly Phe 195 200 205 Phe Asp Ala Ala Ser His Pro Leu Leu Gin Gin Thr Thr Arg Pro Thr 210 215 220 Tyr Xaa Asp Phe Leu Leu Asn Pro Gin Cys Leu Tyr He Ser Lys 225 230 235 (2) INFORMATION FOR SEQ ID NO: 127: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 308 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Oryza sativa (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..129 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 127: CTGCTGTTGC TCCAGAACAA GATCCAAAAG AAAGGAGTGA TCAGGCCTCT GGAACCTGAA 60 ATTTACATTC CAGCGTTGGA GATCTTGGAG TCATCGGGTA TCAAGCTGGC GGAGAGAGTG 120 GAGACCTGAG AATCGGACCC AATATGTATA ATGTAGCATG GTGGTAGCTT CTCTATATAT 180 ATGCTTCAGT GAATAATTGA TTTGCCGTTG TGTGGTAATT AAGCAATGCC CGCTAATAAA 240 TTGTACCGTA GAAGTCCTTC TATGTACATC CGTATCAAAA AATAAAAAAA GCATCGATTA 300 GCTTGAAT 308 (2) INFORMATION FOR SEQ ID NO: 128: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 42 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Oryza sativa (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 128: Leu Leu Leu Leu Gin Asn Lys He Gin Lys Lys Gly Val He Arg Pro 1 5 10 15 Leu Glu Pro Glu He Tyr He Pro Ala Leu Glu He Leu Glu Ser Ser 20 25 30 Gly He Lys Leu Ala Glu Arg Val Glu Thr 35 40 (2) INFORMATION FOR SEQ ID NO: 129: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 429 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA to mRNA (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Triticum aestivum (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..252 (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 172 (D) OTHER INFORMATION: /label= unknown (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 186 (D) OTHER INFORMATION: /label= unknown (ix) FEATURE: (A) NAME/KEY: misc_feature (B) LOCATION: 331 ( D) OTHER INFORMATION : /label= unknown (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 129: TACCCCGACG GGGACCCCAC CGAGAAGCAC CAAGCGACGC TGCTGGAGTT CGGAAAGACC 60 GAGAACGGCA GGCCCACCAC CGCCATGGCC CTCACCGTTG GGGTACCGGC AGCGATAGGA 120 GCCCTGCTCT TGCTCCAGAA CAAGGTCCAG AGGAAAGGGG TGATCCGGCC TNTGGAACCG 180 GAGATNTACA TCCCTGCGCT GGAGATCTTG GAAGCGTCGG GCATCAAGCT GATCGAGAGA 240 GTGGAGACCT GAGGATGTCA GGATGGGATG AGAATCTATC GAGTATATAT GCTGCAGCAA 300 CAGAGGCAGT GAGTAAATAA AATGATGATT NTCGCCGTTG TAAGTAAAAT GAGTGGACTG 360 TATGTATGTA TGTGACTATC TATTGTACTA CATATATACC AAATCTGTCG CCGGTTGATT 420 CTGTTGGTG 429 (2) INFORMATION FOR SEQ ID NO: 130: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 83 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (iii) HYPOTHETICAL: NO (iv) ANTI-SENSE: NO (vi) ORIGINAL SOURCE: (A) ORGANISM: Triticum aestivum (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 130: Tyr Pro Asp Gly Asp Pro Thr Glu Lys His Gin Ala Thr Leu Leu Glu 1 5 10 15 Phe Gly Lys Thr Glu Asn Gly Arg Pro Thr Thr Ala Met Ala Leu Thr 20 25 30 Val Gly Val Pro Ala Ala He Gly Ala Leu Leu Leu Leu Gin Asn Lys 35 40 45 Val Gin Arg Lys Gly Val He Arg Pro Xaa Glu Pro Glu Xaa Tyr He 50 55 60 Pro Ala Leu Glu He Leu Glu Ala Ser Gly He Lys Leu He Glu Arg 65 70 75 80 Val Glu Thr (2) INFORMATION FOR SEQ ID NO: 131: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1449 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 131: ATGACGAAAA AATCAGGTGT TTTGATTCTT GGTGCTGGAC GTGTGTGTCG CCCAGCTGCT 60 GATTTCCTAG CTTCAGTTAG AACCATTTCG TCACAGCAAT GGTACAAAAC ATATTTCGGA 120 GCAGACTCTG AAGAGAAAAC AGATGTTCAT GTGATTGTCG CGTCTCTGTA TCTTAAGGAT 180 GCCAAAGAGA CGGTTGAAGG TATTTCAGAT GTAGAAGCAG TTCGGCTAGA TGTATCTGAT 240 AGTGAAAGTC TCCTTAAGTA TGTTTCTCAG GTTGATGTTG TCCTAAGTTT ATTACCTGCA 300 AGTTGTCATG CTGTTGTAGC AAAGACATGC ATTGAGCTGA AGAAGCATCT CGTCACTGCT 360 AGCTATGTTG ATGATGAAAC GTCCATGTTA CATGAGAAGG CTAAGAGTGC TGGGATAACG 420 ATTCTAGGCG AAATGGGACT GGACCCTGGA ATCGATCACA TGATGGCGAT GAAAATGATC 480 AACGATGCTC ATATCAAAAA AGGGAAAGTG AAGTCTTTTA CCTCTTATTG TGGAGGGCTT 540 CCCTCTCCTG CTGCAGCAAA TAATCCATTA GCATATAAAT TTAGCTGGAA CCCTGCTGGA 600 GCAATTCGAG CTGGTCAAAA CCCCGCCAAA TACAAAAGCA ACGGCGACAT AATACATGTT 660 GATGGGAAGA ATCTCTATGA TTCCGCGGCA AGATTCCGAG TACCTAATCT TCCAGCTTTT 720 GCATTGGAGT GTTTTCCAAA TCGTGACTCC TTGGTTTACG GGGAACATTA TGGCATCGAG 780 AGCGAAGCAA CAACGATATT TCGTGGAACA CTCAGATATG AAGGGTTTAG TATGATAATG 840 GCAACACTTT CGAAACTTGG ATTCTTTGAC AGTGAAGCAA ATCAAGTACT CTCCACTGGA 900 AAGAGGATTA CGTTTGGTGC TCTTTTAAGT AACATTCTAA ATAAGGATGC AGACAATGAA 960 TCAGAGCCCC TAGCGGGAGA AGAAGAGATA AGCAAGAGAA TTATCAAGCT TGGACATTCC 1020 AAGGAGACTG CAGCCAAAGC TGCCAAAACA ATTGTATTCT TGGGGTTCAA CGAAGAGAGG 1080 GAGGTTCCAT CACTGTGTAA AAGCGTATTT GATGCAACTT GTTACCTAAT GGAAGAGAAA 1140 CTAGCTTATT CCGGAAATGA ACAGGACATG GTGCTTTTGC ATCACGAAGT AGAAGTGGAA 1200 TTCCTTGAAA GCAAACGTAT AGAGAAGCAC ACTGCGACTC TTTTGGAATT CGGGGACATC 1260 AAGAATGGAC AAACAACAAC CGCTATGGCC AAGACTGTTG GGATCCCTGC AGCCATTGGA 1320 GCTCTGGTGT TAATTGAAGA CAAGATCAAG ACAAGAGGAG TCTTAAGGCC TCTCGAAGCA 1380 GAGGTGTATT TGCCAGCTTT GGATATATTG CAAGCATATG GTATAAAGCT GATGGAGAAG 1440 GCAGAATGA 1449 (2) INFORMATION FOR SEQ ID NO: 132: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 482 amino acids (B) TYPE: amino acid (C) STRANDEDNESS: unknown (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 132: Met Thr Lys Lys Ser Gly Val Leu He Leu Gly Ala Gly Arg Val Cys 1 5 10 15 Arg Pro Ala Ala Asp Phe Leu Ala Ser Val Arg Thr He Ser Ser Gin 20 25 30 Gin Trp Tyr Lys Thr Tyr Phe Gly Ala Asp Ser Glu Glu Lys Thr Asp 35 40 45 Val His Val He Val Ala Ser Leu Tyr Leu Lys Asp Ala Lys Glu Thr 50 55 60 Val Glu Gly He Ser Asp Val Glu Ala Val Arg Leu Asp Val Ser Asp 65 70 75 80 Ser Glu Ser Leu Leu Lys Tyr Val Ser Gin Val Asp Val Val Leu Ser 85 90 95 Leu Leu Pro Ala Ser Cys His Ala Val Val Ala Lys Thr Cys He Glu 100 105 110 Leu Lys Lys His Leu Val Thr Ala Ser Tyr Val Asp Asp Glu Thr Ser 115 120 125 Met Leu His Glu Lys Ala Lys Ser Ala Gly He Thr He Leu Gly Glu 130 135 140 Met Gly Leu Asp Pro Gly He Asp His Met Met Ala Met Lys Met He 145 150 155 160 Asn Asp Ala His He Lys Lys Gly Lys Val Lys Ser Phe Thr Ser Tyr 165 170 175 Cys Gly Gly Leu Pro Ser Pro Ala Ala Ala Asn Asn Pro Leu Ala Tyr 180 185 190 Lys Phe Ser Trp Asn Pro Ala Gly Ala He Arg Ala Gly Gin Asn Pro 195 200 205 Ala Lys Tyr Lys Ser Asn Gly Asp He He His Val Asp Gly Lys Asn 210 215 220 Leu Tyr Asp Ser Ala Ala Arg Phe Arg Val Pro Asn Leu Pro Ala Phe 225 230 235 240 Ala Leu Glu Cys Phe Pro Asn Arg Asp Ser Leu Val Tyr Gly Glu His 245 250 255 Tyr Gly He Glu Ser Glu Ala Thr Thr He Phe Arg Gly Thr Leu Arg 260 265 270 Tyr Glu Gly Phe Ser Met He Met Ala Thr Leu Ser Lys Leu Gly Phe 275 280 285 Phe Asp Ser Glu Ala Asn Gin Val Leu Ser Thr Gly Lys Arg He Thr 290 295 300 Phe Gly Ala Leu Leu Ser Asn He Leu Asn Lys Asp Ala Asp Asn Glu 305 310 315 320 Ser Glu Pro Leu Ala Gly Glu Glu Glu He Ser Lys Arg He He Lys 325 330 335 Leu Gly His Ser Lys Glu Thr Ala Ala Lys Ala Ala Lys Thr He Val 340 345 350 Phe Leu Gly Phe Asn Glu Glu Arg Glu Val Pro Ser Leu Cys Lys Ser 355 360 365 Val Phe Asp Ala Thr Cys Tyr Leu Met Glu Glu Lys Leu Ala Tyr Ser 370 375 380 Gly Asn Glu Gin Asp Met Val Leu Leu His His Glu Val Glu Val Glu 385 390 395 400 Phe Leu Glu Ser Lys Arg He Glu Lys His Thr Ala Thr Leu Leu Glu 405 410 415 Phe Gly Asp He Lys Asn Gly Gin Thr Thr Thr Ala Met Ala Lys Thr 420 425 430 Val Gly He Pro Ala Ala He Gly Ala Leu Val Leu He Glu Asp Lys 435 440 445 He Lys Thr Arg Gly Val Leu Arg Pro Leu Glu Ala Glu Val Tyr Leu 450 455 460 Pro Ala Leu Asp He Leu Gin Ala Tyr Gly He Lys Leu Met Glu Lys 465 470 475 480 Ala Glu

Claims: What is claimed is: 1. An isolated nucleic acid fragment comprising a nucleic acid sequence encoding all or part of lysine ketoglutarate reductase. 2. The nucleic acid fragment of Claim 1 wherein the nucleic acid sequence encodes a polypeptide essentially similar to the polypeptide described by SEQ ID NO:104, SEQ ID NO:105, SEQ ID NO:112, SEQ ID NO:117, SEQ ID NO:l 18, SEQ ID NO:121, SEQ ID NO:122, SEQ ID NO:124, SEQ ID NO:126, SEQ ID NO: 128, SEQ ID NO: 130 or SEQ ID NO: 132. 3. The nucleic acid fragment of Claim 1 comprising a nucleic acid sequence wherein the nucleic acid sequence is essentially similar to that of SEQ ID NO:110, SEQ ID NO:l l l, SEQ ID NO:115, SEQ ID NO:116, SEQ ID NO: 119, SEQ ID NO: 120, SEQ ID NO: 123, SEQ ID NO: 125, SEQ ID NO: 127, SEQ ID NO:129 or SEQ ID NO:131. 4. The nucleic acid fragment of Claim 1 comprising a nucleic acid sequence of SEQ ID NO: 110, SEQ ID NO: 111, SEQ ID NO: 115, SEQ ID NO:116, SEQ ID NO:119, SEQ ID NO:120, SEQ ID NO:123, SEQ ID NO:125, SEQ ID NO:127, SEQ ID NO:129 or SEQ ID NO:131. 5. The nucleic acid fragment of Claim 1 wherein the nucleic acid sequence encodes a polypeptide as set forth in SEQ ID NO: 104, SEQ ID NO: 105, SEQ ID NO:l 12, SEQ ID NO:117, SEQ ID NO:l 18, SEQ ID NO:121, SEQ ID NO: 122, SEQ ID NO: 124, SEQ ID NO: 126, SEQ ID NO: 128, SEQ ID NO: 130 or SEQ ID NO: 132. 6. A chimeric gene comprising the isolated nucleic acid fragment of Claim 1 encoding lysine ketoglutarate reductase or a subfragment thereof, operably linked to suitable seed-specific regulatory sequences wherein said chimeric gene reduces lysine ketoglutarate reductase activity in seeds of plants transformed with the chimeric gene. 7. The chimeric gene according to Claim 6 wherein the isolated nucleic acid fragment comprises a nucleic acid sequence or subsequence thereof essentially similar to that of SEQ ID NO:l 10, SEQ ID NO:l 11, SEQ ID NO:l 15, SEQ ID NO:l 16, SEQ ID NO:l 19, SEQ ID NO: 120, SEQ ID NO: 123, SEQ ID NO:125, SEQ ID NO:127, SEQ ID NO:129 or SEQ ID NO:131. 8. A plant cell wherein lysine ketoglutarate reductase activity is reduced due to a mutation in a gene encoding lysine ketoglutarate reductase. 9. A plant cell transformed with the chimeric gene of Claim 6 or 7 wherein said transformed plant cell has reduced lysine ketoglutarate reductase activity. 10. A plant seed wherein lysine ketoglutarate reductase activity is reduced due to a mutation in a gene encoding lysine ketoglutarate reductase. 11. A plant seed transformed with the chimeric gene of Claim 6 or 7 wherein said transformed plant seed has reduced lysine ketoglutarate reductase activity. 12. The plant cell according to Claim 9 wherein said plant cell is selected from the group of plants consisting of Arabidopsis, com, soybean, rapeseed, wheat and rice. 13. The plant seed according to Claim 11 wherein said plant cell is selected from the group of plants consisting of Arabidopsis, com, soybean, rapeseed, wheat and rice. 14. A method for reducing lysine ketoglutarate reductase activity in a plant seed which comprises: (a) transforming plant cells with the chimeric gene of claim 6 or 7; (b) regenerating fertile mature plants from the transformed plant cells obtained from step (a) under conditions suitable to obtain seeds; (c) screening progeny seed of step (b) for reduced lysine ketoglutarate reductase activity; and (d) selecting those lines whose seeds contain reduced lysine ketoglutarate reductase activity. 15. Seed obtained from the plant of Claim 14. 16. A nucleic acid fragment comprising (a) a first chimeric gene of Claim 6 or 7 and (b) a second chimeric gene wherein a nucleic acid fragment encoding dihydrodipicolinic acid synthase which is substantially insensitive to inhibition by lysine is operably linked to a plant chloroplast transit sequence and to a plant seed-specific regulatory sequence. 17. A plant comprising in its genome a first chimeric gene of Claim 6 or 7 wherein said gene reduces lysine ketoglutarate reductase activity in seeds of transformed plants and a second chimeric gene wherein a nucleic acid fragment encoding dihydrodipicolinic acid synthase which is substantially insensitive to inhibition by lysine is operably linked to a plant chloroplast transit sequence and to a plant seed-specific regulatory sequence. 18. A plant comprising in its genome the nucleic acid fragment of Claim 16. 19. Seed obtained from the plant of Claim 17 comprising in its genome the first and second chimeric genes. 20. Seed obtained from the plant of Claim 18 comprising in its genome the nucleic fragment of Claim 16.

Inventors: EPELBAUM SABINE URSULA, FALCO SAVERIO CARL, MCDEVITT RAYMOND ERVIN III, EPELBAUM, SABINE, URSULA, FALCO, SAVERIO, CARL, MCDEVITT, RAYMOND, ERVIN, III
Applicants: DU PONT, EPELBAUM SABINE URSULA, FALCO SAVERIO CARL, MCDEVITT RAYMOND ERVIN III, E.I. DU PONT DE NEMOURS AND COMPANY, EPELBAUM, SABINE, URSULA, FALCO, SAVERIO, CARL, MCDEVITT, RAYMOND, ERVIN, III
Application year: 1998
Main classification: C12N15
IPC codes: A01H5, C12N5, C12N9, C12N15